data_2n9u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n9u _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.7 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.846 -0.427 . . . . 0.65000000000000002 109.846 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.26000000000000001 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 1.02 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 1.04 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.68000000000000005 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.3899999999999999 111.47 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.67000000000000004 112.932 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 1.3600000000000001 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 1.21 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.9399999999999999 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 1.05 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67000000000000004 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54000000000000004 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 2.02 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 1.0700000000000001 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.75 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.6599999999999999 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 1.0700000000000001 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32000000000000001 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.65000000000000002 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 1.04 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 1.02 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.20000000000000001 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 1.05 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.33000000000000002 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 1.0600000000000001 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 1.1200000000000001 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.3899999999999999 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 183' ' ' VAL . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.93000000000000005 110.682 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 68.3 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 1.1699999999999999 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.2400000000000002 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.46999999999999997 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 2.0899999999999999 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 1.1399999999999999 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.5699999999999998 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 2.1699999999999999 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.27000000000000002 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.23999999999999999 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.46 ' HB3' HG21 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 1.3300000000000001 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 1.0600000000000001 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 2.0699999999999998 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.77000000000000002 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.539 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 1.1000000000000001 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.9500000000000002 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 1.03 111.009 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 1.1299999999999999 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.94999999999999996 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.40000000000000002 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.76000000000000001 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.6599999999999999 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.17000000000000001 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 1.03 110.141 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.20000000000000001 110.231 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.461 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 1.0600000000000001 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.57999999999999996 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 1.05 110.597 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 1.4199999999999999 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.91000000000000003 110.036 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.56000000000000005 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 1.1000000000000001 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.39000000000000001 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 1.3 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 1.02 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.42999999999999999 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 1.3999999999999999 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 1.04 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 1.1799999999999999 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 1.1799999999999999 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.39000000000000001 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.93999999999999995 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.6400000000000001 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 1.0900000000000001 110.586 177.337 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 121.108 0.379 . . . . 0.63 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.5 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.93000000000000005 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 1.03 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 1.1200000000000001 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 1.05 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.402 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 1.6499999999999999 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 1.03 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.53000000000000003 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 22.9 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.7799999999999998 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.6599999999999999 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.73 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0800000000000001 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 1.0800000000000001 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 3.25 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 1.04 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.97999999999999998 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.74 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.7999999999999998 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 1.0800000000000001 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.7 111.249 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.192 -0.299 . . . . 0.65000000000000002 110.192 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.26000000000000001 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 1.0600000000000001 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 1.02 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 ' HB ' HG21 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 1.04 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.68000000000000005 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.3899999999999999 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.67000000000000004 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 1.3600000000000001 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 1.21 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.8899999999999999 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.9399999999999999 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.3100000000000001 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67000000000000004 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 110.556 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 2.02 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 1.0700000000000001 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.75 110.732 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.6599999999999999 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 250' ' ' ARG . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32000000000000001 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.65000000000000002 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.1899999999999999 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 1.04 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 1.02 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.20000000000000001 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 1.1100000000000001 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 1.05 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 1.0600000000000001 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 1.0900000000000001 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.1200000000000001 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.3899999999999999 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.93000000000000005 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 75.5 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 1.1699999999999999 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.2400000000000002 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.46999999999999997 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 2.0899999999999999 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 1.1399999999999999 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.5699999999999998 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 2.1699999999999999 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.27000000000000002 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.23999999999999999 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 1.3300000000000001 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 1.0600000000000001 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 2.0699999999999998 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.77000000000000002 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.639 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.518 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 1.1000000000000001 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.9500000000000002 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 1.03 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 1.1299999999999999 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' H ' HG23 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.94999999999999996 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.40000000000000002 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.6599999999999999 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.17000000000000001 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 1.03 109.83 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.20000000000000001 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 203' ' ' GLY . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 1.0600000000000001 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.57999999999999996 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 1.05 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 1.4199999999999999 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.91000000000000003 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.56000000000000005 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 1.1000000000000001 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.39000000000000001 112.452 -172.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.428 HG22 ' HB ' ' A' ' 191' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 1.3 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 1.02 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.42999999999999999 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 1.3999999999999999 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 1.04 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 1.1799999999999999 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.39000000000000001 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.93999999999999995 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.6400000000000001 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 1.0900000000000001 111.585 -176.262 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 121.095 0.373 . . . . 0.63 111.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.5 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.93000000000000005 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 1.03 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 1.1200000000000001 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 1.05 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 1.6499999999999999 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 1.03 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.53000000000000003 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.7799999999999998 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.6599999999999999 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.73 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 1.0800000000000001 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.411 ' HB3' HD22 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 3.25 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.536 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 1.04 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 1.0600000000000001 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.97999999999999998 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.74 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.7999999999999998 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 1.0800000000000001 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.7 111.585 -179.163 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.055 0.455 . . . . 0.65000000000000002 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.26000000000000001 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 1.0600000000000001 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 1.02 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 1.0900000000000001 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 1.04 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.68000000000000005 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.3899999999999999 111.144 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.67000000000000004 111.534 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 1.3600000000000001 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 1.21 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.8899999999999999 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.9399999999999999 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.3100000000000001 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 1.05 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67000000000000004 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54000000000000004 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 2.02 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 1.0700000000000001 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.75 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.6599999999999999 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 1.0700000000000001 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32000000000000001 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG21 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.65000000000000002 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 110.758 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 1.04 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 1.02 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.20000000000000001 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 1.1100000000000001 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 1.05 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.33000000000000002 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 1.0600000000000001 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 1.0900000000000001 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 1.1200000000000001 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.3899999999999999 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.93000000000000005 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 1.1699999999999999 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.2400000000000002 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.46999999999999997 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 2.0899999999999999 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.5699999999999998 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 2.1699999999999999 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.27000000000000002 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.23999999999999999 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 1.0600000000000001 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 2.0699999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.523 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.77000000000000002 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.65 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 1.1000000000000001 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.9500000000000002 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 1.03 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 1.1299999999999999 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.446 ' H ' HG23 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.94999999999999996 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.40000000000000002 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.76000000000000001 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.542 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.6599999999999999 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.17000000000000001 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 228' ' ' LEU . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 1.03 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.542 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.20000000000000001 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.419 ' CG1' HG13 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 1.0600000000000001 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.57999999999999996 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 1.05 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 1.4199999999999999 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.91000000000000003 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.56000000000000005 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 1.1000000000000001 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.435 ' O ' HD11 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.39000000000000001 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.419 HG13 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 1.3 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 1.02 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.42999999999999999 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 1.3999999999999999 108.866 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.461 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 1.04 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 1.1799999999999999 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.39000000000000001 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.93999999999999995 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.46 ' HG3' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.6400000000000001 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 204' ' ' ILE . 16.4 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 1.0900000000000001 111.393 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 CA-C-O 121.37 0.487 . . . . 0.63 113.052 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.5 110.275 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.93000000000000005 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 1.03 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 1.1200000000000001 109.5 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 1.05 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 1.6499999999999999 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 1.03 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.53000000000000003 111.885 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.7799999999999998 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.6599999999999999 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.73 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 1.0800000000000001 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 1.0800000000000001 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 3.25 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 1.04 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 1.0600000000000001 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.97999999999999998 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.74 111.227 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.7999999999999998 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 1.0800000000000001 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.7 111.241 -178.35 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.903 -0.406 . . . . 0.65000000000000002 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.26000000000000001 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 1.0600000000000001 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 1.02 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 1.0900000000000001 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 1.04 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.68000000000000005 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.3899999999999999 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.67000000000000004 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 1.3600000000000001 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 1.21 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.8899999999999999 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.404 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.9399999999999999 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.3100000000000001 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 1.05 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67000000000000004 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54000000000000004 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 2.02 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 1.0700000000000001 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.75 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.6599999999999999 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 1.0700000000000001 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32000000000000001 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.458 ' HB2' HG21 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.65000000000000002 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 1.04 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 1.02 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.20000000000000001 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 1.1100000000000001 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 1.05 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.33000000000000002 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 1.0600000000000001 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 1.0900000000000001 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 1.1200000000000001 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.3899999999999999 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.93000000000000005 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 1.1699999999999999 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.2400000000000002 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.46999999999999997 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 2.0899999999999999 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 1.1399999999999999 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.608 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.5699999999999998 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 2.1699999999999999 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.27000000000000002 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.23999999999999999 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.564 HD11 ' O ' ' A' ' 217' ' ' PRO . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 1.3300000000000001 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 1.0600000000000001 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 2.0699999999999998 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.77000000000000002 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.657 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 1.1000000000000001 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.9500000000000002 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 1.03 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 1.1299999999999999 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.455 ' H ' HG23 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.40000000000000002 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.76000000000000001 109.856 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.6599999999999999 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.17000000000000001 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 1.03 110.003 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.20000000000000001 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 1.0600000000000001 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.57999999999999996 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 1.05 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 1.4199999999999999 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.91000000000000003 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.56000000000000005 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 1.1000000000000001 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.564 ' O ' HD11 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.39000000000000001 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 1.3 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 1.02 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.42999999999999999 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.456 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 1.3999999999999999 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 1.04 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 1.1799999999999999 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 1.1799999999999999 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.39000000000000001 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.93999999999999995 111.08 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.6400000000000001 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 1.0900000000000001 112.083 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.458 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 121.056 0.357 . . . . 0.63 111.365 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.5 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.434 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.93000000000000005 109.741 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 1.03 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 1.1200000000000001 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 1.6499999999999999 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 1.03 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.53000000000000003 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 249' ' ' VAL . 24.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.7799999999999998 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.73 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 1.0800000000000001 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 1.0800000000000001 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.437 ' HA ' HD12 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 3.25 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 1.04 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 1.0600000000000001 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.97999999999999998 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.74 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.7999999999999998 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' HA ' ' HH ' ' A' ' 238' ' ' TYR . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 1.0800000000000001 110.918 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.922 179.265 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.65000000000000002 110.595 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.26000000000000001 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 190' ' ' LEU . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 1.0600000000000001 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 1.02 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 1.0900000000000001 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 1.04 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.68000000000000005 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.523 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.3899999999999999 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.67000000000000004 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 1.3600000000000001 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 1.21 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.8899999999999999 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.9399999999999999 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.3100000000000001 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 1.05 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67000000000000004 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54000000000000004 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 2.02 111.407 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 1.0700000000000001 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.75 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.6599999999999999 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 1.0700000000000001 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32000000000000001 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.487 ' HB2' HG23 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.65000000000000002 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.1899999999999999 110.877 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 1.04 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 1.02 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.20000000000000001 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 1.1100000000000001 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 1.05 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.33000000000000002 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 1.0600000000000001 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 1.0900000000000001 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 1.1200000000000001 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.3899999999999999 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.93000000000000005 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 1.1699999999999999 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.2400000000000002 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.46999999999999997 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 2.0899999999999999 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 185' ' ' LYS . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.5699999999999998 110.699 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 2.1699999999999999 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.468 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.27000000000000002 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.23999999999999999 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 217' ' ' PRO . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 1.3300000000000001 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 1.0600000000000001 111.001 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 2.0699999999999998 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.488 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.77000000000000002 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.635 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 202' ' ' SER . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 1.1000000000000001 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.9500000000000002 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 1.03 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 1.1299999999999999 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.457 ' H ' HG23 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.94999999999999996 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.40000000000000002 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.76000000000000001 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.6599999999999999 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.17000000000000001 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.475 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 1.03 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.442 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.20000000000000001 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.429 ' CG1' HG13 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 1.0600000000000001 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.57999999999999996 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 1.05 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 1.4199999999999999 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.91000000000000003 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.56000000000000005 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 1.1000000000000001 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.46 ' O ' HD13 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.39000000000000001 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.429 HG13 ' CG1' ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 1.02 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.42999999999999999 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 1.3999999999999999 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 1.04 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 1.1799999999999999 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 1.1799999999999999 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.39000000000000001 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.853 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG3' HG23 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.6400000000000001 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 1.0900000000000001 110.825 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.463 -0.295 0 CA-C-O 121.176 0.406 . . . . 0.63 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.5 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.93000000000000005 111.012 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 1.03 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 1.1200000000000001 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 1.05 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.472 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 1.6499999999999999 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 1.03 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.53000000000000003 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.511 ' O ' HG21 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.7799999999999998 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.73 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 1.0800000000000001 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 1.0800000000000001 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 3.25 110.664 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.71 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 1.04 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 1.0600000000000001 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.97999999999999998 110.971 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.74 112.147 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.7999999999999998 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.616 ' HA ' ' HH ' ' A' ' 238' ' ' TYR . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 1.0800000000000001 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.7 111.563 -177.016 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.462 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 23.5 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.381 -0.97 . . . . 0.65000000000000002 108.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.26000000000000001 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 190' ' ' LEU . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 1.0600000000000001 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 1.02 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 1.0900000000000001 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 1.04 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.68000000000000005 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.3899999999999999 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.67000000000000004 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 1.3600000000000001 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.407 HD12 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.21 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.8899999999999999 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.9399999999999999 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.3100000000000001 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 1.05 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67000000000000004 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54000000000000004 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 2.02 111.35 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.453 ' HA ' HD13 ' A' ' 165' ' ' LEU . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 1.0700000000000001 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.75 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.6599999999999999 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 1.0700000000000001 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32000000000000001 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HD1' ' CB ' ' A' ' 143' ' ' THR . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.65000000000000002 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.1899999999999999 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 1.04 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 1.02 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.20000000000000001 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 1.1100000000000001 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.33000000000000002 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.427 HG21 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 1.0600000000000001 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 1.0900000000000001 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 1.1200000000000001 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.3899999999999999 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.93000000000000005 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 1.1699999999999999 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.46999999999999997 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 2.0899999999999999 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 1.1399999999999999 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.5699999999999998 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 2.1699999999999999 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.27000000000000002 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.23999999999999999 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 1.3300000000000001 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 1.0600000000000001 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.46 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 2.0699999999999998 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.77000000000000002 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.607 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.524 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 1.1000000000000001 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.9500000000000002 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 1.03 110.36 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 1.1299999999999999 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' H ' HG21 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.94999999999999996 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.40000000000000002 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.76000000000000001 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.6599999999999999 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.17000000000000001 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 1.03 110.069 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.20000000000000001 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 1.0600000000000001 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.57999999999999996 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 1.05 110.662 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 1.4199999999999999 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.56000000000000005 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 1.1000000000000001 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.39000000000000001 112.018 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 1.3 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 1.02 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.434 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.42999999999999999 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.439 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 1.3999999999999999 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.568 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 1.04 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 1.1799999999999999 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 1.1799999999999999 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.39000000000000001 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.93999999999999995 111.533 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.6400000000000001 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 1.0900000000000001 111.371 -178.383 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 N-CA-C 111.315 -0.302 . . . . 0.63 111.315 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.5 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.602 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.93000000000000005 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 1.03 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 1.1200000000000001 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.437 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 1.6499999999999999 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 1.03 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.53000000000000003 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.7799999999999998 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.73 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.0800000000000001 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 1.0800000000000001 110.732 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 3.25 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 1.04 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 1.0600000000000001 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.97999999999999998 110.661 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.74 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.7 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.7999999999999998 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.602 ' HA ' ' HH ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 1.0800000000000001 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.7 111.172 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.391 -0.226 . . . . 0.65000000000000002 110.391 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.26000000000000001 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 1.0600000000000001 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 1.02 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 1.04 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.68000000000000005 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.3899999999999999 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.67000000000000004 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 1.3600000000000001 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 1.21 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.8899999999999999 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.9399999999999999 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.3100000000000001 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 1.05 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54000000000000004 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 2.02 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 1.0700000000000001 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.75 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0700000000000001 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.495 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.65000000000000002 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.1899999999999999 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 1.04 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 1.02 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.20000000000000001 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 1.1100000000000001 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 1.05 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.33000000000000002 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 1.0600000000000001 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 1.0900000000000001 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 1.1200000000000001 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.3899999999999999 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.93000000000000005 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 1.1699999999999999 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.2400000000000002 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.46999999999999997 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 2.0899999999999999 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 1.1399999999999999 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.5699999999999998 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 2.1699999999999999 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.589 ' O ' HG22 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.27000000000000002 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.23999999999999999 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HB3' HG21 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 1.3300000000000001 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.431 ' HB ' HG21 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 1.0600000000000001 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 2.0699999999999998 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.467 ' N ' HD12 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.77000000000000002 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.59 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.481 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 1.1000000000000001 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.9500000000000002 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.403 HD12 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 1.03 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 1.1299999999999999 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.94999999999999996 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.40000000000000002 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.76000000000000001 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.6599999999999999 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.17000000000000001 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 1.03 110.282 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.20000000000000001 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 203' ' ' GLY . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 1.0600000000000001 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.57999999999999996 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 1.05 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 1.4199999999999999 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.91000000000000003 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.56000000000000005 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 1.1000000000000001 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.39000000000000001 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 1.3 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 1.02 109.87 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.404 ' O ' HD11 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.42999999999999999 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 1.3999999999999999 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.52 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 1.04 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 1.1799999999999999 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 1.1799999999999999 111.318 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.39000000000000001 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.93999999999999995 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.6400000000000001 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 1.0900000000000001 111.128 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 N-CA-C 111.062 -0.399 . . . . 0.63 111.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.5 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.93000000000000005 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 1.03 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 1.1200000000000001 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 1.05 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 1.6499999999999999 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 1.03 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.53000000000000003 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.505 ' O ' HG22 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.7799999999999998 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.438 ' HB3' HD23 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.6599999999999999 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.73 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 1.0800000000000001 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 1.0800000000000001 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 3.25 110.708 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 1.04 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 1.0600000000000001 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.97999999999999998 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.74 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.7999999999999998 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 1.0800000000000001 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.7 111.045 -179.143 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.916 -0.402 . . . . 0.65000000000000002 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.26000000000000001 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 1.0600000000000001 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 1.02 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 1.0900000000000001 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.68000000000000005 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.3899999999999999 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.67000000000000004 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 1.3600000000000001 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 1.21 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.8899999999999999 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.42 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.9399999999999999 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.3100000000000001 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 1.05 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54000000000000004 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 2.02 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 167' ' ' HIS . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 1.0700000000000001 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.75 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.6599999999999999 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 1.0700000000000001 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32000000000000001 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.461 ' HB2' HG23 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.65000000000000002 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.1899999999999999 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.04 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 1.02 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.20000000000000001 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 1.1100000000000001 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 1.05 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.33000000000000002 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 1.0600000000000001 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 1.0900000000000001 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 1.1200000000000001 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.3899999999999999 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.93000000000000005 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 1.1699999999999999 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.2400000000000002 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.46999999999999997 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 2.0899999999999999 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 1.1399999999999999 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.5699999999999998 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 2.1699999999999999 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.27000000000000002 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.23999999999999999 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 1.3300000000000001 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 1.0600000000000001 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 2.0699999999999998 107.71 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.77000000000000002 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 1.1000000000000001 112.023 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.9500000000000002 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 1.03 110.864 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 1.1299999999999999 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.94999999999999996 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.40000000000000002 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.76000000000000001 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.6599999999999999 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.17000000000000001 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 1.03 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.20000000000000001 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.448 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 1.0600000000000001 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.57999999999999996 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 1.05 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 1.4199999999999999 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.91000000000000003 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.56000000000000005 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 1.1000000000000001 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.46 ' O ' HD13 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.39000000000000001 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.487 HG21 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 1.3 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.452 ' O ' HD11 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.42999999999999999 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 1.3999999999999999 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 1.04 110.475 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 1.1799999999999999 110.836 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 1.1799999999999999 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.39000000000000001 111.803 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.808 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.6400000000000001 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 204' ' ' ILE . 18.2 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 1.0900000000000001 111.62 -173.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 119.773 -0.178 . . . . 0.63 112.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.5 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.93000000000000005 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 1.03 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.426 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 1.1200000000000001 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 1.05 112.044 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 1.6499999999999999 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 1.03 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.53000000000000003 111.421 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.545 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.7799999999999998 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.6599999999999999 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.73 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 1.0800000000000001 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 3.25 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 1.04 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.521 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 1.0600000000000001 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.97999999999999998 110.664 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.74 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.3 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.7999999999999998 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 1.0800000000000001 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 83.2 mt . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.7 111.06 -179.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.477 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.4 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.411 -0.588 . . . . 0.65000000000000002 109.411 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.26000000000000001 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 1.0600000000000001 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 1.02 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 1.0900000000000001 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 1.04 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.68000000000000005 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.3899999999999999 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.67000000000000004 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 1.3600000000000001 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 1.21 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.9399999999999999 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.3100000000000001 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 1.05 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67000000000000004 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 2.02 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 1.0700000000000001 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.75 110.48 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.6599999999999999 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 1.0700000000000001 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32000000000000001 112.25 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.65000000000000002 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.1899999999999999 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 1.04 109.865 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.548 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 1.02 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.20000000000000001 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 1.1100000000000001 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 1.05 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.33000000000000002 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 1.0600000000000001 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 1.0900000000000001 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 1.1200000000000001 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.3899999999999999 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.93000000000000005 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 1.1699999999999999 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.2400000000000002 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.46999999999999997 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.449 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 2.0899999999999999 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 1.1399999999999999 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.5699999999999998 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.548 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.412 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 2.1699999999999999 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.424 ' O ' HG23 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.27000000000000002 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.23999999999999999 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 1.3300000000000001 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 2.0699999999999998 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.537 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.77000000000000002 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.592 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.485 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 1.1000000000000001 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.9500000000000002 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD12 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 1.03 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 1.1299999999999999 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' H ' HG23 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.94999999999999996 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.40000000000000002 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.76000000000000001 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.6599999999999999 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.17000000000000001 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 1.03 110.433 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.20000000000000001 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 1.0600000000000001 110.954 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.57999999999999996 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 1.05 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 1.4199999999999999 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.449 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.56000000000000005 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 1.1000000000000001 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.406 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.39000000000000001 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 191' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 1.3 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 1.02 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.42999999999999999 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 1.3999999999999999 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 1.04 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 1.1799999999999999 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 1.1799999999999999 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.39000000000000001 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.93999999999999995 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.6400000000000001 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 1.0900000000000001 111.324 -177.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.46 -0.45 0 CA-C-O 121.044 0.352 . . . . 0.63 111.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.5 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.93000000000000005 109.977 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 1.03 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 1.1200000000000001 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 1.05 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.405 ' HE2' HD12 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 1.6499999999999999 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 1.03 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.53000000000000003 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.7799999999999998 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.6599999999999999 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.73 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 1.0800000000000001 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 1.0800000000000001 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 3.25 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.712 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 1.04 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 1.0600000000000001 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.97999999999999998 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.74 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.7999999999999998 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 1.0800000000000001 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.7 111.328 -177.442 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.65000000000000002 109.826 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.26000000000000001 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 1.02 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 1.0900000000000001 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 1.04 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.68000000000000005 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.3899999999999999 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.67000000000000004 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 1.3600000000000001 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 1.21 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.8899999999999999 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.9399999999999999 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.3100000000000001 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 1.05 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67000000000000004 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54000000000000004 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 2.02 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 167' ' ' HIS . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 1.0700000000000001 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.75 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.6599999999999999 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 1.0700000000000001 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.474 ' HB2' HG23 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.65000000000000002 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.1899999999999999 110.199 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 1.04 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 1.02 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.20000000000000001 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 1.1100000000000001 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 1.05 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.33000000000000002 111.182 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 1.0600000000000001 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.0900000000000001 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 1.1200000000000001 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.3899999999999999 111.261 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 1.1699999999999999 112.214 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.2400000000000002 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.46999999999999997 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 2.0899999999999999 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 1.1399999999999999 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.5699999999999998 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 2.1699999999999999 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.485 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.27000000000000002 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.23999999999999999 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.435 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 1.3300000000000001 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG22 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 1.0600000000000001 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 145' ' ' VAL . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 2.0699999999999998 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.77000000000000002 112.472 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.605 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 1.1000000000000001 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.9500000000000002 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 1.03 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 1.1299999999999999 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.448 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.94999999999999996 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.40000000000000002 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.76000000000000001 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.6599999999999999 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.17000000000000001 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.544 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 1.03 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.20000000000000001 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 203' ' ' GLY . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 1.0600000000000001 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.57999999999999996 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 1.05 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 1.4199999999999999 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.91000000000000003 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.56000000000000005 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.503 ' CG1' HG22 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 1.1000000000000001 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.39000000000000001 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 1.3 111.018 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 1.02 110.077 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.42999999999999999 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 1.3999999999999999 108.915 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.418 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 1.04 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 1.1799999999999999 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.39000000000000001 112.176 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.93999999999999995 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.6400000000000001 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 1.0900000000000001 111.528 -177.389 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.016 0.34 . . . . 0.63 111.693 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.5 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.93000000000000005 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 1.03 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 1.1200000000000001 109.639 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 1.05 111.821 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 1.6499999999999999 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 1.03 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.53000000000000003 111.346 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.511 ' O ' HG21 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.7799999999999998 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.6599999999999999 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.73 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 1.0800000000000001 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 1.0800000000000001 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 3.25 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 1.04 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.501 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 1.0600000000000001 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.97999999999999998 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.74 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 25.3 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.7999999999999998 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.554 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 1.0800000000000001 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.7 111.344 -178.448 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.178 -0.304 . . . . 0.65000000000000002 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.26000000000000001 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 1.0600000000000001 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 1.02 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 1.0900000000000001 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 1.04 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.68000000000000005 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.3899999999999999 111.149 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.67000000000000004 113.144 -173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 1.3600000000000001 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 1.21 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.582 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.8899999999999999 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.435 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.9399999999999999 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.3100000000000001 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 1.05 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67000000000000004 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 2.02 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 1.0700000000000001 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.75 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 1.0700000000000001 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32000000000000001 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.508 ' HB2' HG21 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.65000000000000002 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 1.02 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.20000000000000001 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 1.1100000000000001 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 1.05 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.33000000000000002 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.0900000000000001 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 1.1200000000000001 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.3899999999999999 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.93000000000000005 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 1.1699999999999999 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.2400000000000002 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.46999999999999997 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 2.0899999999999999 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 1.1399999999999999 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.5699999999999998 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.27000000000000002 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.23999999999999999 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 1.3300000000000001 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 1.0600000000000001 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 2.0699999999999998 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.77000000000000002 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.614 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 1.1000000000000001 110.857 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.9500000000000002 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 1.03 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 1.1299999999999999 111.686 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.94999999999999996 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.40000000000000002 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.76000000000000001 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.6599999999999999 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.17000000000000001 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 1.03 110.18 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 1.0600000000000001 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.57999999999999996 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 1.05 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 1.4199999999999999 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.91000000000000003 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.56000000000000005 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 1.1000000000000001 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.39000000000000001 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.432 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 1.02 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 1.3999999999999999 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 1.04 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 1.1799999999999999 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.39000000000000001 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.6400000000000001 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 1.0900000000000001 113.004 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.411 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 121.079 0.366 . . . . 0.63 111.509 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.5 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.93000000000000005 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 1.03 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 1.1200000000000001 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 1.05 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.434 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 1.6499999999999999 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 1.03 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.53000000000000003 111.443 -172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.7799999999999998 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.6599999999999999 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.73 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 1.0800000000000001 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 3.25 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.621 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 1.04 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 1.0600000000000001 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.97999999999999998 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.74 111.789 -176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.7999999999999998 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 1.0800000000000001 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.235 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.459 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.341 0.591 . . . . 0.65000000000000002 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.26000000000000001 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 1.0600000000000001 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 1.02 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 1.0900000000000001 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 1.04 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.68000000000000005 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.3899999999999999 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.682 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.67000000000000004 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 1.3600000000000001 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 1.21 110.796 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.8899999999999999 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.9399999999999999 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 1.05 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 2.02 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 1.0700000000000001 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.75 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.6599999999999999 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32000000000000001 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.459 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.65000000000000002 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.1899999999999999 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 1.04 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 1.02 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.20000000000000001 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.425 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 1.1100000000000001 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 1.05 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.33000000000000002 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 1.0600000000000001 110.767 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 1.0900000000000001 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 1.1200000000000001 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.3899999999999999 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.93000000000000005 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 1.1699999999999999 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.46999999999999997 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.414 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 2.0899999999999999 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 1.1399999999999999 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.5699999999999998 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 2.1699999999999999 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.592 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.27000000000000002 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.23999999999999999 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 1.3300000000000001 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 1.0600000000000001 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.431 HD23 ' CG1' ' A' ' 145' ' ' VAL . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 2.0699999999999998 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.77000000000000002 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.617 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.571 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 1.1000000000000001 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.9500000000000002 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 1.03 110.59 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 1.1299999999999999 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.94999999999999996 111.563 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.40000000000000002 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.76000000000000001 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.6599999999999999 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.17000000000000001 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 1.03 110.447 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.20000000000000001 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.566 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 1.0600000000000001 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.57999999999999996 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 1.05 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.91000000000000003 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.56000000000000005 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 1.1000000000000001 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.468 ' HD2' HG12 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.39000000000000001 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 1.3 110.971 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 1.02 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.502 ' O ' HD13 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.42999999999999999 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 1.3999999999999999 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.617 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.04 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.1799999999999999 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 1.1799999999999999 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.39000000000000001 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.93999999999999995 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.6400000000000001 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.743 -176.568 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.142 -0.369 . . . . 0.63 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.5 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.93000000000000005 109.828 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 1.03 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 1.1200000000000001 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 1.05 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.437 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 1.6499999999999999 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 1.03 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.53000000000000003 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.512 ' O ' HG21 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.7799999999999998 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.73 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 1.0800000000000001 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 1.0800000000000001 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 3.25 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 1.04 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 1.0600000000000001 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.97999999999999998 110.643 174.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.74 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 26.6 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.7999999999999998 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 1.0800000000000001 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.7 111.091 -178.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.492 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.75 -0.463 . . . . 0.65000000000000002 109.75 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.26000000000000001 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.46 ' CG1' HD22 ' A' ' 192' ' ' LEU . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 1.0600000000000001 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 1.02 110.616 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 1.0900000000000001 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 1.04 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.68000000000000005 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.3899999999999999 111.366 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.67000000000000004 111.96 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 1.3600000000000001 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 1.21 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.8899999999999999 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.9399999999999999 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.3100000000000001 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 1.05 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67000000000000004 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54000000000000004 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 2.02 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 167' ' ' HIS . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 1.0700000000000001 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.75 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.6599999999999999 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 1.0700000000000001 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32000000000000001 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.492 ' HD1' ' CB ' ' A' ' 143' ' ' THR . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.65000000000000002 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 1.04 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 1.02 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.20000000000000001 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 1.1100000000000001 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 1.05 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.33000000000000002 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.402 HG21 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 1.0600000000000001 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 1.0900000000000001 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 1.1200000000000001 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.3899999999999999 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.93000000000000005 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 1.1699999999999999 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.2400000000000002 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.46999999999999997 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 2.0899999999999999 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 1.1399999999999999 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.5699999999999998 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 2.1699999999999999 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.455 ' CD ' HG11 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.27000000000000002 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.23999999999999999 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 1.3300000000000001 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 1.0600000000000001 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.483 HD11 ' C ' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 2.0699999999999998 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.77000000000000002 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.558 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.533 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 1.1000000000000001 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.9500000000000002 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 1.03 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 1.1299999999999999 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.402 ' H ' HG21 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.94999999999999996 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.40000000000000002 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.76000000000000001 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.6599999999999999 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.17000000000000001 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.437 HG12 HD21 ' A' ' 228' ' ' LEU . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 1.03 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.20000000000000001 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.462 ' CG1' HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 1.0600000000000001 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.57999999999999996 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 1.05 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 1.4199999999999999 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.91000000000000003 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.56000000000000005 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.4 HG12 ' HD2' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 1.1000000000000001 110.035 -173.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 190' ' ' LEU . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.39000000000000001 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 1.3 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 1.02 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.42999999999999999 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 1.3999999999999999 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.533 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 1.04 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 1.1799999999999999 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 1.1799999999999999 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.39000000000000001 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.93999999999999995 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.416 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.6400000000000001 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.437 HD21 HG12 ' A' ' 204' ' ' ILE . 44.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 1.0900000000000001 111.225 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 121.028 0.345 . . . . 0.63 112.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.5 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.93000000000000005 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 1.03 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 1.1200000000000001 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 1.05 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.449 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 1.6499999999999999 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 1.03 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.7799999999999998 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.6599999999999999 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.73 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 1.0800000000000001 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 3.25 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.671 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 1.04 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 1.0600000000000001 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.97999999999999998 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.74 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.7999999999999998 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 1.0800000000000001 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.7 110.779 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.452 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.4 m . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 109.872 -0.418 . . . . 0.65000000000000002 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.26000000000000001 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 1.0600000000000001 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 1.02 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 1.0900000000000001 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 1.04 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.68000000000000005 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.506 ' OD1' ' HB1' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.3899999999999999 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.688 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.67000000000000004 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 1.3600000000000001 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 1.21 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.688 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.8899999999999999 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.9399999999999999 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.3100000000000001 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 1.05 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67000000000000004 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 2.02 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 167' ' ' HIS . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 1.0700000000000001 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.75 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.6599999999999999 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 1.0700000000000001 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32000000000000001 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.452 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.65000000000000002 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 1.04 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 1.02 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.20000000000000001 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 1.1100000000000001 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 1.05 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.33000000000000002 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 1.0600000000000001 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 1.0900000000000001 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 1.1200000000000001 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.3899999999999999 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.93000000000000005 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.4 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 1.1699999999999999 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.2400000000000002 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.46999999999999997 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 2.0899999999999999 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 1.1399999999999999 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.5699999999999998 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 2.1699999999999999 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.412 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.27000000000000002 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.23999999999999999 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 1.3300000000000001 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 1.0600000000000001 111.144 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 2.0699999999999998 109.357 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.77000000000000002 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 1.1000000000000001 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.9500000000000002 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.478 HD12 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 1.03 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.506 ' HB1' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 1.1299999999999999 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.94999999999999996 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.40000000000000002 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.76000000000000001 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.6599999999999999 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.17000000000000001 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 1.03 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.436 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.20000000000000001 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.419 HG12 HG13 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 1.0600000000000001 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.57999999999999996 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 1.05 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 1.4199999999999999 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.91000000000000003 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.56000000000000005 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 1.1000000000000001 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.39000000000000001 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.419 HG13 HG12 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 1.02 110.07 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.42999999999999999 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.423 HG21 ' HE3' ' A' ' 242' ' ' LYS . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 1.3999999999999999 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 1.04 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 1.1799999999999999 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 1.1799999999999999 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.39000000000000001 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.93999999999999995 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.6400000000000001 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 1.0900000000000001 111.048 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.01 0.338 . . . . 0.63 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.5 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.93000000000000005 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 1.03 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 1.1200000000000001 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 1.05 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.423 ' HE3' HG21 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 1.6499999999999999 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 1.03 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.53000000000000003 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.7799999999999998 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.6599999999999999 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.73 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 1.0800000000000001 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 1.0800000000000001 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 3.25 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.595 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 1.04 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 1.0600000000000001 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.97999999999999998 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.74 111.01 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.7999999999999998 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 1.0800000000000001 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.7 110.902 -179.728 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.445 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 4.7 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.65000000000000002 111.069 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.26000000000000001 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 1.0600000000000001 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 1.02 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 1.0900000000000001 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 1.04 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.68000000000000005 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.498 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.3899999999999999 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.67000000000000004 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 1.3600000000000001 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 1.21 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.8899999999999999 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.457 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.9399999999999999 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 10.5 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.3100000000000001 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 1.05 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67000000000000004 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 2.02 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 1.0700000000000001 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.75 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.6599999999999999 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 1.0700000000000001 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32000000000000001 112.185 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.503 ' HB2' HG23 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.65000000000000002 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.1899999999999999 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 1.04 110.364 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 1.02 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.20000000000000001 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 1.1100000000000001 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.33000000000000002 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.55 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 1.0600000000000001 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 1.1200000000000001 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.3899999999999999 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.93000000000000005 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 1.1699999999999999 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2400000000000002 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 2.0899999999999999 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 1.1399999999999999 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.5699999999999998 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 2.1699999999999999 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.27000000000000002 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.23999999999999999 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 1.3300000000000001 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.416 ' HB ' HG21 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 1.0600000000000001 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 2.0699999999999998 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.77000000000000002 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.648 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 1.1000000000000001 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.9500000000000002 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 HD12 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 1.03 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 1.1299999999999999 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.55 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.94999999999999996 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.40000000000000002 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.76000000000000001 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.6599999999999999 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.17000000000000001 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.412 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 1.03 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.20000000000000001 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 1.0600000000000001 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.57999999999999996 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 1.05 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 1.4199999999999999 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.1 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.91000000000000003 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.56000000000000005 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 1.1000000000000001 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' A' ' 216' ' ' VAL . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.39000000000000001 112.241 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 1.3 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 1.02 110.087 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.42999999999999999 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 1.3999999999999999 108.614 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.509 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 1.04 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 1.1799999999999999 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 1.1799999999999999 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.39000000000000001 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.93999999999999995 111.771 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.42 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.6400000000000001 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 1.0900000000000001 112.155 -176.897 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.222 0.426 . . . . 0.63 111.562 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.5 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.93000000000000005 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 1.03 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 1.1200000000000001 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 1.05 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 1.6499999999999999 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 1.03 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.53000000000000003 111.302 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.7799999999999998 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.6599999999999999 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.73 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 1.0800000000000001 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 1.0800000000000001 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 3.25 110.424 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 1.04 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 1.0600000000000001 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.97999999999999998 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.74 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.7999999999999998 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 1.0800000000000001 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.7 111.063 -176.739 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.514 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.65000000000000002 109.584 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.26000000000000001 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 1.0600000000000001 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 1.02 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 1.0900000000000001 111.185 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 1.04 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.68000000000000005 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.3899999999999999 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.67000000000000004 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 1.3600000000000001 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 1.21 110.473 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.6 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.8899999999999999 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.9399999999999999 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 109.784 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 1.05 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67000000000000004 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54000000000000004 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 2.02 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 167' ' ' HIS . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 1.0700000000000001 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.75 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.6599999999999999 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 250' ' ' ARG . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0700000000000001 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32000000000000001 112.247 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.528 ' HB2' HG21 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.65000000000000002 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 1.04 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 1.02 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.20000000000000001 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 1.1100000000000001 110.114 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 1.05 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.33000000000000002 111.202 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 1.0600000000000001 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.488 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 1.0900000000000001 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 1.1200000000000001 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.3899999999999999 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.93000000000000005 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 1.1699999999999999 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.46999999999999997 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.424 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 2.0899999999999999 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 1.1399999999999999 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.5699999999999998 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 2.1699999999999999 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.27000000000000002 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.23999999999999999 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 1.3300000000000001 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 1.0600000000000001 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 2.0699999999999998 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.77000000000000002 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.535 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 1.1000000000000001 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.9500000000000002 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.494 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 1.03 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 1.1299999999999999 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.428 ' H ' HG23 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.94999999999999996 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.40000000000000002 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.76000000000000001 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.489 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.17000000000000001 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 1.03 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.20000000000000001 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 1.0600000000000001 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.57999999999999996 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 1.05 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 1.4199999999999999 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.91000000000000003 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.424 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.56000000000000005 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 1.1000000000000001 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.405 ' O ' HD11 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.39000000000000001 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 1.3 110.869 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 1.02 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.42999999999999999 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 1.3999999999999999 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.628 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 1.04 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 1.1799999999999999 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.39000000000000001 111.543 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.93999999999999995 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.6400000000000001 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 1.0900000000000001 111.676 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.437 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo . . . . . 0 C--O 1.235 0.356 0 N-CA-C 110.994 -0.426 . . . . 0.63 110.994 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.5 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.93000000000000005 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 1.03 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 1.1200000000000001 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 1.6499999999999999 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 1.03 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.53000000000000003 111.586 -173.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.554 ' O ' HG22 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.7799999999999998 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.73 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 1.0800000000000001 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 1.0800000000000001 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 3.25 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 1.04 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 1.0600000000000001 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.97999999999999998 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.74 111.29 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.7999999999999998 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 1.0800000000000001 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.7 111.078 -178.813 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.432 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.287 -0.264 . . . . 0.65000000000000002 110.287 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.26000000000000001 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 1.0600000000000001 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 1.02 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 1.0900000000000001 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 1.04 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.68000000000000005 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.424 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.3899999999999999 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.67000000000000004 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 1.3600000000000001 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 1.21 110.394 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.8899999999999999 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.523 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.9399999999999999 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.3100000000000001 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 1.05 110.79 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67000000000000004 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54000000000000004 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 2.02 111.37 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.447 ' HA ' HD11 ' A' ' 165' ' ' LEU . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 1.0700000000000001 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.75 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.6599999999999999 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0700000000000001 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32000000000000001 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB2' HG21 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.65000000000000002 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.1899999999999999 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 1.04 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 1.02 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.20000000000000001 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 1.1100000000000001 109.939 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 1.05 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.33000000000000002 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 1.0600000000000001 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 1.0900000000000001 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 1.1200000000000001 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.3899999999999999 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.93000000000000005 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 1.1699999999999999 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.2400000000000002 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.46999999999999997 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.4 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 2.0899999999999999 110.072 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 1.1399999999999999 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.5699999999999998 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 2.1699999999999999 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.27000000000000002 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.23999999999999999 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 1.3300000000000001 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 1.0600000000000001 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 2.0699999999999998 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.77000000000000002 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.552 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 1.1000000000000001 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.9500000000000002 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 1.03 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 1.1299999999999999 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.94999999999999996 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.40000000000000002 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.76000000000000001 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.6599999999999999 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.17000000000000001 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.432 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 1.03 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.20000000000000001 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 1.0600000000000001 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.57999999999999996 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 1.05 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 1.4199999999999999 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 37.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.91000000000000003 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.4 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.56000000000000005 109.752 176.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 1.1000000000000001 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.434 ' O ' HD11 ' A' ' 190' ' ' LEU . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.39000000000000001 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 1.3 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.422 ' HB ' HD21 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 1.02 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.42999999999999999 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.489 HG13 ' HB ' ' A' ' 240' ' ' VAL . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 1.3999999999999999 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.552 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 1.04 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 1.1799999999999999 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.1799999999999999 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.39000000000000001 111.806 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.93999999999999995 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.6400000000000001 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 1.0900000000000001 112.362 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.488 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 111.16 -0.362 . . . . 0.63 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.607 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 1.03 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.489 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 1.1200000000000001 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 1.05 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 1.6499999999999999 110.129 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 1.03 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.53000000000000003 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.7799999999999998 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.6599999999999999 111.032 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.73 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 1.0800000000000001 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 3.25 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 1.04 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 1.0600000000000001 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.97999999999999998 111.508 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.74 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.7999999999999998 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 1.0800000000000001 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.4 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.7 111.52 -177.369 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.455 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 2.7 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 110.082 -0.34 . . . . 0.65000000000000002 110.082 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.26000000000000001 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 1.0600000000000001 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 1.02 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 1.04 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.68000000000000005 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.3899999999999999 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.67000000000000004 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 1.3600000000000001 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 1.21 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.8899999999999999 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.9399999999999999 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.3100000000000001 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 1.05 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67000000000000004 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 2.02 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 1.0700000000000001 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 163' ' ' ARG . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.75 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.6599999999999999 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 1.0700000000000001 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32000000000000001 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.471 ' HB2' HG23 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.65000000000000002 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 1.02 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.20000000000000001 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 1.1100000000000001 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 1.05 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.33000000000000002 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 1.0600000000000001 110.015 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 1.0900000000000001 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.3899999999999999 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.93000000000000005 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.6 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 1.1699999999999999 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.46999999999999997 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 2.0899999999999999 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 1.1399999999999999 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.5699999999999998 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 2.1699999999999999 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.27000000000000002 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.23999999999999999 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HB3' HG23 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 1.3300000000000001 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 1.0600000000000001 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 2.0699999999999998 107.655 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.77000000000000002 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.518 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 1.1000000000000001 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.9500000000000002 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 1.03 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 1.1299999999999999 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.94999999999999996 110.973 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.40000000000000002 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.76000000000000001 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.2 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.17000000000000001 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.408 HG12 HD21 ' A' ' 228' ' ' LEU . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 1.03 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.20000000000000001 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.632 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 1.0600000000000001 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.57999999999999996 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 1.05 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 1.4199999999999999 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.2 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.91000000000000003 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.56000000000000005 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 1.1000000000000001 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.39000000000000001 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 1.3 110.738 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 1.02 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.42999999999999999 110.914 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 1.3999999999999999 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.551 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 1.04 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 1.1799999999999999 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.1799999999999999 110.527 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.39000000000000001 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.93999999999999995 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.6400000000000001 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 1.0900000000000001 112.4 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo . . . . . 0 N--CA 1.462 -0.338 0 CA-C-O 121.116 0.382 . . . . 0.63 111.845 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.5 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.93000000000000005 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 1.03 110.291 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 1.1200000000000001 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 1.05 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 221' ' ' ILE . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 1.6499999999999999 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 1.03 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.53000000000000003 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.7799999999999998 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.73 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 1.0800000000000001 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 1.0800000000000001 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 3.25 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 1.04 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 1.0600000000000001 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.97999999999999998 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 27.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.7999999999999998 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 1.0800000000000001 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.7 111.553 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.65000000000000002 109.776 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.26000000000000001 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 1.0600000000000001 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 1.02 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 1.0900000000000001 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.04 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.68000000000000005 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.67000000000000004 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 1.3600000000000001 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 1.21 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.547 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.8899999999999999 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.9399999999999999 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 1.05 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67000000000000004 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 2.02 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 1.0700000000000001 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.75 110.586 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.6599999999999999 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 1.0700000000000001 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32000000000000001 112.019 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.524 ' HB2' HG21 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.65000000000000002 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.1899999999999999 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 1.04 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 1.02 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.20000000000000001 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 1.1100000000000001 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 1.05 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.33000000000000002 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 1.0600000000000001 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 1.0900000000000001 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 1.1200000000000001 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.3899999999999999 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.93000000000000005 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 1.1699999999999999 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.2400000000000002 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.46999999999999997 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 1.1399999999999999 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.5699999999999998 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 2.1699999999999999 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.418 ' CD ' HG11 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.27000000000000002 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.23999999999999999 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.47 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 1.0600000000000001 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 2.0699999999999998 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.77000000000000002 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.497 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 1.1000000000000001 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.9500000000000002 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 1.03 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 1.1299999999999999 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.76000000000000001 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.6599999999999999 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.17000000000000001 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.468 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 1.03 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.20000000000000001 110.087 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.455 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 1.0600000000000001 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.57999999999999996 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.443 ' HA ' HE21 ' A' ' 213' ' ' GLN . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 1.05 110.862 174.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 1.4199999999999999 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 210' ' ' ILE . 34.0 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.91000000000000003 109.728 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.56000000000000005 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 1.1000000000000001 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.39000000000000001 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.455 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 1.3 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 1.02 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.42999999999999999 110.2 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 1.3999999999999999 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 1.04 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 1.1799999999999999 110.403 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 1.1799999999999999 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.39000000000000001 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.93999999999999995 111.712 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.6400000000000001 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 1.0900000000000001 111.067 -178.628 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 121.105 0.377 . . . . 0.63 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.5 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.93000000000000005 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 1.03 111.008 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 1.1200000000000001 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 1.05 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 1.6499999999999999 109.56 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 1.03 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.53000000000000003 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 249' ' ' VAL . 16.2 mm100 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.7799999999999998 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.6599999999999999 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.556 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.73 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 1.0800000000000001 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 3.25 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 1.04 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.97999999999999998 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.74 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.7999999999999998 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 1.0800000000000001 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.2 mt . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.7 111.205 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.414 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 8.4 m . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.65000000000000002 110.757 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.26000000000000001 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 1.0600000000000001 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 1.02 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 1.0900000000000001 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 1.04 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.68000000000000005 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.3899999999999999 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.67000000000000004 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 1.3600000000000001 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.418 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 1.21 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.58 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.8899999999999999 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.9399999999999999 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.3100000000000001 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 1.05 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67000000000000004 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54000000000000004 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 2.02 111.018 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 167' ' ' HIS . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 1.0700000000000001 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.75 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.6599999999999999 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 1.0700000000000001 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32000000000000001 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.488 ' HB2' HG23 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.65000000000000002 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 1.04 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 1.02 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.20000000000000001 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 1.1100000000000001 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.33000000000000002 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 1.0600000000000001 110.272 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.56 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 1.0900000000000001 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 1.1200000000000001 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.3899999999999999 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.93000000000000005 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.2 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 1.1699999999999999 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.2400000000000002 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.46999999999999997 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 2.0899999999999999 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 1.1399999999999999 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.5699999999999998 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 2.1699999999999999 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.27000000000000002 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.23999999999999999 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.421 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 1.3300000000000001 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 1.0600000000000001 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 2.0699999999999998 108.206 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.77000000000000002 112.388 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.635 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 1.1000000000000001 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.9500000000000002 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 1.03 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 1.1299999999999999 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.94999999999999996 111.053 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.40000000000000002 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.76000000000000001 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.6599999999999999 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.17000000000000001 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.453 ' CD1' HD21 ' A' ' 228' ' ' LEU . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 1.03 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.20000000000000001 110.132 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 1.0600000000000001 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 1.05 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 1.4199999999999999 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.91000000000000003 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.428 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.56000000000000005 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 1.1000000000000001 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.39000000000000001 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 191' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 1.3 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 1.02 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . 0.428 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.42999999999999999 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 1.3999999999999999 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.595 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 1.04 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.1799999999999999 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 1.1799999999999999 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.39000000000000001 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.93999999999999995 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.535 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.6400000000000001 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 204' ' ' ILE . 20.8 mt . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 1.0900000000000001 110.613 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.428 ' HG3' HD12 ' A' ' 228' ' ' LEU . 37.2 Cg_endo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.896 0.29 . . . . 0.63 111.533 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.5 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.93000000000000005 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 1.03 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 1.1200000000000001 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 1.05 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 1.6499999999999999 109.345 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 1.03 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.53000000000000003 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.7799999999999998 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.6599999999999999 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.73 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 1.0800000000000001 110.987 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 1.0800000000000001 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 3.25 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.51 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 1.04 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 1.0600000000000001 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.74 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.7999999999999998 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 1.0800000000000001 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.7 111.559 -178.128 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.212 -0.355 . . . . 7.96 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.68 -26.75 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.046 0.451 . . . . 6.6299999999999999 110.74 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.17 4.15 44.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.55 0.691 . . . . 7.8300000000000001 109.533 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.83 166.82 37.5 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.325 -0.852 . . . . 3.02 111.588 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.4 p -70.69 100.52 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.79 -0.448 . . . . 1.6699999999999999 109.79 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.7 m -75.59 118.85 18.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.846 -0.427 . . . . 0.65000000000000002 109.846 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.26000000000000001 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 1.0600000000000001 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 1.02 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 1.04 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.68000000000000005 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.3899999999999999 111.47 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.67000000000000004 112.932 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 1.3600000000000001 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 1.21 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.9399999999999999 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 1.05 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67000000000000004 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54000000000000004 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 2.02 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 1.0700000000000001 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.75 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.6599999999999999 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 1.0700000000000001 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32000000000000001 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.65000000000000002 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 1.04 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 1.02 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.20000000000000001 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 1.05 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.33000000000000002 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 1.0600000000000001 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 1.1200000000000001 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.3899999999999999 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 183' ' ' VAL . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.93000000000000005 110.682 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 68.3 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 1.1699999999999999 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.2400000000000002 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.46999999999999997 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 2.0899999999999999 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 1.1399999999999999 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.5699999999999998 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 2.1699999999999999 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.27000000000000002 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.23999999999999999 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.46 ' HB3' HG21 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 1.3300000000000001 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 1.0600000000000001 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 2.0699999999999998 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.77000000000000002 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.539 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 1.1000000000000001 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.9500000000000002 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 1.03 111.009 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 1.1299999999999999 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.94999999999999996 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.40000000000000002 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.76000000000000001 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.6599999999999999 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.17000000000000001 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 1.03 110.141 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.20000000000000001 110.231 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.461 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 1.0600000000000001 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.57999999999999996 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 1.05 110.597 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 1.4199999999999999 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.91000000000000003 110.036 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.56000000000000005 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 1.1000000000000001 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.39000000000000001 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 1.3 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 1.02 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.42999999999999999 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 1.3999999999999999 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.539 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 1.04 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 1.1799999999999999 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 1.1799999999999999 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.39000000000000001 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.93999999999999995 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.6400000000000001 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.11 -5.02 58.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 1.0900000000000001 110.586 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.67 34.13 5.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.552 -0.749 . . . . 1.6000000000000001 110.508 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 p -99.96 55.15 0.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 2.5499999999999998 111.821 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 73.88 14.83 79.85 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.384 -0.913 . . . . 3.7599999999999998 111.418 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 5.4 m-20 -67.61 -29.14 68.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.284 -0.635 . . . . 5.2199999999999998 109.284 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.546 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 45.2 mtm180 84.89 -80.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.771 1.628 . . . . 7.7400000000000002 113.177 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 37.0 Cg_exo -59.92 146.14 96.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 CA-C-N 122.085 1.78 . . . . 2.9900000000000002 111.841 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -107.39 142.77 25.82 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.661 -0.699 . . . . 1.9299999999999999 110.476 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.11 127.85 25.61 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.962 2.442 . . . . 0.63 111.563 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.5 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.93000000000000005 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 1.03 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 1.1200000000000001 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 1.05 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.402 ' HB3' ' HB1' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 1.6499999999999999 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 1.03 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.53000000000000003 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 22.9 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.7799999999999998 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.6599999999999999 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.73 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0800000000000001 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 1.0800000000000001 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 3.25 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 1.04 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.97999999999999998 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.74 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.7999999999999998 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 1.0800000000000001 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.64 -3.79 42.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.7 111.249 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -78.38 -54.06 6.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.086 -1.079 . . . . 1.5800000000000001 108.086 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -83.86 69.94 10.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.781 -1.1 . . . . 6.3200000000000003 109.752 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.545 ' HA ' HE21 ' A' ' 260' ' ' GLN . 0.0 OUTLIER -59.79 137.32 58.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.826 -0.624 . . . . 5.2999999999999998 110.103 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.46 86.38 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.357 0.599 . . . . 6.9400000000000004 110.598 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 8.4 m -108.05 -48.3 0.1 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.331 -0.85 . . . . 7.9199999999999999 111.086 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 15.7 Cg_exo -69.58 167.06 25.28 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.9 1.733 . . . . 8.9900000000000002 111.568 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.9 p -99.91 93.18 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.047 0.451 . . . . 11.26 110.613 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -79.93 150.68 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.191 -0.459 . . . . 11.789999999999999 110.633 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.078 -0.963 . . . . 13.24 111.075 -178.341 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.034 -0.427 . . . . 7.96 112.034 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.92 126.22 35.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.851 0.357 . . . . 6.6299999999999999 110.729 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 89.0 mtp -98.57 -13.99 20.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 7.8300000000000001 110.461 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -85.65 1.45 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.423 -0.894 . . . . 3.02 111.376 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 133.28 38.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.617 -0.792 . . . . 1.6699999999999999 110.04 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m -77.1 110.89 12.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.538 -0.301 . . . . 0.65000000000000002 110.192 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.26000000000000001 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 1.0600000000000001 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 1.02 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' HB ' HG21 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 1.04 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.68000000000000005 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.3899999999999999 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.67000000000000004 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 1.3600000000000001 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 1.21 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.8899999999999999 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.9399999999999999 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.3100000000000001 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67000000000000004 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 110.556 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 2.02 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 1.0700000000000001 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.75 110.732 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.6599999999999999 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 250' ' ' ARG . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32000000000000001 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.65000000000000002 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.1899999999999999 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 1.04 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 1.02 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.20000000000000001 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 1.1100000000000001 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 1.05 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 1.0600000000000001 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 1.0900000000000001 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 1.1200000000000001 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.3899999999999999 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.93000000000000005 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 75.5 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 1.1699999999999999 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.2400000000000002 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.46999999999999997 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 2.0899999999999999 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 1.1399999999999999 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.5699999999999998 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 2.1699999999999999 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.27000000000000002 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.23999999999999999 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.478 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 1.3300000000000001 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 1.0600000000000001 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 2.0699999999999998 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.77000000000000002 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.639 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.518 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 1.1000000000000001 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.9500000000000002 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 1.03 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 1.1299999999999999 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' H ' HG23 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.94999999999999996 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.40000000000000002 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.76000000000000001 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.6599999999999999 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.17000000000000001 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 1.03 109.83 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.20000000000000001 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 203' ' ' GLY . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 1.0600000000000001 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.57999999999999996 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 1.05 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 1.4199999999999999 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.91000000000000003 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.56000000000000005 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 1.1000000000000001 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD3' ' OE1' ' A' ' 260' ' ' GLN . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.39000000000000001 112.452 -172.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.428 HG22 ' HB ' ' A' ' 191' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 1.3 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 1.02 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.42999999999999999 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 1.3999999999999999 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 1.04 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 1.1799999999999999 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.39000000000000001 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.93999999999999995 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.6400000000000001 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 24.5 mt -82.5 -15.65 51.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 1.0900000000000001 111.585 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.7 mt -106.01 12.67 30.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 1.6000000000000001 110.517 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.9 p -124.53 29.8 6.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.807 -0.633 . . . . 2.5499999999999998 111.24 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -93.34 -18.42 39.09 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.525 -1.03 . . . . 3.7599999999999998 110.525 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 64.47 10.93 6.16 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.685 0.794 . . . . 5.2199999999999998 111.462 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.637 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 3.6 mmp_? -139.38 -65.28 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.8 -0.636 . . . . 7.7400000000000002 111.538 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 1.3 Cg_endo -89.89 147.62 4.77 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.03 1.82 . . . . 2.9900000000000002 113.092 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -134.13 128.36 19.47 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.51 -0.768 . . . . 1.9299999999999999 109.422 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.78 127.0 15.47 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.65 2.234 . . . . 0.63 111.829 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.5 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.93000000000000005 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 1.03 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 1.1200000000000001 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 1.05 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 1.6499999999999999 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 1.03 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.53000000000000003 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.7799999999999998 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.6599999999999999 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.73 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 1.0800000000000001 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.411 ' HB3' HD22 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 3.25 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.536 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 1.04 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 1.0600000000000001 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.97999999999999998 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.74 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.7999999999999998 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 1.0800000000000001 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.98 -16.71 24.78 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.7 111.585 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.28 -48.94 73.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.385 0.612 . . . . 1.5800000000000001 109.366 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -80.76 46.89 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.19 -0.914 . . . . 6.3200000000000003 110.84 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.502 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 18.1 mm-40 -138.22 60.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.97 0.414 . . . . 5.2999999999999998 111.492 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.93 -61.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.461 0.648 . . . . 6.9400000000000004 109.267 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 69.6 m -155.44 -50.79 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.731 -1.122 . . . . 7.9199999999999999 108.769 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 45.1 Cg_endo -93.49 -174.53 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.099 1.866 . . . . 8.9900000000000002 110.417 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.3 t -156.98 136.25 12.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.11 0.481 . . . . 11.26 111.06 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -166.54 134.73 2.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.599 -0.728 . . . . 11.789999999999999 109.688 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.108 -0.949 . . . . 13.24 110.571 178.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.577 -0.609 . . . . 7.96 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.22 106.46 11.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.558 0.218 . . . . 6.6299999999999999 110.456 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.9 tpp 63.21 75.91 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.761 -0.654 . . . . 7.8300000000000001 110.435 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.98 -156.68 32.98 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 3.02 112.169 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.525 ' HB2' ' OD2' ' A' ' 168' ' ' ASP . 53.4 m -84.5 163.66 19.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 1.6699999999999999 110.585 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m -78.59 114.93 17.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 0.65000000000000002 110.742 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.26000000000000001 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 1.0600000000000001 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 1.02 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 1.0900000000000001 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 1.04 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.68000000000000005 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.3899999999999999 111.144 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.67000000000000004 111.534 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 1.3600000000000001 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 1.21 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.8899999999999999 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.9399999999999999 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.3100000000000001 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 1.05 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67000000000000004 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54000000000000004 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 2.02 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 1.0700000000000001 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.75 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.6599999999999999 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 1.0700000000000001 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32000000000000001 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG21 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.65000000000000002 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 142' ' ' SER . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 110.758 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 1.04 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 1.02 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.20000000000000001 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 1.1100000000000001 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 1.05 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.33000000000000002 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 1.0600000000000001 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 1.0900000000000001 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 1.1200000000000001 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.3899999999999999 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.93000000000000005 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 1.1699999999999999 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.2400000000000002 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.46999999999999997 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 2.0899999999999999 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.5699999999999998 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 2.1699999999999999 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.484 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.27000000000000002 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.23999999999999999 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.495 ' HB3' HG21 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 1.0600000000000001 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 2.0699999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.523 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.77000000000000002 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.65 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 1.1000000000000001 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.9500000000000002 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 1.03 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 1.1299999999999999 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.446 ' H ' HG23 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.94999999999999996 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.40000000000000002 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.76000000000000001 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.542 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.6599999999999999 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.17000000000000001 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 228' ' ' LEU . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 1.03 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.542 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.20000000000000001 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.419 ' CG1' HG13 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 1.0600000000000001 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.57999999999999996 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 1.05 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 1.4199999999999999 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.91000000000000003 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.56000000000000005 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 1.1000000000000001 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.435 ' O ' HD11 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.39000000000000001 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.419 HG13 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 1.3 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 1.02 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.42999999999999999 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 1.3999999999999999 108.866 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.461 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 1.04 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 1.1799999999999999 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.39000000000000001 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.93999999999999995 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.46 ' HG3' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.6400000000000001 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 204' ' ' ILE . 16.4 mt -81.28 -13.64 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 1.0900000000000001 111.393 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.2 mt -99.23 2.73 45.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.58 0.705 . . . . 1.6000000000000001 109.86 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 55.9 p -129.32 20.34 5.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.055 -0.975 . . . . 2.5499999999999998 110.405 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.08 6.22 80.1 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.75 -0.738 . . . . 3.7599999999999998 113.198 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 233' ' ' ARG . 4.1 m-20 67.03 16.3 10.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.125 0.488 . . . . 5.2199999999999998 110.907 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.683 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 21.9 mmt180 -132.75 -173.81 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.105 -0.702 . . . . 7.7400000000000002 109.105 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.683 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 16.1 Cg_exo -69.31 139.49 41.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.059 1.839 . . . . 2.9900000000000002 110.554 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.64 148.82 93.0 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.021 -0.536 . . . . 1.9299999999999999 109.875 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 139.29 37.1 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.018 2.479 . . . . 0.63 113.052 -170.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.562 ' HA ' ' H ' ' A' ' 266' ' ' VAL . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.5 110.275 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.93000000000000005 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 1.03 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 1.1200000000000001 109.5 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 1.05 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 1.6499999999999999 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 1.03 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.53000000000000003 111.885 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.7799999999999998 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.6599999999999999 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.73 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 1.0800000000000001 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 1.0800000000000001 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 3.25 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 1.04 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 1.0600000000000001 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.97999999999999998 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.74 111.227 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.7999999999999998 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 1.0800000000000001 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt -90.93 -16.62 27.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.7 111.241 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 254' ' ' SER . 16.7 t80 -83.38 -46.88 12.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.53 0.681 . . . . 1.5800000000000001 109.379 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -106.61 73.38 0.95 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.005 -0.998 . . . . 6.3200000000000003 110.0 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.47 -35.07 75.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.123 0.487 . . . . 5.2999999999999998 110.43 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 262' ' ' SER . 46.1 t-20 -143.11 117.16 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 6.9400000000000004 109.257 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.571 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 29.9 t 171.36 -53.16 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.389 -0.823 . . . . 7.9199999999999999 110.432 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' A' ' 262' ' ' SER . 71.9 Cg_endo -98.82 153.35 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.761 2.308 . . . . 8.9900000000000002 112.392 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -162.74 148.79 12.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.999 -0.28 . . . . 11.26 110.681 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 56.35 63.69 1.91 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.715 0.635 . . . . 11.789999999999999 111.3 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.562 ' H ' ' HA ' ' A' ' 237' ' ' THR . 55.8 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.707 -0.679 . . . . 13.24 111.023 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.815 -0.514 . . . . 7.96 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.21 108.5 10.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.79 0.329 . . . . 6.6299999999999999 110.286 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.8 mmt -89.2 58.68 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.425 . . . . 7.8300000000000001 110.37 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.12 -130.12 3.04 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.414 -0.898 . . . . 3.02 112.991 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 p -63.37 132.84 52.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.715 0.406 . . . . 1.6699999999999999 111.51 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m -76.8 114.05 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.65000000000000002 109.903 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.26000000000000001 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 1.0600000000000001 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 1.02 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 1.0900000000000001 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 1.04 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.68000000000000005 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.3899999999999999 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.67000000000000004 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 1.3600000000000001 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 1.21 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.556 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.8899999999999999 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.404 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.9399999999999999 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.3100000000000001 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 1.05 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67000000000000004 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54000000000000004 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 2.02 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 1.0700000000000001 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.75 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.6599999999999999 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 1.0700000000000001 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32000000000000001 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.458 ' HB2' HG21 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.65000000000000002 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 1.04 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 1.02 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.20000000000000001 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 1.1100000000000001 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 1.05 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.33000000000000002 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 1.0600000000000001 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 1.0900000000000001 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 1.1200000000000001 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.3899999999999999 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.93000000000000005 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 1.1699999999999999 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.608 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.2400000000000002 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.46999999999999997 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 2.0899999999999999 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 1.1399999999999999 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.608 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.5699999999999998 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 2.1699999999999999 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.27000000000000002 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.23999999999999999 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.564 HD11 ' O ' ' A' ' 217' ' ' PRO . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 1.3300000000000001 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 1.0600000000000001 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 2.0699999999999998 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.77000000000000002 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.657 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 1.1000000000000001 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.9500000000000002 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 1.03 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 1.1299999999999999 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.455 ' H ' HG23 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.40000000000000002 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.76000000000000001 109.856 175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.6599999999999999 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.17000000000000001 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 1.03 110.003 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.20000000000000001 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 1.0600000000000001 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.57999999999999996 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 1.05 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 1.4199999999999999 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.91000000000000003 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.56000000000000005 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 1.1000000000000001 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.564 ' O ' HD11 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.39000000000000001 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 1.3 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 1.02 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.42999999999999999 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.456 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 1.3999999999999999 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 1.04 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 1.1799999999999999 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 1.1799999999999999 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.39000000000000001 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 230' ' ' THR . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.93999999999999995 111.08 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.6400000000000001 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt -94.53 -26.83 16.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 1.0900000000000001 112.083 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -75.35 -4.55 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.499 0.666 . . . . 1.6000000000000001 110.818 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 226' ' ' GLU . 9.4 t -144.75 31.12 1.17 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.068 -0.969 . . . . 2.5499999999999998 109.627 175.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.82 96.89 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.598 -0.728 . . . . 3.7599999999999998 111.923 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.89 -78.56 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.093 -0.706 . . . . 5.2199999999999998 109.093 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.606 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 20.5 mmm180 -140.49 -58.41 0.02 OUTLIER Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 7.7400000000000002 111.423 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 7.7 Cg_exo -70.72 159.62 52.11 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.83 1.687 . . . . 2.9900000000000002 112.022 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -98.56 155.89 36.28 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.414 -0.812 . . . . 1.9299999999999999 109.71 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.458 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo -62.44 132.53 38.69 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.733 2.289 . . . . 0.63 111.365 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.5 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.598 ' HH ' ' HG3' ' A' ' 260' ' ' GLN . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.93000000000000005 109.741 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 1.03 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 1.1200000000000001 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.456 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 1.6499999999999999 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 1.03 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.53000000000000003 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 249' ' ' VAL . 24.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.7799999999999998 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.73 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 1.0800000000000001 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 1.0800000000000001 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.437 ' HA ' HD12 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 3.25 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.659 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 1.04 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 1.0600000000000001 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.97999999999999998 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.74 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.7999999999999998 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.607 ' O ' ' HB2' ' A' ' 260' ' ' GLN . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 1.0800000000000001 110.918 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt -106.97 21.61 17.29 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.922 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -78.93 -68.67 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 1.5800000000000001 109.692 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -143.13 9.84 1.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.084 -0.507 . . . . 6.3200000000000003 110.883 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 16.3 mm100 -72.21 -29.02 63.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.469 0.652 . . . . 5.2999999999999998 109.805 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -87.82 136.25 33.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.114 -0.948 . . . . 6.9400000000000004 110.16 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 264' ' ' THR . 9.6 t -163.43 -51.03 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.776 -0.647 . . . . 7.9199999999999999 110.131 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 3.81 2.1 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.824 1.683 . . . . 8.9900000000000002 111.363 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 262' ' ' SER . 20.0 m -136.29 126.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.997 -1.001 . . . . 11.26 109.951 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.64 161.73 37.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.985 -0.552 . . . . 11.789999999999999 109.669 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.577 -0.725 . . . . 13.24 110.375 178.323 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.011 -0.435 . . . . 7.96 112.011 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 141' ' ' GLY . . . -71.77 125.43 27.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.455 -0.202 . . . . 6.6299999999999999 110.455 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 tpt 73.36 -11.98 0.86 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.908 0.755 . . . . 7.8300000000000001 110.885 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 139' ' ' ALA . . . 127.95 -133.21 7.7 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.092 -0.803 . . . . 3.02 111.092 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.5 m -105.24 150.37 25.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.667 -0.494 . . . . 1.6699999999999999 109.667 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m -77.58 112.64 14.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.65000000000000002 110.595 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.26000000000000001 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 190' ' ' LEU . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 1.0600000000000001 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 1.02 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 1.0900000000000001 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 1.04 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.68000000000000005 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.523 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.3899999999999999 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.67000000000000004 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 1.3600000000000001 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 1.21 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.8899999999999999 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.9399999999999999 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.3100000000000001 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 1.05 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67000000000000004 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54000000000000004 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 2.02 111.407 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 1.0700000000000001 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.75 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.6599999999999999 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 1.0700000000000001 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32000000000000001 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.487 ' HB2' HG23 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.65000000000000002 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.1899999999999999 110.877 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 1.04 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 1.02 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.20000000000000001 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 1.1100000000000001 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 1.05 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.523 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.33000000000000002 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 1.0600000000000001 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 1.0900000000000001 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 1.1200000000000001 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.3899999999999999 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.93000000000000005 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 1.1699999999999999 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.2400000000000002 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.46999999999999997 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 2.0899999999999999 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 185' ' ' LYS . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.5699999999999998 110.699 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 2.1699999999999999 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.468 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.27000000000000002 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.23999999999999999 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 217' ' ' PRO . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 1.3300000000000001 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 1.0600000000000001 111.001 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 2.0699999999999998 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.488 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.77000000000000002 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.635 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 202' ' ' SER . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 1.1000000000000001 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.9500000000000002 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 1.03 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 1.1299999999999999 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.457 ' H ' HG23 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.94999999999999996 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.40000000000000002 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.76000000000000001 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.6599999999999999 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.17000000000000001 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.475 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 1.03 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.442 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.20000000000000001 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.429 ' CG1' HG13 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 1.0600000000000001 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.57999999999999996 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 1.05 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 1.4199999999999999 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.91000000000000003 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.56000000000000005 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 1.1000000000000001 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.46 ' O ' HD13 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.39000000000000001 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.429 HG13 ' CG1' ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 1.02 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.42999999999999999 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 1.3999999999999999 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 1.04 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 1.1799999999999999 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 1.1799999999999999 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.39000000000000001 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 230' ' ' THR . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.853 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG3' HG23 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.6400000000000001 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.74 1.28 27.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 1.0900000000000001 110.825 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 52.9 mt -122.01 20.95 10.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.876 -0.602 . . . . 1.6000000000000001 110.464 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 226' ' ' GLU . 8.8 t -148.12 -36.98 0.19 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.946 -0.57 . . . . 2.5499999999999998 111.111 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -97.61 2.62 60.67 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.769 -0.933 . . . . 3.7599999999999998 110.769 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.58 91.64 1.99 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.311 -0.996 . . . . 5.2199999999999998 108.311 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.503 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 25.6 mmm180 -43.38 -56.67 6.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 7.7400000000000002 111.996 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 72.1 Cg_endo -68.89 146.29 65.09 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.442 2.094 . . . . 2.9900000000000002 113.069 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.48 139.05 28.17 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.021 -0.99 . . . . 1.9299999999999999 111.001 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.81 137.51 32.54 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.865 2.376 . . . . 0.63 111.255 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.5 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.93000000000000005 111.012 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 1.03 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 1.1200000000000001 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 1.05 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.472 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 1.6499999999999999 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 1.03 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.53000000000000003 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.511 ' O ' HG21 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.7799999999999998 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.73 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 1.0800000000000001 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 1.0800000000000001 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 3.25 110.664 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.71 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 1.04 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 1.0600000000000001 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.97999999999999998 110.971 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.74 112.147 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.7999999999999998 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.616 ' HA ' ' HH ' ' A' ' 238' ' ' TYR . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 1.0800000000000001 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.2 0.26 50.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.7 111.563 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.566 ' HB2' ' O ' ' A' ' 254' ' ' SER . 40.9 t80 -85.34 -49.7 7.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.491 0.662 . . . . 1.5800000000000001 109.679 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.29 2.26 41.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.028 -0.987 . . . . 6.3200000000000003 111.189 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -131.62 96.06 3.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.219 0.533 . . . . 5.2999999999999998 110.728 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.81 -60.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.408 -0.815 . . . . 6.9400000000000004 109.952 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 263' ' ' PRO . 36.3 p -137.93 58.93 17.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 7.9199999999999999 110.57 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 262' ' ' SER . 86.7 Cg_endo -92.65 47.77 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.728 2.286 . . . . 8.9900000000000002 112.39 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.2 m -74.98 102.39 4.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.115 -0.493 . . . . 11.26 109.929 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.87 48.95 10.44 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.085 -0.507 . . . . 11.789999999999999 110.346 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.278 -0.867 . . . . 13.24 111.054 -176.53 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.058 -0.417 . . . . 7.96 112.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 64.64 20.49 12.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.137 0.575 . . . . 6.6299999999999999 111.848 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.9 mtt -110.43 -14.81 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.431 . . . . 7.8300000000000001 110.389 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 -154.22 14.21 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.918 -0.658 . . . . 3.02 112.569 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -80.31 151.11 29.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.447 0.641 . . . . 1.6699999999999999 111.558 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.462 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 23.5 m -147.46 117.88 7.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.381 -0.97 . . . . 0.65000000000000002 108.381 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.26000000000000001 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 190' ' ' LEU . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 1.0600000000000001 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 1.02 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 1.0900000000000001 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 1.04 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.68000000000000005 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.3899999999999999 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.67000000000000004 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 1.3600000000000001 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.407 HD12 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 1.21 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.8899999999999999 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.9399999999999999 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.3100000000000001 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 1.05 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67000000000000004 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54000000000000004 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 2.02 111.35 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.453 ' HA ' HD13 ' A' ' 165' ' ' LEU . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 1.0700000000000001 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.75 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.6599999999999999 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 1.0700000000000001 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32000000000000001 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HD1' ' CB ' ' A' ' 143' ' ' THR . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.65000000000000002 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.1899999999999999 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 1.04 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 1.02 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.20000000000000001 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 1.1100000000000001 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.33000000000000002 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.427 HG21 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 1.0600000000000001 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 1.0900000000000001 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 1.1200000000000001 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.3899999999999999 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.93000000000000005 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 1.1699999999999999 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.46999999999999997 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 2.0899999999999999 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 1.1399999999999999 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.5699999999999998 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 2.1699999999999999 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.27000000000000002 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.23999999999999999 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 1.3300000000000001 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 1.0600000000000001 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.46 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 2.0699999999999998 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.77000000000000002 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.607 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.524 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 1.1000000000000001 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.9500000000000002 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 1.03 110.36 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 1.1299999999999999 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' H ' HG21 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.94999999999999996 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.40000000000000002 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.76000000000000001 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.6599999999999999 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.17000000000000001 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 1.03 110.069 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.20000000000000001 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 1.0600000000000001 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.57999999999999996 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 1.05 110.662 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 1.4199999999999999 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.56000000000000005 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 1.1000000000000001 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.39000000000000001 112.018 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 1.3 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 1.02 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.434 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.42999999999999999 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.439 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 1.3999999999999999 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.568 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 1.04 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 1.1799999999999999 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 1.1799999999999999 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.39000000000000001 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.627 ' O ' HG23 ' A' ' 230' ' ' THR . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.93999999999999995 111.533 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.6400000000000001 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.32 -7.84 43.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 1.0900000000000001 111.371 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.44 19.75 14.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.096 0.474 . . . . 1.6000000000000001 111.24 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 226' ' ' GLU . 13.4 t -163.27 -39.18 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 2.5499999999999998 110.906 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -87.17 6.97 82.38 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.863 -0.684 . . . . 3.7599999999999998 111.87 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -162.26 96.29 0.97 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.866 -1.161 . . . . 5.2199999999999998 107.866 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.574 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 34.5 mtp-105 -42.45 -53.4 9.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 113.975 -1.466 . . . . 7.7400000000000002 113.943 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 19.6 Cg_exo -61.99 134.36 49.26 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.649 1.566 . . . . 2.9900000000000002 111.805 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.65 136.9 30.6 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.494 -0.775 . . . . 1.9299999999999999 110.999 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.93 128.09 17.18 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.98 2.454 . . . . 0.63 111.315 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.5 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.602 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.93000000000000005 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 1.03 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 1.1200000000000001 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.437 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 1.6499999999999999 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 1.03 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.53000000000000003 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.7799999999999998 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.73 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.0800000000000001 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 1.0800000000000001 110.732 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 3.25 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 1.04 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 1.0600000000000001 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.97999999999999998 110.661 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.74 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.7 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.7999999999999998 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.602 ' HA ' ' HH ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 1.0800000000000001 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt -82.68 -9.92 59.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.7 111.172 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.544 ' O ' ' HG2' ' A' ' 263' ' ' PRO . 50.2 t80 -78.87 -42.91 26.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.198 -0.668 . . . . 1.5800000000000001 109.198 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -80.92 60.82 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.677 -0.692 . . . . 6.3200000000000003 110.692 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 263' ' ' PRO . 23.8 mm-40 -131.02 178.73 6.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.552 -0.749 . . . . 5.2999999999999998 110.929 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.89 12.14 9.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.754 -0.657 . . . . 6.9400000000000004 111.043 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.522 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 6.6 m -91.26 -49.89 0.33 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.282 -0.417 . . . . 7.9199999999999999 111.34 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 258' ' ' PHE . 4.4 Cg_exo -77.66 170.21 19.55 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.224 1.95 . . . . 8.9900000000000002 111.815 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 t -116.28 13.03 15.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 11.26 110.805 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -135.26 69.51 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.539 . . . . 11.789999999999999 110.401 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.112 -0.947 . . . . 13.24 111.61 -174.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.798 -0.521 . . . . 7.96 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 54.59 43.86 29.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 6.6299999999999999 111.453 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -91.95 74.6 5.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.225 0.536 . . . . 7.8300000000000001 110.439 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.34 -128.88 5.35 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.249 -0.74 . . . . 3.02 111.249 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.43 123.31 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 1.6699999999999999 110.686 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m -78.01 110.7 13.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.922 -0.581 . . . . 0.65000000000000002 110.391 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.26000000000000001 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 1.0600000000000001 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 1.02 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 1.04 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.68000000000000005 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.3899999999999999 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.67000000000000004 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 1.3600000000000001 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 1.21 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.8899999999999999 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.9399999999999999 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.3100000000000001 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 1.05 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54000000000000004 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 2.02 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 1.0700000000000001 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.75 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 1.0700000000000001 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.495 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.65000000000000002 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.1899999999999999 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 1.04 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 1.02 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.20000000000000001 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 1.1100000000000001 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 1.05 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.33000000000000002 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 1.0600000000000001 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 1.0900000000000001 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 1.1200000000000001 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.3899999999999999 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.93000000000000005 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 1.1699999999999999 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.2400000000000002 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.46999999999999997 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 2.0899999999999999 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 1.1399999999999999 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.5699999999999998 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 2.1699999999999999 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.589 ' O ' HG22 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.27000000000000002 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.23999999999999999 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HB3' HG21 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 1.3300000000000001 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.431 ' HB ' HG21 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 1.0600000000000001 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 2.0699999999999998 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.467 ' N ' HD12 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.77000000000000002 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.59 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.481 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 1.1000000000000001 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.9500000000000002 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.403 HD12 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 1.03 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 1.1299999999999999 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.94999999999999996 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.40000000000000002 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.76000000000000001 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.6599999999999999 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.17000000000000001 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 1.03 110.282 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.20000000000000001 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 203' ' ' GLY . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 1.0600000000000001 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.57999999999999996 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 1.05 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 1.4199999999999999 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.91000000000000003 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.56000000000000005 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 1.1000000000000001 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.39000000000000001 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 1.3 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 1.02 109.87 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.404 ' O ' HD11 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.42999999999999999 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 1.3999999999999999 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.52 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 1.04 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 1.1799999999999999 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 1.1799999999999999 111.318 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.39000000000000001 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.93999999999999995 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.6400000000000001 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt -80.02 -8.21 59.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 1.0900000000000001 111.128 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.9 mt -115.17 13.37 16.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 1.6000000000000001 111.36 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.6 p -124.16 -94.1 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.064 -0.516 . . . . 2.5499999999999998 112.285 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.0 -14.02 67.53 Favored Glycine 0 C--O 1.23 -0.11 0 CA-C-N 116.097 -0.501 . . . . 3.7599999999999998 112.476 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.27 74.79 1.05 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.59 -0.892 . . . . 5.2199999999999998 108.59 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 32.9 mmt180 -37.31 -54.27 2.05 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.901 -1.499 . . . . 7.7400000000000002 113.75 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 21.3 Cg_exo -59.58 132.36 45.42 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.12 1.213 . . . . 2.9900000000000002 111.636 176.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.68 135.11 36.26 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.672 -0.695 . . . . 1.9299999999999999 110.59 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.68 126.99 18.6 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.726 2.284 . . . . 0.63 111.062 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.5 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.93000000000000005 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 1.03 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 1.1200000000000001 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 1.05 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 1.6499999999999999 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 1.03 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.53000000000000003 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.505 ' O ' HG22 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.7799999999999998 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.438 ' HB3' HD23 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.6599999999999999 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.73 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 1.0800000000000001 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 1.0800000000000001 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 3.25 110.708 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 1.04 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 1.0600000000000001 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.97999999999999998 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.74 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.7999999999999998 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 1.0800000000000001 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.96 -24.53 32.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.7 111.045 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.12 -15.21 59.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.47 0.652 . . . . 1.5800000000000001 109.989 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.9 -11.56 50.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.874 0.845 . . . . 6.3200000000000003 110.016 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -98.4 135.08 40.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.834 -1.076 . . . . 5.2999999999999998 110.894 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -92.64 43.39 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.284 1.04 . . . . 6.9400000000000004 109.526 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.0 m -90.96 -54.01 0.28 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.742 -1.117 . . . . 7.9199999999999999 111.271 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.51 -42.29 5.34 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.146 1.23 . . . . 8.9900000000000002 112.148 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 4.3 m 49.66 56.67 7.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 11.26 110.624 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -151.86 49.65 0.8 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 11.789999999999999 110.596 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.478 -0.772 . . . . 13.24 110.1 179.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.815 -0.514 . . . . 7.96 111.815 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.57 84.02 0.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 6.6299999999999999 110.235 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.5 ptp -120.27 127.06 52.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.236 0.541 . . . . 7.8300000000000001 111.408 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.94 64.53 0.57 Allowed Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 109.781 -1.327 . . . . 3.02 109.781 173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -53.85 139.58 32.99 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.669 -1.265 . . . . 1.6699999999999999 112.166 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m -76.54 106.53 8.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.387 -0.824 . . . . 0.65000000000000002 109.916 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.26000000000000001 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 1.0600000000000001 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 1.02 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 1.0900000000000001 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.68000000000000005 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.3899999999999999 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.67000000000000004 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 1.3600000000000001 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 1.21 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.8899999999999999 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.42 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.9399999999999999 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.3100000000000001 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 1.05 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54000000000000004 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 2.02 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 167' ' ' HIS . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 1.0700000000000001 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.75 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.6599999999999999 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 1.0700000000000001 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32000000000000001 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.461 ' HB2' HG23 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.65000000000000002 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.1899999999999999 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 1.04 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 1.02 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.20000000000000001 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 1.1100000000000001 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 1.05 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.33000000000000002 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.418 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 1.0600000000000001 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 1.0900000000000001 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 1.1200000000000001 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.3899999999999999 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.93000000000000005 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 1.1699999999999999 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.2400000000000002 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.46999999999999997 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 2.0899999999999999 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 1.1399999999999999 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.5699999999999998 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 2.1699999999999999 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.27000000000000002 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.23999999999999999 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 1.3300000000000001 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 1.0600000000000001 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 2.0699999999999998 107.71 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.77000000000000002 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 1.1000000000000001 112.023 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.9500000000000002 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 1.03 110.864 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 1.1299999999999999 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.94999999999999996 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.40000000000000002 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.76000000000000001 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.6599999999999999 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.17000000000000001 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 1.03 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.20000000000000001 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.448 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 1.0600000000000001 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.57999999999999996 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 1.05 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 1.4199999999999999 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.91000000000000003 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.56000000000000005 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 1.1000000000000001 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.46 ' O ' HD13 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.39000000000000001 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.487 HG21 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 1.3 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.452 ' O ' HD11 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.42999999999999999 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 1.3999999999999999 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 1.04 110.475 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 1.1799999999999999 110.836 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 1.1799999999999999 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.411 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.39000000000000001 111.803 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.466 ' O ' HG21 ' A' ' 230' ' ' THR . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.808 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.6400000000000001 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 204' ' ' ILE . 18.2 mt -86.27 -3.93 59.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 1.0900000000000001 111.62 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 85.8 mt -107.05 31.52 5.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.217 -0.447 . . . . 1.6000000000000001 111.009 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 226' ' ' GLU . 9.3 t -171.37 116.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.514 0.673 . . . . 2.5499999999999998 111.413 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.17 -43.84 3.19 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 3.7599999999999998 112.991 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.08 48.95 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.481 . . . . 5.2199999999999998 111.114 -176.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.664 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 5.6 mmp_? 66.97 -175.27 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.91 -1.041 . . . . 7.7400000000000002 110.585 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.664 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 31.7 Cg_exo -63.58 175.03 3.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.99 2.46 . . . . 2.9900000000000002 112.528 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -51.45 122.41 19.72 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.435 -0.802 . . . . 1.9299999999999999 111.061 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.34 142.7 56.59 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.952 2.435 . . . . 0.63 112.06 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.5 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.93000000000000005 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 1.03 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.426 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 1.1200000000000001 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 1.05 112.044 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 1.6499999999999999 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 1.03 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.53000000000000003 111.421 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.545 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.7799999999999998 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.6599999999999999 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.73 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 1.0800000000000001 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 3.25 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 1.04 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.521 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 1.0600000000000001 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.97999999999999998 110.664 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.74 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.3 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.7999999999999998 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 1.0800000000000001 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 83.2 mt -86.72 -14.85 41.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.7 111.06 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.8 -52.38 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.035 0.445 . . . . 1.5800000000000001 109.87 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -78.5 1.26 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.692 . . . . 6.3200000000000003 111.173 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.408 ' HG2' ' OD1' ' A' ' 261' ' ' ASN . 7.7 tt0 -65.64 -53.46 41.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.2999999999999998 110.55 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 260' ' ' GLN . 17.6 m120 -137.13 171.95 13.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.776 -0.647 . . . . 6.9400000000000004 110.017 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 263' ' ' PRO . 5.7 t -140.73 132.89 14.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.599 -0.519 . . . . 7.9199999999999999 109.599 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 262' ' ' SER . 30.6 Cg_exo -62.01 106.58 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.827 2.351 . . . . 8.9900000000000002 112.296 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 49.9 m -78.99 -34.87 43.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.142 -0.481 . . . . 11.26 110.569 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.78 73.61 4.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.873 -0.603 . . . . 11.789999999999999 110.526 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.721 -0.672 . . . . 13.24 111.007 -179.299 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.812 -0.515 . . . . 7.96 111.812 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.99 -171.34 0.15 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.884 0.474 . . . . 6.6299999999999999 111.319 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 mmt 59.81 86.46 0.09 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.848 -0.614 . . . . 7.8300000000000001 111.04 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -118.85 0.3 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.495 -0.775 . . . . 3.02 112.197 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 4.8 p -81.62 92.07 6.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.543 0.687 . . . . 1.6699999999999999 110.952 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.477 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.4 m -79.71 122.89 27.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.461 -0.79 . . . . 0.65000000000000002 109.411 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.26000000000000001 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 1.0600000000000001 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 1.02 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 1.0900000000000001 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 1.04 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.68000000000000005 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.3899999999999999 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.67000000000000004 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 1.3600000000000001 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 1.21 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.9399999999999999 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.3100000000000001 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 1.05 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67000000000000004 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 2.02 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 1.0700000000000001 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.75 110.48 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.6599999999999999 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 1.0700000000000001 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32000000000000001 112.25 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.65000000000000002 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.1899999999999999 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 1.04 109.865 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.548 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 1.02 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.20000000000000001 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 1.1100000000000001 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 1.05 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.33000000000000002 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 1.0600000000000001 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 1.0900000000000001 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 1.1200000000000001 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.3899999999999999 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.93000000000000005 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 1.1699999999999999 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.2400000000000002 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.46999999999999997 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.449 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 2.0899999999999999 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 1.1399999999999999 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.5699999999999998 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.548 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.412 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 2.1699999999999999 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.424 ' O ' HG23 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.27000000000000002 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.23999999999999999 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 1.3300000000000001 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 2.0699999999999998 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.537 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.77000000000000002 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.592 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.485 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 1.1000000000000001 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.9500000000000002 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD12 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 1.03 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 1.1299999999999999 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' H ' HG23 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.94999999999999996 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.40000000000000002 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.76000000000000001 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.6599999999999999 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.17000000000000001 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 1.03 110.433 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.20000000000000001 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 1.0600000000000001 110.954 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.57999999999999996 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 1.05 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 1.4199999999999999 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.449 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.56000000000000005 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 1.1000000000000001 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.445 ' HG3' HE22 ' A' ' 260' ' ' GLN . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.39000000000000001 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 191' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 1.3 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 1.02 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.42999999999999999 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 1.3999999999999999 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 1.04 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 1.1799999999999999 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 1.1799999999999999 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.39000000000000001 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.93999999999999995 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.6400000000000001 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.28 -42.73 7.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 1.0900000000000001 111.324 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.4 mt -87.45 73.41 9.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.683 -0.69 . . . . 1.6000000000000001 109.759 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 8.4 p -103.76 -3.68 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.531 -0.758 . . . . 2.5499999999999998 111.857 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 86.45 -68.96 3.21 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.753 -0.737 . . . . 3.7599999999999998 113.225 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.05 -19.5 57.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 5.2199999999999998 111.272 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.673 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 27.9 mmt180 -94.58 179.47 1.2 Allowed Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.552 -0.536 . . . . 7.7400000000000002 109.552 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.2 Cg_exo -71.4 142.88 41.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.686 2.257 . . . . 2.9900000000000002 111.386 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.6 140.56 21.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 109.002 -0.74 . . . . 1.9299999999999999 109.002 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.24 127.34 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.428 2.085 . . . . 0.63 111.47 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.5 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 256' ' ' ALA . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.93000000000000005 109.977 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 1.03 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 1.1200000000000001 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 1.05 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.405 ' HE2' HD12 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 1.6499999999999999 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 1.03 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.53000000000000003 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.7799999999999998 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.6599999999999999 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.73 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 1.0800000000000001 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 1.0800000000000001 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 3.25 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.712 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 1.04 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 1.0600000000000001 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.97999999999999998 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.74 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.7999999999999998 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 1.0800000000000001 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.21 3.63 54.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.7 111.328 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -79.38 -31.65 42.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.399 0.618 . . . . 1.5800000000000001 109.438 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -111.34 96.8 6.33 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.914 0.864 . . . . 6.3200000000000003 108.977 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.445 HE22 ' HG3' ' A' ' 217' ' ' PRO . 27.8 mm-40 -106.74 92.7 4.21 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.456 -1.247 . . . . 5.2999999999999998 110.949 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -73.67 -39.46 64.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.938 -0.764 . . . . 6.9400000000000004 108.938 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.6 t -121.11 80.06 34.9 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.174 -0.921 . . . . 7.9199999999999999 109.252 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.25 147.36 65.99 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.642 2.228 . . . . 8.9900000000000002 112.356 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.8 p -66.74 128.49 36.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 11.26 110.893 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -66.55 119.46 11.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.791 0.329 . . . . 11.789999999999999 110.479 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.344 -0.836 . . . . 13.24 110.656 -177.457 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.247 -0.341 . . . . 7.96 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.25 143.34 35.38 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.926 -0.161 . . . . 6.6299999999999999 110.899 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.86 45.76 17.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.164 -0.471 . . . . 7.8300000000000001 110.922 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.05 169.41 21.05 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.682 -0.771 . . . . 3.02 111.686 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 1.5 m -81.57 143.95 31.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.996 -0.372 . . . . 1.6699999999999999 109.996 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m -77.82 107.46 10.34 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.826 -0.435 . . . . 0.65000000000000002 109.826 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.26000000000000001 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 1.0600000000000001 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 1.02 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 1.0900000000000001 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 1.04 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.68000000000000005 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.3899999999999999 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.67000000000000004 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 1.3600000000000001 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 1.21 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.8899999999999999 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.9399999999999999 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.3100000000000001 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 1.05 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67000000000000004 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54000000000000004 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 2.02 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 167' ' ' HIS . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 1.0700000000000001 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.75 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.6599999999999999 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 1.0700000000000001 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.474 ' HB2' HG23 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.65000000000000002 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 142' ' ' SER . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.1899999999999999 110.199 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 1.04 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 1.02 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.20000000000000001 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 1.1100000000000001 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 1.05 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.33000000000000002 111.182 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 1.0600000000000001 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 1.0900000000000001 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 1.1200000000000001 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.3899999999999999 111.261 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 1.1699999999999999 112.214 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.2400000000000002 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.46999999999999997 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 2.0899999999999999 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 1.1399999999999999 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.5699999999999998 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 2.1699999999999999 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.485 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.27000000000000002 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.23999999999999999 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.435 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 1.3300000000000001 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG22 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 1.0600000000000001 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 145' ' ' VAL . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 2.0699999999999998 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.77000000000000002 112.472 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.605 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 1.1000000000000001 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.9500000000000002 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 1.03 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 1.1299999999999999 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.448 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.94999999999999996 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.40000000000000002 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.76000000000000001 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.6599999999999999 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.17000000000000001 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.544 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 1.03 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.20000000000000001 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 203' ' ' GLY . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 1.0600000000000001 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.57999999999999996 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 1.05 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 1.4199999999999999 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.91000000000000003 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.56000000000000005 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.503 ' CG1' HG22 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 1.1000000000000001 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.39000000000000001 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 1.3 111.018 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 1.02 110.077 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.42999999999999999 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 1.3999999999999999 108.915 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.418 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 1.04 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 1.1799999999999999 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.54 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.39000000000000001 112.176 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.93999999999999995 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.6400000000000001 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.31 0.24 55.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 1.0900000000000001 111.528 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 37.3 mt -108.47 7.2 26.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.105 -0.498 . . . . 1.6000000000000001 110.746 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t 179.98 124.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.857 -0.61 . . . . 2.5499999999999998 111.187 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.62 12.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.932 -0.651 . . . . 3.7599999999999998 113.109 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.04 85.7 1.02 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.342 0.591 . . . . 5.2199999999999998 111.718 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.714 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 31.3 mmm180 65.06 -175.6 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.194 -0.912 . . . . 7.7400000000000002 112.039 169.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.714 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 40.7 Cg_exo -61.15 166.75 10.29 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.143 2.562 . . . . 2.9900000000000002 113.012 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 139.64 97.28 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.323 -0.853 . . . . 1.9299999999999999 110.412 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.66 146.65 43.83 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.934 2.423 . . . . 0.63 111.693 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.5 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.93000000000000005 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 1.03 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 1.1200000000000001 109.639 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 1.05 111.821 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.516 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 1.6499999999999999 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 1.03 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.53000000000000003 111.346 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.511 ' O ' HG21 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.7799999999999998 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.6599999999999999 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.73 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 1.0800000000000001 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 1.0800000000000001 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 3.25 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 1.04 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.501 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 1.0600000000000001 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.97999999999999998 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.74 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 25.3 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.7999999999999998 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.554 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 1.0800000000000001 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt -95.65 14.87 21.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.7 111.344 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -94.89 -70.43 0.71 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.405 -0.361 . . . . 1.5800000000000001 110.297 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -158.47 31.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 6.3200000000000003 110.741 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . 18.9 mp0 63.53 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.347 0.404 . . . . 5.2999999999999998 111.64 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -80.83 68.37 7.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.473 0.654 . . . . 6.9400000000000004 110.202 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' A' ' 263' ' ' PRO . 26.7 t -76.15 -48.79 3.34 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.633 -0.712 . . . . 7.9199999999999999 111.231 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 262' ' ' SER . 37.6 Cg_endo -66.18 83.74 0.27 Allowed 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.839 1.692 . . . . 8.9900000000000002 111.697 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.7 m -87.85 -34.14 18.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.684 -0.689 . . . . 11.26 110.28 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -112.75 86.52 2.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.807 -0.633 . . . . 11.789999999999999 109.937 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.7 -0.667 . . . . 13.24 110.349 -179.352 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.86 -0.496 . . . . 7.96 111.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.59 66.01 9.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.526 . . . . 6.6299999999999999 110.496 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.9 ttt -70.61 -39.72 73.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 7.8300000000000001 111.112 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.97 -129.31 1.32 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.698 -0.763 . . . . 3.02 112.07 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -75.45 126.91 31.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.108 0.48 . . . . 1.6699999999999999 110.561 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -77.11 110.44 11.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.65000000000000002 110.178 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.26000000000000001 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 1.0600000000000001 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 1.02 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 1.0900000000000001 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 1.04 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.68000000000000005 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.3899999999999999 111.149 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.67000000000000004 113.144 -173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 1.3600000000000001 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 1.21 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.582 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.8899999999999999 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.435 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.9399999999999999 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.3100000000000001 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 1.05 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67000000000000004 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 2.02 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 1.0700000000000001 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.75 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 1.0700000000000001 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32000000000000001 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.508 ' HB2' HG21 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.65000000000000002 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 1.02 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.20000000000000001 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 1.1100000000000001 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 1.05 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.33000000000000002 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.0900000000000001 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 1.1200000000000001 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.3899999999999999 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.93000000000000005 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 1.1699999999999999 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.2400000000000002 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.46999999999999997 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 2.0899999999999999 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 1.1399999999999999 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.5699999999999998 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.27000000000000002 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.23999999999999999 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 1.3300000000000001 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 1.0600000000000001 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 2.0699999999999998 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.77000000000000002 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.614 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 1.1000000000000001 110.857 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.9500000000000002 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 1.03 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 1.1299999999999999 111.686 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.94999999999999996 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.40000000000000002 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.76000000000000001 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.6599999999999999 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.17000000000000001 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 1.03 110.18 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 1.0600000000000001 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.57999999999999996 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 1.05 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 1.4199999999999999 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.91000000000000003 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.56000000000000005 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 1.1000000000000001 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.39000000000000001 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.432 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 1.02 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 1.3999999999999999 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 1.04 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 1.1799999999999999 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.39000000000000001 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.6400000000000001 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt -99.12 -29.24 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 1.0900000000000001 113.004 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.426 ' HG ' ' HG2' ' A' ' 235' ' ' GLU . 10.0 mp -72.33 -3.56 24.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.427 0.529 . . . . 1.6000000000000001 112.427 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -164.56 134.55 3.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.673 -0.492 . . . . 2.5499999999999998 109.673 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 161.26 -30.84 0.33 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.717 -0.754 . . . . 3.7599999999999998 112.704 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -162.24 -73.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.315 0.579 . . . . 5.2199999999999998 111.297 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.614 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -110.73 -177.43 0.46 Allowed Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.284 -0.871 . . . . 7.7400000000000002 109.958 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.614 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 52.2 Cg_exo -59.02 175.19 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.462 2.108 . . . . 2.9900000000000002 113.768 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HG2' ' HG ' ' A' ' 229' ' ' LEU . 38.5 mt-10 -53.34 149.78 13.27 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.991 -1.004 . . . . 1.9299999999999999 111.851 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.411 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo -71.07 154.45 62.46 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.776 2.317 . . . . 0.63 111.509 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.5 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.93000000000000005 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 1.03 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 1.1200000000000001 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 1.05 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.434 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 1.6499999999999999 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 1.03 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.53000000000000003 111.443 -172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.7799999999999998 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.6599999999999999 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.73 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 1.0800000000000001 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 3.25 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.621 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 1.04 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 1.0600000000000001 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.97999999999999998 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.74 111.789 -176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.7999999999999998 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 1.0800000000000001 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt -97.88 -0.71 44.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.235 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.566 ' HB2' ' O ' ' A' ' 254' ' ' SER . 10.7 t80 -86.28 -43.27 13.06 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.292 -1.003 . . . . 1.5800000000000001 108.292 173.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.71 80.84 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 6.3200000000000003 110.518 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -79.79 -51.65 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.15 -0.685 . . . . 5.2999999999999998 109.15 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -164.8 69.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.146 -0.933 . . . . 6.9400000000000004 108.934 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.3 p -106.71 126.43 30.32 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 7.9199999999999999 111.125 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.97 -1.22 11.42 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.872 2.381 . . . . 8.9900000000000002 112.283 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.4 t -174.06 164.96 4.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 11.26 109.724 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.04 82.01 1.86 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.785 -0.189 . . . . 11.789999999999999 110.511 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.179 -0.915 . . . . 13.24 110.758 -179.608 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.008 -0.437 . . . . 7.96 112.008 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.96 -59.84 4.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 6.6299999999999999 111.08 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.35 88.15 2.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.716 -0.846 . . . . 7.8300000000000001 108.716 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.11 -116.52 4.46 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.429 -0.891 . . . . 3.02 111.261 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 159.11 21.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.037 0.446 . . . . 1.6699999999999999 110.156 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.459 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m -77.98 97.61 5.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.65000000000000002 109.705 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.26000000000000001 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 1.0600000000000001 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 1.02 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 1.0900000000000001 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 1.04 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.68000000000000005 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.3899999999999999 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.682 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.67000000000000004 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 1.3600000000000001 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 1.21 110.796 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.8899999999999999 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.9399999999999999 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 1.05 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 2.02 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 1.0700000000000001 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.75 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.6599999999999999 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32000000000000001 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.459 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.65000000000000002 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.1899999999999999 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 1.04 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 1.02 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.20000000000000001 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.425 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 1.1100000000000001 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 1.05 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.33000000000000002 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 1.0600000000000001 110.767 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 1.0900000000000001 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 1.1200000000000001 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.3899999999999999 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.93000000000000005 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 1.1699999999999999 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.46999999999999997 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.414 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 2.0899999999999999 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 1.1399999999999999 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.5699999999999998 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 2.1699999999999999 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.592 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.27000000000000002 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.23999999999999999 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 1.3300000000000001 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 1.0600000000000001 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.431 HD23 ' CG1' ' A' ' 145' ' ' VAL . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 2.0699999999999998 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.77000000000000002 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.617 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.571 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 1.1000000000000001 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.9500000000000002 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 1.03 110.59 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 1.1299999999999999 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.94999999999999996 111.563 -176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.40000000000000002 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.76000000000000001 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.6599999999999999 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.17000000000000001 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 1.03 110.447 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.20000000000000001 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.566 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 1.0600000000000001 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.57999999999999996 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 1.05 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.91000000000000003 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.56000000000000005 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 1.1000000000000001 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.468 ' HD2' HG12 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.39000000000000001 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 1.3 110.971 -174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 1.02 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.502 ' O ' HD13 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.42999999999999999 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 1.3999999999999999 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.617 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.04 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.1799999999999999 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 1.1799999999999999 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.39000000000000001 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.93999999999999995 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.6400000000000001 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -88.93 -13.46 38.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 111.743 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 36.91 3.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.207 -0.451 . . . . 1.6000000000000001 110.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.4 t -140.58 24.49 2.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.623 0.725 . . . . 2.5499999999999998 110.423 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -98.49 -6.3 56.54 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.8 -0.92 . . . . 3.7599999999999998 110.8 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.0 t70 73.0 -9.88 1.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.644 0.777 . . . . 5.2199999999999998 111.324 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.582 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 26.4 mmt180 -141.59 -60.84 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.775 0.658 . . . . 7.7400000000000002 112.775 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 8.1 Cg_exo -67.16 136.92 42.29 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.404 1.403 . . . . 2.9900000000000002 112.397 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 129.85 21.54 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.387 -0.824 . . . . 1.9299999999999999 110.045 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.68 128.2 14.87 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.679 2.253 . . . . 0.63 111.142 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.5 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.93000000000000005 109.828 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 1.03 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 1.1200000000000001 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 1.05 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.437 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 1.6499999999999999 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 1.03 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.53000000000000003 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.512 ' O ' HG21 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.7799999999999998 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.73 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 1.0800000000000001 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 1.0800000000000001 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 3.25 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 1.04 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 1.0600000000000001 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.97999999999999998 110.643 174.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.74 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 26.6 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.7999999999999998 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 1.0800000000000001 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt -84.11 -26.59 28.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.7 111.091 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.32 -22.9 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.397 0.618 . . . . 1.5800000000000001 109.66 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -80.6 -3.41 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.13 -0.941 . . . . 6.3200000000000003 110.221 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.417 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 69.8 mt-30 -130.05 -166.31 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.915 . . . . 5.2999999999999998 109.633 177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 59.2 46.63 12.71 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.324 -0.621 . . . . 6.9400000000000004 109.324 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.4 m 68.34 76.32 0.26 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.362 -1.29 . . . . 7.9199999999999999 109.851 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 103.3 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.707 2.271 . . . . 8.9900000000000002 112.626 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.8 m -73.67 -42.3 61.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.842 -0.617 . . . . 11.26 109.706 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 48.24 65.74 1.24 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.453 -0.794 . . . . 11.789999999999999 112.05 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.998 -1.001 . . . . 13.24 110.712 179.228 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.939 -0.465 . . . . 7.96 111.939 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.88 -66.9 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.13 0.491 . . . . 6.6299999999999999 110.261 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -130.53 40.52 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.491 0.662 . . . . 7.8300000000000001 110.01 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.67 -19.27 13.79 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 115.29 -0.868 . . . . 3.02 111.402 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.6 p -72.37 141.49 48.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.292 -0.954 . . . . 1.6699999999999999 110.413 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.492 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 3.6 m -147.43 124.39 11.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.706 -0.679 . . . . 0.65000000000000002 109.75 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.524 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.26000000000000001 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.46 ' CG1' HD22 ' A' ' 192' ' ' LEU . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 1.0600000000000001 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 1.02 110.616 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 1.0900000000000001 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 1.04 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.68000000000000005 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.3899999999999999 111.366 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.67000000000000004 111.96 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 1.3600000000000001 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 1.21 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.8899999999999999 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.9399999999999999 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.3100000000000001 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 1.05 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67000000000000004 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54000000000000004 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 2.02 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 167' ' ' HIS . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 1.0700000000000001 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.75 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.6599999999999999 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 1.0700000000000001 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32000000000000001 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.492 ' HD1' ' CB ' ' A' ' 143' ' ' THR . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.65000000000000002 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 1.04 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 1.02 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.20000000000000001 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 1.1100000000000001 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 1.05 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.33000000000000002 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.402 HG21 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 1.0600000000000001 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 1.0900000000000001 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 1.1200000000000001 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.3899999999999999 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.93000000000000005 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 1.1699999999999999 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.2400000000000002 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.46999999999999997 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 2.0899999999999999 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 1.1399999999999999 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.5699999999999998 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 2.1699999999999999 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.455 ' CD ' HG11 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.27000000000000002 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.23999999999999999 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 1.3300000000000001 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 1.0600000000000001 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.483 HD11 ' C ' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 2.0699999999999998 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.77000000000000002 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.558 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.533 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 1.1000000000000001 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.9500000000000002 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 1.03 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 1.1299999999999999 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.402 ' H ' HG21 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.94999999999999996 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.40000000000000002 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.76000000000000001 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.6599999999999999 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.17000000000000001 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.437 HG12 HD21 ' A' ' 228' ' ' LEU . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 1.03 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.20000000000000001 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.462 ' CG1' HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 1.0600000000000001 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.57999999999999996 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 1.05 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 1.4199999999999999 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.91000000000000003 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.56000000000000005 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.4 HG12 ' HD2' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 1.1000000000000001 110.035 -173.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 190' ' ' LEU . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.39000000000000001 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 1.3 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 1.02 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.42999999999999999 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 1.3999999999999999 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.533 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 1.04 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 1.1799999999999999 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 1.1799999999999999 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.39000000000000001 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.93999999999999995 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.416 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.6400000000000001 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.437 HD21 HG12 ' A' ' 204' ' ' ILE . 44.5 mt -99.34 -25.86 14.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 1.0900000000000001 111.225 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.2 57.27 0.72 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 109.914 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 p -87.41 -27.37 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.56 -0.745 . . . . 2.5499999999999998 110.917 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 88.17 -28.91 5.84 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.673 -0.694 . . . . 3.7599999999999998 111.946 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.34 -31.22 19.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 5.2199999999999998 110.632 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.661 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 33.6 mmt180 -100.39 -179.61 0.85 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.807 -0.633 . . . . 7.7400000000000002 109.571 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.661 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.0 Cg_exo -70.51 142.96 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.461 2.108 . . . . 2.9900000000000002 111.727 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.58 136.6 25.05 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.01 -0.541 . . . . 1.9299999999999999 109.778 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.6 134.72 31.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.843 2.362 . . . . 0.63 112.083 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.5 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.93000000000000005 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 1.03 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 1.1200000000000001 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 1.05 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.449 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 1.6499999999999999 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 1.03 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.7799999999999998 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.6599999999999999 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.73 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 1.0800000000000001 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 3.25 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.671 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 1.04 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 1.0600000000000001 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.97999999999999998 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.74 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.7999999999999998 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 1.0800000000000001 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.85 -29.9 26.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.7 110.779 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -67.25 -13.18 61.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 1.5800000000000001 110.273 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -73.69 -3.12 26.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.731 0.777 . . . . 6.3200000000000003 111.143 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.76 53.87 9.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.282 -1.326 . . . . 5.2999999999999998 112.514 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.82 126.28 28.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 6.9400000000000004 110.253 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.9 t -71.3 123.86 90.04 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.096 -0.502 . . . . 7.9199999999999999 110.602 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.38 121.65 9.93 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.352 2.035 . . . . 8.9900000000000002 110.466 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.8 m 63.54 78.64 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 11.26 108.93 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -53.76 137.18 38.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 11.789999999999999 112.548 -171.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.245 0.819 0 CA-C-N 115.257 -0.883 . . . . 13.24 110.008 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 143' ' ' THR . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.985 -0.446 . . . . 7.96 111.985 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.84 169.09 9.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.554 -0.165 . . . . 6.6299999999999999 110.554 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 60.4 mtm 57.61 78.87 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.607 0.567 . . . . 7.8300000000000001 111.286 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.28 -118.37 4.1 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.458 -0.877 . . . . 3.02 111.877 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 p -69.59 95.83 0.88 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.122 0.486 . . . . 1.6699999999999999 110.855 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 1.4 m -78.4 116.48 18.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.923 -0.58 . . . . 0.65000000000000002 109.872 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.26000000000000001 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 1.0600000000000001 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 1.02 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 1.0900000000000001 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 1.04 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.68000000000000005 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.506 ' OD1' ' HB1' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.3899999999999999 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.688 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.67000000000000004 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 1.3600000000000001 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 1.21 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.688 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.8899999999999999 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.9399999999999999 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.3100000000000001 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 1.05 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67000000000000004 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 2.02 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 167' ' ' HIS . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 1.0700000000000001 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.75 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.6599999999999999 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 1.0700000000000001 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32000000000000001 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.452 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.65000000000000002 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 1.04 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 1.02 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.20000000000000001 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 1.1100000000000001 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 1.05 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.33000000000000002 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 1.0600000000000001 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 1.0900000000000001 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 1.1200000000000001 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.3899999999999999 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.93000000000000005 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.4 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 1.1699999999999999 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.2400000000000002 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.46999999999999997 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 2.0899999999999999 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 1.1399999999999999 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.5699999999999998 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 2.1699999999999999 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.412 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.27000000000000002 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.23999999999999999 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 1.3300000000000001 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 1.0600000000000001 111.144 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 2.0699999999999998 109.357 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.77000000000000002 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 1.1000000000000001 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.9500000000000002 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.478 HD12 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 1.03 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.506 ' HB1' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 1.1299999999999999 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.94999999999999996 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.40000000000000002 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.76000000000000001 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.6599999999999999 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.17000000000000001 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 1.03 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.436 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.20000000000000001 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.419 HG12 HG13 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 1.0600000000000001 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.57999999999999996 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 1.05 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 1.4199999999999999 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.91000000000000003 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.56000000000000005 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 1.1000000000000001 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.39000000000000001 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.419 HG13 HG12 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 1.02 110.07 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.42999999999999999 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.423 HG21 ' HE3' ' A' ' 242' ' ' LYS . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 1.3999999999999999 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 1.04 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 1.1799999999999999 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 1.1799999999999999 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.39000000000000001 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.93999999999999995 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.6400000000000001 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.48 -15.45 56.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 1.0900000000000001 111.048 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.4 mt -103.15 34.26 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.706 -0.679 . . . . 1.6000000000000001 110.167 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -170.19 151.92 4.04 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.34 -0.615 . . . . 2.5499999999999998 109.34 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 119.51 11.44 7.27 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.686 -0.688 . . . . 3.7599999999999998 112.249 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.1 t70 65.1 27.18 12.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.763 0.792 . . . . 5.2199999999999998 109.724 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.423 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 87.4 mtt180 -115.1 171.06 4.81 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.447 -0.797 . . . . 7.7400000000000002 110.413 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 38.1 Cg_exo -67.76 160.1 49.79 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.533 2.822 . . . . 2.9900000000000002 111.894 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.26 22.97 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.425 -0.583 . . . . 1.9299999999999999 109.425 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.02 127.18 14.03 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.716 2.277 . . . . 0.63 112.553 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.5 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.93000000000000005 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 1.03 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 1.1200000000000001 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 1.05 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.423 ' HE3' HG21 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 1.6499999999999999 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 1.03 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.53000000000000003 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.7799999999999998 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.6599999999999999 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.73 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 1.0800000000000001 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 1.0800000000000001 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 3.25 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.595 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 1.04 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 1.0600000000000001 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.97999999999999998 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.74 111.01 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.7999999999999998 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 1.0800000000000001 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -92.36 -8.99 43.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.7 110.902 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 254' ' ' SER . 70.8 t80 -78.05 -52.41 8.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.372 0.606 . . . . 1.5800000000000001 109.725 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -85.6 -11.85 52.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.474 -0.784 . . . . 6.3200000000000003 110.888 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 53.37 31.65 12.35 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.624 -1.171 . . . . 5.2999999999999998 112.137 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -156.42 158.16 36.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.812 -0.44 . . . . 6.9400000000000004 109.812 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.488 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 34.3 m -147.94 -48.22 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.271 -0.422 . . . . 7.9199999999999999 111.375 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 3.5 Cg_exo -76.38 162.59 33.41 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.872 1.715 . . . . 8.9900000000000002 111.673 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 82.5 p 50.41 34.26 8.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.355 0.662 . . . . 11.26 111.968 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -102.17 127.18 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.16 -0.473 . . . . 11.789999999999999 111.051 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.679 -0.677 . . . . 13.24 109.848 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.965 -0.454 . . . . 7.96 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.53 -28.6 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 6.6299999999999999 110.845 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -78.69 121.04 24.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.104 -0.498 . . . . 7.8300000000000001 110.697 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.6 -138.24 2.38 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.717 -0.674 . . . . 3.02 111.495 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 0.6 OUTLIER -81.26 94.52 6.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 1.6699999999999999 110.315 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.445 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 4.7 m -77.19 132.15 38.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 111.069 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.26000000000000001 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 1.0600000000000001 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 1.02 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 1.0900000000000001 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 1.04 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.68000000000000005 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.498 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.3899999999999999 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.67000000000000004 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 1.3600000000000001 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 1.21 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.8899999999999999 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.457 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.9399999999999999 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 10.5 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.3100000000000001 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 1.05 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67000000000000004 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 2.02 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 1.0700000000000001 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.75 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.6599999999999999 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 1.0700000000000001 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32000000000000001 112.185 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.503 ' HB2' HG23 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.65000000000000002 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.1899999999999999 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 1.04 110.364 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 1.02 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.20000000000000001 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 1.1100000000000001 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.33000000000000002 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.55 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 1.0600000000000001 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 1.1200000000000001 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.3899999999999999 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.93000000000000005 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 1.1699999999999999 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2400000000000002 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 2.0899999999999999 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 1.1399999999999999 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.5699999999999998 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 2.1699999999999999 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.27000000000000002 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.23999999999999999 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 1.3300000000000001 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.416 ' HB ' HG21 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 1.0600000000000001 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 2.0699999999999998 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' N ' HD11 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.77000000000000002 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.648 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 1.1000000000000001 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.9500000000000002 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 HD12 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 1.03 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 1.1299999999999999 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.55 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.94999999999999996 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.40000000000000002 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.76000000000000001 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.6599999999999999 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.17000000000000001 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.412 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 1.03 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.20000000000000001 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 1.0600000000000001 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.57999999999999996 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 1.05 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 1.4199999999999999 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.1 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.91000000000000003 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.56000000000000005 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 1.1000000000000001 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' A' ' 216' ' ' VAL . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.39000000000000001 112.241 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 1.3 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 1.02 110.087 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.42999999999999999 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 1.3999999999999999 108.614 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.509 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 1.04 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 1.1799999999999999 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 1.1799999999999999 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.39000000000000001 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.93999999999999995 111.771 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.42 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.6400000000000001 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.02 -29.24 13.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 1.0900000000000001 112.155 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.57 53.24 2.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 1.6000000000000001 110.609 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.3 t 174.94 158.86 0.18 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.911 -0.774 . . . . 2.5499999999999998 108.911 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 233' ' ' ARG . . . 110.0 21.0 7.26 Favored Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.846 -0.616 . . . . 3.7599999999999998 112.662 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 t70 73.61 -28.31 0.19 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.438 0.695 . . . . 5.2199999999999998 111.804 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 231' ' ' GLY . 18.1 ptt180 -65.72 167.27 11.66 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.547 -0.751 . . . . 7.7400000000000002 111.542 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -72.21 153.62 56.71 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.185 2.59 . . . . 2.9900000000000002 111.635 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -63.28 139.73 97.6 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 109.018 -0.734 . . . . 1.9299999999999999 109.018 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.67 127.0 22.92 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.499 2.133 . . . . 0.63 111.562 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.5 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.93000000000000005 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 1.03 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 1.1200000000000001 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 1.05 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 1.6499999999999999 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 1.03 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.53000000000000003 111.302 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.7799999999999998 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.6599999999999999 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.73 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 1.0800000000000001 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 1.0800000000000001 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 3.25 110.424 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 1.04 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 1.0600000000000001 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.97999999999999998 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.74 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.7999999999999998 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 1.0800000000000001 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.06 -28.25 60.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.7 111.063 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.61 -24.36 67.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.868 -0.79 . . . . 1.5800000000000001 108.868 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 22.9 t80 55.92 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.428 -1.26 . . . . 6.3200000000000003 111.978 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.03 108.26 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.301 -1.318 . . . . 5.2999999999999998 110.105 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 261' ' ' ASN . 0.9 OUTLIER -64.43 145.1 56.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 6.9400000000000004 110.74 -176.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.504 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 33.3 m -52.63 -51.89 69.2 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.531 0.567 . . . . 7.9199999999999999 112.531 -176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 51.8 Cg_exo -53.72 -62.95 0.26 Allowed 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 121.972 1.781 . . . . 8.9900000000000002 112.564 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.1 t -156.04 147.91 23.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.634 -0.712 . . . . 11.26 110.695 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -157.75 36.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 11.789999999999999 109.842 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.211 -0.9 . . . . 13.24 110.942 -176.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.015 -0.434 . . . . 7.96 112.015 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.41 107.71 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.995 0.426 . . . . 6.6299999999999999 110.976 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.9 ptm -137.46 21.74 2.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.267 0.556 . . . . 7.8300000000000001 110.094 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.25 171.76 32.34 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.997 -0.841 . . . . 3.02 110.997 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 2.5 p -80.06 94.14 5.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 1.6699999999999999 111.056 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.514 ' CB ' ' HD1' ' A' ' 167' ' ' HIS . 1.3 m -78.31 118.8 20.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.502 -0.772 . . . . 0.65000000000000002 109.584 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.26000000000000001 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 1.0600000000000001 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 1.02 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 1.0900000000000001 111.185 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 1.04 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.68000000000000005 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.3899999999999999 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.67000000000000004 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 1.3600000000000001 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 1.21 110.473 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.6 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.8899999999999999 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.9399999999999999 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 109.784 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 1.05 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67000000000000004 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54000000000000004 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 2.02 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 167' ' ' HIS . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 1.0700000000000001 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.75 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.6599999999999999 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 250' ' ' ARG . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0700000000000001 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32000000000000001 112.247 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.528 ' HB2' HG21 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.65000000000000002 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 1.04 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 1.02 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.20000000000000001 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 1.1100000000000001 110.114 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 1.05 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.33000000000000002 111.202 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 1.0600000000000001 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.488 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 1.0900000000000001 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 1.1200000000000001 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.3899999999999999 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.93000000000000005 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 1.1699999999999999 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.46999999999999997 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.424 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 2.0899999999999999 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 1.1399999999999999 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.5699999999999998 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 2.1699999999999999 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.27000000000000002 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.23999999999999999 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.449 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 1.3300000000000001 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 1.0600000000000001 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 2.0699999999999998 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.77000000000000002 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.535 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 1.1000000000000001 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.9500000000000002 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.494 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 1.03 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 1.1299999999999999 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.428 ' H ' HG23 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.94999999999999996 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.40000000000000002 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.76000000000000001 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.489 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.17000000000000001 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 1.03 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.20000000000000001 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 1.0600000000000001 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.57999999999999996 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 1.05 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 1.4199999999999999 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.91000000000000003 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.424 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.56000000000000005 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 1.1000000000000001 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.405 ' O ' HD11 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.39000000000000001 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 1.3 110.869 -175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 1.02 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.42999999999999999 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 1.3999999999999999 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.628 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 1.04 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 1.1799999999999999 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.441 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.39000000000000001 111.543 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.93999999999999995 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.6400000000000001 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt -77.25 -27.65 53.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 1.0900000000000001 111.676 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 52.6 mt -77.91 -13.15 59.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 1.6000000000000001 109.972 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 61.7 p -112.59 14.46 20.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.035 -0.984 . . . . 2.5499999999999998 110.538 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.22 97.88 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.189 -0.764 . . . . 3.7599999999999998 111.189 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -162.7 -76.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.106 -0.702 . . . . 5.2199999999999998 109.106 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 95.2 mtt180 -154.06 -54.62 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.74 -1.118 . . . . 7.7400000000000002 109.989 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 27.7 Cg_exo -63.09 160.85 32.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.142 1.895 . . . . 2.9900000000000002 111.93 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.14 154.4 37.66 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.686 -0.688 . . . . 1.9299999999999999 110.449 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.437 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo -62.84 141.28 84.1 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.78 2.32 . . . . 0.63 110.994 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.5 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.93000000000000005 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 1.03 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 1.1200000000000001 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 1.6499999999999999 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 1.03 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.53000000000000003 111.586 -173.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.554 ' O ' HG22 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.7799999999999998 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.73 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 1.0800000000000001 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 1.0800000000000001 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 3.25 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 1.04 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 1.0600000000000001 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.97999999999999998 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.74 111.29 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.7999999999999998 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 1.0800000000000001 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt -93.62 -2.13 54.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.7 111.078 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.76 -24.74 24.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.524 -0.762 . . . . 1.5800000000000001 109.801 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 33.6 t80 65.81 118.13 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 6.3200000000000003 111.283 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.66 69.51 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.479 -0.782 . . . . 5.2999999999999998 111.246 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.01 -63.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.468 -0.567 . . . . 6.9400000000000004 109.468 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 46.1 m -154.21 65.09 4.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.12 -0.491 . . . . 7.9199999999999999 110.036 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.94 -58.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.828 2.352 . . . . 8.9900000000000002 112.295 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.4 m 63.28 63.23 0.92 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.293 -0.867 . . . . 11.26 109.993 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.65 156.96 31.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.563 -0.744 . . . . 11.789999999999999 110.638 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.163 -0.922 . . . . 13.24 111.37 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.859 -0.497 . . . . 7.96 111.859 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.45 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.866 -0.42 . . . . 6.6299999999999999 109.866 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp 62.87 24.64 14.66 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.461 0.476 . . . . 7.8300000000000001 109.899 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.23 -134.15 36.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.552 -0.749 . . . . 3.02 111.795 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 p -129.23 142.03 50.97 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.981 0.42 . . . . 1.6699999999999999 110.808 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.432 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m -77.35 116.48 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.65000000000000002 110.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.26000000000000001 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 1.0600000000000001 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 1.02 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 1.0900000000000001 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 1.04 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.68000000000000005 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.3899999999999999 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.67000000000000004 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 1.3600000000000001 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 1.21 110.394 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.8899999999999999 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.523 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.9399999999999999 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.3100000000000001 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 1.05 110.79 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67000000000000004 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54000000000000004 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 2.02 111.37 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.447 ' HA ' HD11 ' A' ' 165' ' ' LEU . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 1.0700000000000001 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.75 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.6599999999999999 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 1.0700000000000001 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32000000000000001 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.441 ' HB2' HG21 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.65000000000000002 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.1899999999999999 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 1.04 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 1.02 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.20000000000000001 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 1.1100000000000001 109.939 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 1.05 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.33000000000000002 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 1.0600000000000001 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 1.0900000000000001 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 1.1200000000000001 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.3899999999999999 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.93000000000000005 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 1.1699999999999999 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.2400000000000002 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.46999999999999997 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.4 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 2.0899999999999999 110.072 -177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 1.1399999999999999 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.5699999999999998 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 2.1699999999999999 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.27000000000000002 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.23999999999999999 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 1.3300000000000001 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 1.0600000000000001 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 2.0699999999999998 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.77000000000000002 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.552 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 1.1000000000000001 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.9500000000000002 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 1.03 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 1.1299999999999999 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.94999999999999996 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.40000000000000002 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.76000000000000001 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.6599999999999999 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.17000000000000001 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.432 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 1.03 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.20000000000000001 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 1.0600000000000001 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.57999999999999996 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 1.05 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 1.4199999999999999 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 37.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.91000000000000003 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.4 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.56000000000000005 109.752 176.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 1.1000000000000001 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.434 ' O ' HD11 ' A' ' 190' ' ' LEU . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.39000000000000001 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 1.3 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.422 ' HB ' HD21 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 1.02 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.42999999999999999 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.489 HG13 ' HB ' ' A' ' 240' ' ' VAL . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 1.3999999999999999 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.552 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 1.04 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 1.1799999999999999 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 1.1799999999999999 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.592 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.39000000000000001 111.806 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.93999999999999995 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.6400000000000001 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt -83.13 -22.03 33.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 1.0900000000000001 112.362 -172.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 58.8 mt -80.48 12.11 3.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.083 0.468 . . . . 1.6000000000000001 110.774 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.1 t -151.25 44.52 0.8 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.583 0.706 . . . . 2.5499999999999998 110.295 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.4 -73.77 0.44 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.914 -0.66 . . . . 3.7599999999999998 111.503 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -130.35 -45.49 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.903 -0.777 . . . . 5.2199999999999998 108.903 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.601 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 57.2 mtp180 -148.9 -59.52 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.368 -0.833 . . . . 7.7400000000000002 111.636 173.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 4.0 Cg_exo -76.68 153.58 34.09 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.236 1.957 . . . . 2.9900000000000002 112.625 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 236' ' ' PRO . 7.7 pt-20 -95.71 160.29 30.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.649 -0.871 . . . . 1.9299999999999999 108.649 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.488 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo -67.4 133.61 30.8 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.515 2.143 . . . . 0.63 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.402 HG23 HE22 ' A' ' 260' ' ' GLN . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.607 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 1.03 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.489 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 1.1200000000000001 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 1.05 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 1.6499999999999999 110.129 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 1.03 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.53000000000000003 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.7799999999999998 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.6599999999999999 111.032 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.73 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 1.0800000000000001 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 3.25 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 1.04 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 1.0600000000000001 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.97999999999999998 111.508 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.74 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.7999999999999998 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 1.0800000000000001 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.27 6.62 39.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.7 111.52 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -84.3 -4.43 58.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.411 -0.959 . . . . 1.5800000000000001 108.411 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 10.4 t80 69.45 51.24 0.49 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.71 -1.586 . . . . 6.3200000000000003 111.591 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.402 HE22 HG23 ' A' ' 237' ' ' THR . 20.5 mm-40 66.79 102.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.829 -1.078 . . . . 5.2999999999999998 112.278 172.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.79 -27.27 15.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 6.9400000000000004 110.739 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 15.4 m -60.88 -46.05 96.79 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.188 -0.46 . . . . 7.9199999999999999 111.804 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 10.7 Cg_exo -74.34 62.69 5.29 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.041 1.827 . . . . 8.9900000000000002 110.884 171.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.6 m -58.63 129.97 44.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.416 -0.811 . . . . 11.26 111.055 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -78.46 78.91 4.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.992 -0.549 . . . . 11.789999999999999 110.927 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.978 -0.556 . . . . 13.24 111.013 179.667 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.133 -0.387 . . . . 7.96 112.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.23 171.03 8.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.634 0.254 . . . . 6.6299999999999999 110.679 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.2 mtt -139.51 85.35 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.842 0.353 . . . . 7.8300000000000001 110.845 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.16 -153.8 24.79 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.687 -0.768 . . . . 3.02 112.181 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.2 p -69.04 96.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 1.6699999999999999 110.988 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.455 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 2.7 m -76.65 118.6 19.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.568 -0.742 . . . . 0.65000000000000002 110.082 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.26000000000000001 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 1.0600000000000001 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 1.02 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 1.04 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.68000000000000005 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.3899999999999999 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.67000000000000004 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 1.3600000000000001 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 1.21 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.8899999999999999 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.9399999999999999 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.3100000000000001 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 1.05 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67000000000000004 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 2.02 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 167' ' ' HIS . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 1.0700000000000001 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 163' ' ' ARG . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.75 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.6599999999999999 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 1.0700000000000001 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32000000000000001 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.471 ' HB2' HG23 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.65000000000000002 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 1.02 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.20000000000000001 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 1.1100000000000001 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 1.05 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.33000000000000002 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 1.0600000000000001 110.015 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 1.0900000000000001 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.3899999999999999 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.515 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.93000000000000005 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.6 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 1.1699999999999999 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.46999999999999997 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 2.0899999999999999 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 1.1399999999999999 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.5699999999999998 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 2.1699999999999999 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.27000000000000002 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.23999999999999999 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HB3' HG23 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 1.3300000000000001 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 1.0600000000000001 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 2.0699999999999998 107.655 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.77000000000000002 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.518 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 1.1000000000000001 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.9500000000000002 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 1.03 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 1.1299999999999999 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.94999999999999996 110.973 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.40000000000000002 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.76000000000000001 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.2 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.17000000000000001 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.408 HG12 HD21 ' A' ' 228' ' ' LEU . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 1.03 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.20000000000000001 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.632 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 1.0600000000000001 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.57999999999999996 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 1.05 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 1.4199999999999999 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.2 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.91000000000000003 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.56000000000000005 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 1.1000000000000001 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.39000000000000001 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 1.3 110.738 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 1.02 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.42999999999999999 110.914 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 1.3999999999999999 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.551 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 1.04 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 1.1799999999999999 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.1799999999999999 110.527 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.39000000000000001 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.93999999999999995 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.6400000000000001 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt -98.22 -12.7 21.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 1.0900000000000001 112.4 -177.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.93 0.94 54.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.483 0.658 . . . . 1.6000000000000001 110.395 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.6 t -167.16 48.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.938 -1.028 . . . . 2.5499999999999998 110.046 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.16 -63.1 1.75 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.685 -0.769 . . . . 3.7599999999999998 111.749 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -172.08 -32.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.532 0.682 . . . . 5.2199999999999998 109.705 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.634 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 38.3 mtt180 -104.82 -170.65 0.21 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.126 -0.943 . . . . 7.7400000000000002 108.765 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 12.4 Cg_exo -70.0 175.3 8.48 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.943 1.762 . . . . 2.9900000000000002 111.756 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.93 138.02 97.11 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.38 -0.827 . . . . 1.9299999999999999 109.955 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo -66.36 127.92 18.33 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.946 2.431 . . . . 0.63 111.845 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.5 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.93000000000000005 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 1.03 110.291 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 1.1200000000000001 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 1.05 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 221' ' ' ILE . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 1.6499999999999999 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 1.03 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.53000000000000003 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.508 ' O ' HG22 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.7799999999999998 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.73 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 1.0800000000000001 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 1.0800000000000001 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 3.25 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 1.04 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 1.0600000000000001 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.97999999999999998 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 27.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.7999999999999998 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 1.0800000000000001 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt -78.52 -24.52 45.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.7 111.553 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -73.71 -12.84 60.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 1.5800000000000001 109.867 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 58.3 t80 -81.66 -2.87 51.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.766 0.793 . . . . 6.3200000000000003 110.341 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.31 122.71 29.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.381 -0.827 . . . . 5.2999999999999998 110.647 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.98 123.51 22.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.165 -0.47 . . . . 6.9400000000000004 109.893 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.5 m -119.58 85.48 32.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.968 0.413 . . . . 7.9199999999999999 110.974 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.23 -8.72 21.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.077 2.518 . . . . 8.9900000000000002 111.923 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.9 p -81.89 -21.33 37.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.485 -0.78 . . . . 11.26 110.901 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.97 81.76 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.529 . . . . 11.789999999999999 110.637 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.53 -0.747 . . . . 13.24 109.987 -179.419 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.939 -0.464 . . . . 7.96 111.939 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.5 -27.75 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.764 0.316 . . . . 6.6299999999999999 111.483 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.83 29.53 7.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.334 0.588 . . . . 7.8300000000000001 110.666 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.04 123.65 1.37 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.172 -0.771 . . . . 3.02 111.172 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 p -92.46 118.12 30.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.039 0.447 . . . . 1.6699999999999999 111.505 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m -78.54 125.3 29.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.98 -0.555 . . . . 0.65000000000000002 109.776 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.26000000000000001 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 1.0600000000000001 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 1.02 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 1.0900000000000001 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.04 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.68000000000000005 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.67000000000000004 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 1.3600000000000001 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 1.21 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.547 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.8899999999999999 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.9399999999999999 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 1.05 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67000000000000004 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 2.02 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 1.0700000000000001 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.75 110.586 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.6599999999999999 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 1.0700000000000001 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 138' ' ' GLY . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32000000000000001 112.019 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.524 ' HB2' HG21 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.65000000000000002 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.1899999999999999 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 1.04 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 1.02 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.20000000000000001 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 1.1100000000000001 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 1.05 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.33000000000000002 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 1.0600000000000001 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 1.0900000000000001 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 1.1200000000000001 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.3899999999999999 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.93000000000000005 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 1.1699999999999999 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.2400000000000002 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.46999999999999997 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 1.1399999999999999 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.5699999999999998 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 2.1699999999999999 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.418 ' CD ' HG11 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.27000000000000002 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.23999999999999999 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.47 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 1.0600000000000001 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 2.0699999999999998 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.77000000000000002 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.497 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 1.1000000000000001 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.9500000000000002 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 1.03 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 1.1299999999999999 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.76000000000000001 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.6599999999999999 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.17000000000000001 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.468 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 1.03 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.20000000000000001 110.087 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.455 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 1.0600000000000001 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.57999999999999996 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.443 ' HA ' HE21 ' A' ' 213' ' ' GLN . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 1.05 110.862 174.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 1.4199999999999999 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 210' ' ' ILE . 34.0 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.91000000000000003 109.728 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.56000000000000005 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 1.1000000000000001 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.39000000000000001 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.455 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 1.3 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 1.02 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.42999999999999999 110.2 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 1.3999999999999999 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 1.04 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 1.1799999999999999 110.403 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 1.1799999999999999 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.39000000000000001 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 230' ' ' THR . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.93999999999999995 111.712 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.6400000000000001 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt -97.87 1.23 47.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 1.0900000000000001 111.067 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -120.69 -133.17 0.3 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.719 -0.673 . . . . 1.6000000000000001 110.225 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 226' ' ' GLU . 14.8 p 58.61 4.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.017 1.327 . . . . 2.5499999999999998 112.461 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.47 67.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.203 -0.523 . . . . 3.7599999999999998 112.553 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 -37.46 10.07 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 5.2199999999999998 111.21 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.577 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 26.1 mmt180 -113.84 -178.29 0.51 Allowed Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.585 -0.734 . . . . 7.7400000000000002 110.217 -174.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 10.4 Cg_exo -72.83 137.29 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.632 2.222 . . . . 2.9900000000000002 111.347 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.45 119.61 75.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.602 -0.726 . . . . 1.9299999999999999 110.207 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.06 139.94 19.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.14 2.56 . . . . 0.63 112.358 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.5 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.93000000000000005 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 1.03 111.008 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 1.1200000000000001 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 1.05 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 1.6499999999999999 109.56 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 1.03 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.53000000000000003 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 249' ' ' VAL . 16.2 mm100 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.7799999999999998 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.6599999999999999 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.556 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.73 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 1.0800000000000001 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 3.25 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 1.04 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.97999999999999998 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.74 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.7999999999999998 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 1.0800000000000001 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 37.2 mt -80.3 -12.01 59.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.7 111.205 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -86.59 -45.49 11.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.523 -0.917 . . . . 1.5800000000000001 108.523 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HD2' ' ND2' ' A' ' 261' ' ' ASN . 1.4 t80 60.26 88.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.519 -1.219 . . . . 6.3200000000000003 110.933 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -79.39 104.6 10.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.23 -1.35 . . . . 5.2999999999999998 110.234 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 259' ' ' PHE . 7.5 p30 -159.16 -44.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.768 -0.196 . . . . 6.9400000000000004 110.902 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.5 p 176.49 146.63 0.27 Allowed Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 122.939 0.496 . . . . 7.9199999999999999 109.669 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.96 53.29 4.11 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.682 2.255 . . . . 8.9900000000000002 111.697 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.7 m -148.69 123.22 9.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.752 -0.658 . . . . 11.26 110.134 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.73 44.94 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.214 0.531 . . . . 11.789999999999999 111.083 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.248 1.005 0 CA-C-N 116.102 -0.499 . . . . 13.24 110.522 179.112 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.939 -0.464 . . . . 7.96 111.939 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.56 77.87 9.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.853 0.359 . . . . 6.6299999999999999 110.156 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.1 mmt 63.64 44.95 4.85 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.509 -0.769 . . . . 7.8300000000000001 110.552 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.51 -129.09 30.69 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.128 -0.789 . . . . 3.02 111.128 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -82.55 118.68 23.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.799 -0.815 . . . . 1.6699999999999999 108.799 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.414 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 8.4 m -76.23 122.45 24.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.016 0.436 . . . . 0.65000000000000002 110.757 -173.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.26000000000000001 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 1.0600000000000001 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 1.02 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 1.0900000000000001 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 1.04 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.68000000000000005 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.3899999999999999 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.67000000000000004 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 1.3600000000000001 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.418 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 1.21 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.58 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.8899999999999999 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.9399999999999999 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.3100000000000001 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 1.05 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67000000000000004 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54000000000000004 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 2.02 111.018 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 167' ' ' HIS . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 1.0700000000000001 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.75 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.6599999999999999 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 1.0700000000000001 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32000000000000001 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.488 ' HB2' HG23 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.65000000000000002 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 1.04 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 1.02 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.20000000000000001 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 1.1100000000000001 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.33000000000000002 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 1.0600000000000001 110.272 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.56 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 1.0900000000000001 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 1.1200000000000001 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.3899999999999999 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.93000000000000005 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.2 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 1.1699999999999999 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.2400000000000002 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.46999999999999997 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 2.0899999999999999 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 1.1399999999999999 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.5699999999999998 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 2.1699999999999999 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.27000000000000002 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.23999999999999999 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.421 ' HB3' HG23 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 1.3300000000000001 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 1.0600000000000001 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 2.0699999999999998 108.206 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.77000000000000002 112.388 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.635 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.535 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 1.1000000000000001 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.9500000000000002 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 1.03 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 1.1299999999999999 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.94999999999999996 111.053 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.40000000000000002 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.76000000000000001 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.6599999999999999 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.17000000000000001 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.453 ' CD1' HD21 ' A' ' 228' ' ' LEU . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 1.03 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.20000000000000001 110.132 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 1.0600000000000001 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 1.05 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 1.4199999999999999 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.91000000000000003 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.428 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.56000000000000005 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 1.1000000000000001 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.47 ' HG3' ' NE2' ' A' ' 260' ' ' GLN . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.39000000000000001 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 191' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 1.3 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 1.02 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . 0.428 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.42999999999999999 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 1.3999999999999999 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.595 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 1.04 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.1799999999999999 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 1.1799999999999999 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.39000000000000001 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.93999999999999995 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.535 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.6400000000000001 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.453 HD21 ' CD1' ' A' ' 204' ' ' ILE . 20.8 mt -92.48 -46.66 7.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 1.0900000000000001 110.613 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.92 69.84 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 1.6000000000000001 110.791 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 2.2 p -81.44 51.92 1.75 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.851 -0.613 . . . . 2.5499999999999998 111.782 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.67 -110.86 3.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.632 . . . . 3.7599999999999998 112.959 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.52 4.78 53.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.827 0.346 . . . . 5.2199999999999998 111.414 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.582 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 76.3 mtt180 -85.16 -178.85 1.26 Allowed Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.398 -0.594 . . . . 7.7400000000000002 109.398 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.582 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 2.8 Cg_exo -70.86 141.6 41.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.412 2.075 . . . . 2.9900000000000002 112.814 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.99 142.21 24.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 115.375 -0.829 . . . . 1.9299999999999999 109.893 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.428 ' HG3' HD12 ' A' ' 228' ' ' LEU . 37.2 Cg_endo -66.55 130.9 24.7 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.994 2.463 . . . . 0.63 111.533 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.5 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.93000000000000005 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 1.03 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 1.1200000000000001 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 1.05 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 1.6499999999999999 109.345 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 1.03 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.53000000000000003 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.7799999999999998 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.6599999999999999 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.73 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 1.0800000000000001 110.987 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 1.0800000000000001 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 3.25 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.51 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 1.04 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 1.0600000000000001 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.74 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.7999999999999998 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 1.0800000000000001 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.559 ' HA ' ' NE2' ' A' ' 260' ' ' GLN . 82.8 mt -93.68 5.25 52.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.7 111.559 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -104.64 -52.68 2.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.868 -0.605 . . . . 1.5800000000000001 110.138 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -79.42 72.46 6.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.473 -0.785 . . . . 6.3200000000000003 111.077 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 257' ' ' LEU . 80.3 mt-30 -134.05 156.73 47.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.55 -0.75 . . . . 5.2999999999999998 110.325 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.75 -62.84 1.52 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.549 -0.537 . . . . 6.9400000000000004 109.549 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.0 p -142.89 105.55 5.29 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.798 -0.637 . . . . 7.9199999999999999 110.402 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.39 -2.29 11.9 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.34 2.027 . . . . 8.9900000000000002 112.356 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 40.5 p -113.32 3.53 15.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.911 -0.586 . . . . 11.26 111.025 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -148.21 169.74 19.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 11.789999999999999 111.234 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.246 -0.883 . . . . 13.24 110.213 178.197 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.846 -0.427 . . . . 0.51 109.846 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.23 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 0.24 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 0.16 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 0.23 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 0.16 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.5 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.29 111.47 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.59 112.932 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 0.71 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 0.46 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.29 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.35 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.31 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.24 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 246' ' ' GLU . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.42 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 145' ' ' VAL . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 0.29 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.25 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.16 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.4 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.532 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.5 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.19 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 0.24 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.17 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.35 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 0.29 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.29 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 0.32 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 0.9 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.4 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.19 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.25 110.682 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 19.5 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 0.99 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.24 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.4 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 1.33 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 0.44 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.02 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 1.62 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.26 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.24 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.2 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 1.47 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.18 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.558 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 0.23 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.28 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 0.27 111.009 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.45 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.95 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.36 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.33 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.48 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.21 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.15 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' A' ' 227' ' ' ARG . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.21 110.141 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.17 110.231 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 0.21 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.58 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 0.24 110.597 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.72 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.86 110.036 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.39 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 0.25 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.451 ' O ' HD12 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.28 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.47 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 0.63 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 0.19 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.35 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 0.67 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.558 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 0.25 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.42 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.7 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.36 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.94 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.05 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 0.52 110.586 177.337 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 121.108 0.379 . . . . 0.52 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.1 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.52 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 0.28 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 0.3 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 0.49 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 0.78 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 0.76 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.45 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 249' ' ' VAL . 72.4 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.14 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.544 ' HG2' HD11 ' A' ' 161' ' ' LEU . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.66 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.34 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 0.19 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 2.69 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 0.27 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.23 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.17 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.34 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 0.36 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.02 111.249 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.192 -0.299 . . . . 0.51 110.192 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.23 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 0.24 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 0.16 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 0.23 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 0.16 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.5 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.29 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.59 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 0.71 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 0.46 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.29 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.35 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.31 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.24 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 163' ' ' ARG . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54 110.556 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 1.42 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 0.29 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' ASP . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.25 110.732 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.16 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 162' ' ' VAL . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.4 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.5 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.19 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 0.23 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 0.24 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.17 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.431 HG22 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 0.35 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.29 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.32 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 0.9 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.4 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.19 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.25 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.7 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 0.99 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.24 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.4 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.33 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 0.44 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.02 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 1.62 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.26 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.24 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.604 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 0.65 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 0.2 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 1.47 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.18 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.641 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.537 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 0.23 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.28 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 0.27 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 0.45 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.95 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.36 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.33 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.21 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.15 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 195' ' ' ILE . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 0.21 109.83 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.17 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.475 HG13 HG21 ' A' ' 218' ' ' VAL . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.21 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.58 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 0.24 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.72 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.86 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.39 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 0.25 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' A' ' 216' ' ' VAL . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.28 112.452 -172.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.475 HG21 HG13 ' A' ' 207' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.35 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 0.67 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 0.25 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.42 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.7 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.36 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.94 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.473 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.05 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 195' ' ' ILE . 24.5 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 0.52 111.585 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 121.095 0.373 . . . . 0.52 111.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.1 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.52 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 0.28 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 0.3 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 0.49 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 0.78 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 0.76 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.45 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.14 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.66 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.34 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 0.25 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.19 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HB3' HD21 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 2.69 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 0.27 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 0.2 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.23 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.17 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.34 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 0.36 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.02 111.585 -179.163 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.055 0.455 . . . . 0.51 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.23 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.24 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 0.16 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.23 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 0.16 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.5 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.29 111.144 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.59 111.534 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 0.71 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 0.46 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.29 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.35 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.31 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 0.24 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 1.42 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 0.29 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.25 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.16 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 0.4 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.499 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.5 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.19 110.758 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 0.23 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 0.24 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.17 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 0.35 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 0.29 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.29 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.32 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 0.9 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 0.4 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.25 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 0.99 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.24 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.4 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 1.33 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.44 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.02 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 1.62 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.495 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.26 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.24 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 0.65 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 0.2 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 1.47 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.18 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.653 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.54 HD12 HD11 ' A' ' 204' ' ' ILE . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 0.23 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.28 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 0.27 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 0.45 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.95 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.36 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.33 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.555 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.21 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.15 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 195' ' ' ILE . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.21 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.17 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.438 ' CG1' HG11 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.21 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.58 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 0.24 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 0.72 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.86 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.39 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 0.25 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD12 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.28 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.438 HG11 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.63 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 0.19 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.35 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 0.67 108.866 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 0.25 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.42 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.7 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.36 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.94 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.472 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.05 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 0.52 111.393 -178.063 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 CA-C-O 121.37 0.487 . . . . 0.52 113.052 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.1 110.275 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.52 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.28 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 221' ' ' ILE . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 0.3 109.5 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 0.49 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 0.78 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 0.76 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.406 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.45 111.885 -171.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.14 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.66 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.34 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 0.25 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.19 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 2.69 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 0.27 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 0.2 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.23 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.17 111.227 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.34 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.02 111.241 -178.35 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.903 -0.406 . . . . 0.51 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.23 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.24 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.16 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 0.23 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 0.16 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.5 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.29 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.59 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 0.71 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 0.46 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.29 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.35 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.31 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 0.24 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 1.42 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 0.29 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.25 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.16 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 0.4 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.5 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.19 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 0.23 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 0.24 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.17 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 0.35 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 0.29 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.29 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 0.32 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 0.9 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.4 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.19 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 0.99 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.621 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.24 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.4 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 1.33 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 0.44 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.621 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 1.62 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.26 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.24 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 145' ' ' VAL . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 0.65 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 0.2 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 1.47 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.18 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.66 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 0.23 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.28 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.27 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 0.45 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.95 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.36 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.33 109.856 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.21 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.15 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 195' ' ' ILE . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.21 110.003 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.17 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 0.21 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.58 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 0.24 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 0.72 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.86 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.39 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 0.25 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.568 ' O ' HD12 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.28 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 0.63 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 0.19 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.35 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 0.67 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 0.25 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.42 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.7 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.36 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.94 111.08 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.05 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 0.52 112.083 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 121.056 0.357 . . . . 0.52 111.365 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.1 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.52 109.741 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 0.28 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.3 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 0.49 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.473 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.78 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 0.76 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.45 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 76.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.14 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.34 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 0.25 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 0.19 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 2.69 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 0.27 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 0.2 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.23 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.17 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.34 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 0.36 110.918 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.02 110.922 179.265 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.51 110.595 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.23 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 162' ' ' VAL . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 0.24 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.16 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 0.23 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 0.16 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.5 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.29 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.59 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.71 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 0.46 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.29 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.35 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.31 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 0.24 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD23 ' HE ' ' A' ' 250' ' ' ARG . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 1.42 111.407 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 0.29 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.25 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.16 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.4 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.5 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.19 110.877 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 0.23 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 0.24 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.17 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 0.35 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 0.29 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.29 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.32 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 0.9 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.4 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.19 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.99 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.24 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.4 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 1.33 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.02 110.699 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 1.62 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.26 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.24 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 145' ' ' VAL . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 0.65 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.4 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 0.2 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 1.47 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.452 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.18 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 204' ' ' ILE . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 0.23 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.28 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.27 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.45 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.95 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.36 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.33 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.21 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.15 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 195' ' ' ILE . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 0.21 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.449 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.17 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 0.21 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.58 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 0.24 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.72 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.86 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.39 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 0.25 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.466 ' O ' HD12 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.28 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.476 HG21 HG13 ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 0.63 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 0.19 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.35 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.453 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 0.67 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 0.25 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.42 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.7 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.36 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.94 111.853 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.05 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.52 110.825 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.463 -0.295 0 CA-C-O 121.176 0.406 . . . . 0.52 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.1 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.52 111.012 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.3 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 0.49 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.78 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 0.76 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.45 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.14 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.66 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.34 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HE ' HD23 ' A' ' 161' ' ' LEU . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 2.69 110.664 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 0.27 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 0.2 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.441 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.23 110.971 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.17 112.147 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.34 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 0.36 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.02 111.563 -177.016 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.436 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 23.5 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.381 -0.97 . . . . 0.51 108.381 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.23 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 162' ' ' VAL . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 0.24 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 0.16 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 0.23 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 0.16 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.5 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.29 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.59 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.71 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.46 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.29 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.35 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.31 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 0.24 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 249' ' ' VAL . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 1.42 111.35 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 145' ' ' VAL . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 0.29 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.25 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.16 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 0.4 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.5 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.19 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 0.23 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 0.24 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.17 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 0.35 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 0.29 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.29 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.32 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 0.9 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.4 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.19 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.25 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.9 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 0.99 110.802 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.24 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.4 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 1.33 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.02 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 1.62 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.26 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.24 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 0.65 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.2 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 1.47 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.18 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.612 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.54 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 0.23 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.28 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.404 HD11 ' HA2' ' A' ' 203' ' ' GLY . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.27 110.36 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 0.45 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.485 ' H ' HG22 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.95 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.36 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.33 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.21 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.15 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 195' ' ' ILE . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 0.21 110.069 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.17 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 0.21 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.58 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.406 HG21 HG21 ' A' ' 191' ' ' VAL . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 0.24 110.662 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 0.72 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.86 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.39 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 0.25 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.486 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.28 112.018 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 0.63 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 0.19 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.45 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.35 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 0.67 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.569 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 0.25 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 0.42 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.7 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.36 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.94 111.533 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.05 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 0.52 111.371 -178.383 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 N-CA-C 111.315 -0.302 . . . . 0.52 111.315 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.1 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.52 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 0.28 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 0.3 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 0.49 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 154' ' ' ILE . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 0.78 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 0.76 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.45 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.14 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.66 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.34 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 0.25 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 161' ' ' LEU . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 0.19 110.732 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 2.69 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 0.27 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.23 110.661 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.17 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 238' ' ' TYR . 13.4 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.34 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 0.36 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.02 111.172 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.391 -0.226 . . . . 0.51 110.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.23 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 0.24 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.23 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 0.16 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.5 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.29 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.59 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 0.71 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.46 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.29 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.35 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.31 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 0.24 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 1.42 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.572 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 0.29 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.25 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.16 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.4 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.5 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.19 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 0.23 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 0.24 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.17 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 0.35 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 0.29 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.29 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.9 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 0.4 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.19 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.25 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.99 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.24 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.4 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.02 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 1.62 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.26 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.24 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 0.65 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 0.2 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 1.47 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.442 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.18 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.591 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.5 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 0.23 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.28 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 0.27 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 0.45 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.95 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.36 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.33 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.21 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.15 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.41 ' CD1' ' HD2' ' A' ' 227' ' ' ARG . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.21 110.282 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.17 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 218' ' ' VAL . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 0.21 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.58 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 0.24 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.72 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.86 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.39 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 0.25 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.28 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 0.63 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.411 ' HB ' HD22 ' A' ' 192' ' ' LEU . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 0.19 109.87 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.425 ' O ' HD12 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.35 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 0.67 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 0.25 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 0.42 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 0.7 111.318 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.36 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.94 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.05 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.52 111.128 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 N-CA-C 111.062 -0.399 . . . . 0.52 111.062 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.1 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.52 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.28 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 0.3 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 0.49 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.78 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 0.76 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.45 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.14 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.448 ' HB3' HD21 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.66 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.34 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 0.25 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 0.19 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.439 ' HA ' HD11 ' A' ' 165' ' ' LEU . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 2.69 110.708 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 0.27 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 0.2 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.23 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.34 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 0.36 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.02 111.045 -179.143 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.916 -0.402 . . . . 0.51 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.23 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 0.24 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 0.16 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 0.23 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 0.16 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.5 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.29 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.59 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 0.71 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.46 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.29 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.427 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.35 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.31 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 0.24 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 1.42 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 0.29 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.25 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.16 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.4 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.5 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.19 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 0.23 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.24 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.17 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 0.35 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 0.29 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.29 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.32 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 0.9 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 0.4 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.19 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.25 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 0.99 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.24 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.4 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 1.33 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.44 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.02 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 1.62 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.26 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.24 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 0.65 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.2 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 1.47 107.71 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.18 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.403 HG12 ' OG1' ' A' ' 222' ' ' THR . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 0.23 112.023 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.28 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.864 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 0.45 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.95 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.36 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.33 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.21 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.15 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 0.21 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.17 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 0.21 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.58 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 0.24 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 0.72 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.86 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.39 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 0.25 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.28 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.63 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.472 ' O ' HD12 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.35 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 0.67 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 0.25 110.475 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 242' ' ' LYS . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.42 110.836 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 0.7 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.36 111.803 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.94 110.808 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.05 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 236' ' ' PRO . 18.2 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 0.52 111.62 -173.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HG3' HD22 ' A' ' 228' ' ' LEU . 52.1 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 119.773 -0.178 . . . . 0.52 112.06 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.1 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.52 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 0.28 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 0.3 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 0.49 112.044 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.43 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.78 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 0.76 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.405 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.45 111.421 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.558 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.14 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.66 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.34 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 0.25 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.19 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 2.69 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 0.27 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.2 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.413 HG13 HD21 ' A' ' 190' ' ' LEU . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.23 110.664 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.17 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 252' ' ' THR . 13.1 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.34 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 0.36 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 190' ' ' LEU . 83.2 mt . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.02 111.06 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.411 -0.588 . . . . 0.51 109.411 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.23 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 0.24 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 0.16 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 0.23 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 0.16 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.29 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.59 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.71 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 242' ' ' LYS . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.46 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.29 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.35 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.31 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 0.24 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 1.42 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 145' ' ' VAL . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 0.29 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 163' ' ' ARG . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.25 110.48 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.16 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 0.4 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32 112.25 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.5 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.19 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 159' ' ' GLU . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.23 109.865 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.56 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 0.24 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.17 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 0.35 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 0.29 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.29 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 0.32 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 0.9 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.4 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.19 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.25 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.99 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.24 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.4 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 1.33 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 0.44 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.02 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.425 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 1.62 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.26 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.24 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 0.65 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 0.2 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 1.47 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.18 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.502 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 0.23 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.28 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 0.27 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 0.45 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.95 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.36 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.33 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.21 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.15 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 195' ' ' ILE . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 0.21 110.433 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.17 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 218' ' ' VAL . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 0.21 110.954 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.58 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.24 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 0.72 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.86 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.444 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.39 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 0.25 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.28 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 207' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 0.63 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 0.19 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.35 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 0.67 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 0.25 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.7 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.36 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.94 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.05 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.41 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 34.3 mt . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 0.52 111.324 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 40.5 Cg_endo . . . . . 0 N--CA 1.46 -0.45 0 CA-C-O 121.044 0.352 . . . . 0.52 111.47 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.1 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.52 109.977 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 0.28 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 0.3 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 0.49 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.78 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 0.76 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.45 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.14 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.66 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.34 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.25 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 0.19 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 2.69 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 0.27 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.2 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.23 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.17 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.34 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 0.36 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.02 111.328 -177.442 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.51 109.826 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.23 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 162' ' ' VAL . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 0.24 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 0.23 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.5 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.29 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.59 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.71 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 0.46 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.29 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.35 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.31 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 0.24 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.42 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 0.29 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.25 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.16 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.4 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.5 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.19 110.199 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 0.23 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 0.24 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.17 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 0.35 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 0.29 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.29 111.182 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 0.32 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 0.9 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 0.4 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 181' ' ' GLU . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.19 111.261 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.25 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 0.99 112.214 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.24 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.4 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 1.33 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.02 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 1.62 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.26 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.24 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 0.65 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 0.2 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.481 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 1.47 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.18 112.472 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 0.23 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.28 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.538 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 0.27 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 0.45 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.95 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.36 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.33 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.21 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.15 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 0.21 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.527 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.17 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 218' ' ' VAL . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 0.21 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.58 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.24 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.72 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.86 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.39 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 0.25 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.28 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 207' ' ' VAL . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 0.63 111.018 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 192' ' ' LEU . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 0.19 110.077 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 240' ' ' VAL . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 0.67 108.915 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 0.25 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 0.42 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 0.7 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.36 112.176 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.94 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.447 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.05 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 0.52 111.528 -177.389 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.016 0.34 . . . . 0.52 111.693 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.1 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.52 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 0.28 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 0.3 109.639 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 222' ' ' THR . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 0.49 111.821 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 0.78 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 0.76 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.405 ' N ' ' HA ' ' A' ' 242' ' ' LYS . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.45 111.346 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.14 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.66 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.34 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 0.25 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 2.69 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 0.27 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 0.2 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.23 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.17 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 2.6 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.34 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 0.36 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.02 111.344 -178.448 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.178 -0.304 . . . . 0.51 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.23 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 0.24 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.16 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.23 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 0.16 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.5 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.29 111.149 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.59 113.144 -173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.71 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 0.46 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.29 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.441 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.35 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.31 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 0.24 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.42 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.25 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.16 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.4 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.5 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.19 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.23 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 0.24 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.17 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 0.35 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.29 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 0.32 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 0.9 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 0.4 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.19 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.25 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 0.99 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.24 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.4 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 1.33 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 0.44 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.02 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 1.62 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.606 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.26 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.24 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.649 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 0.2 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 1.47 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.18 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.496 HD12 HD11 ' A' ' 204' ' ' ILE . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 0.23 110.857 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.28 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.423 HD11 ' HA2' ' A' ' 203' ' ' GLY . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.27 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.419 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 0.45 111.686 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.95 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.36 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.33 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.21 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.15 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 195' ' ' ILE . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 0.21 110.18 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.17 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.414 HG13 HG21 ' A' ' 218' ' ' VAL . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 0.21 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.58 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.24 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 0.72 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.86 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.39 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 0.25 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.598 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.28 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 0.63 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 0.19 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.35 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 0.67 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 0.25 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 0.42 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.7 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.36 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.94 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.05 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 0.52 113.004 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 121.079 0.366 . . . . 0.52 111.509 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.1 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.52 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 0.28 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.3 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 0.49 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.78 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 0.76 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.45 111.443 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.14 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.66 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.34 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.25 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.19 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 2.69 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 0.27 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 0.2 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.23 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.17 111.789 -176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.34 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 0.36 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.02 111.235 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.466 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.341 0.591 . . . . 0.51 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.23 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 0.24 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 0.23 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.16 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.5 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.29 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.722 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.59 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 0.71 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.425 HG21 ' HE3' ' A' ' 242' ' ' LYS . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 0.46 110.796 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.722 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.29 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.35 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.31 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 0.24 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 1.42 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 0.29 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.25 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.16 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 0.4 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.466 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.5 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.19 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 0.23 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 0.24 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.17 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 0.35 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 0.29 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.29 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.32 110.767 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 0.9 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 0.4 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.19 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.25 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 0.99 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.24 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.412 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 1.33 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 0.44 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.02 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 1.62 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.603 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.26 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.24 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 0.65 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 0.2 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 1.47 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.18 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.589 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 0.23 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.28 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.4 HD11 ' HA2' ' A' ' 203' ' ' GLY . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.59 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 0.45 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 175' ' ' THR . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.95 111.563 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.36 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.33 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.21 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.15 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 195' ' ' ILE . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 0.21 110.447 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.17 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 0.21 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.58 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 0.24 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.72 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.86 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.39 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 0.25 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.504 ' HD2' HG13 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.28 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 207' ' ' VAL . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.63 110.971 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.512 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 0.19 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.517 ' O ' HD12 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.35 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 0.67 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.618 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 0.25 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 0.42 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 0.7 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.36 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.497 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.05 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 0.52 111.743 -176.568 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.142 -0.369 . . . . 0.52 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.1 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 219' ' ' ILE . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.52 109.828 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 0.28 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 0.3 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 0.49 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 0.78 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 0.76 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.45 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG23 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.14 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.66 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.34 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 0.25 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 0.19 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 2.69 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 0.27 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 0.2 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.463 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.23 110.643 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.17 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.1 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.34 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 0.36 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.091 -178.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.75 -0.463 . . . . 0.51 109.75 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.23 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 162' ' ' VAL . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 0.24 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.506 ' O ' HD22 ' A' ' 192' ' ' LEU . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 0.16 110.616 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.438 ' HA ' HD23 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 0.23 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.16 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.5 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.29 111.366 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.59 111.96 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 0.71 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.46 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.29 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.35 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.31 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.24 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 1.42 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 165' ' ' LEU . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 0.29 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.25 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.16 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.4 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.5 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.19 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 0.23 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 0.24 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.17 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 0.35 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 0.29 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.29 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.32 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 0.9 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 0.4 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.19 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.25 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.99 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.24 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.4 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 1.33 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.02 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 1.62 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.26 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.24 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 0.65 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 0.2 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.607 HD22 ' H ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 1.47 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.18 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.554 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 0.23 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.28 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.27 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.45 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.95 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.36 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.33 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.21 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.15 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 195' ' ' ILE . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 0.21 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.17 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 0.21 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.58 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 0.24 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.72 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.86 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.39 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 0.25 110.035 -173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.57 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.28 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 0.63 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 0.19 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.35 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 0.67 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.554 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 0.25 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 0.42 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 0.7 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.36 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.94 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.05 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 44.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 0.52 111.225 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 46.0 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 121.028 0.345 . . . . 0.52 112.083 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.1 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.52 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.28 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 0.3 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 0.49 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 0.78 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 0.76 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.45 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.14 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.66 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.34 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 0.25 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.19 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 2.69 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.685 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.27 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 0.2 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.23 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.17 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.34 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 0.36 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.779 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.477 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.4 m . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 109.872 -0.418 . . . . 0.51 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.23 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 0.24 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 0.16 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 0.23 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 0.16 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.5 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.535 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.29 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.725 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.59 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.71 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.46 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.725 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.29 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.35 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.31 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 0.24 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 1.42 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 0.29 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.25 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.16 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.4 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.477 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.5 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.19 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 0.23 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 0.24 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.17 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 0.35 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 0.29 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.29 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 0.32 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 0.9 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.4 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.19 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.25 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.3 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 0.99 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.24 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.4 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 1.33 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.02 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 1.62 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.26 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.24 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 0.65 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.403 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.2 111.144 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 221' ' ' ILE . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 1.47 109.357 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.18 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.561 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 0.23 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.28 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.27 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 0.45 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.455 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.95 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.36 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.33 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.21 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.15 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 0.21 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.451 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.17 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.21 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.58 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 0.24 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.72 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.86 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.39 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 0.25 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.517 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.28 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 0.63 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 192' ' ' LEU . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 0.19 110.07 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.35 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 192' ' ' LEU . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 0.67 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 0.25 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 0.42 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.7 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.36 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.94 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.05 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.048 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.01 0.338 . . . . 0.52 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.1 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.52 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 0.28 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.419 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 0.3 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 0.49 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 0.78 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 0.76 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.45 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.14 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.66 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.34 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 0.25 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 0.19 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 2.69 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.27 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.2 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.23 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.17 111.01 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.34 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 0.36 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.902 -179.728 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.51 111.069 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.23 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 0.24 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 0.16 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.23 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.5 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.29 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.59 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 0.71 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 0.46 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.456 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.35 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 50.8 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.31 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 0.24 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 1.42 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 0.29 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.25 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.16 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.4 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32 112.185 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.5 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.19 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 159' ' ' GLU . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.23 110.364 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 0.24 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.17 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 0.35 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 0.29 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 0.32 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 0.9 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.4 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.99 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.24 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.4 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 1.33 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.02 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 1.62 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.438 ' O ' HG21 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.26 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.24 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB3' HG22 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 0.65 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 0.2 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 1.47 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.18 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.647 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 0.23 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.28 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.487 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.27 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.45 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.567 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.95 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.36 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.33 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.21 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.15 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 0.21 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.17 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 0.21 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.58 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 0.24 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 0.72 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 33.7 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.86 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.39 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 0.25 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.28 112.241 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 0.63 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.408 ' HB ' HD22 ' A' ' 192' ' ' LEU . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.087 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.35 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 242' ' ' LYS . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 0.67 108.614 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 0.25 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 0.42 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 0.7 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.36 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 226' ' ' GLU . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.94 111.771 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.05 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 26.6 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 0.52 112.155 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 16.8 Cg_endo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.222 0.426 . . . . 0.52 111.562 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.1 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.52 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 0.28 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 0.3 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 0.49 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.78 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 0.76 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.45 111.302 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.14 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.66 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.34 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.25 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 0.19 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' A' ' 165' ' ' LEU . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 2.69 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 0.27 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 0.2 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.23 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.17 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.34 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 0.36 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.063 -176.739 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.51 109.584 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.23 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 0.24 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 0.23 111.185 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 0.16 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.5 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.29 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.59 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 0.71 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 0.46 110.473 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.29 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.35 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.31 109.784 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 0.24 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 1.42 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 145' ' ' VAL . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.29 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.25 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.16 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.4 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32 112.247 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.5 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.19 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 0.23 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.24 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.17 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 147' ' ' ILE . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.35 110.114 175.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 0.29 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.29 111.202 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 0.32 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 0.9 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.4 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.19 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.25 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 0.99 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.24 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.4 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 1.33 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 0.44 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.02 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 1.62 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.26 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.24 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 0.65 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.2 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 1.47 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.18 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.551 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 0.23 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.28 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 0.27 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 0.45 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.95 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.36 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.33 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.501 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.21 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.15 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 0.21 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.17 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 0.21 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.58 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 0.24 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.72 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.86 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.39 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 0.25 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.28 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 207' ' ' VAL . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 0.63 110.869 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 0.19 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.35 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 0.67 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.629 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 0.25 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.42 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 0.7 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.36 111.543 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.94 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.05 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 0.52 111.676 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo . . . . . 0 C--O 1.235 0.356 0 N-CA-C 110.994 -0.426 . . . . 0.52 110.994 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.1 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.52 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 0.28 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.3 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.49 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.78 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 0.76 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.45 111.586 -173.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.14 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.507 ' HG2' HD11 ' A' ' 161' ' ' LEU . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.66 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.34 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.25 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 0.19 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HB3' HD21 ' A' ' 165' ' ' LEU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 2.69 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.65 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 0.27 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.2 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.23 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.17 111.29 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.34 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 0.36 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.02 111.078 -178.813 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.287 -0.264 . . . . 0.51 110.287 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.23 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 0.24 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 0.23 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.29 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.59 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.71 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 0.46 110.394 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.29 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.529 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.35 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.31 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 0.24 110.79 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 246' ' ' GLU . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 1.42 111.37 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 145' ' ' VAL . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 0.29 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.25 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.16 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.4 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.5 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.19 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 0.23 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.24 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.17 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 0.35 109.939 175.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 0.29 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.29 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 0.32 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 0.9 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.4 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.19 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.25 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.99 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.24 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.4 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 1.33 110.072 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 0.44 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.02 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 1.62 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.26 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.24 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 0.65 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.481 ' HB ' HG22 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.2 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 1.47 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.18 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.629 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.572 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 0.23 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.28 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 0.27 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 0.45 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.95 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.36 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.33 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.21 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.15 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.429 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 0.21 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.17 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.452 ' CG1' HG11 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 0.21 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.58 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 0.24 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.72 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.86 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.39 109.752 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 0.25 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.494 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.28 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.63 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 0.19 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.35 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 221' ' ' ILE . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 0.67 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 0.25 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 0.42 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.7 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.36 111.806 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.94 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.05 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 0.52 112.362 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.511 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 111.16 -0.362 . . . . 0.52 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.1 111.607 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.52 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 0.28 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.3 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 0.49 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.404 ' HE2' HD13 ' A' ' 154' ' ' ILE . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 0.78 110.129 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 0.76 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.45 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.14 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.416 ' HB3' HD21 ' A' ' 161' ' ' LEU . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.66 111.032 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.34 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.25 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.19 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 2.69 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 0.27 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 0.2 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.23 111.508 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.17 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.34 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 0.36 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 190' ' ' LEU . 64.4 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.02 111.52 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 110.082 -0.34 . . . . 0.51 110.082 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.23 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 0.24 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 0.16 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 0.23 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.16 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.5 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.29 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.59 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 0.71 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 0.46 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.35 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.31 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 0.24 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 1.42 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 165' ' ' LEU . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 0.29 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.25 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.16 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 0.4 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.19 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 0.23 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.17 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 0.35 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 0.29 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.29 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 0.32 110.015 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 0.9 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.19 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.525 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.25 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.4 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 0.99 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.24 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.4 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 1.33 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.02 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 1.62 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.26 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.24 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.549 ' HB3' HG22 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 0.65 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.2 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 1.47 107.655 178.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.18 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.534 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 0.23 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.28 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 0.27 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 0.45 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 175' ' ' THR . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.95 110.973 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.36 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.33 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.21 110.2 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.15 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 195' ' ' ILE . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 0.21 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.17 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.21 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.58 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 0.24 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 0.72 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 31.0 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.86 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.39 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 0.25 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.28 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG21 HG13 ' A' ' 207' ' ' VAL . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.63 110.738 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 0.19 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 239' ' ' LEU . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.35 110.914 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.461 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 0.67 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.554 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 0.25 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 0.42 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' A' ' 195' ' ' ILE . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.7 110.527 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.36 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.94 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.05 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 0.52 112.4 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo . . . . . 0 N--CA 1.462 -0.338 0 CA-C-O 121.116 0.382 . . . . 0.52 111.845 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.1 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.52 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 220' ' ' PHE . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 0.28 110.291 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 0.3 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 0.49 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 222' ' ' THR . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.78 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 0.76 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.45 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.14 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.66 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.34 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 0.25 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 0.19 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 2.69 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 0.27 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.52 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 0.2 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.23 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.17 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.34 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 0.36 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.02 111.553 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.51 109.776 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.23 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 0.24 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 0.16 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 0.23 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.5 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.29 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.59 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 0.71 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 0.46 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.561 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.29 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.35 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.31 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 0.24 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 1.42 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 163' ' ' ARG . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.25 110.586 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.16 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 0.4 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32 112.019 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.6 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.5 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.19 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 0.23 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 0.24 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.17 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 0.35 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.29 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.29 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 0.32 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 0.9 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.4 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.19 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.25 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 0.99 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.24 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.4 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 1.33 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.02 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 1.62 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.427 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.26 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.24 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.603 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 0.65 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 0.2 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 1.47 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.18 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 0.23 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.28 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.27 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.45 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.95 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.36 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.33 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.515 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.21 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.15 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.501 HD11 HD12 ' A' ' 195' ' ' ILE . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 0.21 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.17 110.087 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.21 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.58 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 0.24 110.862 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 0.72 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.86 109.728 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.39 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 0.25 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.28 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 0.63 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.19 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 239' ' ' LEU . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.35 110.2 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 0.67 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 0.25 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.42 110.403 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.7 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.36 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.94 111.712 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.05 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 0.52 111.067 -178.628 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 121.105 0.377 . . . . 0.52 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.1 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 220' ' ' PHE . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 0.28 111.008 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 0.3 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 0.49 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.78 109.56 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 0.76 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.45 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 249' ' ' VAL . 83.5 mm-40 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.14 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.66 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.605 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.34 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.25 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.19 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 247' ' ' SER . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 2.69 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 0.27 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.2 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.23 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.17 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.34 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 0.36 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 190' ' ' LEU . 37.2 mt . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.02 111.205 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.51 110.757 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.23 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 0.24 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.16 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 0.23 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.16 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.5 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.421 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.29 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.59 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 0.71 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.46 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.29 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.35 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.31 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.24 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 161' ' ' LEU . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 1.42 111.018 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.29 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.25 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.16 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.4 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.5 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.19 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 0.23 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 0.24 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 0.35 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 0.29 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.29 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 0.32 110.272 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 0.9 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.4 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.19 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.25 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.4 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 0.99 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.24 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.4 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 1.33 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 0.44 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.02 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 1.62 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.472 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.26 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.24 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 0.65 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.2 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 1.47 108.206 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.18 112.388 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.577 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 0.23 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.28 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 0.27 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 0.45 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 175' ' ' THR . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.95 111.053 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.36 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.21 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.15 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 195' ' ' ILE . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.21 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.17 110.132 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 0.21 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.58 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 0.24 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.86 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.583 ' HE2' HG22 ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.39 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 0.25 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.28 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.511 HG21 HG13 ' A' ' 207' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 0.63 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.19 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.35 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 0.67 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.594 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 0.25 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 0.42 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 0.7 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.36 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.94 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.05 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 236' ' ' PRO . 20.8 mt . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 0.52 110.613 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 228' ' ' LEU . 37.2 Cg_endo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.896 0.29 . . . . 0.52 111.533 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.1 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.52 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 0.28 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 0.3 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 0.49 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 0.78 109.345 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 0.76 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.45 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.14 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.66 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.34 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 251' ' ' THR . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.987 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.19 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 2.69 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 0.27 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.23 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.17 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.34 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 0.36 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.02 111.559 -178.128 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.212 -0.355 . . . . 7.67 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.68 -26.75 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.046 0.451 . . . . 6.23 110.74 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.17 4.15 44.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.55 0.691 . . . . 7.45 109.533 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.83 166.82 37.5 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.325 -0.852 . . . . 2.81 111.588 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.4 p -70.69 100.52 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.79 -0.448 . . . . 1.3 109.79 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m -75.59 118.85 18.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.846 -0.427 . . . . 0.51 109.846 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.23 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 0.24 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 0.16 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 0.23 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 0.16 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.5 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.29 111.47 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.59 112.932 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 0.71 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 0.46 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.29 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.35 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.31 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.24 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 246' ' ' GLU . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.42 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 145' ' ' VAL . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 0.29 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.25 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.16 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.4 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.532 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.5 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.19 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 0.24 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.17 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.35 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 0.29 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.29 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 0.32 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 0.9 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.4 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.19 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.25 110.682 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 19.5 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 0.99 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.24 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.4 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 1.33 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 0.44 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.02 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 1.62 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.26 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.24 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.2 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 1.47 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.18 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.558 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 0.23 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.28 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 0.27 111.009 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.45 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.95 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.36 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.33 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.48 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.21 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.15 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' A' ' 227' ' ' ARG . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.21 110.141 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.17 110.231 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 0.21 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.58 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 0.24 110.597 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.72 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.86 110.036 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.39 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 0.25 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.451 ' O ' HD12 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.28 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.47 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 0.63 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 0.19 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.35 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 0.67 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.558 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 0.25 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.42 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.7 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.36 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.94 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.05 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.11 -5.02 58.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 0.52 110.586 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.67 34.13 5.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.552 -0.749 . . . . 1.26 110.508 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 p -99.96 55.15 0.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 2.1 111.821 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 73.88 14.83 79.85 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.384 -0.913 . . . . 3.43 111.418 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 5.4 m-20 -67.61 -29.14 68.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.284 -0.635 . . . . 5.22 109.284 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 45.2 mtm180 84.89 -80.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.771 1.628 . . . . 7.1 113.177 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 37.0 Cg_exo -59.92 146.14 96.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 CA-C-N 122.085 1.78 . . . . 2.52 111.841 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -107.39 142.77 25.82 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.661 -0.699 . . . . 1.93 110.476 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.11 127.85 25.61 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.962 2.442 . . . . 0.52 111.563 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.1 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.52 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 0.28 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 0.3 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 0.49 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 0.78 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 0.76 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.45 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 249' ' ' VAL . 72.4 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.14 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.544 ' HG2' HD11 ' A' ' 161' ' ' LEU . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.66 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.34 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 0.19 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 2.69 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 0.27 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.23 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.17 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.34 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 0.36 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.64 -3.79 42.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.02 111.249 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -78.38 -54.06 6.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.086 -1.079 . . . . 1.38 108.086 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -83.86 69.94 10.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.781 -1.1 . . . . 5.37 109.752 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -59.79 137.32 58.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.826 -0.624 . . . . 5.25 110.103 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.46 86.38 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.357 0.599 . . . . 6.4 110.598 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.489 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 8.4 m -108.05 -48.3 0.1 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.331 -0.85 . . . . 7.92 111.086 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 15.7 Cg_exo -69.58 167.06 25.28 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.9 1.733 . . . . 8.99 111.568 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.9 p -99.91 93.18 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.047 0.451 . . . . 10.84 110.613 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -79.93 150.68 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.191 -0.459 . . . . 11.79 110.633 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.078 -0.963 . . . . 13.24 111.075 -178.341 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.034 -0.427 . . . . 7.67 112.034 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.92 126.22 35.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.851 0.357 . . . . 6.23 110.729 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 89.0 mtp -98.57 -13.99 20.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 7.45 110.461 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -85.65 1.45 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.423 -0.894 . . . . 2.81 111.376 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 133.28 38.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.617 -0.792 . . . . 1.3 110.04 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m -77.1 110.89 12.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.538 -0.301 . . . . 0.51 110.192 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.23 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 0.24 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 0.16 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 0.23 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 0.16 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.5 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.29 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.59 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 0.71 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 0.46 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.29 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.35 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.31 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.24 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 163' ' ' ARG . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54 110.556 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 1.42 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 0.29 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' ASP . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.25 110.732 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.16 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 162' ' ' VAL . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.4 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.5 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.19 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 0.23 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 0.24 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.17 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.431 HG22 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 0.35 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.29 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.32 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 0.9 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.4 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.19 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.25 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.7 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 0.99 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.24 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.4 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.33 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 0.44 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.02 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 1.62 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.26 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.24 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.604 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 0.65 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 0.2 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 1.47 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.18 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.641 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.537 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 0.23 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.28 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 0.27 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 0.45 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.95 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.36 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.33 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.21 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.15 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 195' ' ' ILE . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 0.21 109.83 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.17 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.475 HG13 HG21 ' A' ' 218' ' ' VAL . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.21 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.58 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 0.24 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.72 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.86 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.39 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 0.25 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.518 ' HD3' ' OE1' ' A' ' 260' ' ' GLN . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.28 112.452 -172.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.475 HG21 HG13 ' A' ' 207' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.35 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 0.67 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 0.25 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.42 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.7 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.36 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.94 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.473 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.05 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 195' ' ' ILE . 24.5 mt -82.5 -15.65 51.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 0.52 111.585 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.7 mt -106.01 12.67 30.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 1.26 110.517 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.9 p -124.53 29.8 6.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.807 -0.633 . . . . 2.1 111.24 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -93.34 -18.42 39.09 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.525 -1.03 . . . . 3.43 110.525 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 64.47 10.93 6.16 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.685 0.794 . . . . 5.22 111.462 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.691 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 3.6 mmp_? -139.38 -65.28 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.8 -0.636 . . . . 7.1 111.538 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 1.3 Cg_endo -89.89 147.62 4.77 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.03 1.82 . . . . 2.52 113.092 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -134.13 128.36 19.47 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.51 -0.768 . . . . 1.93 109.422 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.78 127.0 15.47 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.65 2.234 . . . . 0.52 111.829 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.1 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.52 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 0.28 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 0.3 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 0.49 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 0.78 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 0.76 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.45 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.14 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.66 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.34 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 0.25 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.19 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HB3' HD21 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 2.69 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 0.27 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 0.2 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.23 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.17 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.34 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 0.36 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.98 -16.71 24.78 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.02 111.585 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.28 -48.94 73.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.385 0.612 . . . . 1.38 109.366 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -80.76 46.89 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.19 -0.914 . . . . 5.37 110.84 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.518 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 18.1 mm-40 -138.22 60.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.97 0.414 . . . . 5.25 111.492 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.93 -61.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.461 0.648 . . . . 6.4 109.267 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.578 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 69.6 m -155.44 -50.79 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.731 -1.122 . . . . 7.92 108.769 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 45.1 Cg_endo -93.49 -174.53 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.099 1.866 . . . . 8.99 110.417 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.3 t -156.98 136.25 12.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.11 0.481 . . . . 10.84 111.06 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -166.54 134.73 2.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.599 -0.728 . . . . 11.79 109.688 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.108 -0.949 . . . . 13.24 110.571 178.123 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.577 -0.609 . . . . 7.67 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.22 106.46 11.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.558 0.218 . . . . 6.23 110.456 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.9 tpp 63.21 75.91 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.761 -0.654 . . . . 7.45 110.435 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.98 -156.68 32.98 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 2.81 112.169 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.545 ' HB2' ' OD2' ' A' ' 168' ' ' ASP . 53.4 m -84.5 163.66 19.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 1.3 110.585 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m -78.59 114.93 17.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 0.51 110.742 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.23 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.24 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 0.16 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.23 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 0.16 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.5 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.29 111.144 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.59 111.534 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 0.71 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 0.46 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.29 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.35 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.31 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 0.24 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 1.42 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 0.29 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.25 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.16 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 0.4 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.499 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.5 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.545 ' OD2' ' HB2' ' A' ' 142' ' ' SER . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.19 110.758 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 0.23 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 0.24 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.17 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 0.35 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 0.29 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.29 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.32 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 0.9 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 0.4 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.25 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 0.99 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.24 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.4 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 1.33 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.44 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.02 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 1.62 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.495 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.26 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.24 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 0.65 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 0.2 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 1.47 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.18 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.653 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.54 HD12 HD11 ' A' ' 204' ' ' ILE . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 0.23 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.28 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 0.27 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 0.45 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.95 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.36 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.33 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.555 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.21 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.15 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 195' ' ' ILE . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.21 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.17 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.438 ' CG1' HG11 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.21 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.58 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 0.24 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 0.72 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.86 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.39 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 0.25 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD12 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.28 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.438 HG11 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.63 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 0.19 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.35 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 0.67 108.866 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 0.25 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.42 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.7 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.36 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.94 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.472 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.05 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 16.4 mt -81.28 -13.64 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 0.52 111.393 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 235' ' ' GLU . 58.2 mt -99.23 2.73 45.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.58 0.705 . . . . 1.26 109.86 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 55.9 p -129.32 20.34 5.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.055 -0.975 . . . . 2.1 110.405 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.08 6.22 80.1 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.75 -0.738 . . . . 3.43 113.198 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' HD3' ' A' ' 233' ' ' ARG . 4.1 m-20 67.03 16.3 10.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.125 0.488 . . . . 5.22 110.907 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.696 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 21.9 mmt180 -132.75 -173.81 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.105 -0.702 . . . . 7.1 109.105 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.696 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 16.1 Cg_exo -69.31 139.49 41.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.059 1.839 . . . . 2.52 110.554 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.407 ' HB2' ' CD2' ' A' ' 229' ' ' LEU . 6.5 pt-20 -71.64 148.82 93.0 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.021 -0.536 . . . . 1.93 109.875 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 139.29 37.1 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.018 2.479 . . . . 0.52 113.052 -170.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.648 ' HA ' ' H ' ' A' ' 266' ' ' VAL . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.1 110.275 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.52 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.28 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 221' ' ' ILE . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 0.3 109.5 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 0.49 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 0.78 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 0.76 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.406 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.45 111.885 -171.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.14 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.66 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.34 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 0.25 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.19 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 2.69 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 0.27 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 0.2 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.23 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.17 111.227 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.34 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 0.36 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt -90.93 -16.62 27.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.02 111.241 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 254' ' ' SER . 16.7 t80 -83.38 -46.88 12.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.53 0.681 . . . . 1.38 109.379 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -106.61 73.38 0.95 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.005 -0.998 . . . . 5.37 110.0 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.47 -35.07 75.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.123 0.487 . . . . 5.25 110.43 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 262' ' ' SER . 46.1 t-20 -143.11 117.16 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 6.4 109.257 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.587 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 29.9 t 171.36 -53.16 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.389 -0.823 . . . . 7.92 110.432 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 262' ' ' SER . 71.9 Cg_endo -98.82 153.35 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.761 2.308 . . . . 8.99 112.392 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -162.74 148.79 12.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.999 -0.28 . . . . 10.84 110.681 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 56.35 63.69 1.91 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.715 0.635 . . . . 11.79 111.3 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 237' ' ' THR . 55.8 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.707 -0.679 . . . . 13.24 111.023 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.815 -0.514 . . . . 7.67 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.21 108.5 10.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.79 0.329 . . . . 6.23 110.286 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.8 mmt -89.2 58.68 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.425 . . . . 7.45 110.37 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.12 -130.12 3.04 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.414 -0.898 . . . . 2.81 112.991 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 p -63.37 132.84 52.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.715 0.406 . . . . 1.3 111.51 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m -76.8 114.05 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.51 109.903 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.23 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.24 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.16 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 0.23 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 0.16 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.5 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.29 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.59 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 0.71 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 0.46 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.29 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.35 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.31 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 0.24 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 1.42 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 0.29 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.25 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.16 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 0.4 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.5 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.19 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 0.23 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 0.24 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.17 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 0.35 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 0.29 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.29 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 0.32 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 0.9 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.4 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.19 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 0.99 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.621 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.24 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.4 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 1.33 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 0.44 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.621 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 1.62 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.26 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.24 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 145' ' ' VAL . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 0.65 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 0.2 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 1.47 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.18 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.66 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 0.23 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.28 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.27 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 0.45 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.95 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.36 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.33 109.856 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.21 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.15 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 195' ' ' ILE . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.21 110.003 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.17 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 0.21 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.58 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 0.24 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 0.72 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.86 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.39 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 0.25 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.568 ' O ' HD12 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.28 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 0.63 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 0.19 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.35 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 0.67 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 0.25 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.42 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.7 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.36 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.492 ' O ' HG22 ' A' ' 230' ' ' THR . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.94 111.08 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.05 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt -94.53 -26.83 16.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 0.52 112.083 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -75.35 -4.55 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.499 0.666 . . . . 1.26 110.818 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 226' ' ' GLU . 9.4 t -144.75 31.12 1.17 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.068 -0.969 . . . . 2.1 109.627 175.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.82 96.89 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.598 -0.728 . . . . 3.43 111.923 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.89 -78.56 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.093 -0.706 . . . . 5.22 109.093 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 20.5 mmm180 -140.49 -58.41 0.02 OUTLIER Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 7.1 111.423 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 7.7 Cg_exo -70.72 159.62 52.11 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.83 1.687 . . . . 2.52 112.022 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -98.56 155.89 36.28 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.414 -0.812 . . . . 1.93 109.71 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo -62.44 132.53 38.69 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.733 2.289 . . . . 0.52 111.365 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.1 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.52 109.741 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 0.28 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.3 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 0.49 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.473 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.78 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 0.76 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.45 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 76.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.14 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.34 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 0.25 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 0.19 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 2.69 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 0.27 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 0.2 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.23 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.17 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.34 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 260' ' ' GLN . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 0.36 110.918 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt -106.97 21.61 17.29 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.02 110.922 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -78.93 -68.67 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 1.38 109.692 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -143.13 9.84 1.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.084 -0.507 . . . . 5.37 110.883 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.618 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 16.3 mm100 -72.21 -29.02 63.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.469 0.652 . . . . 5.25 109.805 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -87.82 136.25 33.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.114 -0.948 . . . . 6.4 110.16 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.43 ' H ' ' HD2' ' A' ' 263' ' ' PRO . 9.6 t -163.43 -51.03 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.776 -0.647 . . . . 7.92 110.131 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 262' ' ' SER . 41.4 Cg_endo -68.73 3.81 2.1 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.824 1.683 . . . . 8.99 111.363 169.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 262' ' ' SER . 20.0 m -136.29 126.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.997 -1.001 . . . . 10.84 109.951 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.64 161.73 37.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.985 -0.552 . . . . 11.79 109.669 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.577 -0.725 . . . . 13.24 110.375 178.323 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.011 -0.435 . . . . 7.67 112.011 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 125.43 27.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.455 -0.202 . . . . 6.23 110.455 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 tpt 73.36 -11.98 0.86 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.908 0.755 . . . . 7.45 110.885 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 127.95 -133.21 7.7 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.092 -0.803 . . . . 2.81 111.092 -177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.4 ' HB2' ' OD2' ' A' ' 168' ' ' ASP . 18.5 m -105.24 150.37 25.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.667 -0.494 . . . . 1.3 109.667 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m -77.58 112.64 14.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.51 110.595 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.23 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 162' ' ' VAL . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 0.24 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.16 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 0.23 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 0.16 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.5 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.29 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.59 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.71 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 0.46 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.29 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.35 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.31 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 0.24 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD23 ' HE ' ' A' ' 250' ' ' ARG . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 1.42 111.407 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 0.29 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.25 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.16 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.4 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.5 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 142' ' ' SER . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.19 110.877 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 0.23 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 0.24 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.17 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 0.35 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 0.29 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.29 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.32 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 0.9 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.4 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.19 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.99 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.24 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.4 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 1.33 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.02 110.699 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 1.62 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.26 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.24 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 145' ' ' VAL . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 0.65 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.4 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 0.2 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 1.47 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.452 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.18 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 204' ' ' ILE . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 0.23 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.28 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.27 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.45 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.95 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.36 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.33 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.21 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.15 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 195' ' ' ILE . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 0.21 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.449 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.17 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 0.21 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.58 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 0.24 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.72 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.86 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.39 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 0.25 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.466 ' O ' HD12 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.28 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.476 HG21 HG13 ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 0.63 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 0.19 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.35 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.453 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 0.67 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 0.25 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.42 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.7 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.36 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 230' ' ' THR . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.94 111.853 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.05 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.74 1.28 27.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.52 110.825 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 52.9 mt -122.01 20.95 10.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.876 -0.602 . . . . 1.26 110.464 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 226' ' ' GLU . 8.8 t -148.12 -36.98 0.19 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.946 -0.57 . . . . 2.1 111.111 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -97.61 2.62 60.67 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.769 -0.933 . . . . 3.43 110.769 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.58 91.64 1.99 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.311 -0.996 . . . . 5.22 108.311 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 25.6 mmm180 -43.38 -56.67 6.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 7.1 111.996 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 72.1 Cg_endo -68.89 146.29 65.09 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.442 2.094 . . . . 2.52 113.069 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.48 139.05 28.17 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.021 -0.99 . . . . 1.93 111.001 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.81 137.51 32.54 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.865 2.376 . . . . 0.52 111.255 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.1 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.52 111.012 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 0.28 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.3 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 0.49 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.78 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 0.76 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.45 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.14 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.66 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.34 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HE ' HD23 ' A' ' 161' ' ' LEU . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 2.69 110.664 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 0.27 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 0.2 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.441 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.23 110.971 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.17 112.147 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.34 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 0.36 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.2 0.26 50.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.02 111.563 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 254' ' ' SER . 40.9 t80 -85.34 -49.7 7.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.491 0.662 . . . . 1.38 109.679 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.29 2.26 41.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.028 -0.987 . . . . 5.37 111.189 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -131.62 96.06 3.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.219 0.533 . . . . 5.25 110.728 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.81 -60.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.408 -0.815 . . . . 6.4 109.952 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 263' ' ' PRO . 36.3 p -137.93 58.93 17.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 7.92 110.57 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 262' ' ' SER . 86.7 Cg_endo -92.65 47.77 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.728 2.286 . . . . 8.99 112.39 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.2 m -74.98 102.39 4.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.115 -0.493 . . . . 10.84 109.929 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.87 48.95 10.44 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.085 -0.507 . . . . 11.79 110.346 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.278 -0.867 . . . . 13.24 111.054 -176.53 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.058 -0.417 . . . . 7.67 112.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 64.64 20.49 12.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.137 0.575 . . . . 6.23 111.848 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.9 mtt -110.43 -14.81 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.431 . . . . 7.45 110.389 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 -154.22 14.21 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.918 -0.658 . . . . 2.81 112.569 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -80.31 151.11 29.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.447 0.641 . . . . 1.3 111.558 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.436 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 23.5 m -147.46 117.88 7.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.381 -0.97 . . . . 0.51 108.381 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.23 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 162' ' ' VAL . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 0.24 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 0.16 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 0.23 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 0.16 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.5 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.29 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.59 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.71 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.46 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.29 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.35 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.31 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 0.24 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 249' ' ' VAL . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 1.42 111.35 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 145' ' ' VAL . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 0.29 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.25 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.16 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 0.4 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.5 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.19 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 0.23 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 0.24 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.17 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 0.35 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 0.29 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.29 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.32 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 0.9 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.4 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.19 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.25 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.9 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 0.99 110.802 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.24 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.4 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 1.33 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.02 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 1.62 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.26 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.24 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 0.65 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.2 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 1.47 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.18 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.612 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.54 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 0.23 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.28 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD11 ' HA2' ' A' ' 203' ' ' GLY . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.27 110.36 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 0.45 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.485 ' H ' HG22 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.95 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.36 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.33 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.21 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.15 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 195' ' ' ILE . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 0.21 110.069 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.17 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 0.21 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.58 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.406 HG21 HG21 ' A' ' 191' ' ' VAL . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 0.24 110.662 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 0.72 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.86 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.39 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 0.25 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.486 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.28 112.018 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 0.63 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 0.19 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.45 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.35 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 0.67 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.569 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 0.25 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 0.42 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.7 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.36 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.637 ' O ' HG22 ' A' ' 230' ' ' THR . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.94 111.533 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.05 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.32 -7.84 43.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 0.52 111.371 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.44 19.75 14.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.096 0.474 . . . . 1.26 111.24 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 226' ' ' GLU . 13.4 t -163.27 -39.18 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 2.1 110.906 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -87.17 6.97 82.38 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.863 -0.684 . . . . 3.43 111.87 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -162.26 96.29 0.97 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.866 -1.161 . . . . 5.22 107.866 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 34.5 mtp-105 -42.45 -53.4 9.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 113.975 -1.466 . . . . 7.1 113.943 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 19.6 Cg_exo -61.99 134.36 49.26 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.649 1.566 . . . . 2.52 111.805 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.65 136.9 30.6 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.494 -0.775 . . . . 1.93 110.999 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.93 128.09 17.18 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.98 2.454 . . . . 0.52 111.315 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.1 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.52 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 0.28 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 0.3 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 0.49 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 154' ' ' ILE . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 0.78 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 0.76 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.45 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.14 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.66 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.34 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 0.25 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 161' ' ' LEU . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 0.19 110.732 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 2.69 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 0.27 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.23 110.661 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.17 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 238' ' ' TYR . 13.4 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.34 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 0.36 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt -82.68 -9.92 59.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.02 111.172 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 263' ' ' PRO . 50.2 t80 -78.87 -42.91 26.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.198 -0.668 . . . . 1.38 109.198 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -80.92 60.82 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.677 -0.692 . . . . 5.37 110.692 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 263' ' ' PRO . 23.8 mm-40 -131.02 178.73 6.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.552 -0.749 . . . . 5.25 110.929 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.89 12.14 9.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.754 -0.657 . . . . 6.4 111.043 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 6.6 m -91.26 -49.89 0.33 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.282 -0.417 . . . . 7.92 111.34 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.55 ' HG2' ' O ' ' A' ' 258' ' ' PHE . 4.4 Cg_exo -77.66 170.21 19.55 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.224 1.95 . . . . 8.99 111.815 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 t -116.28 13.03 15.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 10.84 110.805 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -135.26 69.51 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.539 . . . . 11.79 110.401 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.112 -0.947 . . . . 13.24 111.61 -174.806 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.798 -0.521 . . . . 7.67 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 54.59 43.86 29.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 6.23 111.453 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -91.95 74.6 5.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.225 0.536 . . . . 7.45 110.439 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.34 -128.88 5.35 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.249 -0.74 . . . . 2.81 111.249 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.43 123.31 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 1.3 110.686 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m -78.01 110.7 13.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.922 -0.581 . . . . 0.51 110.391 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.23 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 0.24 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.23 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 0.16 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.5 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.29 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.59 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 0.71 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.46 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.29 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.35 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.31 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 0.24 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 1.42 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.572 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 0.29 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.25 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.16 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.4 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.5 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.19 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 0.23 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 0.24 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.17 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 0.35 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 0.29 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.29 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.9 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 0.4 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.19 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.25 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.99 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.24 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.4 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.02 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 1.62 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.26 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.24 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 0.65 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 0.2 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 1.47 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.442 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.18 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.591 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.5 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 0.23 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.28 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 0.27 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 0.45 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.95 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.36 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.33 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.21 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.15 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.41 ' CD1' ' HD2' ' A' ' 227' ' ' ARG . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.21 110.282 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.17 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 218' ' ' VAL . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 0.21 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.58 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 0.24 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.72 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.86 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.39 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 0.25 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.28 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 0.63 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.411 ' HB ' HD22 ' A' ' 192' ' ' LEU . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 0.19 109.87 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.425 ' O ' HD12 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.35 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 0.67 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 0.25 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 0.42 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 0.7 111.318 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.36 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.94 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.05 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt -80.02 -8.21 59.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.52 111.128 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.9 mt -115.17 13.37 16.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 1.26 111.36 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.6 p -124.16 -94.1 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.064 -0.516 . . . . 2.1 112.285 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.0 -14.02 67.53 Favored Glycine 0 C--O 1.23 -0.11 0 CA-C-N 116.097 -0.501 . . . . 3.43 112.476 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.27 74.79 1.05 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.59 -0.892 . . . . 5.22 108.59 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 32.9 mmt180 -37.31 -54.27 2.05 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.901 -1.499 . . . . 7.1 113.75 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 21.3 Cg_exo -59.58 132.36 45.42 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.12 1.213 . . . . 2.52 111.636 176.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.68 135.11 36.26 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.672 -0.695 . . . . 1.93 110.59 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.68 126.99 18.6 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.726 2.284 . . . . 0.52 111.062 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.1 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.52 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.28 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 0.3 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 0.49 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.78 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 0.76 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.45 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.14 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.448 ' HB3' HD21 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.66 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.34 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 0.25 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 0.19 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.439 ' HA ' HD11 ' A' ' 165' ' ' LEU . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 2.69 110.708 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 0.27 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 0.2 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.23 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.34 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 0.36 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.96 -24.53 32.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.02 111.045 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.12 -15.21 59.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.47 0.652 . . . . 1.38 109.989 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.9 -11.56 50.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.874 0.845 . . . . 5.37 110.016 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -98.4 135.08 40.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.834 -1.076 . . . . 5.25 110.894 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -92.64 43.39 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.284 1.04 . . . . 6.4 109.526 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.0 m -90.96 -54.01 0.28 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.742 -1.117 . . . . 7.92 111.271 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.51 -42.29 5.34 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.146 1.23 . . . . 8.99 112.148 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 4.3 m 49.66 56.67 7.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 10.84 110.624 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -151.86 49.65 0.8 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 11.79 110.596 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.478 -0.772 . . . . 13.24 110.1 179.61 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.815 -0.514 . . . . 7.67 111.815 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.57 84.02 0.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 6.23 110.235 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.5 ptp -120.27 127.06 52.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.236 0.541 . . . . 7.45 111.408 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.94 64.53 0.57 Allowed Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 109.781 -1.327 . . . . 2.81 109.781 173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -53.85 139.58 32.99 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.669 -1.265 . . . . 1.3 112.166 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m -76.54 106.53 8.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.387 -0.824 . . . . 0.51 109.916 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.23 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 0.24 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 0.16 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 0.23 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 0.16 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.5 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.29 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.59 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 0.71 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.46 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.29 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.427 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.35 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.31 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 0.24 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 1.42 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 0.29 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.25 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.16 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.4 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.5 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.19 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 0.23 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.24 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.17 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 0.35 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 0.29 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.29 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.32 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 0.9 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 0.4 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.19 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.25 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 0.99 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.24 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.4 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 1.33 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.44 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.02 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 1.62 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.26 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.24 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 0.65 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.2 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 1.47 107.71 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.18 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.403 HG12 ' OG1' ' A' ' 222' ' ' THR . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 0.23 112.023 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.28 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 0.27 110.864 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 0.45 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.95 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.36 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.33 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.21 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.15 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 0.21 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.17 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 0.21 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.58 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 0.24 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 0.72 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.86 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.39 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 0.25 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.28 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.63 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.472 ' O ' HD12 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.35 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 0.67 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 0.25 110.475 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 242' ' ' LYS . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.42 110.836 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 0.7 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.418 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.36 111.803 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 230' ' ' THR . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.94 110.808 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.05 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 236' ' ' PRO . 18.2 mt -86.27 -3.93 59.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 0.52 111.62 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 85.8 mt -107.05 31.52 5.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.009 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 226' ' ' GLU . 9.3 t -171.37 116.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.514 0.673 . . . . 2.1 111.413 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.17 -43.84 3.19 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 3.43 112.991 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.08 48.95 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.481 . . . . 5.22 111.114 -176.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.678 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 5.6 mmp_? 66.97 -175.27 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.91 -1.041 . . . . 7.1 110.585 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.678 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 31.7 Cg_exo -63.58 175.03 3.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.99 2.46 . . . . 2.52 112.528 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -51.45 122.41 19.72 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.435 -0.802 . . . . 1.93 111.061 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HG3' HD22 ' A' ' 228' ' ' LEU . 52.1 Cg_exo -53.34 142.7 56.59 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.952 2.435 . . . . 0.52 112.06 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.1 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.52 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 0.28 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 0.3 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 0.49 112.044 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.43 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.78 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 0.76 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.405 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.45 111.421 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.558 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.14 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.66 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.34 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 0.25 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.19 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 2.69 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 0.27 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.2 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.413 HG13 HD21 ' A' ' 190' ' ' LEU . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.23 110.664 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.17 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 252' ' ' THR . 13.1 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.34 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 0.36 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 190' ' ' LEU . 83.2 mt -86.72 -14.85 41.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.02 111.06 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.8 -52.38 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.035 0.445 . . . . 1.38 109.87 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -78.5 1.26 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.692 . . . . 5.37 111.173 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 261' ' ' ASN . 56.6 tt0 -65.64 -53.46 41.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.25 110.55 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 260' ' ' GLN . 17.6 m120 -137.13 171.95 13.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.776 -0.647 . . . . 6.4 110.017 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 263' ' ' PRO . 5.7 t -140.73 132.89 14.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.599 -0.519 . . . . 7.92 109.599 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 262' ' ' SER . 30.6 Cg_exo -62.01 106.58 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.827 2.351 . . . . 8.99 112.296 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 49.9 m -78.99 -34.87 43.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.142 -0.481 . . . . 10.84 110.569 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.78 73.61 4.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.873 -0.603 . . . . 11.79 110.526 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.721 -0.672 . . . . 13.24 111.007 -179.299 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.812 -0.515 . . . . 7.67 111.812 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.99 -171.34 0.15 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.884 0.474 . . . . 6.23 111.319 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 mmt 59.81 86.46 0.09 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.848 -0.614 . . . . 7.45 111.04 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -118.85 0.3 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.495 -0.775 . . . . 2.81 112.197 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 4.8 p -81.62 92.07 6.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.543 0.687 . . . . 1.3 110.952 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -79.71 122.89 27.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.461 -0.79 . . . . 0.51 109.411 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.23 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 0.24 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 0.16 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 0.23 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 0.16 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.29 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.59 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.71 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 242' ' ' LYS . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.46 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.29 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.35 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.31 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 0.24 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 1.42 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 145' ' ' VAL . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 0.29 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 163' ' ' ARG . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.25 110.48 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.16 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 0.4 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32 112.25 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.5 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.19 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 159' ' ' GLU . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.23 109.865 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.56 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 0.24 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.17 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 0.35 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 0.29 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.29 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 0.32 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 0.9 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.4 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.19 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.25 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.99 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.24 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.4 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 1.33 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 0.44 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.02 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.425 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 1.62 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.26 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.24 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 0.65 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 0.2 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 1.47 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.18 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.502 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 0.23 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.28 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 0.27 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 0.45 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.95 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.36 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.33 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.21 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.15 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 195' ' ' ILE . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 0.21 110.433 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.17 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 218' ' ' VAL . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 0.21 110.954 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.58 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.24 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 0.72 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.86 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.444 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.39 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 0.25 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.28 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 207' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 0.63 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 0.19 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.35 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 0.67 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 0.25 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.7 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.36 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.94 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.05 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.41 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 34.3 mt -98.28 -42.73 7.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 0.52 111.324 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.4 mt -87.45 73.41 9.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.683 -0.69 . . . . 1.26 109.759 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 8.4 p -103.76 -3.68 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.531 -0.758 . . . . 2.1 111.857 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 86.45 -68.96 3.21 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.753 -0.737 . . . . 3.43 113.225 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.05 -19.5 57.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 5.22 111.272 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.686 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 27.9 mmt180 -94.58 179.47 1.2 Allowed Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.552 -0.536 . . . . 7.1 109.552 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.686 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.2 Cg_exo -71.4 142.88 41.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.686 2.257 . . . . 2.52 111.386 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.6 140.56 21.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 109.002 -0.74 . . . . 1.93 109.002 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 40.5 Cg_endo -67.24 127.34 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.428 2.085 . . . . 0.52 111.47 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.1 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.52 109.977 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 0.28 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 0.3 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 0.49 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.78 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 0.76 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.45 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.14 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.66 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.34 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.25 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 0.19 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 2.69 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 0.27 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.2 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.23 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.17 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.34 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 0.36 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.21 3.63 54.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.02 111.328 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -79.38 -31.65 42.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.399 0.618 . . . . 1.38 109.438 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -111.34 96.8 6.33 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.914 0.864 . . . . 5.37 108.977 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -106.74 92.7 4.21 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.456 -1.247 . . . . 5.25 110.949 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -73.67 -39.46 64.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.938 -0.764 . . . . 6.4 108.938 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.6 t -121.11 80.06 34.9 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.174 -0.921 . . . . 7.92 109.252 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.25 147.36 65.99 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.642 2.228 . . . . 8.99 112.356 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.8 p -66.74 128.49 36.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 10.84 110.893 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -66.55 119.46 11.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.791 0.329 . . . . 11.79 110.479 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.344 -0.836 . . . . 13.24 110.656 -177.457 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.247 -0.341 . . . . 7.67 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.25 143.34 35.38 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.926 -0.161 . . . . 6.23 110.899 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.86 45.76 17.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.164 -0.471 . . . . 7.45 110.922 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.05 169.41 21.05 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.682 -0.771 . . . . 2.81 111.686 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 1.5 m -81.57 143.95 31.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.996 -0.372 . . . . 1.3 109.996 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m -77.82 107.46 10.34 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.826 -0.435 . . . . 0.51 109.826 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.23 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 162' ' ' VAL . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 0.24 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 0.23 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.5 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.29 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.59 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.71 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 0.46 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.29 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.35 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.31 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 0.24 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.42 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 0.29 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.25 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.16 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.4 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.5 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 142' ' ' SER . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.19 110.199 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 0.23 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 0.24 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.17 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 0.35 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 0.29 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.29 111.182 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 0.32 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 0.9 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 0.4 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 181' ' ' GLU . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.19 111.261 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.25 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 0.99 112.214 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.24 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.4 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 1.33 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.02 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 1.62 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.26 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.24 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 0.65 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 0.2 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.481 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 1.47 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.18 112.472 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 0.23 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.28 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.538 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 0.27 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 0.45 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.95 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.36 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.33 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.21 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.15 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 0.21 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.527 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.17 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 218' ' ' VAL . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 0.21 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.58 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.24 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.72 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.86 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.39 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 0.25 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.28 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 207' ' ' VAL . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 0.63 111.018 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 192' ' ' LEU . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 0.19 110.077 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 240' ' ' VAL . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 0.67 108.915 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 0.25 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 0.42 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 0.7 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.546 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.36 112.176 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.94 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.447 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.05 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.31 0.24 55.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 0.52 111.528 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 37.3 mt -108.47 7.2 26.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.105 -0.498 . . . . 1.26 110.746 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t 179.98 124.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.857 -0.61 . . . . 2.1 111.187 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.62 12.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.932 -0.651 . . . . 3.43 113.109 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.04 85.7 1.02 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.342 0.591 . . . . 5.22 111.718 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.734 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 31.3 mmm180 65.06 -175.6 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.194 -0.912 . . . . 7.1 112.039 169.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.734 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 40.7 Cg_exo -61.15 166.75 10.29 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.143 2.562 . . . . 2.52 113.012 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 139.64 97.28 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.323 -0.853 . . . . 1.93 110.412 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.66 146.65 43.83 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.934 2.423 . . . . 0.52 111.693 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.1 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.52 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 0.28 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 0.3 109.639 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 222' ' ' THR . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 0.49 111.821 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 0.78 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 0.76 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.405 ' N ' ' HA ' ' A' ' 242' ' ' LYS . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.45 111.346 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.14 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.66 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.34 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 0.25 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 2.69 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 0.27 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 0.2 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.23 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.17 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 25.3 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.34 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 0.36 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt -95.65 14.87 21.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.02 111.344 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -94.89 -70.43 0.71 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.405 -0.361 . . . . 1.38 110.297 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -158.47 31.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 5.37 110.741 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.488 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . 18.9 mp0 63.53 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.347 0.404 . . . . 5.25 111.64 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -80.83 68.37 7.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.473 0.654 . . . . 6.4 110.202 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.505 ' N ' ' HD2' ' A' ' 263' ' ' PRO . 26.7 t -76.15 -48.79 3.34 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.633 -0.712 . . . . 7.92 111.231 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 262' ' ' SER . 37.6 Cg_endo -66.18 83.74 0.27 Allowed 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.839 1.692 . . . . 8.99 111.697 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.7 m -87.85 -34.14 18.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.684 -0.689 . . . . 10.84 110.28 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -112.75 86.52 2.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.807 -0.633 . . . . 11.79 109.937 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.7 -0.667 . . . . 13.24 110.349 -179.352 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.86 -0.496 . . . . 7.67 111.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.59 66.01 9.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.526 . . . . 6.23 110.496 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.9 ttt -70.61 -39.72 73.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 7.45 111.112 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.97 -129.31 1.32 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.698 -0.763 . . . . 2.81 112.07 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -75.45 126.91 31.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.108 0.48 . . . . 1.3 110.561 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -77.11 110.44 11.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.51 110.178 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.23 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 0.24 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.16 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.23 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 0.16 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.5 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.29 111.149 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.59 113.144 -173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.71 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 0.46 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.29 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.441 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.35 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.31 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 0.24 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.42 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.25 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.16 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.4 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.5 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.19 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.23 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 0.24 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.17 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 0.35 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.29 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 0.32 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 0.9 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 0.4 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.19 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.25 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 0.99 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.24 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.4 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 1.33 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 0.44 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.02 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 1.62 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.606 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.26 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.24 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.649 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 0.2 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 1.47 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.18 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.496 HD12 HD11 ' A' ' 204' ' ' ILE . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 0.23 110.857 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.28 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.423 HD11 ' HA2' ' A' ' 203' ' ' GLY . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.27 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.419 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 0.45 111.686 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.95 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.36 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.33 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.21 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.15 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 195' ' ' ILE . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 0.21 110.18 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.17 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.414 HG13 HG21 ' A' ' 218' ' ' VAL . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 0.21 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.58 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.24 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 0.72 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.86 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.39 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 0.25 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.598 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.28 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 0.63 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 0.19 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.35 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 0.67 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 0.25 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 0.42 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.7 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.36 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.94 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.05 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt -99.12 -29.24 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 0.52 113.004 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.451 ' HG ' ' HG2' ' A' ' 235' ' ' GLU . 10.0 mp -72.33 -3.56 24.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.427 0.529 . . . . 1.26 112.427 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -164.56 134.55 3.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.673 -0.492 . . . . 2.1 109.673 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 161.26 -30.84 0.33 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.717 -0.754 . . . . 3.43 112.704 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -162.24 -73.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.315 0.579 . . . . 5.22 111.297 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -110.73 -177.43 0.46 Allowed Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.284 -0.871 . . . . 7.1 109.958 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.628 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 52.2 Cg_exo -59.02 175.19 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.462 2.108 . . . . 2.52 113.768 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HG2' ' HG ' ' A' ' 229' ' ' LEU . 38.5 mt-10 -53.34 149.78 13.27 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.991 -1.004 . . . . 1.93 111.851 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo -71.07 154.45 62.46 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.776 2.317 . . . . 0.52 111.509 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.1 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.52 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 0.28 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.3 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 0.49 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.78 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 0.76 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.45 111.443 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.14 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.66 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.34 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.25 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.19 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 2.69 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 0.27 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 0.2 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.23 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.17 111.789 -176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.34 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 0.36 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt -97.88 -0.71 44.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.02 111.235 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 254' ' ' SER . 10.7 t80 -86.28 -43.27 13.06 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.292 -1.003 . . . . 1.38 108.292 173.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.71 80.84 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 5.37 110.518 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -79.79 -51.65 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.15 -0.685 . . . . 5.25 109.15 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -164.8 69.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.146 -0.933 . . . . 6.4 108.934 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.3 p -106.71 126.43 30.32 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 7.92 111.125 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.97 -1.22 11.42 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.872 2.381 . . . . 8.99 112.283 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.4 t -174.06 164.96 4.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 10.84 109.724 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.04 82.01 1.86 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.785 -0.189 . . . . 11.79 110.511 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.179 -0.915 . . . . 13.24 110.758 -179.608 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.008 -0.437 . . . . 7.67 112.008 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.96 -59.84 4.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 6.23 111.08 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.35 88.15 2.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.716 -0.846 . . . . 7.45 108.716 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.11 -116.52 4.46 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.429 -0.891 . . . . 2.81 111.261 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 159.11 21.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.037 0.446 . . . . 1.3 110.156 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.466 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m -77.98 97.61 5.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.51 109.705 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.23 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 0.24 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 0.23 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.16 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.5 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.29 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.722 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.59 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 0.71 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.425 HG21 ' HE3' ' A' ' 242' ' ' LYS . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 0.46 110.796 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.722 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.29 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.35 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.31 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 0.24 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 1.42 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 0.29 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.25 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.16 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 0.4 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.466 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.5 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.19 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 0.23 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 0.24 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.17 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 0.35 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 0.29 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.29 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.32 110.767 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 0.9 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 0.4 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.19 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.25 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 0.99 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.24 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.412 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 1.33 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 0.44 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.02 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 1.62 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.603 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.26 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.24 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 0.65 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 0.2 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 1.47 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.18 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.589 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 0.23 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.28 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.4 HD11 ' HA2' ' A' ' 203' ' ' GLY . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.59 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 0.45 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 175' ' ' THR . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.95 111.563 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.36 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.33 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.21 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.15 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 195' ' ' ILE . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 0.21 110.447 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.17 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 0.21 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.58 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 0.24 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.72 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.86 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.39 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 0.25 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.504 ' HD2' HG13 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.28 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 207' ' ' VAL . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.63 110.971 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.512 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 0.19 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.517 ' O ' HD12 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.35 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 0.67 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.618 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 0.25 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 0.42 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 0.7 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.36 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.94 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.497 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.05 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -88.93 -13.46 38.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 0.52 111.743 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 36.91 3.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.207 -0.451 . . . . 1.26 110.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.4 t -140.58 24.49 2.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.623 0.725 . . . . 2.1 110.423 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -98.49 -6.3 56.54 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.8 -0.92 . . . . 3.43 110.8 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.0 t70 73.0 -9.88 1.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.644 0.777 . . . . 5.22 111.324 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 26.4 mmt180 -141.59 -60.84 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.775 0.658 . . . . 7.1 112.775 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 8.1 Cg_exo -67.16 136.92 42.29 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.404 1.403 . . . . 2.52 112.397 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 129.85 21.54 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.387 -0.824 . . . . 1.93 110.045 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.68 128.2 14.87 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.679 2.253 . . . . 0.52 111.142 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.1 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 219' ' ' ILE . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.52 109.828 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 0.28 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 0.3 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 0.49 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 0.78 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 0.76 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.45 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG23 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.14 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.66 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.34 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 0.25 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 0.19 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 2.69 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 0.27 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 0.2 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.463 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.23 110.643 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.17 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.1 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.34 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 0.36 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt -84.11 -26.59 28.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.091 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.32 -22.9 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.397 0.618 . . . . 1.38 109.66 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -80.6 -3.41 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.13 -0.941 . . . . 5.37 110.221 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.423 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 69.8 mt-30 -130.05 -166.31 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.915 . . . . 5.25 109.633 177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 59.2 46.63 12.71 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.324 -0.621 . . . . 6.4 109.324 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.4 m 68.34 76.32 0.26 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.362 -1.29 . . . . 7.92 109.851 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 103.3 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.707 2.271 . . . . 8.99 112.626 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.8 m -73.67 -42.3 61.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.842 -0.617 . . . . 10.84 109.706 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 48.24 65.74 1.24 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.453 -0.794 . . . . 11.79 112.05 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.998 -1.001 . . . . 13.24 110.712 179.228 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.939 -0.465 . . . . 7.67 111.939 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.88 -66.9 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.13 0.491 . . . . 6.23 110.261 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -130.53 40.52 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.491 0.662 . . . . 7.45 110.01 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.67 -19.27 13.79 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 115.29 -0.868 . . . . 2.81 111.402 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.6 p -72.37 141.49 48.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.292 -0.954 . . . . 1.3 110.413 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -147.43 124.39 11.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.706 -0.679 . . . . 0.51 109.75 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.23 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 162' ' ' VAL . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 0.24 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.506 ' O ' HD22 ' A' ' 192' ' ' LEU . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 0.16 110.616 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.438 ' HA ' HD23 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 0.23 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.16 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.5 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.29 111.366 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.59 111.96 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 0.71 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.46 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.29 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.35 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.31 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.24 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 1.42 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 165' ' ' LEU . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 0.29 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.25 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.16 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.4 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.5 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.19 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 0.23 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 0.24 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.17 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 0.35 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 0.29 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.29 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.32 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 0.9 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 0.4 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.19 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.25 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.99 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.24 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.4 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 1.33 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.02 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 1.62 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.26 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.24 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 0.65 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 0.2 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.607 HD22 ' H ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 1.47 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.18 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.554 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 0.23 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.28 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.27 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.45 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.95 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.36 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.33 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.21 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.15 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 195' ' ' ILE . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 0.21 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.17 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 0.21 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.58 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 0.24 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.72 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.86 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.39 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 0.25 110.035 -173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.57 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.28 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 0.63 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 0.19 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.35 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 0.67 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.554 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 0.25 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 0.42 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 0.7 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.36 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.94 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.05 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 44.5 mt -99.34 -25.86 14.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 0.52 111.225 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.2 57.27 0.72 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 1.26 109.914 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 p -87.41 -27.37 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.56 -0.745 . . . . 2.1 110.917 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 88.17 -28.91 5.84 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.673 -0.694 . . . . 3.43 111.946 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.34 -31.22 19.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 5.22 110.632 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.674 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 33.6 mmt180 -100.39 -179.61 0.85 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.807 -0.633 . . . . 7.1 109.571 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.674 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.0 Cg_exo -70.51 142.96 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.461 2.108 . . . . 2.52 111.727 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.58 136.6 25.05 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.01 -0.541 . . . . 1.93 109.778 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 46.0 Cg_endo -68.6 134.72 31.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.843 2.362 . . . . 0.52 112.083 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.1 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.52 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.28 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 0.3 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 0.49 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 0.78 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 0.76 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.45 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.14 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.66 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.34 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 0.25 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.19 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 2.69 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.685 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.27 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 0.2 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.23 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.17 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.34 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 0.36 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.85 -29.9 26.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.779 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -67.25 -13.18 61.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 1.38 110.273 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -73.69 -3.12 26.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.731 0.777 . . . . 5.37 111.143 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.76 53.87 9.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.282 -1.326 . . . . 5.25 112.514 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.82 126.28 28.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 6.4 110.253 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.9 t -71.3 123.86 90.04 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.096 -0.502 . . . . 7.92 110.602 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.38 121.65 9.93 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.352 2.035 . . . . 8.99 110.466 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.8 m 63.54 78.64 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 10.84 108.93 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -53.76 137.18 38.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 11.79 112.548 -171.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.245 0.819 0 CA-C-N 115.257 -0.883 . . . . 13.24 110.008 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 143' ' ' THR . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.985 -0.446 . . . . 7.67 111.985 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.84 169.09 9.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.554 -0.165 . . . . 6.23 110.554 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 60.4 mtm 57.61 78.87 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.607 0.567 . . . . 7.45 111.286 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.28 -118.37 4.1 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.458 -0.877 . . . . 2.81 111.877 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 p -69.59 95.83 0.88 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.122 0.486 . . . . 1.3 110.855 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 1.4 m -78.4 116.48 18.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.923 -0.58 . . . . 0.51 109.872 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.23 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 0.24 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 0.16 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 0.23 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 0.16 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.5 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.535 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.29 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.725 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.59 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.71 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.46 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.725 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.29 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.35 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.31 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 0.24 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 1.42 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 0.29 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.25 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.16 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.4 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.477 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.5 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.19 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 0.23 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 0.24 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.17 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 0.35 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 0.29 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.29 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 0.32 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 0.9 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.4 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.19 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.25 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.3 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 0.99 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.24 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.4 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 1.33 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.02 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 1.62 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.26 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.24 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 0.65 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.403 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.2 111.144 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 221' ' ' ILE . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 1.47 109.357 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.18 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.561 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 0.23 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.28 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.27 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 0.45 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.455 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.95 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.36 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.33 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.21 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.15 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 0.21 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.451 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.17 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.21 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.58 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 0.24 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.72 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.86 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.39 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 0.25 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.517 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.28 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 0.63 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 192' ' ' LEU . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 0.19 110.07 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.35 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 192' ' ' LEU . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 0.67 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 0.25 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 0.42 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.7 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.36 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.94 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.05 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.48 -15.45 56.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.048 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.4 mt -103.15 34.26 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.706 -0.679 . . . . 1.26 110.167 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -170.19 151.92 4.04 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.34 -0.615 . . . . 2.1 109.34 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 119.51 11.44 7.27 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.686 -0.688 . . . . 3.43 112.249 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.1 t70 65.1 27.18 12.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.763 0.792 . . . . 5.22 109.724 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.424 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 87.4 mtt180 -115.1 171.06 4.81 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.447 -0.797 . . . . 7.1 110.413 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 38.1 Cg_exo -67.76 160.1 49.79 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.533 2.822 . . . . 2.52 111.894 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.26 22.97 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.425 -0.583 . . . . 1.93 109.425 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.02 127.18 14.03 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.716 2.277 . . . . 0.52 112.553 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.1 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.52 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 0.28 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.419 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 0.3 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 0.49 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 0.78 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 0.76 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.45 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.14 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.66 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.34 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 0.25 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 0.19 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 2.69 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.27 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.2 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.23 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.17 111.01 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.34 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 0.36 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -92.36 -8.99 43.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.902 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 254' ' ' SER . 70.8 t80 -78.05 -52.41 8.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.372 0.606 . . . . 1.38 109.725 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -85.6 -11.85 52.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.474 -0.784 . . . . 5.37 110.888 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 53.37 31.65 12.35 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.624 -1.171 . . . . 5.25 112.137 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -156.42 158.16 36.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.812 -0.44 . . . . 6.4 109.812 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 263' ' ' PRO . 34.3 m -147.94 -48.22 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.271 -0.422 . . . . 7.92 111.375 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.518 ' CD ' ' H ' ' A' ' 262' ' ' SER . 3.5 Cg_exo -76.38 162.59 33.41 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.872 1.715 . . . . 8.99 111.673 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 82.5 p 50.41 34.26 8.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.355 0.662 . . . . 10.84 111.968 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -102.17 127.18 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.16 -0.473 . . . . 11.79 111.051 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.679 -0.677 . . . . 13.24 109.848 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.965 -0.454 . . . . 7.67 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.53 -28.6 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 6.23 110.845 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -78.69 121.04 24.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.104 -0.498 . . . . 7.45 110.697 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.6 -138.24 2.38 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.717 -0.674 . . . . 2.81 111.495 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 0.6 OUTLIER -81.26 94.52 6.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 1.3 110.315 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -77.19 132.15 38.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.381 -0.827 . . . . 0.51 111.069 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.23 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 0.24 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 0.16 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.23 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.5 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.29 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.59 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 0.71 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 0.46 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.456 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.35 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 50.8 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.31 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 0.24 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 1.42 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 0.29 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.25 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.16 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.4 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32 112.185 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.5 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.19 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 159' ' ' GLU . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.23 110.364 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 0.24 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.17 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 0.35 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 0.29 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.29 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 0.32 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 0.9 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.4 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.99 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.24 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.4 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 1.33 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.02 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 1.62 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.438 ' O ' HG21 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.26 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.24 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB3' HG22 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 0.65 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 0.2 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 1.47 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.18 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.647 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 0.23 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.28 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.487 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.27 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.45 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.567 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.95 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.36 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.33 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.21 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.15 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 0.21 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.17 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 0.21 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.58 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 0.24 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 0.72 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 33.7 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.86 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.39 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 0.25 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.28 112.241 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 0.63 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.408 ' HB ' HD22 ' A' ' 192' ' ' LEU . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.087 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.35 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 242' ' ' LYS . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 0.67 108.614 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 0.25 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 0.42 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 0.7 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.36 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 226' ' ' GLU . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.94 111.771 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.05 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 26.6 mt -97.02 -29.24 13.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 0.52 112.155 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.57 53.24 2.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 1.26 110.609 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.3 t 174.94 158.86 0.18 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.911 -0.774 . . . . 2.1 108.911 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 233' ' ' ARG . . . 110.0 21.0 7.26 Favored Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.846 -0.616 . . . . 3.43 112.662 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 t70 73.61 -28.31 0.19 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.438 0.695 . . . . 5.22 111.804 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 231' ' ' GLY . 18.1 ptt180 -65.72 167.27 11.66 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.547 -0.751 . . . . 7.1 111.542 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -72.21 153.62 56.71 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.185 2.59 . . . . 2.52 111.635 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -63.28 139.73 97.6 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 109.018 -0.734 . . . . 1.93 109.018 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 16.8 Cg_endo -58.67 127.0 22.92 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.499 2.133 . . . . 0.52 111.562 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.1 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.52 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 0.28 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 0.3 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 0.49 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.78 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 0.76 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.45 111.302 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.14 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.66 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.34 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.25 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 0.19 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' A' ' 165' ' ' LEU . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 2.69 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 0.27 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 0.2 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.23 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.17 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.34 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 0.36 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.06 -28.25 60.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.063 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.61 -24.36 67.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.868 -0.79 . . . . 1.38 108.868 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 22.9 t80 55.92 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.428 -1.26 . . . . 5.37 111.978 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.03 108.26 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.301 -1.318 . . . . 5.25 110.105 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -64.43 145.1 56.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 6.4 110.74 -176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.526 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 33.3 m -52.63 -51.89 69.2 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.531 0.567 . . . . 7.92 112.531 -176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 51.8 Cg_exo -53.72 -62.95 0.26 Allowed 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 121.972 1.781 . . . . 8.99 112.564 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.1 t -156.04 147.91 23.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.634 -0.712 . . . . 10.84 110.695 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -157.75 36.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 11.79 109.842 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.211 -0.9 . . . . 13.24 110.942 -176.914 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.533 ' N ' ' HG ' ' A' ' 254' ' ' SER . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.015 -0.434 . . . . 7.67 112.015 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.41 107.71 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.995 0.426 . . . . 6.23 110.976 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.9 ptm -137.46 21.74 2.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.267 0.556 . . . . 7.45 110.094 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.25 171.76 32.34 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.997 -0.841 . . . . 2.81 110.997 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 2.5 p -80.06 94.14 5.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 1.3 111.056 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m -78.31 118.8 20.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.502 -0.772 . . . . 0.51 109.584 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.23 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 0.24 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 0.23 111.185 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 0.16 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.5 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.29 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.59 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 0.71 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 0.46 110.473 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.29 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.35 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.31 109.784 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 0.24 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 1.42 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 145' ' ' VAL . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.29 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.25 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.16 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.4 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32 112.247 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.5 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.19 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 0.23 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.24 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.17 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 147' ' ' ILE . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.35 110.114 175.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 0.29 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.29 111.202 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 0.32 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 0.9 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.4 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.19 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.25 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 0.99 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.24 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.4 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 1.33 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 0.44 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.02 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 1.62 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.26 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.24 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 0.65 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.2 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 1.47 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.18 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.551 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 0.23 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.28 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 0.27 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 0.45 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.95 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.36 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.33 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.501 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.21 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.15 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 0.21 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.17 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 0.21 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.58 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 0.24 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.72 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.86 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.39 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 0.25 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.28 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 207' ' ' VAL . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 0.63 110.869 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 0.19 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.35 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 0.67 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.629 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 0.25 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.42 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 0.7 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.452 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.36 111.543 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.94 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.05 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt -77.25 -27.65 53.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 0.52 111.676 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 52.6 mt -77.91 -13.15 59.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 1.26 109.972 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 61.7 p -112.59 14.46 20.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.035 -0.984 . . . . 2.1 110.538 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.22 97.88 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.189 -0.764 . . . . 3.43 111.189 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -162.7 -76.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.106 -0.702 . . . . 5.22 109.106 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.663 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 95.2 mtt180 -154.06 -54.62 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.74 -1.118 . . . . 7.1 109.989 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 27.7 Cg_exo -63.09 160.85 32.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.142 1.895 . . . . 2.52 111.93 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.14 154.4 37.66 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.686 -0.688 . . . . 1.93 110.449 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo -62.84 141.28 84.1 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.78 2.32 . . . . 0.52 110.994 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.1 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.52 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 0.28 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.3 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.49 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.78 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 0.76 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.45 111.586 -173.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.14 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.507 ' HG2' HD11 ' A' ' 161' ' ' LEU . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.66 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.34 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.25 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 0.19 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HB3' HD21 ' A' ' 165' ' ' LEU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 2.69 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.65 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 0.27 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.2 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.23 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 138' ' ' GLY . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.17 111.29 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.34 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 0.36 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt -93.62 -2.13 54.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.02 111.078 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.76 -24.74 24.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.524 -0.762 . . . . 1.38 109.801 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 33.6 t80 65.81 118.13 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 5.37 111.283 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.66 69.51 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.479 -0.782 . . . . 5.25 111.246 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.01 -63.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.468 -0.567 . . . . 6.4 109.468 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 46.1 m -154.21 65.09 4.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.12 -0.491 . . . . 7.92 110.036 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.94 -58.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.828 2.352 . . . . 8.99 112.295 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.4 m 63.28 63.23 0.92 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.293 -0.867 . . . . 10.84 109.993 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.65 156.96 31.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.563 -0.744 . . . . 11.79 110.638 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.163 -0.922 . . . . 13.24 111.37 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.859 -0.497 . . . . 7.67 111.859 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.45 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.866 -0.42 . . . . 6.23 109.866 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp 62.87 24.64 14.66 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.461 0.476 . . . . 7.45 109.899 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.23 -134.15 36.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.552 -0.749 . . . . 2.81 111.795 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 p -129.23 142.03 50.97 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.981 0.42 . . . . 1.3 110.808 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m -77.35 116.48 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.51 110.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.23 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 0.24 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 0.23 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.29 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.59 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.71 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 0.46 110.394 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.29 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.529 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.35 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.31 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 0.24 110.79 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 246' ' ' GLU . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 1.42 111.37 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 145' ' ' VAL . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 0.29 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.25 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.16 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.4 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.5 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.19 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 0.23 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.24 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.17 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 0.35 109.939 175.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 0.29 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.29 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 0.32 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 0.9 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.4 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.19 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.25 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.99 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.24 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.4 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 1.33 110.072 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 0.44 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.02 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 1.62 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.26 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.24 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 0.65 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.481 ' HB ' HG22 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.2 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 1.47 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.18 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.629 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.572 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 0.23 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.28 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 0.27 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 0.45 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.95 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.36 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.33 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.21 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.15 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.429 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 0.21 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.17 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.452 ' CG1' HG11 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 0.21 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.58 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 0.24 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.72 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.86 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.39 109.752 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 0.25 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.494 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.28 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.63 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 0.19 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.35 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 221' ' ' ILE . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 0.67 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 0.25 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 0.42 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.7 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.603 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.36 111.806 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.94 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.05 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt -83.13 -22.03 33.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 0.52 112.362 -172.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 58.8 mt -80.48 12.11 3.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.083 0.468 . . . . 1.26 110.774 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.1 t -151.25 44.52 0.8 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.583 0.706 . . . . 2.1 110.295 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.4 -73.77 0.44 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.914 -0.66 . . . . 3.43 111.503 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -130.35 -45.49 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.903 -0.777 . . . . 5.22 108.903 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.649 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 57.2 mtp180 -148.9 -59.52 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.368 -0.833 . . . . 7.1 111.636 173.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 4.0 Cg_exo -76.68 153.58 34.09 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.236 1.957 . . . . 2.52 112.625 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 236' ' ' PRO . 7.7 pt-20 -95.71 160.29 30.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.649 -0.871 . . . . 1.93 108.649 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.511 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo -67.4 133.61 30.8 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.515 2.143 . . . . 0.52 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.1 111.607 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.52 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 0.28 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.3 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 0.49 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.404 ' HE2' HD13 ' A' ' 154' ' ' ILE . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 0.78 110.129 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 0.76 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.45 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.14 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.416 ' HB3' HD21 ' A' ' 161' ' ' LEU . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.66 111.032 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.34 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.25 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.19 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 2.69 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 0.27 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 0.2 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.23 111.508 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.17 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.34 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 0.36 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 190' ' ' LEU . 64.4 mt -89.27 6.62 39.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.02 111.52 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -84.3 -4.43 58.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.411 -0.959 . . . . 1.38 108.411 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 10.4 t80 69.45 51.24 0.49 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.71 -1.586 . . . . 5.37 111.591 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.79 102.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.829 -1.078 . . . . 5.25 112.278 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.79 -27.27 15.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 6.4 110.739 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 15.4 m -60.88 -46.05 96.79 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.188 -0.46 . . . . 7.92 111.804 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 10.7 Cg_exo -74.34 62.69 5.29 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.041 1.827 . . . . 8.99 110.884 171.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.6 m -58.63 129.97 44.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.416 -0.811 . . . . 10.84 111.055 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -78.46 78.91 4.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.992 -0.549 . . . . 11.79 110.927 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.978 -0.556 . . . . 13.24 111.013 179.667 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.659 ' N ' ' HG ' ' A' ' 262' ' ' SER . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.133 -0.387 . . . . 7.67 112.133 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.23 171.03 8.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.634 0.254 . . . . 6.23 110.679 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.2 mtt -139.51 85.35 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.842 0.353 . . . . 7.45 110.845 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.16 -153.8 24.79 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.687 -0.768 . . . . 2.81 112.181 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.2 p -69.04 96.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 1.3 110.988 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -76.65 118.6 19.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.568 -0.742 . . . . 0.51 110.082 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.23 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 0.24 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 0.16 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 0.23 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.16 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.5 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.29 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.59 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 0.71 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 0.46 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.35 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.31 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 0.24 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 1.42 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 165' ' ' LEU . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 0.29 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.25 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.16 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 0.4 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.19 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 0.23 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.17 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 0.35 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 0.29 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.29 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 0.32 110.015 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 0.9 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.19 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.525 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.25 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.4 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 0.99 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.24 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.4 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 1.33 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.02 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 1.62 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.26 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.24 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.549 ' HB3' HG22 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 0.65 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.2 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 1.47 107.655 178.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.18 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.534 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 0.23 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.28 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 0.27 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 0.45 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 175' ' ' THR . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.95 110.973 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.36 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.33 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.21 110.2 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.15 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 195' ' ' ILE . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 0.21 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.17 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.21 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.58 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 0.24 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 0.72 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 31.0 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.86 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.39 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 0.25 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.28 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG21 HG13 ' A' ' 207' ' ' VAL . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.63 110.738 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 0.19 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 239' ' ' LEU . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.35 110.914 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.461 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 0.67 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.554 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 0.25 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 0.42 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' A' ' 195' ' ' ILE . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.7 110.527 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.36 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.94 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.05 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt -98.22 -12.7 21.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 0.52 112.4 -177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.93 0.94 54.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.483 0.658 . . . . 1.26 110.395 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.6 t -167.16 48.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.938 -1.028 . . . . 2.1 110.046 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.16 -63.1 1.75 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.685 -0.769 . . . . 3.43 111.749 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -172.08 -32.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.532 0.682 . . . . 5.22 109.705 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.649 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 38.3 mtt180 -104.82 -170.65 0.21 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.126 -0.943 . . . . 7.1 108.765 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.649 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 12.4 Cg_exo -70.0 175.3 8.48 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.943 1.762 . . . . 2.52 111.756 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.93 138.02 97.11 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.38 -0.827 . . . . 1.93 109.955 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo -66.36 127.92 18.33 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.946 2.431 . . . . 0.52 111.845 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.1 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.52 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 220' ' ' PHE . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 0.28 110.291 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 0.3 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 0.49 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 222' ' ' THR . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.78 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 0.76 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.45 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.14 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.66 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.34 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 0.25 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 0.19 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 2.69 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 0.27 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.52 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 0.2 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.23 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.17 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.34 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 0.36 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt -78.52 -24.52 45.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.02 111.553 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -73.71 -12.84 60.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 1.38 109.867 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 58.3 t80 -81.66 -2.87 51.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.766 0.793 . . . . 5.37 110.341 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.31 122.71 29.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.381 -0.827 . . . . 5.25 110.647 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.98 123.51 22.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.165 -0.47 . . . . 6.4 109.893 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.659 ' HG ' ' N ' ' A' ' 138' ' ' GLY . 23.5 m -119.58 85.48 32.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.968 0.413 . . . . 7.92 110.974 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.23 -8.72 21.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.077 2.518 . . . . 8.99 111.923 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.9 p -81.89 -21.33 37.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.485 -0.78 . . . . 10.84 110.901 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.97 81.76 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.529 . . . . 11.79 110.637 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.53 -0.747 . . . . 13.24 109.987 -179.419 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.939 -0.464 . . . . 7.67 111.939 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.5 -27.75 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.764 0.316 . . . . 6.23 111.483 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.83 29.53 7.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.334 0.588 . . . . 7.45 110.666 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.04 123.65 1.37 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.172 -0.771 . . . . 2.81 111.172 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 p -92.46 118.12 30.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.039 0.447 . . . . 1.3 111.505 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m -78.54 125.3 29.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.98 -0.555 . . . . 0.51 109.776 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.23 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 0.24 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 0.16 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 0.23 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.5 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.29 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.59 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 0.71 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 0.46 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.561 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.29 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.35 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.31 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 0.24 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 1.42 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 163' ' ' ARG . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.25 110.586 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.16 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 0.4 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 138' ' ' GLY . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32 112.019 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.6 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.5 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.19 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 0.23 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 0.24 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.17 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 0.35 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.29 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.29 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 0.32 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 0.9 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.4 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.19 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.25 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 0.99 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.24 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.4 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 1.33 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.02 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 1.62 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.427 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.26 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.24 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.603 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 0.65 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 0.2 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 1.47 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.18 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 0.23 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.28 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.27 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.45 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.95 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.36 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.33 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.515 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.21 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.15 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.501 HD11 HD12 ' A' ' 195' ' ' ILE . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 0.21 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.17 110.087 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.21 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.58 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 0.24 110.862 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 0.72 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.86 109.728 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.39 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 0.25 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.28 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 0.63 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.19 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 239' ' ' LEU . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.35 110.2 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 0.67 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 0.25 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.42 110.403 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.7 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.36 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 230' ' ' THR . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.94 111.712 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.05 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt -97.87 1.23 47.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 0.52 111.067 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -120.69 -133.17 0.3 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.719 -0.673 . . . . 1.26 110.225 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 226' ' ' GLU . 14.8 p 58.61 4.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.017 1.327 . . . . 2.1 112.461 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.47 67.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.203 -0.523 . . . . 3.43 112.553 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 -37.46 10.07 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 5.22 111.21 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.588 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 26.1 mmt180 -113.84 -178.29 0.51 Allowed Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.585 -0.734 . . . . 7.1 110.217 -174.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 10.4 Cg_exo -72.83 137.29 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.632 2.222 . . . . 2.52 111.347 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.45 119.61 75.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.602 -0.726 . . . . 1.93 110.207 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.06 139.94 19.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.14 2.56 . . . . 0.52 112.358 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.1 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 220' ' ' PHE . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 0.28 111.008 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 0.3 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 0.49 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.78 109.56 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 0.76 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.45 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 249' ' ' VAL . 83.5 mm-40 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.14 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.66 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.605 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.34 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.25 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.19 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 247' ' ' SER . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 2.69 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 0.27 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.2 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.23 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.17 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.34 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 0.36 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 190' ' ' LEU . 37.2 mt -80.3 -12.01 59.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.02 111.205 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -86.59 -45.49 11.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.523 -0.917 . . . . 1.38 108.523 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HD2' ' ND2' ' A' ' 261' ' ' ASN . 1.4 t80 60.26 88.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.519 -1.219 . . . . 5.37 110.933 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -79.39 104.6 10.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.23 -1.35 . . . . 5.25 110.234 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 259' ' ' PHE . 7.5 p30 -159.16 -44.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.768 -0.196 . . . . 6.4 110.902 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.5 p 176.49 146.63 0.27 Allowed Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 122.939 0.496 . . . . 7.92 109.669 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.96 53.29 4.11 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.682 2.255 . . . . 8.99 111.697 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.7 m -148.69 123.22 9.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.752 -0.658 . . . . 10.84 110.134 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.73 44.94 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.214 0.531 . . . . 11.79 111.083 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.248 1.005 0 CA-C-N 116.102 -0.499 . . . . 13.24 110.522 179.112 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.939 -0.464 . . . . 7.67 111.939 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.56 77.87 9.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.853 0.359 . . . . 6.23 110.156 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.1 mmt 63.64 44.95 4.85 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.509 -0.769 . . . . 7.45 110.552 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.51 -129.09 30.69 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.128 -0.789 . . . . 2.81 111.128 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -82.55 118.68 23.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.799 -0.815 . . . . 1.3 108.799 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -76.23 122.45 24.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.016 0.436 . . . . 0.51 110.757 -173.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.23 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 0.24 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.16 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 0.23 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.16 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.5 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.421 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.29 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.59 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 0.71 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.46 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.29 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.35 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.31 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.24 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 161' ' ' LEU . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 1.42 111.018 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.29 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.25 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.16 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.4 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.5 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.19 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 0.23 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 0.24 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 0.35 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 0.29 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.29 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 0.32 110.272 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 0.9 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.4 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.19 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.25 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 22.4 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 0.99 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.24 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.4 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 1.33 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 0.44 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.02 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 1.62 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.472 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.26 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.24 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 0.65 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.2 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 1.47 108.206 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.18 112.388 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.577 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 0.23 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.28 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 0.27 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 0.45 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 175' ' ' THR . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.95 111.053 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.36 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.33 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.21 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.15 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 195' ' ' ILE . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.21 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.17 110.132 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 0.21 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.58 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 0.24 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.86 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.583 ' HE2' HG22 ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.39 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 0.25 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.28 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.511 HG21 HG13 ' A' ' 207' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 0.63 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.19 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.35 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 0.67 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.594 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 0.25 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 0.42 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 0.7 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.36 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.94 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.05 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 236' ' ' PRO . 20.8 mt -92.48 -46.66 7.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 0.52 110.613 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.92 69.84 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 1.26 110.791 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 2.2 p -81.44 51.92 1.75 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.851 -0.613 . . . . 2.1 111.782 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.67 -110.86 3.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.632 . . . . 3.43 112.959 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.52 4.78 53.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.827 0.346 . . . . 5.22 111.414 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.596 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 76.3 mtt180 -85.16 -178.85 1.26 Allowed Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.398 -0.594 . . . . 7.1 109.398 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.596 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 2.8 Cg_exo -70.86 141.6 41.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.412 2.075 . . . . 2.52 112.814 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.99 142.21 24.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 115.375 -0.829 . . . . 1.93 109.893 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 228' ' ' LEU . 37.2 Cg_endo -66.55 130.9 24.7 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.994 2.463 . . . . 0.52 111.533 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.1 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.52 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 0.28 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 0.3 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 0.49 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 0.78 109.345 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 0.76 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.45 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.14 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.66 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.34 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 251' ' ' THR . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.987 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.19 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 2.69 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 0.27 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.23 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.17 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.34 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 0.36 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 260' ' ' GLN . 82.8 mt -93.68 5.25 52.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.02 111.559 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -104.64 -52.68 2.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.868 -0.605 . . . . 1.38 110.138 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -79.42 72.46 6.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.473 -0.785 . . . . 5.37 111.077 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 257' ' ' LEU . 28.1 mt-30 -134.05 156.73 47.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.55 -0.75 . . . . 5.25 110.325 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.75 -62.84 1.52 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.549 -0.537 . . . . 6.4 109.549 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.0 p -142.89 105.55 5.29 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.798 -0.637 . . . . 7.92 110.402 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.39 -2.29 11.9 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.34 2.027 . . . . 8.99 112.356 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 40.5 p -113.32 3.53 15.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.911 -0.586 . . . . 10.84 111.025 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -148.21 169.74 19.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 11.79 111.234 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.246 -0.883 . . . . 13.24 110.213 178.197 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.846 -0.427 . . . . 0.51000000000000001 109.846 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.23000000000000001 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 0.23999999999999999 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 0.16 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 0.23000000000000001 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 0.16 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.5 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.29 111.47 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.58999999999999997 112.932 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 0.70999999999999996 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 0.46000000000000002 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.29 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.3500000000000001 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.23999999999999999 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67000000000000004 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54000000000000004 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 246' ' ' GLU . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.4199999999999999 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 145' ' ' VAL . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 0.28999999999999998 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.25 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.40000000000000002 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32000000000000001 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.532 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.5 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 0.23999999999999999 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.17000000000000001 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.34999999999999998 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 0.28999999999999998 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.28999999999999998 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 0.32000000000000001 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.538 ' HG2' HE21 ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 0.90000000000000002 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.40000000000000002 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.1899999999999999 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.25 110.682 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.538 HE21 ' HG2' ' A' ' 176' ' ' ARG . 68.3 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 0.98999999999999999 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.2400000000000002 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.40000000000000002 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 1.3300000000000001 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 0.44 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.02 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 1.6200000000000001 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.26000000000000001 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.23999999999999999 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 0.65000000000000002 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.20000000000000001 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 1.47 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.17999999999999999 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.558 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 0.23000000000000001 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.2799999999999998 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 0.27000000000000002 111.009 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.45000000000000001 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.94999999999999996 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.35999999999999999 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.33000000000000002 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.48 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.21 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.14999999999999999 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' A' ' 227' ' ' ARG . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.20999999999999999 110.141 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.17000000000000001 110.231 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 0.20999999999999999 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.57999999999999996 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.401 ' HA ' HE21 ' A' ' 213' ' ' GLN . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 0.23999999999999999 110.597 174.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.71999999999999997 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 210' ' ' ILE . 38.5 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.85999999999999999 110.036 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.39000000000000001 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 0.25 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.451 ' O ' HD12 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.28000000000000003 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.47 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 0.63 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 0.19 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.34999999999999998 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 0.67000000000000004 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.558 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 0.25 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.41999999999999998 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.69999999999999996 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.35999999999999999 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.93999999999999995 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.0499999999999998 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 0.52000000000000002 110.586 177.337 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 121.108 0.379 . . . . 0.52000000000000002 111.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.1000000000000001 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.52000000000000002 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 0.28000000000000003 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 0.29999999999999999 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 0.48999999999999999 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 0.78000000000000003 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 0.76000000000000001 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.45000000000000001 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 249' ' ' VAL . 22.9 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.1400000000000001 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.544 ' HG2' HD11 ' A' ' 161' ' ' LEU . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.6599999999999999 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.3400000000000001 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 0.19 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 2.6899999999999999 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 0.27000000000000002 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.20000000000000001 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.23000000000000001 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.1699999999999999 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.3399999999999999 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 0.35999999999999999 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.02 111.249 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.192 -0.299 . . . . 0.51000000000000001 110.192 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.23000000000000001 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 0.23999999999999999 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 0.16 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 0.23000000000000001 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 0.16 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.5 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.29 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.58999999999999997 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 0.70999999999999996 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 0.46000000000000002 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.29 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.3500000000000001 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.3100000000000001 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.23999999999999999 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67000000000000004 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 163' ' ' ARG . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 110.556 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 1.4199999999999999 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 0.28999999999999998 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' ASP . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.25 110.732 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.1599999999999999 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 162' ' ' VAL . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.40000000000000002 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32000000000000001 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.5 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.1899999999999999 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 0.23000000000000001 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 0.23999999999999999 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.17000000000000001 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.431 HG22 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 0.34999999999999998 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.28999999999999998 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.32000000000000001 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 0.90000000000000002 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.40000000000000002 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.25 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 75.5 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 0.98999999999999999 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.2400000000000002 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.40000000000000002 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.3300000000000001 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 0.44 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.02 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 1.6200000000000001 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.26000000000000001 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.23999999999999999 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.604 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 0.65000000000000002 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 0.20000000000000001 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 1.47 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.17999999999999999 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.641 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.537 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 0.23000000000000001 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.2799999999999998 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 0.27000000000000002 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 0.45000000000000001 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.94999999999999996 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.35999999999999999 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.33000000000000002 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.21 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.14999999999999999 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 195' ' ' ILE . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 0.20999999999999999 109.83 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.17000000000000001 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.475 HG13 HG21 ' A' ' 218' ' ' VAL . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.20999999999999999 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.57999999999999996 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 0.23999999999999999 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.85999999999999999 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.39000000000000001 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 0.25 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' A' ' 216' ' ' VAL . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.28000000000000003 112.452 -172.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.475 HG21 HG13 ' A' ' 207' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.34999999999999998 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 0.67000000000000004 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 0.25 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.41999999999999998 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.35999999999999999 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.93999999999999995 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.0499999999999998 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 195' ' ' ILE . 24.5 mt . . . . . 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 0.52000000000000002 111.585 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 121.095 0.373 . . . . 0.52000000000000002 111.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.1000000000000001 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.52000000000000002 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 0.28000000000000003 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 0.29999999999999999 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 0.48999999999999999 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 0.76000000000000001 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.45000000000000001 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.1400000000000001 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.6599999999999999 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.3400000000000001 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 0.25 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.19 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HB3' HD21 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 2.6899999999999999 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 0.27000000000000002 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 0.20000000000000001 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.1699999999999999 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.3399999999999999 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 0.35999999999999999 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.02 111.585 -179.163 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.055 0.455 . . . . 0.51000000000000001 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.23000000000000001 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.23999999999999999 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 0.16 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.23000000000000001 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 0.16 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.5 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.29 111.144 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.58999999999999997 111.534 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 0.70999999999999996 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 0.46000000000000002 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.29 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.3500000000000001 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.3100000000000001 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 0.23999999999999999 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67000000000000004 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54000000000000004 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 1.4199999999999999 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 0.28999999999999998 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.25 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.1599999999999999 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 0.40000000000000002 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32000000000000001 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.499 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.5 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 110.758 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 0.23000000000000001 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 0.23999999999999999 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.17000000000000001 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 0.34999999999999998 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 0.28999999999999998 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.28999999999999998 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.32000000000000001 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 0.90000000000000002 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 0.40000000000000002 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.1899999999999999 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.25 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 0.98999999999999999 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.2400000000000002 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.40000000000000002 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 1.3300000000000001 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.44 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.02 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 1.6200000000000001 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.495 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.26000000000000001 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.23999999999999999 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 0.65000000000000002 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 0.20000000000000001 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 1.47 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.17999999999999999 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.653 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.54 HD12 HD11 ' A' ' 204' ' ' ILE . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 0.23000000000000001 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.2799999999999998 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 0.27000000000000002 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 0.45000000000000001 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.94999999999999996 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.35999999999999999 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.33000000000000002 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.555 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.21 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.14999999999999999 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 195' ' ' ILE . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.20999999999999999 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.17000000000000001 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.438 ' CG1' HG11 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.57999999999999996 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 0.23999999999999999 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 0.71999999999999997 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.85999999999999999 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.39000000000000001 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 0.25 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD12 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.28000000000000003 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.438 HG11 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.63 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 0.19 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.34999999999999998 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 0.67000000000000004 108.866 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 0.25 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.41999999999999998 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.69999999999999996 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.35999999999999999 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.93999999999999995 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.472 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.0499999999999998 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 0.52000000000000002 111.393 -178.063 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.465 -0.171 0 CA-C-O 121.37 0.487 . . . . 0.52000000000000002 113.052 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.1000000000000001 110.275 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.52000000000000002 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.28000000000000003 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 221' ' ' ILE . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 0.29999999999999999 109.5 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 0.48999999999999999 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 0.78000000000000003 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 0.76000000000000001 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.406 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.45000000000000001 111.885 -171.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.1400000000000001 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.6599999999999999 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.3400000000000001 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 0.25 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.19 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 2.6899999999999999 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 0.27000000000000002 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 0.20000000000000001 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.23000000000000001 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.1699999999999999 111.227 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.3399999999999999 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 0.35999999999999999 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.02 111.241 -178.35 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.903 -0.406 . . . . 0.51000000000000001 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.23000000000000001 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.23999999999999999 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.16 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 0.23000000000000001 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 0.16 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.5 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.29 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.58999999999999997 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 0.70999999999999996 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.29 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.3500000000000001 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.3100000000000001 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67000000000000004 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54000000000000004 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 1.4199999999999999 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 0.28999999999999998 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.25 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.1599999999999999 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 0.40000000000000002 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32000000000000001 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.5 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 0.23999999999999999 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.17000000000000001 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 0.34999999999999998 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 0.28999999999999998 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.28999999999999998 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 0.32000000000000001 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 0.90000000000000002 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.40000000000000002 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.1899999999999999 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 0.98999999999999999 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.621 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.2400000000000002 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.40000000000000002 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 1.3300000000000001 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 0.44 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.621 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 1.6200000000000001 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.26000000000000001 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.23999999999999999 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 145' ' ' VAL . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 0.20000000000000001 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 1.47 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.17999999999999999 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.66 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 0.23000000000000001 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.2799999999999998 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.27000000000000002 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 0.45000000000000001 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.35999999999999999 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.33000000000000002 109.856 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.21 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.14999999999999999 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 195' ' ' ILE . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.20999999999999999 110.003 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.17000000000000001 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 0.20999999999999999 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.57999999999999996 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 0.23999999999999999 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 0.71999999999999997 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.85999999999999999 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.39000000000000001 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 0.25 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.568 ' O ' HD12 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.28000000000000003 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 0.63 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 0.19 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.34999999999999998 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 0.67000000000000004 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 0.25 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.41999999999999998 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.69999999999999996 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.35999999999999999 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.93999999999999995 111.08 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.0499999999999998 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 0.52000000000000002 112.083 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 121.056 0.357 . . . . 0.52000000000000002 111.365 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.1000000000000001 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.52000000000000002 109.741 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 0.28000000000000003 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.29999999999999999 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 0.48999999999999999 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.473 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.78000000000000003 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 0.76000000000000001 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.45000000000000001 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 24.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.1400000000000001 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.3400000000000001 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 0.25 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 0.19 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 2.6899999999999999 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 0.27000000000000002 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 0.20000000000000001 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.23000000000000001 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.1699999999999999 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.3399999999999999 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 0.35999999999999999 110.918 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.02 110.922 179.265 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.51000000000000001 110.595 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 162' ' ' VAL . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 0.23999999999999999 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.16 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 0.23000000000000001 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 0.16 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.5 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.29 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.58999999999999997 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.70999999999999996 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 0.46000000000000002 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.29 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.3500000000000001 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.3100000000000001 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 0.23999999999999999 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67000000000000004 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54000000000000004 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD23 ' HE ' ' A' ' 250' ' ' ARG . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 1.4199999999999999 111.407 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 0.28999999999999998 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.25 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.40000000000000002 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32000000000000001 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.5 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.1899999999999999 110.877 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 0.23000000000000001 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 0.23999999999999999 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.17000000000000001 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 0.34999999999999998 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.28999999999999998 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.32000000000000001 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 0.90000000000000002 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.40000000000000002 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.1899999999999999 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.98999999999999999 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.2400000000000002 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.40000000000000002 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.02 110.699 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 1.6200000000000001 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.26000000000000001 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.23999999999999999 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 145' ' ' VAL . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 0.65000000000000002 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.4 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 0.20000000000000001 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 1.47 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.452 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.17999999999999999 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 204' ' ' ILE . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 0.23000000000000001 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.2799999999999998 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.27000000000000002 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.45000000000000001 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.94999999999999996 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.35999999999999999 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.33000000000000002 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.21 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.14999999999999999 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 195' ' ' ILE . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 0.20999999999999999 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.449 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.17000000000000001 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 0.20999999999999999 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.57999999999999996 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 0.23999999999999999 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.85999999999999999 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.39000000000000001 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 0.25 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.466 ' O ' HD12 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.28000000000000003 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.476 HG21 HG13 ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 0.63 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 0.19 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.34999999999999998 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.453 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 0.67000000000000004 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 0.25 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.41999999999999998 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.35999999999999999 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.853 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.0499999999999998 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.52000000000000002 110.825 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.463 -0.295 0 CA-C-O 121.176 0.406 . . . . 0.52000000000000002 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.1000000000000001 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.52000000000000002 111.012 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.29999999999999999 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 0.48999999999999999 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.78000000000000003 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 0.76000000000000001 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.45000000000000001 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.1400000000000001 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.3400000000000001 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HE ' HD23 ' A' ' 161' ' ' LEU . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 2.6899999999999999 110.664 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 0.27000000000000002 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 0.20000000000000001 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.441 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.23000000000000001 110.971 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.1699999999999999 112.147 -174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.3399999999999999 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 0.35999999999999999 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.02 111.563 -177.016 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.436 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 23.5 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.381 -0.97 . . . . 0.51000000000000001 108.381 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.23000000000000001 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 162' ' ' VAL . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 0.23999999999999999 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 0.16 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 0.23000000000000001 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 0.16 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.5 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.29 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.58999999999999997 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.70999999999999996 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.46000000000000002 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.29 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.3500000000000001 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.3100000000000001 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 0.23999999999999999 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67000000000000004 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54000000000000004 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 249' ' ' VAL . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 1.4199999999999999 111.35 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 145' ' ' VAL . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.25 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32000000000000001 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.5 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.1899999999999999 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 0.23000000000000001 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 0.34999999999999998 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 0.28999999999999998 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.28999999999999998 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.32000000000000001 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.452 ' HG2' HE21 ' A' ' 180' ' ' GLN . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.40000000000000002 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.1899999999999999 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.25 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.452 HE21 ' HG2' ' A' ' 176' ' ' ARG . 76.0 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 0.98999999999999999 110.802 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.02 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 1.6200000000000001 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.26000000000000001 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.23999999999999999 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 0.65000000000000002 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.20000000000000001 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 1.47 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.17999999999999999 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.612 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.54 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 0.23000000000000001 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.2799999999999998 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.404 HD11 ' HA2' ' A' ' 203' ' ' GLY . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.27000000000000002 110.36 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 0.45000000000000001 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.485 ' H ' HG22 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.94999999999999996 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.35999999999999999 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.33000000000000002 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.21 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.14999999999999999 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 195' ' ' ILE . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 0.20999999999999999 110.069 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.17000000000000001 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 0.20999999999999999 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.57999999999999996 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.406 HG21 HG21 ' A' ' 191' ' ' VAL . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 110.662 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 0.71999999999999997 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.85999999999999999 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 0.25 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.486 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.28000000000000003 112.018 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 0.63 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 0.19 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.45 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.34999999999999998 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 0.67000000000000004 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.569 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 0.25 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 0.41999999999999998 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.69999999999999996 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.35999999999999999 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.93999999999999995 111.533 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.0499999999999998 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 111.371 -178.383 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 N-CA-C 111.315 -0.302 . . . . 0.52000000000000002 111.315 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.1000000000000001 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.52000000000000002 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 0.28000000000000003 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 154' ' ' ILE . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 0.78000000000000003 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 0.76000000000000001 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.45000000000000001 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.1400000000000001 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.3400000000000001 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 0.25 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 161' ' ' LEU . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 0.19 110.732 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 2.6899999999999999 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 0.27000000000000002 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.661 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.1699999999999999 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.7 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.3399999999999999 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 0.35999999999999999 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.02 111.172 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 110.391 -0.226 . . . . 0.51000000000000001 110.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.23000000000000001 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 0.16 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.5 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.29 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.58999999999999997 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.46000000000000002 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.29 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.3500000000000001 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.3100000000000001 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 0.23999999999999999 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54000000000000004 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 1.4199999999999999 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.572 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 0.28999999999999998 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.25 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.1599999999999999 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.40000000000000002 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.5 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.1899999999999999 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 0.23999999999999999 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.17000000000000001 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 0.34999999999999998 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 0.28999999999999998 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.32000000000000001 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.90000000000000002 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 0.40000000000000002 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.1899999999999999 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.25 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.98999999999999999 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.2400000000000002 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.40000000000000002 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.02 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 1.6200000000000001 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.26000000000000001 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.23999999999999999 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 0.65000000000000002 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 0.20000000000000001 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 1.47 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.442 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.17999999999999999 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.591 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.5 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 0.23000000000000001 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.2799999999999998 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 0.27000000000000002 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 0.45000000000000001 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.94999999999999996 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.35999999999999999 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.33000000000000002 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.21 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.14999999999999999 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.41 ' CD1' ' HD2' ' A' ' 227' ' ' ARG . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.20999999999999999 110.282 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.17000000000000001 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 218' ' ' VAL . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 0.20999999999999999 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.57999999999999996 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 0.23999999999999999 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.71999999999999997 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.85999999999999999 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.39000000000000001 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 0.25 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.28000000000000003 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 0.63 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.411 ' HB ' HD22 ' A' ' 192' ' ' LEU . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 0.19 109.87 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.425 ' O ' HD12 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.34999999999999998 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 0.67000000000000004 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 0.25 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 0.41999999999999998 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 0.69999999999999996 111.318 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.35999999999999999 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.93999999999999995 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.0499999999999998 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.52000000000000002 111.128 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 N-CA-C 111.062 -0.399 . . . . 0.52000000000000002 111.062 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.52000000000000002 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.28000000000000003 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 0.29999999999999999 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 0.48999999999999999 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.78000000000000003 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 0.76000000000000001 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.45000000000000001 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.1400000000000001 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.448 ' HB3' HD21 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.6599999999999999 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.3400000000000001 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 0.25 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 0.19 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.439 ' HA ' HD11 ' A' ' 165' ' ' LEU . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 2.6899999999999999 110.708 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 0.27000000000000002 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 0.20000000000000001 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.1699999999999999 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.3399999999999999 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 0.35999999999999999 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.02 111.045 -179.143 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.916 -0.402 . . . . 0.51000000000000001 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.23000000000000001 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 0.23999999999999999 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 0.16 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 0.23000000000000001 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 0.16 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.5 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.29 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.58999999999999997 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 0.70999999999999996 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.46000000000000002 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.29 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.427 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.3500000000000001 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.3100000000000001 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54000000000000004 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 1.4199999999999999 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 0.28999999999999998 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.25 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.1599999999999999 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.40000000000000002 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32000000000000001 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.5 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.1899999999999999 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 0.23000000000000001 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.23999999999999999 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.17000000000000001 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 0.34999999999999998 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 0.28999999999999998 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.28999999999999998 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.32000000000000001 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 0.90000000000000002 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 0.40000000000000002 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.25 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 0.98999999999999999 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.2400000000000002 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.40000000000000002 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 1.3300000000000001 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.44 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.02 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 1.6200000000000001 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.26000000000000001 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.23999999999999999 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 0.65000000000000002 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.20000000000000001 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 1.47 107.71 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.17999999999999999 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.403 HG12 ' OG1' ' A' ' 222' ' ' THR . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 0.23000000000000001 112.023 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.2799999999999998 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 0.27000000000000002 110.864 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 0.45000000000000001 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.94999999999999996 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.35999999999999999 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.33000000000000002 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.21 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.14999999999999999 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 0.20999999999999999 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.17000000000000001 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 0.20999999999999999 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.57999999999999996 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 0.23999999999999999 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 0.71999999999999997 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.85999999999999999 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.39000000000000001 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 0.25 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.28000000000000003 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.63 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.472 ' O ' HD12 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.34999999999999998 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 0.67000000000000004 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 0.25 110.475 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 242' ' ' LYS . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.41999999999999998 110.836 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 0.69999999999999996 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.35999999999999999 111.803 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.808 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.0499999999999998 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 236' ' ' PRO . 18.2 mt . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 0.52000000000000002 111.62 -173.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HG3' HD22 ' A' ' 228' ' ' LEU . 52.1 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 CA-C-O 119.773 -0.178 . . . . 0.52000000000000002 112.06 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.1000000000000001 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.52000000000000002 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 0.28000000000000003 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 0.29999999999999999 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 0.48999999999999999 112.044 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.43 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.78000000000000003 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 0.76000000000000001 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.405 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.45000000000000001 111.421 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.558 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.1400000000000001 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.6599999999999999 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.3400000000000001 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 0.25 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.19 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 2.6899999999999999 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 0.27000000000000002 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.20000000000000001 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.413 HG13 HD21 ' A' ' 190' ' ' LEU . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.23000000000000001 110.664 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.1699999999999999 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.3 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.3399999999999999 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 0.35999999999999999 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 190' ' ' LEU . 83.2 mt . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.02 111.06 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.411 -0.588 . . . . 0.51000000000000001 109.411 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.23000000000000001 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 0.23999999999999999 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 0.16 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 0.16 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.29 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.58999999999999997 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.70999999999999996 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 242' ' ' LYS . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.46000000000000002 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.29 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.3500000000000001 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.3100000000000001 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67000000000000004 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 1.4199999999999999 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 145' ' ' VAL . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 0.28999999999999998 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 163' ' ' ARG . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.25 110.48 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.1599999999999999 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 0.40000000000000002 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32000000000000001 112.25 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.5 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.1899999999999999 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 159' ' ' GLU . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.23000000000000001 109.865 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.56 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 0.23999999999999999 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.17000000000000001 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 0.34999999999999998 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 0.28999999999999998 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.28999999999999998 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 0.32000000000000001 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 0.90000000000000002 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.40000000000000002 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.25 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.98999999999999999 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.2400000000000002 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.40000000000000002 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 1.3300000000000001 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 0.44 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.02 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.425 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 1.6200000000000001 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.26000000000000001 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.23999999999999999 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 0.65000000000000002 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 0.20000000000000001 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 1.47 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.17999999999999999 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.502 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 0.23000000000000001 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.2799999999999998 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 0.27000000000000002 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 0.45000000000000001 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.94999999999999996 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.35999999999999999 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.33000000000000002 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.21 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.14999999999999999 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 195' ' ' ILE . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 0.20999999999999999 110.433 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.17000000000000001 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 218' ' ' VAL . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 0.20999999999999999 110.954 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.57999999999999996 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.23999999999999999 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 0.71999999999999997 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.85999999999999999 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.444 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.39000000000000001 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 0.25 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.28000000000000003 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 207' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 0.63 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 0.19 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.34999999999999998 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 0.67000000000000004 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 0.25 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.41999999999999998 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.69999999999999996 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.35999999999999999 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.93999999999999995 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.0499999999999998 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.41 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 34.3 mt . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 0.52000000000000002 111.324 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 40.5 Cg_endo . . . . . 0 N--CA 1.46 -0.45 0 CA-C-O 121.044 0.352 . . . . 0.52000000000000002 111.47 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.1000000000000001 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.52000000000000002 109.977 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 0.28000000000000003 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 0.29999999999999999 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 0.48999999999999999 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.78000000000000003 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 0.76000000000000001 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.45000000000000001 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.1400000000000001 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.6599999999999999 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.3400000000000001 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.25 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 0.19 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 2.6899999999999999 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 0.27000000000000002 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.20000000000000001 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.23000000000000001 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.1699999999999999 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.3399999999999999 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 0.35999999999999999 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.02 111.328 -177.442 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.826 -0.435 . . . . 0.51000000000000001 109.826 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.23000000000000001 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 162' ' ' VAL . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 0.23999999999999999 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 0.23000000000000001 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.5 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.29 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.58999999999999997 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.70999999999999996 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 0.46000000000000002 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.29 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.3500000000000001 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.3100000000000001 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 0.23999999999999999 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67000000000000004 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54000000000000004 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.4199999999999999 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 0.28999999999999998 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.25 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.1599999999999999 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.40000000000000002 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.5 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.1899999999999999 110.199 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 0.23999999999999999 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.17000000000000001 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 0.34999999999999998 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 0.28999999999999998 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.28999999999999998 111.182 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 0.32000000000000001 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 0.90000000000000002 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 0.40000000000000002 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 181' ' ' GLU . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.1899999999999999 111.261 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.25 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.447 HE21 ' HG2' ' A' ' 176' ' ' ARG . 77.4 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 0.98999999999999999 112.214 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.2400000000000002 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.40000000000000002 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 1.3300000000000001 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.02 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 1.6200000000000001 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.26000000000000001 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.23999999999999999 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 0.65000000000000002 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 0.20000000000000001 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.481 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 1.47 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.17999999999999999 112.472 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 0.23000000000000001 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.2799999999999998 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.538 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 0.27000000000000002 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 0.45000000000000001 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.94999999999999996 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.35999999999999999 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.33000000000000002 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.21 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.14999999999999999 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 0.20999999999999999 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.527 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.17000000000000001 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 218' ' ' VAL . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 0.20999999999999999 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.57999999999999996 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.23999999999999999 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.71999999999999997 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.85999999999999999 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.39000000000000001 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 0.25 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.28000000000000003 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 207' ' ' VAL . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 0.63 111.018 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 192' ' ' LEU . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 0.19 110.077 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.34999999999999998 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 240' ' ' VAL . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 0.67000000000000004 108.915 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 0.25 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 0.41999999999999998 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 0.69999999999999996 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.35999999999999999 112.176 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.93999999999999995 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.447 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.0499999999999998 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 0.52000000000000002 111.528 -177.389 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.016 0.34 . . . . 0.52000000000000002 111.693 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.1000000000000001 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.52000000000000002 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 0.28000000000000003 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 0.29999999999999999 109.639 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 222' ' ' THR . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 0.48999999999999999 111.821 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 0.78000000000000003 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 0.76000000000000001 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.405 ' N ' ' HA ' ' A' ' 242' ' ' LYS . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.45000000000000001 111.346 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.1400000000000001 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.6599999999999999 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.3400000000000001 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 0.25 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 2.6899999999999999 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 0.27000000000000002 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 0.20000000000000001 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.23000000000000001 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.1699999999999999 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 25.3 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.3399999999999999 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 0.35999999999999999 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.02 111.344 -178.448 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.178 -0.304 . . . . 0.51000000000000001 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.23000000000000001 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 0.23999999999999999 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.16 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.23000000000000001 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 0.16 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.5 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.29 111.149 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.58999999999999997 113.144 -173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.70999999999999996 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 0.46000000000000002 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.29 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.441 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.3500000000000001 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.3100000000000001 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 0.23999999999999999 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67000000000000004 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.4199999999999999 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 0.28999999999999998 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.25 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.1599999999999999 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.40000000000000002 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32000000000000001 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.5 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.23000000000000001 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 0.23999999999999999 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.17000000000000001 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 0.34999999999999998 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 0.28999999999999998 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.28999999999999998 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 0.32000000000000001 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 0.40000000000000002 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.1899999999999999 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.25 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 0.98999999999999999 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.2400000000000002 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.40000000000000002 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 0.44 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.02 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 1.6200000000000001 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.606 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.26000000000000001 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.23999999999999999 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.649 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 0.65000000000000002 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 0.20000000000000001 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 1.47 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.17999999999999999 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.496 HD12 HD11 ' A' ' 204' ' ' ILE . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 0.23000000000000001 110.857 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.2799999999999998 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.423 HD11 ' HA2' ' A' ' 203' ' ' GLY . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.419 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 111.686 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.94999999999999996 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.35999999999999999 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.33000000000000002 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.21 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.14999999999999999 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 195' ' ' ILE . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 0.20999999999999999 110.18 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.17000000000000001 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.414 HG13 HG21 ' A' ' 218' ' ' VAL . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 0.20999999999999999 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.57999999999999996 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 0.71999999999999997 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.85999999999999999 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.39000000000000001 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 0.25 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.598 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.28000000000000003 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 0.63 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 0.19 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.34999999999999998 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 0.67000000000000004 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 0.25 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 0.41999999999999998 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.69999999999999996 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.35999999999999999 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.0499999999999998 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 0.52000000000000002 113.004 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 121.079 0.366 . . . . 0.52000000000000002 111.509 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.1000000000000001 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.52000000000000002 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 0.28000000000000003 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.29999999999999999 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 0.48999999999999999 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.78000000000000003 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 0.76000000000000001 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.45000000000000001 111.443 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.1400000000000001 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.6599999999999999 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.3400000000000001 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.25 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.19 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 2.6899999999999999 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 0.27000000000000002 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 0.20000000000000001 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.23000000000000001 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.1699999999999999 111.789 -176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.3399999999999999 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 0.35999999999999999 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.02 111.235 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.466 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.341 0.591 . . . . 0.51000000000000001 109.705 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.23000000000000001 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 0.23999999999999999 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 0.23000000000000001 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.16 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.5 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.29 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.722 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.58999999999999997 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 0.70999999999999996 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.425 HG21 ' HE3' ' A' ' 242' ' ' LYS . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 0.46000000000000002 110.796 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.722 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.29 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.3500000000000001 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 0.23999999999999999 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 1.4199999999999999 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.25 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.1599999999999999 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 0.40000000000000002 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32000000000000001 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.466 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.5 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.1899999999999999 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 0.23000000000000001 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 0.23999999999999999 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.17000000000000001 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 0.34999999999999998 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 0.28999999999999998 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.28999999999999998 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.32000000000000001 110.767 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 0.90000000000000002 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 0.40000000000000002 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.1899999999999999 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.25 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 0.98999999999999999 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.40000000000000002 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.412 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 1.3300000000000001 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 0.44 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.02 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 1.6200000000000001 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.603 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.26000000000000001 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.23999999999999999 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 0.65000000000000002 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 0.20000000000000001 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 1.47 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.17999999999999999 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.589 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 0.23000000000000001 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.2799999999999998 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.4 HD11 ' HA2' ' A' ' 203' ' ' GLY . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 0.27000000000000002 110.59 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 0.45000000000000001 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 175' ' ' THR . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.94999999999999996 111.563 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.35999999999999999 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.33000000000000002 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.21 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.14999999999999999 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 195' ' ' ILE . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 0.20999999999999999 110.447 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.17000000000000001 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.57999999999999996 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 0.23999999999999999 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.71999999999999997 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.85999999999999999 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.39000000000000001 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 0.25 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.504 ' HD2' HG13 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.28000000000000003 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 207' ' ' VAL . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.63 110.971 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.512 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 0.19 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.517 ' O ' HD12 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.34999999999999998 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 0.67000000000000004 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.618 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 0.25 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 0.41999999999999998 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 0.69999999999999996 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.35999999999999999 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.93999999999999995 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.0499999999999998 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 0.52000000000000002 111.743 -176.568 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.142 -0.369 . . . . 0.52000000000000002 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.1000000000000001 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 219' ' ' ILE . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.52000000000000002 109.828 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 0.28000000000000003 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 0.29999999999999999 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 0.48999999999999999 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 0.76000000000000001 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.45000000000000001 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG23 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.1400000000000001 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.3400000000000001 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 0.25 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 0.19 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 2.6899999999999999 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 0.27000000000000002 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 0.20000000000000001 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.463 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.643 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.1699999999999999 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 26.6 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.3399999999999999 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 0.35999999999999999 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.091 -178.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.75 -0.463 . . . . 0.51000000000000001 109.75 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.23000000000000001 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 162' ' ' VAL . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 0.23999999999999999 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.506 ' O ' HD22 ' A' ' 192' ' ' LEU . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 0.16 110.616 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.438 ' HA ' HD23 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 0.23000000000000001 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.16 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.5 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.29 111.366 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.58999999999999997 111.96 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 0.70999999999999996 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.46000000000000002 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.29 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.3500000000000001 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.3100000000000001 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.23999999999999999 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67000000000000004 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54000000000000004 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 1.4199999999999999 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 165' ' ' LEU . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 0.28999999999999998 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.25 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.1599999999999999 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.40000000000000002 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32000000000000001 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.5 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 0.23000000000000001 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.17000000000000001 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 0.34999999999999998 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 0.28999999999999998 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.28999999999999998 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.32000000000000001 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 0.90000000000000002 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 0.40000000000000002 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.1899999999999999 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.25 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.98999999999999999 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.2400000000000002 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 1.3300000000000001 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.02 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 1.6200000000000001 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.26000000000000001 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.23999999999999999 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 0.65000000000000002 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 0.20000000000000001 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.607 ' H ' HD22 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 1.47 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.17999999999999999 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.554 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 0.23000000000000001 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.2799999999999998 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.27000000000000002 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.45000000000000001 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.94999999999999996 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.35999999999999999 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.33000000000000002 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.21 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.14999999999999999 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 195' ' ' ILE . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 0.20999999999999999 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.17000000000000001 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 0.20999999999999999 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.57999999999999996 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 0.23999999999999999 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.71999999999999997 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.85999999999999999 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.39000000000000001 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 0.25 110.035 -173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.57 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.28000000000000003 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 0.63 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 0.19 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.34999999999999998 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 0.67000000000000004 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.554 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 0.25 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 0.41999999999999998 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 0.69999999999999996 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.35999999999999999 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.93999999999999995 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.0499999999999998 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 44.5 mt . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 0.52000000000000002 111.225 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 46.0 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 121.028 0.345 . . . . 0.52000000000000002 112.083 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.1000000000000001 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.52000000000000002 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.28000000000000003 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 0.29999999999999999 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 0.48999999999999999 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 0.78000000000000003 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 0.76000000000000001 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.45000000000000001 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.1400000000000001 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.6599999999999999 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.3400000000000001 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 0.25 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.19 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 2.6899999999999999 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.685 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.27000000000000002 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 0.20000000000000001 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.23000000000000001 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.1699999999999999 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.3399999999999999 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 0.35999999999999999 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.779 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.477 ' HB ' ' HD1' ' A' ' 167' ' ' HIS . 1.4 m . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 109.872 -0.418 . . . . 0.51000000000000001 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.23000000000000001 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 0.23999999999999999 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 0.16 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 0.23000000000000001 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 0.16 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.5 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.535 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.29 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.725 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.58999999999999997 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.70999999999999996 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.46000000000000002 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.725 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.29 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.3100000000000001 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 0.23999999999999999 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67000000000000004 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 1.4199999999999999 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 0.28999999999999998 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.25 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.1599999999999999 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.40000000000000002 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32000000000000001 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.477 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.5 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 0.23000000000000001 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 0.23999999999999999 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.17000000000000001 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 0.34999999999999998 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 0.28999999999999998 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.28999999999999998 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 0.32000000000000001 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' HE21 ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.40000000000000002 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.1899999999999999 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.25 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.515 HE21 ' HG2' ' A' ' 176' ' ' ARG . 73.4 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 0.98999999999999999 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.2400000000000002 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.40000000000000002 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 1.3300000000000001 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.02 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 1.6200000000000001 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.26000000000000001 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.23999999999999999 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 0.65000000000000002 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.403 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.20000000000000001 111.144 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 221' ' ' ILE . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 1.47 109.357 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.17999999999999999 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.561 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 0.23000000000000001 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.2799999999999998 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 0.45000000000000001 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.455 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.94999999999999996 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.35999999999999999 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.33000000000000002 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.21 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.14999999999999999 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 0.20999999999999999 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.451 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.17000000000000001 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.20999999999999999 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.57999999999999996 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 0.23999999999999999 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.71999999999999997 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.85999999999999999 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.39000000000000001 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 0.25 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.517 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.28000000000000003 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 0.63 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 192' ' ' LEU . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 0.19 110.07 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.34999999999999998 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 192' ' ' LEU . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 0.67000000000000004 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 0.25 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 0.41999999999999998 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.69999999999999996 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.35999999999999999 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.93999999999999995 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.0499999999999998 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 0.52000000000000002 111.048 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.01 0.338 . . . . 0.52000000000000002 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.1000000000000001 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.52000000000000002 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 0.28000000000000003 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.419 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 0.29999999999999999 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 0.48999999999999999 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 0.78000000000000003 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 0.76000000000000001 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.1400000000000001 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.6599999999999999 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.3400000000000001 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 0.25 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 0.19 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 2.6899999999999999 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.27000000000000002 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.20000000000000001 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.23000000000000001 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.1699999999999999 111.01 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.3399999999999999 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 0.35999999999999999 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.902 -179.728 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.51000000000000001 111.069 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.23000000000000001 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 0.23999999999999999 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 0.16 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.5 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.29 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.58999999999999997 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 0.70999999999999996 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 0.46000000000000002 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.456 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.3500000000000001 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 157' ' ' GLN . 10.5 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.3100000000000001 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 0.23999999999999999 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67000000000000004 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 1.4199999999999999 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 0.28999999999999998 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.25 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.1599999999999999 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.40000000000000002 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32000000000000001 112.185 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.5 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.1899999999999999 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 159' ' ' GLU . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.23000000000000001 110.364 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 0.23999999999999999 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.17000000000000001 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 0.34999999999999998 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 0.28999999999999998 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.28999999999999998 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 0.32000000000000001 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 0.90000000000000002 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.40000000000000002 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.1899999999999999 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.98999999999999999 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2400000000000002 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.40000000000000002 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 1.3300000000000001 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.02 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 1.6200000000000001 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.438 ' O ' HG21 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.26000000000000001 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.23999999999999999 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB3' HG22 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 0.65000000000000002 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 0.20000000000000001 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 1.47 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.17999999999999999 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.647 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 0.23000000000000001 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.2799999999999998 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.487 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.27000000000000002 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.45000000000000001 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.567 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.94999999999999996 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.35999999999999999 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.33000000000000002 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.21 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.14999999999999999 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 0.20999999999999999 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.17000000000000001 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.57999999999999996 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 0.23999999999999999 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 0.71999999999999997 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.1 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.85999999999999999 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.39000000000000001 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 0.25 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.28000000000000003 112.241 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 0.63 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.408 ' HB ' HD22 ' A' ' 192' ' ' LEU . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.087 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.34999999999999998 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 242' ' ' LYS . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 0.67000000000000004 108.614 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 0.25 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 0.41999999999999998 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 0.69999999999999996 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.35999999999999999 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 226' ' ' GLU . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.93999999999999995 111.771 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.0499999999999998 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 26.6 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 0.52000000000000002 112.155 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 16.8 Cg_endo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.222 0.426 . . . . 0.52000000000000002 111.562 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.1000000000000001 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.52000000000000002 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 0.28000000000000003 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 0.29999999999999999 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 0.48999999999999999 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.78000000000000003 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 0.76000000000000001 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.45000000000000001 111.302 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.1400000000000001 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.6599999999999999 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.25 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 0.19 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' A' ' 165' ' ' LEU . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 2.6899999999999999 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 0.27000000000000002 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 0.20000000000000001 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.23000000000000001 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.1699999999999999 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.3399999999999999 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 0.35999999999999999 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.063 -176.739 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.51000000000000001 109.584 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.23000000000000001 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 0.23999999999999999 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 0.23000000000000001 111.185 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 0.16 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.5 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.29 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.58999999999999997 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 0.46000000000000002 110.473 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.29 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.3500000000000001 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 109.784 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67000000000000004 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54000000000000004 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 1.4199999999999999 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 145' ' ' VAL . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.28999999999999998 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.25 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.1599999999999999 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.40000000000000002 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32000000000000001 112.247 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.5 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 0.23000000000000001 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.23999999999999999 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.17000000000000001 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 147' ' ' ILE . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.34999999999999998 110.114 175.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 0.28999999999999998 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.28999999999999998 111.202 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 0.32000000000000001 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 0.90000000000000002 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.40000000000000002 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.1899999999999999 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.25 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 0.98999999999999999 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.40000000000000002 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 1.3300000000000001 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 0.44 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.02 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 1.6200000000000001 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.26000000000000001 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.23999999999999999 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 0.65000000000000002 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.20000000000000001 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 1.47 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.17999999999999999 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.551 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 0.23000000000000001 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.2799999999999998 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 0.27000000000000002 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 0.45000000000000001 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.94999999999999996 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.35999999999999999 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.33000000000000002 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.501 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.21 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.14999999999999999 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 0.20999999999999999 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.17000000000000001 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 0.20999999999999999 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.57999999999999996 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 0.23999999999999999 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.71999999999999997 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.85999999999999999 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.39000000000000001 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 0.25 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.28000000000000003 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 207' ' ' VAL . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 0.63 110.869 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 0.19 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.34999999999999998 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 0.67000000000000004 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.629 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 0.25 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.41999999999999998 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.35999999999999999 111.543 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.93999999999999995 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.0499999999999998 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 0.52000000000000002 111.676 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo . . . . . 0 C--O 1.235 0.356 0 N-CA-C 110.994 -0.426 . . . . 0.52000000000000002 110.994 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.1000000000000001 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.52000000000000002 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 0.28000000000000003 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.29999999999999999 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.48999999999999999 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 0.76000000000000001 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.45000000000000001 111.586 -173.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.1400000000000001 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.507 ' HG2' HD11 ' A' ' 161' ' ' LEU . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.3400000000000001 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.25 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 0.19 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HB3' HD21 ' A' ' 165' ' ' LEU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 2.6899999999999999 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.65 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.20000000000000001 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.23000000000000001 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.1699999999999999 111.29 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.3399999999999999 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 0.35999999999999999 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.02 111.078 -178.813 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 110.287 -0.264 . . . . 0.51000000000000001 110.287 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.23000000000000001 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 0.23999999999999999 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 0.23000000000000001 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.29 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.58999999999999997 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.70999999999999996 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 0.46000000000000002 110.394 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.29 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.529 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.3500000000000001 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.3100000000000001 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 0.23999999999999999 110.79 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67000000000000004 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54000000000000004 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 246' ' ' GLU . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 1.4199999999999999 111.37 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 145' ' ' VAL . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 0.28999999999999998 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.25 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.1599999999999999 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.40000000000000002 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32000000000000001 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.5 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.1899999999999999 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 0.23000000000000001 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.23999999999999999 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.17000000000000001 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 0.34999999999999998 109.939 175.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 0.28999999999999998 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.28999999999999998 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 0.32000000000000001 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 0.90000000000000002 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.40000000000000002 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.1899999999999999 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.25 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.98999999999999999 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.2400000000000002 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 1.3300000000000001 110.072 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 0.44 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.02 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 1.6200000000000001 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.26000000000000001 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.23999999999999999 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 0.65000000000000002 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.481 ' HB ' HG22 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 1.47 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.17999999999999999 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.629 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.572 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.2799999999999998 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 0.27000000000000002 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 0.45000000000000001 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.94999999999999996 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.35999999999999999 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.33000000000000002 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.21 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.14999999999999999 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.429 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 0.20999999999999999 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.17000000000000001 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.452 ' CG1' HG11 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 0.20999999999999999 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.57999999999999996 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 0.23999999999999999 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.71999999999999997 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 37.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.85999999999999999 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.39000000000000001 109.752 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 0.25 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.494 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.28000000000000003 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.63 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 0.19 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.34999999999999998 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 221' ' ' ILE . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 0.67000000000000004 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 0.25 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 0.41999999999999998 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.69999999999999996 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.35999999999999999 111.806 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.93999999999999995 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.0499999999999998 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 0.52000000000000002 112.362 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.511 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 111.16 -0.362 . . . . 0.52000000000000002 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.1000000000000001 111.607 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.52000000000000002 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.29999999999999999 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 0.48999999999999999 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.404 ' HE2' HD13 ' A' ' 154' ' ' ILE . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 0.78000000000000003 110.129 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 0.76000000000000001 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.45000000000000001 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.1400000000000001 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.416 ' HB3' HD21 ' A' ' 161' ' ' LEU . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.6599999999999999 111.032 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.3400000000000001 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.25 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.19 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 2.6899999999999999 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 0.27000000000000002 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 0.20000000000000001 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.23000000000000001 111.508 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.3399999999999999 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 0.35999999999999999 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 190' ' ' LEU . 64.4 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.02 111.52 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 110.082 -0.34 . . . . 0.51000000000000001 110.082 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.23000000000000001 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 0.23999999999999999 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 0.16 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 0.23000000000000001 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.16 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.5 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.29 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.58999999999999997 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 0.70999999999999996 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 0.46000000000000002 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.3500000000000001 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.3100000000000001 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 0.23999999999999999 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67000000000000004 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 1.4199999999999999 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 165' ' ' LEU . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 0.28999999999999998 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.25 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 0.40000000000000002 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32000000000000001 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 0.23000000000000001 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.17000000000000001 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 0.34999999999999998 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 0.28999999999999998 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.28999999999999998 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 0.32000000000000001 110.015 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.40000000000000002 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.1899999999999999 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.525 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.25 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.6 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 0.98999999999999999 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.40000000000000002 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 1.3300000000000001 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.02 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 1.6200000000000001 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.26000000000000001 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.23999999999999999 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.549 ' HB3' HG22 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 0.65000000000000002 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.20000000000000001 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 1.47 107.655 178.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.17999999999999999 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.534 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 0.23000000000000001 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.2799999999999998 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 0.27000000000000002 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 0.45000000000000001 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 175' ' ' THR . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.94999999999999996 110.973 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.35999999999999999 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.33000000000000002 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.21 110.2 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.14999999999999999 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 195' ' ' ILE . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 0.20999999999999999 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.17000000000000001 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.20999999999999999 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.57999999999999996 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 0.23999999999999999 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 0.71999999999999997 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.2 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.85999999999999999 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.39000000000000001 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 0.25 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.28000000000000003 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG21 HG13 ' A' ' 207' ' ' VAL . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.63 110.738 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 0.19 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 239' ' ' LEU . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.34999999999999998 110.914 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.461 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 0.67000000000000004 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.554 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 0.25 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 0.41999999999999998 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' A' ' 195' ' ' ILE . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.69999999999999996 110.527 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.35999999999999999 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.93999999999999995 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.0499999999999998 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 0.52000000000000002 112.4 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo . . . . . 0 N--CA 1.462 -0.338 0 CA-C-O 121.116 0.382 . . . . 0.52000000000000002 111.845 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.52000000000000002 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 220' ' ' PHE . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 0.28000000000000003 110.291 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 0.29999999999999999 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 0.48999999999999999 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 222' ' ' THR . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.78000000000000003 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 0.76000000000000001 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.45000000000000001 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.1400000000000001 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.3400000000000001 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 0.25 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 0.19 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 2.6899999999999999 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 0.27000000000000002 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.52 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 0.20000000000000001 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.23000000000000001 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.1699999999999999 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 27.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.3399999999999999 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 0.35999999999999999 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.02 111.553 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.51000000000000001 109.776 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.23000000000000001 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 0.23999999999999999 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 0.16 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 0.23000000000000001 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.5 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.29 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.58999999999999997 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 0.70999999999999996 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 0.46000000000000002 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.561 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.29 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.3500000000000001 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 0.23999999999999999 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67000000000000004 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 1.4199999999999999 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 0.28999999999999998 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 163' ' ' ARG . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.25 110.586 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.1599999999999999 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 0.40000000000000002 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32000000000000001 112.019 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.6 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.5 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.1899999999999999 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 0.23000000000000001 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 0.23999999999999999 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.17000000000000001 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 0.34999999999999998 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.28999999999999998 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.28999999999999998 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 0.32000000000000001 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 0.90000000000000002 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.40000000000000002 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.1899999999999999 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.25 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 0.98999999999999999 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.2400000000000002 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.40000000000000002 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 1.3300000000000001 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.02 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 1.6200000000000001 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.427 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.26000000000000001 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.23999999999999999 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.603 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 0.65000000000000002 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 0.20000000000000001 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 1.47 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.17999999999999999 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 0.23000000000000001 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.45000000000000001 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.35999999999999999 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.33000000000000002 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.515 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.21 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.14999999999999999 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.501 HD11 HD12 ' A' ' 195' ' ' ILE . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 0.20999999999999999 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.17000000000000001 110.087 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.20999999999999999 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.57999999999999996 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.514 ' HA ' HE21 ' A' ' 213' ' ' GLN . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 0.23999999999999999 110.862 174.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 0.71999999999999997 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 210' ' ' ILE . 34.0 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.85999999999999999 109.728 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.39000000000000001 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 0.25 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.28000000000000003 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 0.63 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.19 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 239' ' ' LEU . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.34999999999999998 110.2 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 0.67000000000000004 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 0.25 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.41999999999999998 110.403 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.69999999999999996 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.35999999999999999 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.93999999999999995 111.712 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.0499999999999998 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 111.067 -178.628 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.46 -0.474 0 CA-C-O 121.105 0.377 . . . . 0.52000000000000002 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.1000000000000001 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.52000000000000002 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 220' ' ' PHE . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 0.28000000000000003 111.008 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 0.29999999999999999 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 0.48999999999999999 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.78000000000000003 109.56 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 0.76000000000000001 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.45000000000000001 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 249' ' ' VAL . 16.2 mm100 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.1400000000000001 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.6599999999999999 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.605 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.3400000000000001 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.25 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.19 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 247' ' ' SER . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 2.6899999999999999 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 0.27000000000000002 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.20000000000000001 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.1699999999999999 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.3399999999999999 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 0.35999999999999999 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 190' ' ' LEU . 37.2 mt . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.02 111.205 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.51000000000000001 110.757 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 0.23999999999999999 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.16 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.16 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.5 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.421 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.29 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.58999999999999997 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 0.70999999999999996 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.46000000000000002 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.29 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.3500000000000001 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.3100000000000001 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.23999999999999999 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67000000000000004 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54000000000000004 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 161' ' ' LEU . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 1.4199999999999999 111.018 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.25 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.40000000000000002 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32000000000000001 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.5 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 0.23999999999999999 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.17000000000000001 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 0.34999999999999998 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 0.28999999999999998 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.28999999999999998 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 0.32000000000000001 110.272 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 0.90000000000000002 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.40000000000000002 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.1899999999999999 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.25 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.2 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 0.98999999999999999 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.2400000000000002 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.40000000000000002 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 1.3300000000000001 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 0.44 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.02 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 1.6200000000000001 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.472 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.26000000000000001 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.23999999999999999 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.20000000000000001 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 1.47 108.206 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.17999999999999999 112.388 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.577 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 0.23000000000000001 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.2799999999999998 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 0.27000000000000002 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 0.45000000000000001 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 175' ' ' THR . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.94999999999999996 111.053 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.35999999999999999 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.33000000000000002 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.21 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.14999999999999999 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 195' ' ' ILE . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.20999999999999999 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.17000000000000001 110.132 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 0.20999999999999999 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 0.23999999999999999 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.71999999999999997 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.85999999999999999 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.583 ' HE2' HG22 ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.39000000000000001 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 0.25 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.28000000000000003 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.511 HG21 HG13 ' A' ' 207' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 0.63 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.19 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.34999999999999998 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 0.67000000000000004 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.594 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 0.25 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 0.41999999999999998 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 0.69999999999999996 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.35999999999999999 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.93999999999999995 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.0499999999999998 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 236' ' ' PRO . 20.8 mt . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 0.52000000000000002 110.613 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 228' ' ' LEU . 37.2 Cg_endo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.896 0.29 . . . . 0.52000000000000002 111.533 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.1000000000000001 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 0.28000000000000003 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 0.29999999999999999 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 0.48999999999999999 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 0.78000000000000003 109.345 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 0.76000000000000001 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.45000000000000001 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.1400000000000001 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.6599999999999999 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.3400000000000001 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 251' ' ' THR . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.987 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.19 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 2.6899999999999999 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 0.27000000000000002 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 0.20000000000000001 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.23000000000000001 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.1699999999999999 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.3399999999999999 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 0.35999999999999999 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.02 111.559 -178.128 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.212 -0.355 . . . . 7.6699999999999999 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.68 -26.75 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.046 0.451 . . . . 6.2300000000000004 110.74 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.17 4.15 44.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.55 0.691 . . . . 7.4500000000000002 109.533 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.83 166.82 37.5 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.325 -0.852 . . . . 2.8100000000000001 111.588 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.4 p -70.69 100.52 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.79 -0.448 . . . . 1.3 109.79 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.7 m -75.59 118.85 18.88 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.846 -0.427 . . . . 0.51000000000000001 109.846 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.9 p-10 -71.25 138.16 49.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.734 -0.666 . . . . 0.23000000000000001 110.347 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.8 t -120.97 138.52 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.184 0.516 . . . . 0.23999999999999999 111.527 -175.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.8 tp -95.06 114.48 26.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.351 -0.841 . . . . 0.16 110.187 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.77 110.87 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.088 0.471 . . . . 0.23000000000000001 111.219 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -100.65 99.55 8.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.708 -0.678 . . . . 0.16 109.835 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.9 122.47 3.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.258 -0.883 . . . . 0.5 109.066 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.71 -39.47 80.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.791 -0.641 . . . . 1.04 110.945 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 44.9 mt-10 -71.83 111.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.397 0.618 . . . . 1.29 111.47 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 31.5 Cg_exo -59.27 -41.5 58.7 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.676 2.917 . . . . 0.58999999999999997 112.932 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.97 -28.14 69.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.419 . . . . 0.70999999999999996 111.121 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.42 -41.2 15.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.065 -0.346 . . . . 0.46000000000000002 110.065 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.2 t -56.03 -57.78 10.7 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.29 110.738 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 88.7 mtp -65.53 -26.27 67.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.821 0.343 . . . . 2.3500000000000001 111.147 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.0 tp60 -64.89 -49.0 72.2 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 109.633 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.82 -38.51 90.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.23999999999999999 110.736 176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 155' ' ' SER . 51.2 mt-10 -59.45 -52.99 63.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.67000000000000004 110.681 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.79 -40.71 95.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.971 -0.558 . . . . 0.54000000000000004 110.464 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' HG2' ' A' ' 246' ' ' GLU . 0.4 OUTLIER -57.78 -55.68 31.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.458 -0.792 . . . . 1.4199999999999999 110.964 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 145' ' ' VAL . 2.4 p -68.89 -27.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.223 0.535 . . . . 0.28999999999999998 110.624 -177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.34 -36.79 79.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.707 . . . . 3.25 110.321 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 m -63.6 -30.07 71.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 110.215 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -77.28 0.04 23.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.40000000000000002 111.414 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.61 23.87 44.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.973 -0.632 . . . . 0.32000000000000001 112.544 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.532 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.4 m-70 -108.9 -177.65 3.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.737 -0.272 . . . . 0.5 110.529 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.7 177.66 7.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.433 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.6 mm -114.38 119.13 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 110.23 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.44 -21.36 32.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.78 -0.645 . . . . 0.23999999999999999 110.245 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.41 158.48 10.25 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 0.17000000000000001 111.62 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -117.89 133.07 56.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.106 0.479 . . . . 0.34999999999999998 110.093 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -131.81 123.01 26.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.923 -0.581 . . . . 0.28999999999999998 111.016 -175.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -90.76 -14.34 32.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.28999999999999998 110.227 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.8 p -131.84 168.53 17.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.921 -0.581 . . . . 0.32000000000000001 110.251 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.538 ' HG2' HE21 ' A' ' 180' ' ' GLN . 77.5 ttt180 -68.0 -34.55 76.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.135 0.493 . . . . 0.90000000000000002 109.899 176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 5.4 m -63.87 -49.13 73.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.40000000000000002 110.761 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -59.94 -32.5 70.84 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.889 0.376 . . . . 1.1899999999999999 110.51 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.24 -42.86 96.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.901 -0.59 . . . . 0.25 110.682 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.538 HE21 ' HG2' ' A' ' 176' ' ' ARG . 68.3 mt-30 -69.15 -34.45 75.01 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.261 -0.427 . . . . 0.98999999999999999 110.33 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 45.8 mt-10 -67.36 -41.92 84.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.876 -0.602 . . . . 2.2400000000000002 110.917 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.39 -49.01 73.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.40000000000000002 110.159 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.524 HG13 ' CE2' ' A' ' 214' ' ' PHE . 93.7 t -64.05 -41.6 92.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.502 -0.772 . . . . 1.3300000000000001 111.249 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.97 50.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.584 -0.735 . . . . 0.44 110.618 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 67.3 mttm -88.57 -53.73 4.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 2.02 110.965 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -144.64 137.51 26.71 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.063 -0.517 . . . . 0.63 111.615 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -82.91 119.39 74.25 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.512 -0.767 . . . . 1.6200000000000001 110.382 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.28 146.13 12.33 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.384 2.723 . . . . 0.26000000000000001 111.841 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.3 -10.2 64.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 0.23999999999999999 111.555 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.5 tp -149.26 143.89 26.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.936 -0.764 . . . . 0.65000000000000002 108.936 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.7 t -121.91 139.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.20000000000000001 111.151 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.48 133.22 51.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.04 -1.096 . . . . 1.47 108.04 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.09 25.8 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.518 -0.473 . . . . 0.17999999999999999 112.212 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 t70 -98.21 -177.79 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.542 -0.91 . . . . 0.38 108.542 171.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.558 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.4 mm -87.04 -50.65 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.983 -0.448 . . . . 0.23000000000000001 110.493 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.57 119.61 30.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.604 . . . . 2.2799999999999998 110.705 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.5 mt -106.66 167.87 9.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.372 -0.376 . . . . 0.27000000000000002 111.009 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.9 97.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.125 0.488 . . . . 0.45000000000000001 111.599 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 175' ' ' THR . 27.5 t70 -72.98 -12.14 60.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.717 -0.674 . . . . 0.94999999999999996 111.109 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.67 -3.95 63.39 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.755 -0.736 . . . . 0.35999999999999999 111.435 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.8 p -75.7 159.89 30.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 110.162 -0.31 . . . . 0.33000000000000002 110.162 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.48 ' HB2' ' OD2' ' A' ' 205' ' ' ASP . 17.4 m -91.56 129.78 37.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.195 0.521 . . . . 1.21 110.412 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.58 -28.87 65.82 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.199 -0.91 . . . . 0.14999999999999999 112.521 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' A' ' 227' ' ' ARG . 58.6 mt -61.21 -45.9 97.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.20999999999999999 110.141 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 202' ' ' SER . 9.8 m-20 -63.25 -36.72 84.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.646 -0.706 . . . . 1.73 110.39 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -63.37 -45.25 91.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.067 -0.515 . . . . 0.17000000000000001 110.231 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HG11 ' A' ' 218' ' ' VAL . 33.4 t -58.45 -50.85 77.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.481 -0.781 . . . . 0.20999999999999999 111.131 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.64 -33.76 71.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.027 -0.533 . . . . 0.57999999999999996 111.468 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.92 -49.22 75.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.438 0.637 . . . . 1.72 109.661 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.401 ' HA ' HE21 ' A' ' 213' ' ' GLN . 50.4 mt -58.5 -42.25 83.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.016 -0.993 . . . . 0.23999999999999999 110.597 174.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.5 mt -67.19 -14.24 62.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.71999999999999997 111.613 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.98 -5.44 86.11 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.044 -0.822 . . . . 0.31 111.044 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 210' ' ' ILE . 38.5 mt-30 -112.45 -49.92 2.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.85999999999999999 110.036 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 183' ' ' VAL . 3.8 m-85 -122.64 169.68 10.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.285 -0.87 . . . . 0.39000000000000001 110.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.88 74.91 0.96 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.001 -1.111 . . . . 1.98 108.001 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.62 152.78 50.13 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.777 -1.101 . . . . 0.25 110.018 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.451 ' O ' HD12 ' A' ' 190' ' ' LEU . 51.4 Cg_endo -66.42 133.42 32.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.474 2.116 . . . . 0.28000000000000003 112.059 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.47 HG11 ' CG1' ' A' ' 207' ' ' VAL . 40.7 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 0.63 110.641 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.24 122.7 70.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.836 -0.62 . . . . 0.19 110.066 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.28 109.67 21.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.162 -0.472 . . . . 0.34999999999999998 110.111 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.7 mt -113.71 107.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.273 -0.64 . . . . 0.67000000000000004 109.273 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.558 ' OG1' HG12 ' A' ' 195' ' ' ILE . 9.6 t -153.86 164.37 38.49 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.55 -0.46 . . . . 0.25 111.638 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.14 5.32 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.41999999999999998 110.971 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 72.9 m-85 -125.01 71.99 63.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.365 . . . . 0.69999999999999996 111.225 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.73 -38.46 30.94 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.259 1.972 . . . . 0.35999999999999999 110.829 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.66 -22.8 66.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.619 -1.173 . . . . 0.93999999999999995 111.884 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -74.09 -25.46 59.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 2.0499999999999998 110.119 -175.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.11 -5.02 58.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.193 0.521 . . . . 0.52000000000000002 110.586 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.67 34.13 5.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.552 -0.749 . . . . 1.26 110.508 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 p -99.96 55.15 0.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 2.1000000000000001 111.821 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 73.88 14.83 79.85 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.384 -0.913 . . . . 3.4300000000000002 111.418 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 234' ' ' PRO . 5.4 m-20 -67.61 -29.14 68.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.284 -0.635 . . . . 5.2199999999999998 109.284 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 45.2 mtm180 84.89 -80.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.771 1.628 . . . . 7.0999999999999996 113.177 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 37.0 Cg_exo -59.92 146.14 96.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 CA-C-N 122.085 1.78 . . . . 2.52 111.841 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -107.39 142.77 25.82 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.661 -0.699 . . . . 1.9299999999999999 110.476 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.11 127.85 25.61 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.962 2.442 . . . . 0.52000000000000002 111.563 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -55.1 -39.79 69.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.845 -1.07 . . . . 1.1000000000000001 111.885 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 97.2 m-85 -134.92 121.55 20.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.851 -0.425 . . . . 0.52000000000000002 109.851 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.3 tp -134.91 127.83 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.473 . . . . 0.28000000000000003 111.396 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 96.2 t -129.74 140.05 50.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.367 -0.833 . . . . 0.29999999999999999 108.838 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.6 p -99.44 142.65 30.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.135 0.493 . . . . 0.48999999999999999 112.256 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.8 OUTLIER -85.69 132.02 45.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.226 -0.897 . . . . 0.78000000000000003 109.125 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.14 146.08 76.93 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.394 -1.086 . . . . 0.76000000000000001 111.825 -0.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -98.13 160.69 14.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.275 0.56 . . . . 0.45000000000000001 111.933 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.46 ' O ' HG23 ' A' ' 249' ' ' VAL . 22.9 mt-30 -98.33 129.84 45.01 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.081 -1.081 . . . . 2.1400000000000001 108.081 169.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.544 ' HG2' HD11 ' A' ' 161' ' ' LEU . 47.6 mt-10 -55.85 -35.39 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.317 0.386 . . . . 1.6599999999999999 111.062 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.1 m -56.72 -47.87 79.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.351 . . . . 1.3400000000000001 110.539 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 251' ' ' THR . 89.3 m -63.03 -44.77 94.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.126 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 245' ' ' GLN . 41.6 t -61.87 -54.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.402 -0.363 . . . . 0.19 110.727 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 93.3 mtt180 -54.02 -40.72 67.29 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.459 0.647 . . . . 2.6899999999999999 110.244 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.658 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 31.2 m -58.03 -52.51 65.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.059 . . . . 0.27000000000000002 111.173 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.1 m -61.59 -46.68 88.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.20000000000000001 111.934 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.72 -45.9 49.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.983 0.42 . . . . 0.23000000000000001 110.87 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 33.8 t -64.87 -29.81 70.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.743 -0.662 . . . . 1.1699999999999999 111.231 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 251' ' ' THR . 8.3 mm100 -77.44 -48.06 18.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.283 0.563 . . . . 2.3399999999999999 110.222 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.46 -33.8 66.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.131 -0.94 . . . . 0.35999999999999999 111.255 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.64 -3.79 42.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.858 -0.61 . . . . 1.02 111.249 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -78.38 -54.06 6.59 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.086 -1.079 . . . . 1.3799999999999999 108.086 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -83.86 69.94 10.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.781 -1.1 . . . . 5.3700000000000001 109.752 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.589 ' HA ' HE21 ' A' ' 260' ' ' GLN . 0.0 OUTLIER -59.79 137.32 58.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.826 -0.624 . . . . 5.25 110.103 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.46 86.38 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.357 0.599 . . . . 6.4000000000000004 110.598 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.489 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 8.4 m -108.05 -48.3 0.1 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.331 -0.85 . . . . 7.9199999999999999 111.086 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 15.7 Cg_exo -69.58 167.06 25.28 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.9 1.733 . . . . 8.9900000000000002 111.568 176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.9 p -99.91 93.18 5.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.047 0.451 . . . . 10.84 110.613 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -79.93 150.68 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.191 -0.459 . . . . 11.789999999999999 110.633 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.078 -0.963 . . . . 13.24 111.075 -178.341 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.034 -0.427 . . . . 7.6699999999999999 112.034 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.92 126.22 35.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.851 0.357 . . . . 6.2300000000000004 110.729 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 89.0 mtp -98.57 -13.99 20.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.153 -0.476 . . . . 7.4500000000000002 110.461 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.78 -85.65 1.45 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.423 -0.894 . . . . 2.8100000000000001 111.376 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 133.28 38.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.617 -0.792 . . . . 1.3 110.04 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 3.8 m -77.1 110.89 12.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.538 -0.301 . . . . 0.51000000000000001 110.192 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 30.0 p-10 -69.55 136.5 51.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.865 -0.607 . . . . 0.23000000000000001 110.926 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 190' ' ' LEU . 62.6 t -120.71 137.79 53.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.224 -0.444 . . . . 0.23999999999999999 111.277 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.2 tp -95.65 114.68 26.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.647 -0.706 . . . . 0.16 110.224 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.431 ' HB ' HG22 ' A' ' 172' ' ' THR . 86.4 mt -102.51 106.69 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.102 0.477 . . . . 0.23000000000000001 111.153 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -95.19 98.84 8.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.721 -0.672 . . . . 0.16 109.768 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -158.58 124.01 4.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.829 -1.078 . . . . 0.5 108.726 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -67.28 -36.49 81.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.713 -0.676 . . . . 1.04 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.8 mt-10 -76.12 112.11 18.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.449 . . . . 1.29 111.573 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 20.7 Cg_exo -63.69 -34.29 63.22 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.258 2.639 . . . . 0.58999999999999997 112.275 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.23 -47.72 83.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.371 -0.377 . . . . 0.70999999999999996 110.668 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.99 -41.38 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.057 -0.349 . . . . 0.46000000000000002 110.057 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 39.7 t -54.34 -58.79 6.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 1.29 110.876 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mtp -64.45 -29.14 70.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.312 . . . . 2.3500000000000001 110.992 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 46.2 tp60 -61.18 -49.32 77.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.352 -0.61 . . . . 1.3100000000000001 109.352 173.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.92 -37.62 88.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.23999999999999999 111.016 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 155' ' ' SER . 50.3 mt-10 -60.48 -47.4 86.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.67000000000000004 110.728 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 163' ' ' ARG . 24.1 t70 -70.19 -42.1 72.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 110.556 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -55.2 -51.01 67.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 1.4199999999999999 111.216 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.4 p -72.89 -24.78 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.813 -0.63 . . . . 0.28999999999999998 110.414 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' ASP . 35.3 ttm180 -64.5 -42.5 95.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.394 -0.821 . . . . 3.25 110.732 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.4 m -59.31 -24.3 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 1.1599999999999999 111.195 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 162' ' ' VAL . 52.7 mt -81.17 -13.7 58.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.40000000000000002 111.47 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.3 19.8 31.91 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.634 -0.793 . . . . 0.32000000000000001 112.073 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.6 m-70 -104.29 179.06 4.38 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.757 -0.46 . . . . 0.5 109.757 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.22 -179.42 4.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.606 0.241 . . . . 1.1899999999999999 110.768 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 159' ' ' GLU . 42.4 mm -116.52 122.57 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.387 -0.369 . . . . 0.23000000000000001 110.451 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.61 -22.4 23.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.074 -0.512 . . . . 0.23999999999999999 110.452 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.27 167.97 20.67 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.749 -0.66 . . . . 0.17000000000000001 111.643 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.431 HG22 ' HB ' ' A' ' 147' ' ' ILE . 7.8 p -124.43 142.66 51.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.933 0.397 . . . . 0.34999999999999998 110.328 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.64 129.69 25.02 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 110.781 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -98.14 -8.83 26.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.688 0.28 . . . . 0.28999999999999998 111.107 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.54 HG22 ' H ' ' A' ' 199' ' ' ASP . 62.0 p -140.27 169.84 16.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.32000000000000001 110.154 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 20.9 ttt180 -66.92 -37.59 84.61 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.071 -0.652 . . . . 0.90000000000000002 109.936 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.0 m -61.45 -44.29 97.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.40000000000000002 110.803 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -63.58 -35.49 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 110.577 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.32 -42.16 98.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.938 -0.574 . . . . 0.25 110.627 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 75.5 mt-30 -61.09 -40.54 94.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.955 -0.566 . . . . 0.98999999999999999 110.581 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -66.79 -40.73 88.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.55 -0.75 . . . . 2.2400000000000002 111.18 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.86 53.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.008 -0.542 . . . . 0.40000000000000002 111.158 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 179' ' ' ALA . 12.1 m -70.44 -27.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.3300000000000001 111.722 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.17 -31.05 70.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.242 0.544 . . . . 0.44 110.21 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -85.38 -55.43 4.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.498 -0.773 . . . . 2.02 110.72 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.45 136.56 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.67 -0.696 . . . . 0.63 110.962 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.32 122.22 70.92 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.938 -0.574 . . . . 1.6200000000000001 110.398 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.8 Cg_endo -77.09 149.67 28.75 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 123.131 2.554 . . . . 0.26000000000000001 112.402 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.5 -8.97 73.16 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.138 -0.785 . . . . 0.23999999999999999 111.138 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.604 ' HB3' HG22 ' A' ' 145' ' ' VAL . 32.7 tp -154.03 144.79 22.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.214 -0.662 . . . . 0.65000000000000002 109.214 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.2 t -121.59 142.09 39.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.126 0.489 . . . . 0.20000000000000001 111.096 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.4 OUTLIER -125.13 137.93 54.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.799 -1.186 . . . . 1.47 107.799 178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -156.8 145.89 20.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.626 0.602 . . . . 0.17999999999999999 112.626 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.641 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.1 t70 -96.47 178.27 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.215 -1.032 . . . . 0.38 108.215 169.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.537 HG12 ' OG1' ' A' ' 222' ' ' THR . 30.0 mm -85.97 -44.15 16.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.135 0.493 . . . . 0.23000000000000001 110.034 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -93.38 112.8 24.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.61 -0.723 . . . . 2.2799999999999998 110.957 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' A' ' 203' ' ' GLY . 60.6 mt -102.21 166.12 10.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.567 -0.288 . . . . 0.27000000000000002 111.059 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.03 -45.3 83.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.058 0.456 . . . . 0.45000000000000001 112.108 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 175' ' ' THR . 16.6 t70 -71.3 -18.2 62.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.719 -0.673 . . . . 0.94999999999999996 111.373 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.47 -5.48 41.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.92 -0.872 . . . . 0.35999999999999999 110.92 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.4 p -71.99 156.32 39.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.845 0.355 . . . . 0.33000000000000002 110.266 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.2 t -87.19 133.75 33.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.1 0.476 . . . . 1.21 110.064 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.94 -27.36 66.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.364 -0.835 . . . . 0.14999999999999999 111.392 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.451 HD11 HD12 ' A' ' 195' ' ' ILE . 62.4 mt -64.12 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.118 0.485 . . . . 0.20999999999999999 109.83 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -64.95 -39.76 93.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.553 -0.748 . . . . 1.73 109.828 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.43 93.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.343 -0.844 . . . . 0.17000000000000001 110.547 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.475 HG13 HG21 ' A' ' 218' ' ' VAL . 39.1 t -61.1 -49.31 85.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.503 -0.771 . . . . 0.20999999999999999 111.166 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -31.15 70.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.185 -0.462 . . . . 0.57999999999999996 111.496 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.7 -51.42 70.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.664 0.745 . . . . 1.72 109.399 175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.0 mt -60.34 -44.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.355 -1.293 . . . . 0.23999999999999999 110.894 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.41 -14.42 62.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 112.063 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -84.56 -7.16 84.9 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.012 -0.835 . . . . 0.31 111.012 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -113.0 -52.81 2.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.85999999999999999 110.19 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.16 179.69 4.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.342 -0.845 . . . . 0.39000000000000001 110.564 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -128.31 74.86 1.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.182 -0.917 . . . . 1.98 109.043 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.8 OUTLIER -117.48 151.27 47.98 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 114.735 -1.121 . . . . 0.25 109.562 -174.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.518 ' HD3' ' OE1' ' A' ' 260' ' ' GLN . 61.2 Cg_endo -69.43 140.64 44.45 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.581 2.188 . . . . 0.28000000000000003 112.452 -172.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.475 HG21 HG13 ' A' ' 207' ' ' VAL . 40.4 t -126.74 132.73 69.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.776 -176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.17 124.74 72.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.779 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.63 105.43 17.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.282 -0.417 . . . . 0.34999999999999998 110.449 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 8.0 mt -107.93 107.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.675 -0.861 . . . . 0.67000000000000004 108.675 173.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 241' ' ' THR . 6.3 t -147.99 163.07 37.98 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.104 0.478 . . . . 0.25 111.416 -172.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.13 6.96 42.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.882 -0.599 . . . . 0.41999999999999998 110.495 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -128.05 74.79 78.98 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.959 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.29 -34.45 44.71 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.374 2.049 . . . . 0.35999999999999999 111.425 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.69 -31.63 71.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 0.93999999999999995 111.551 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -62.92 -35.68 80.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.235 0.54 . . . . 2.0499999999999998 110.099 -177.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 195' ' ' ILE . 24.5 mt -82.5 -15.65 51.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.547 -0.752 . . . . 0.52000000000000002 111.585 -176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 74.7 mt -106.01 12.67 30.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 1.26 110.517 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.9 p -124.53 29.8 6.18 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.807 -0.633 . . . . 2.1000000000000001 111.24 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -93.34 -18.42 39.09 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.525 -1.03 . . . . 3.4300000000000002 110.525 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 64.47 10.93 6.16 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.685 0.794 . . . . 5.2199999999999998 111.462 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.691 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 3.6 mmp_? -139.38 -65.28 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.8 -0.636 . . . . 7.0999999999999996 111.538 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 1.3 Cg_endo -89.89 147.62 4.77 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.03 1.82 . . . . 2.52 113.092 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -134.13 128.36 19.47 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.51 -0.768 . . . . 1.9299999999999999 109.422 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.78 127.0 15.47 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.65 2.234 . . . . 0.52000000000000002 111.829 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 27.7 m -73.19 -28.21 62.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 1.1000000000000001 109.928 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 61.6 m-85 -126.34 104.94 8.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.38 -0.827 . . . . 0.52000000000000002 110.059 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 46.3 tp -132.88 118.59 19.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.47 -0.787 . . . . 0.28000000000000003 110.751 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 60.1 t -121.75 149.48 24.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.89 -0.781 . . . . 0.29999999999999999 108.89 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 222' ' ' THR . 18.5 p -119.43 147.5 44.31 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.303 0.483 . . . . 0.48999999999999999 112.303 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.53 135.51 53.12 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 110.263 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.22 142.9 68.56 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.47 -1.471 . . . . 0.76000000000000001 111.588 -3.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -102.27 159.03 15.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.438 . . . . 0.45000000000000001 111.481 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.0 mt-30 -100.45 134.99 42.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.772 -0.649 . . . . 2.1400000000000001 109.685 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 161' ' ' LEU . 45.0 mt-10 -57.99 -34.91 70.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.383 -0.826 . . . . 1.6599999999999999 110.895 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.7 p -62.15 -52.06 65.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 1.3400000000000001 110.502 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 41.2 m -55.19 -46.45 75.86 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 115.814 -0.63 . . . . 0.25 111.093 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.9 t -60.1 -55.19 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.19 110.688 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HB3' HD21 ' A' ' 165' ' ' LEU . 88.7 mtt180 -53.51 -43.05 67.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.167 0.508 . . . . 2.6899999999999999 110.709 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 54.4 m -56.78 -44.94 82.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.026 -0.988 . . . . 0.27000000000000002 111.195 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.1 m -68.97 -44.07 73.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.996 -0.547 . . . . 0.20000000000000001 111.615 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.36 -45.83 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.192 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 22.8 t -65.03 -31.58 72.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.027 -0.533 . . . . 1.1699999999999999 111.06 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.6 mm-40 -76.84 -45.83 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.103 0.478 . . . . 2.3399999999999999 110.196 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -53.2 -36.16 60.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.172 -0.922 . . . . 0.35999999999999999 111.167 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.98 -16.71 24.78 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.788 -0.642 . . . . 1.02 111.585 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.28 -48.94 73.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.385 0.612 . . . . 1.3799999999999999 109.366 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -80.76 46.89 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.19 -0.914 . . . . 5.3700000000000001 110.84 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.518 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 18.1 mm-40 -138.22 60.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.97 0.414 . . . . 5.25 111.492 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.93 -61.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.461 0.648 . . . . 6.4000000000000004 109.267 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.578 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 69.6 m -155.44 -50.79 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.731 -1.122 . . . . 7.9199999999999999 108.769 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 45.1 Cg_endo -93.49 -174.53 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.099 1.866 . . . . 8.9900000000000002 110.417 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.3 t -156.98 136.25 12.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.11 0.481 . . . . 10.84 111.06 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -166.54 134.73 2.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.599 -0.728 . . . . 11.789999999999999 109.688 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.108 -0.949 . . . . 13.24 110.571 178.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.577 -0.609 . . . . 7.6699999999999999 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.22 106.46 11.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.558 0.218 . . . . 6.2300000000000004 110.456 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 48.9 tpp 63.21 75.91 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.761 -0.654 . . . . 7.4500000000000002 110.435 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.98 -156.68 32.98 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 2.8100000000000001 112.169 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.545 ' HB2' ' OD2' ' A' ' 168' ' ' ASP . 53.4 m -84.5 163.66 19.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 1.3 110.585 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.4 m -78.59 114.93 17.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.928 -0.578 . . . . 0.51000000000000001 110.742 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -80.71 146.63 30.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 0.23000000000000001 110.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.7 t -122.76 136.16 60.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.23999999999999999 111.424 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.62 117.4 30.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.747 -0.66 . . . . 0.16 110.259 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.7 mt -104.5 106.79 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.23000000000000001 111.322 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.0 mt -98.22 99.32 8.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.82 -0.627 . . . . 0.16 109.746 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.0 123.5 4.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.5 109.405 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.84 -49.05 66.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 1.04 111.444 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.0 mt-10 -69.36 117.69 54.96 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 1.29 111.144 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.2 Cg_exo -63.55 -33.32 68.36 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.021 2.481 . . . . 0.58999999999999997 111.534 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.5 -40.99 79.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.727 -0.67 . . . . 0.70999999999999996 110.636 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.7 mt -84.21 -43.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.013 -0.54 . . . . 0.46000000000000002 110.754 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 42.1 t -57.5 -52.81 63.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.642 -0.254 . . . . 1.29 110.983 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.8 mtt -68.81 -27.42 65.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 2.3500000000000001 110.941 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -63.96 -47.46 80.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.326 -0.62 . . . . 1.3100000000000001 109.326 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 98.1 mt -64.28 -39.2 93.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.05 -0.977 . . . . 0.23999999999999999 110.814 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -55.67 -56.0 25.51 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.076 0.465 . . . . 0.67000000000000004 110.253 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.59 -40.72 88.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.431 -0.804 . . . . 0.54000000000000004 110.899 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.31 -52.35 48.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.364 -0.834 . . . . 1.4199999999999999 111.51 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 167' ' ' HIS . 4.3 p -69.57 -28.7 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.168 0.509 . . . . 0.28999999999999998 110.671 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -70.23 -33.89 72.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.696 -0.684 . . . . 3.25 109.96 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.7 t -63.45 -28.13 69.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.275 0.56 . . . . 1.1599999999999999 110.139 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 162' ' ' VAL . 66.8 mt -78.28 -1.65 34.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.824 -0.625 . . . . 0.40000000000000002 111.181 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.96 17.15 61.86 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.987 -0.625 . . . . 0.32000000000000001 112.426 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.499 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.1 m-70 -100.85 171.05 7.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.664 -0.315 . . . . 0.5 110.357 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.545 ' OD2' ' HB2' ' A' ' 142' ' ' SER . 6.9 m-20 -114.25 165.65 12.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 110.758 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 37.7 mm -100.53 119.66 48.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 0.23000000000000001 109.927 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -85.35 -20.11 30.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.137 0.494 . . . . 0.23999999999999999 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.97 159.22 10.03 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.653 -0.703 . . . . 0.17000000000000001 111.988 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.46 133.39 54.61 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.057 -0.349 . . . . 0.34999999999999998 110.057 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -136.72 121.59 18.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.303 -0.408 . . . . 0.28999999999999998 111.478 -173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.19 -12.22 36.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.442 -0.344 . . . . 0.28999999999999998 110.863 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 71.0 p -134.15 172.28 13.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.32000000000000001 110.579 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 79.8 ttt180 -69.96 -39.3 76.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.96 -0.385 . . . . 0.90000000000000002 109.96 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -57.6 -45.64 85.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.869 0.366 . . . . 0.40000000000000002 110.506 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -60.42 -36.95 79.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 1.1899999999999999 110.92 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.449 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -64.5 -43.25 94.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.034 0.445 . . . . 0.25 110.502 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -62.27 -42.62 99.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.47 -0.786 . . . . 0.98999999999999999 110.474 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.0 -41.05 87.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.695 -0.684 . . . . 2.2400000000000002 111.283 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.08 -54.22 42.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.946 -0.57 . . . . 0.40000000000000002 111.246 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.8 m -74.19 -25.71 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.161 -0.472 . . . . 1.3300000000000001 111.632 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -28.25 69.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.44 110.114 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -92.01 -51.76 5.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.524 -0.762 . . . . 2.02 110.933 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 43.6 tt0 -139.62 136.53 34.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.987 -0.552 . . . . 0.63 111.115 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -90.8 118.64 68.78 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.895 -0.593 . . . . 1.6200000000000001 110.48 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.495 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.8 Cg_endo -76.77 160.51 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.272 2.648 . . . . 0.26000000000000001 111.994 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -101.53 -5.85 51.13 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.845 -0.902 . . . . 0.23999999999999999 110.845 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 145' ' ' VAL . 41.4 tp -154.79 144.61 21.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.962 -0.755 . . . . 0.65000000000000002 108.962 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.406 ' HB ' HG22 ' A' ' 218' ' ' VAL . 99.4 t -121.3 143.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.89 0.376 . . . . 0.20000000000000001 110.6 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 1.1 tm? -129.68 132.81 46.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.318 -1.364 . . . . 1.47 107.318 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.32 148.22 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.796 0.665 . . . . 0.17999999999999999 112.796 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.653 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.6 t70 -98.8 175.2 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.846 -1.07 . . . . 0.38 108.303 169.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.54 HD12 HD11 ' A' ' 204' ' ' ILE . 30.8 mm -85.35 -44.32 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 118.26 0.482 . . . . 0.23000000000000001 110.684 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -97.45 102.3 14.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.874 -0.603 . . . . 2.2799999999999998 110.854 -171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.1 mt -89.96 173.23 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.267 -0.424 . . . . 0.27000000000000002 110.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.49 69.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.224 0.453 . . . . 0.45000000000000001 112.224 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 26.1 t70 -69.44 -19.76 63.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.94999999999999996 111.56 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.26 -0.21 33.17 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.414 -0.898 . . . . 0.35999999999999999 111.132 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -76.95 157.33 31.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.408 -0.59 . . . . 0.33000000000000002 109.408 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.555 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 23.6 t -94.27 138.22 32.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 1.21 110.545 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -64.28 -26.87 70.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.972 -1.013 . . . . 0.14999999999999999 111.84 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 195' ' ' ILE . 68.1 mt -62.8 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.20999999999999999 109.954 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 2.2 m-20 -60.98 -41.75 97.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.278 -0.874 . . . . 1.73 110.574 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.77 98.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 0.17000000000000001 110.644 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.438 ' CG1' HG11 ' A' ' 218' ' ' VAL . 23.5 t -63.35 -51.51 70.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 111.326 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.397 -0.365 . . . . 0.57999999999999996 110.774 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.46 -52.75 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.439 0.638 . . . . 1.72 109.586 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.0 mt -61.76 -44.47 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.784 -1.098 . . . . 0.23999999999999999 111.176 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.08 -15.01 63.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.116 -0.493 . . . . 0.71999999999999997 111.871 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -79.12 -9.57 86.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.897 -0.881 . . . . 0.31 110.897 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -112.1 -54.86 2.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.341 0.591 . . . . 0.85999999999999999 109.46 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -108.43 178.36 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.39000000000000001 111.112 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.46 45.76 2.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.115 0.959 . . . . 1.98 108.94 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -92.81 149.91 38.61 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.978 -1.01 . . . . 0.25 110.751 -173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.442 ' O ' HD12 ' A' ' 190' ' ' LEU . 55.2 Cg_endo -67.84 139.06 46.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.872 2.381 . . . . 0.28000000000000003 112.092 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.438 HG11 ' CG1' ' A' ' 207' ' ' VAL . 41.2 t -124.22 133.84 68.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.63 111.099 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.05 130.6 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.589 -0.732 . . . . 0.19 109.752 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -103.6 115.57 30.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.481 -0.327 . . . . 0.34999999999999998 110.732 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.8 mt -113.29 108.31 25.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.791 . . . . 0.67000000000000004 108.866 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.458 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 14.9 t -155.13 163.16 40.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.21 -0.596 . . . . 0.25 111.311 -171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.4 13.58 23.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.034 -0.53 . . . . 0.41999999999999998 110.499 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -128.81 68.97 79.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.69999999999999996 110.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.7 -40.2 57.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.654 2.236 . . . . 0.35999999999999999 112.654 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -63.6 -25.84 68.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.949 -0.569 . . . . 0.93999999999999995 110.75 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.472 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -66.12 -36.35 82.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.544 0.688 . . . . 2.0499999999999998 109.527 -177.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 16.4 mt -81.28 -13.64 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.6 -0.727 . . . . 0.52000000000000002 111.393 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 235' ' ' GLU . 58.2 mt -99.23 2.73 45.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.58 0.705 . . . . 1.26 109.86 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 55.9 p -129.32 20.34 5.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.055 -0.975 . . . . 2.1000000000000001 110.405 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.08 6.22 80.1 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.75 -0.738 . . . . 3.4300000000000002 113.198 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' HD3' ' A' ' 233' ' ' ARG . 4.1 m-20 67.03 16.3 10.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.125 0.488 . . . . 5.2199999999999998 110.907 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.696 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 21.9 mmt180 -132.75 -173.81 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.105 -0.702 . . . . 7.0999999999999996 109.105 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.696 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 16.1 Cg_exo -69.31 139.49 41.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.059 1.839 . . . . 2.52 110.554 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.407 ' HB2' ' CD2' ' A' ' 229' ' ' LEU . 6.5 pt-20 -71.64 148.82 93.0 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.021 -0.536 . . . . 1.9299999999999999 109.875 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 139.29 37.1 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.018 2.479 . . . . 0.52000000000000002 113.052 -170.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.648 ' HA ' ' H ' ' A' ' 266' ' ' VAL . 40.7 m -79.62 -25.15 41.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.343 -0.844 . . . . 1.1000000000000001 110.275 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -126.61 102.77 7.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.739 -0.664 . . . . 0.52000000000000002 110.305 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.0 tp -134.46 121.69 21.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.28000000000000003 110.863 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 221' ' ' ILE . 48.2 t -118.07 125.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.408 -0.815 . . . . 0.29999999999999999 109.5 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.3 p -91.35 141.94 28.23 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.772 -0.649 . . . . 0.48999999999999999 111.719 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.475 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 87.4 mttt -92.61 142.13 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.805 -0.634 . . . . 0.78000000000000003 110.985 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 10.9 Cg_exo -69.28 139.66 54.51 Favored 'Cis proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.54 -1.442 . . . . 0.76000000000000001 111.559 -1.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.406 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -99.56 166.7 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.373 0.606 . . . . 0.45000000000000001 111.885 -171.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 249' ' ' VAL . 48.2 mt-30 -105.82 124.22 49.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.113 -0.949 . . . . 2.1400000000000001 109.316 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.0 mp0 -58.49 -32.89 69.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.582 -0.281 . . . . 1.6599999999999999 111.334 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.5 m -60.88 -51.68 68.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.669 -0.493 . . . . 1.3400000000000001 109.669 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 68.9 m -56.36 -40.94 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.691 -0.686 . . . . 0.25 110.889 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 245' ' ' GLN . 97.1 t -57.99 -56.17 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.19 110.491 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 27.4 mtm180 -55.11 -42.08 72.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.883 0.373 . . . . 2.6899999999999999 110.632 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 97.9 m -56.23 -38.64 71.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 0.27000000000000002 111.067 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.7 m -77.36 -42.14 37.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.329 -0.396 . . . . 0.20000000000000001 111.204 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.86 -48.26 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.996 0.427 . . . . 0.23000000000000001 110.344 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 22.8 t -68.47 -33.23 73.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.787 -0.642 . . . . 1.1699999999999999 111.227 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 10.2 pt20 -77.48 -44.2 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 2.3399999999999999 110.635 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -56.99 -35.77 69.59 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.222 -0.899 . . . . 0.35999999999999999 111.46 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 79.0 mt -90.93 -16.62 27.79 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.869 -0.605 . . . . 1.02 111.241 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 254' ' ' SER . 16.7 t80 -83.38 -46.88 12.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.53 0.681 . . . . 1.3799999999999999 109.379 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -106.61 73.38 0.95 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.005 -0.998 . . . . 5.3700000000000001 110.0 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.47 -35.07 75.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.123 0.487 . . . . 5.25 110.43 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 262' ' ' SER . 46.1 t-20 -143.11 117.16 9.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 6.4000000000000004 109.257 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.587 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 29.9 t 171.36 -53.16 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.389 -0.823 . . . . 7.9199999999999999 110.432 -175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 262' ' ' SER . 71.9 Cg_endo -98.82 153.35 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.761 2.308 . . . . 8.9900000000000002 112.392 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.1 t -162.74 148.79 12.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.999 -0.28 . . . . 10.84 110.681 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 56.35 63.69 1.91 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.715 0.635 . . . . 11.789999999999999 111.3 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 237' ' ' THR . 55.8 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.707 -0.679 . . . . 13.24 111.023 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.815 -0.514 . . . . 7.6699999999999999 111.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.21 108.5 10.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.79 0.329 . . . . 6.2300000000000004 110.286 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.8 mmt -89.2 58.68 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.425 . . . . 7.4500000000000002 110.37 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.12 -130.12 3.04 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.414 -0.898 . . . . 2.8100000000000001 112.991 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 p -63.37 132.84 52.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.715 0.406 . . . . 1.3 111.51 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.3 m -76.8 114.05 15.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.51000000000000001 109.903 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 31.5 p-10 -67.95 139.91 56.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.23000000000000001 110.922 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 190' ' ' LEU . 87.5 t -124.48 135.27 64.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 0.23999999999999999 111.59 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.41 117.55 31.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.16 110.11 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.78 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.782 0.325 . . . . 0.23000000000000001 110.8 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 37.8 mt -93.32 98.56 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.494 -0.558 . . . . 0.16 109.494 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -152.91 119.18 5.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.328 -0.851 . . . . 0.5 109.49 -174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.62 -32.44 71.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.927 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.7 mt-10 -73.0 108.12 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.281 0.562 . . . . 1.29 111.18 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 24.5 Cg_exo -62.19 -40.09 43.98 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.474 2.783 . . . . 0.58999999999999997 112.077 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.4 mt -59.99 -47.67 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.458 -0.792 . . . . 0.70999999999999996 110.389 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.93 -31.97 26.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 111.145 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.3 t -56.52 -52.2 65.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.612 -0.144 . . . . 1.29 110.612 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 62.6 mtt -62.85 -35.83 81.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 2.3500000000000001 111.056 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.15 -49.81 76.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.3100000000000001 110.005 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.42 -37.05 84.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 110.948 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 155' ' ' SER . 45.5 mt-10 -55.6 -57.31 12.48 Favored 'General case' 0 CA--C 1.521 -0.145 0 O-C-N 123.302 0.376 . . . . 0.67000000000000004 110.386 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.23 -43.45 94.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.54000000000000004 110.984 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.88 -48.0 81.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.452 -0.794 . . . . 1.4199999999999999 111.632 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 167' ' ' HIS . 6.3 p -75.53 -28.37 19.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.512 0.672 . . . . 0.28999999999999998 110.617 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -67.46 -30.79 70.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.322 -0.854 . . . . 3.25 110.455 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.7 m -63.61 -29.14 70.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.475 0.655 . . . . 1.1599999999999999 110.437 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 250' ' ' ARG . 36.7 mt -79.67 7.65 8.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.388 -0.824 . . . . 0.40000000000000002 111.018 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.89 72.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.902 -0.666 . . . . 0.32000000000000001 112.081 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.472 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.2 m-70 -102.11 171.54 7.43 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.354 . . . . 0.5 110.13 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.87 178.66 4.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 110.176 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.7 119.85 63.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 110.126 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.46 -24.66 22.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.932 -0.577 . . . . 0.23999999999999999 110.167 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.43 169.19 26.54 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.894 -0.67 . . . . 0.17000000000000001 111.998 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 p -124.19 137.31 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.017 -0.364 . . . . 0.34999999999999998 110.017 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.03 127.08 29.74 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.196 -0.456 . . . . 0.28999999999999998 110.892 -176.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -99.63 -7.34 25.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 121.096 -0.241 . . . . 0.28999999999999998 111.302 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 199' ' ' ASP . 60.7 p -139.34 171.52 14.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.17 -0.308 . . . . 0.32000000000000001 110.17 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 34.1 ttt180 -67.15 -37.86 84.52 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.689 -0.805 . . . . 0.90000000000000002 109.897 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 m -60.16 -44.1 95.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.40000000000000002 110.694 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -63.03 -36.54 83.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 1.1899999999999999 110.567 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.71 -43.7 98.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.439 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 94.9 mt-30 -60.2 -45.57 92.7 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.615 -0.72 . . . . 0.98999999999999999 110.485 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.621 ' O ' ' HD3' ' A' ' 185' ' ' LYS . 16.9 mm-40 -64.07 -42.56 96.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 2.2400000000000002 111.497 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.64 66.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.923 -0.58 . . . . 0.40000000000000002 111.102 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.4 m -74.31 -26.2 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.24 -0.436 . . . . 1.3300000000000001 111.613 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.35 70.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.932 -0.577 . . . . 0.44 110.26 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.621 ' HD3' ' O ' ' A' ' 181' ' ' GLU . 4.1 mptp? -83.01 -57.67 3.19 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.718 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.4 tt0 -141.22 139.48 33.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.078 -0.51 . . . . 0.63 111.248 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -88.37 118.1 69.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.646 -0.706 . . . . 1.6200000000000001 110.485 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.58 161.38 39.87 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.235 2.623 . . . . 0.26000000000000001 112.297 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.29 -3.47 55.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.23999999999999999 111.386 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.57 ' HB3' HG22 ' A' ' 145' ' ' VAL . 16.7 tp -159.12 142.73 14.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 218' ' ' VAL . 52.9 t -125.09 139.96 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.16 0.505 . . . . 0.20000000000000001 111.358 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.527 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.9 mm? -119.17 149.05 42.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.763 -0.828 . . . . 1.47 108.763 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -163.45 141.72 7.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.501 0.556 . . . . 0.17999999999999999 112.501 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.66 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 t70 -96.43 166.72 11.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.219 -1.03 . . . . 0.38 108.219 170.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 202' ' ' SER . 23.9 mm -73.32 -43.85 55.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 118.331 0.514 . . . . 0.23000000000000001 109.675 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -89.26 110.52 21.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 2.2799999999999998 110.835 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 56.3 mt -103.82 168.68 8.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.27000000000000002 110.425 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.11 -51.54 66.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.693 0.627 . . . . 0.45000000000000001 112.693 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 175' ' ' THR . 23.7 t70 -72.85 -18.28 61.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.273 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.85 0.63 32.06 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.713 -0.756 . . . . 0.35999999999999999 111.396 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.3 p -73.46 148.84 42.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.856 -0.424 . . . . 0.33000000000000002 109.856 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 66.5 m -83.17 133.15 35.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.071 0.463 . . . . 1.21 110.329 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.77 -25.58 63.89 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.14999999999999999 112.177 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 195' ' ' ILE . 62.8 mt -60.31 -43.45 93.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.20999999999999999 110.003 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.61 -40.6 97.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.538 -0.755 . . . . 1.73 109.912 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.8 95.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.428 -0.805 . . . . 0.17000000000000001 110.905 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.13 -48.67 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.556 . . . . 0.20999999999999999 111.027 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.44 -31.24 69.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 0.57999999999999996 111.195 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.95 -55.51 32.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.61 0.719 . . . . 1.72 109.989 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.04 -43.82 85.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.319 -1.309 . . . . 0.23999999999999999 111.018 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.4 -15.24 63.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.595 . . . . 0.71999999999999997 111.722 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.19 -3.15 90.37 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.137 -0.785 . . . . 0.31 111.137 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -117.61 -57.55 2.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.85999999999999999 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.51 -179.87 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.995 -1.002 . . . . 0.39000000000000001 111.072 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.15 80.55 1.97 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.82 -1.082 . . . . 1.98 108.701 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -121.45 148.33 49.77 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.671 -1.149 . . . . 0.25 110.17 -171.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.568 ' O ' HD12 ' A' ' 190' ' ' LEU . 72.3 Cg_endo -75.43 133.82 16.41 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.653 2.235 . . . . 0.28000000000000003 111.47 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -134.21 144.55 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.296 0.57 . . . . 0.63 111.781 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 57.2 mt -116.65 126.79 74.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.934 -1.03 . . . . 0.19 109.716 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.23 100.61 13.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.355 -0.384 . . . . 0.34999999999999998 110.396 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.473 HG22 ' HD2' ' A' ' 242' ' ' LYS . 9.3 mt -99.67 107.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.938 -0.764 . . . . 0.67000000000000004 108.938 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.7 t -156.47 161.92 40.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.864 0.364 . . . . 0.25 110.844 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.32 7.57 42.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.296 -0.411 . . . . 0.41999999999999998 110.857 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -123.76 73.14 53.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.69999999999999996 111.01 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.95 -36.01 62.97 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.764 2.309 . . . . 0.35999999999999999 112.709 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.492 ' O ' HG22 ' A' ' 230' ' ' THR . 12.9 pt-20 -65.67 -25.88 67.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.82 0.343 . . . . 0.93999999999999995 111.08 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.3 tmt_? -62.38 -28.87 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.448 0.642 . . . . 2.0499999999999998 109.655 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 22.0 mt -94.53 -26.83 16.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.326 -0.852 . . . . 0.52000000000000002 112.083 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -75.35 -4.55 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.499 0.666 . . . . 1.26 110.818 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 226' ' ' GLU . 9.4 t -144.75 31.12 1.17 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.068 -0.969 . . . . 2.1000000000000001 109.627 175.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.82 96.89 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.598 -0.728 . . . . 3.4300000000000002 111.923 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.89 -78.56 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.093 -0.706 . . . . 5.2199999999999998 109.093 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 20.5 mmm180 -140.49 -58.41 0.02 OUTLIER Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 7.0999999999999996 111.423 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 7.7 Cg_exo -70.72 159.62 52.11 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.83 1.687 . . . . 2.52 112.022 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -98.56 155.89 36.28 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.414 -0.812 . . . . 1.9299999999999999 109.71 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 30.9 Cg_endo -62.44 132.53 38.69 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.733 2.289 . . . . 0.52000000000000002 111.365 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.7 m -57.49 -40.51 78.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.241 -0.89 . . . . 1.1000000000000001 111.075 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -134.23 120.69 20.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.912 -0.585 . . . . 0.52000000000000002 109.741 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.3 tp -130.75 114.29 15.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.079 0.466 . . . . 0.28000000000000003 111.028 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 65.2 t -114.41 127.69 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.29999999999999999 109.723 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 222' ' ' THR . 25.4 p -92.71 145.33 24.5 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.028 -0.533 . . . . 0.48999999999999999 111.626 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.473 ' HD2' HG22 ' A' ' 221' ' ' ILE . 49.7 mtpt -104.12 139.78 20.43 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 0.78000000000000003 110.857 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 53.2 Cg_endo -71.32 138.62 53.91 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.372 -1.512 . . . . 0.76000000000000001 112.647 1.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -96.42 165.07 12.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.768 -0.651 . . . . 0.45000000000000001 111.613 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 249' ' ' VAL . 24.4 mt-30 -97.44 131.89 43.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.016 -0.735 . . . . 2.1400000000000001 109.016 171.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.33 -32.5 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.079 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.0 p -64.67 -51.67 61.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.895 -0.593 . . . . 1.3400000000000001 110.711 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 60.6 m -54.41 -44.86 72.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.872 -0.604 . . . . 0.25 111.022 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.7 t -60.54 -58.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.385 . . . . 0.19 110.819 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 165' ' ' LEU . 96.7 mtt180 -50.67 -43.16 57.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.305 0.574 . . . . 2.6899999999999999 110.712 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 51.9 m -57.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.024 -0.989 . . . . 0.27000000000000002 111.236 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 28.0 m -62.31 -43.71 98.19 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.398 -0.365 . . . . 0.20000000000000001 111.936 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.21 -45.14 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.991 0.424 . . . . 0.23000000000000001 110.852 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 30.6 t -67.85 -24.69 65.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.897 -0.592 . . . . 1.1699999999999999 111.208 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 251' ' ' THR . 7.4 mm100 -79.56 -47.05 16.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.293 0.568 . . . . 2.3399999999999999 109.961 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 260' ' ' GLN . . . -59.77 -30.65 69.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.161 -0.927 . . . . 0.35999999999999999 110.918 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 93.0 mt -106.97 21.61 17.29 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.818 -0.628 . . . . 1.02 110.922 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -78.93 -68.67 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 1.3799999999999999 109.692 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -143.13 9.84 1.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.084 -0.507 . . . . 5.3700000000000001 110.883 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.618 ' HB2' ' O ' ' A' ' 256' ' ' ALA . 16.3 mm100 -72.21 -29.02 63.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.469 0.652 . . . . 5.25 109.805 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -87.82 136.25 33.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.114 -0.948 . . . . 6.4000000000000004 110.16 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.43 ' H ' ' HD2' ' A' ' 263' ' ' PRO . 9.6 t -163.43 -51.03 0.01 OUTLIER Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.776 -0.647 . . . . 7.9199999999999999 110.131 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 262' ' ' SER . 41.4 Cg_endo -68.73 3.81 2.1 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.824 1.683 . . . . 8.9900000000000002 111.363 169.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 262' ' ' SER . 20.0 m -136.29 126.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.997 -1.001 . . . . 10.84 109.951 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.64 161.73 37.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.985 -0.552 . . . . 11.789999999999999 109.669 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.577 -0.725 . . . . 13.24 110.375 178.323 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.011 -0.435 . . . . 7.6699999999999999 112.011 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 125.43 27.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.455 -0.202 . . . . 6.2300000000000004 110.455 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 tpt 73.36 -11.98 0.86 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.908 0.755 . . . . 7.4500000000000002 110.885 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 127.95 -133.21 7.7 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.092 -0.803 . . . . 2.8100000000000001 111.092 -177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.4 ' HB2' ' OD2' ' A' ' 168' ' ' ASP . 18.5 m -105.24 150.37 25.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.667 -0.494 . . . . 1.3 109.667 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.1 m -77.58 112.64 14.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.94 0.4 . . . . 0.51000000000000001 110.595 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.1 p-10 -79.85 143.21 34.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 110.462 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 162' ' ' VAL . 54.3 t -120.17 139.62 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.141 0.496 . . . . 0.23999999999999999 111.446 -176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.4 tp -94.54 114.36 26.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.16 110.018 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 75.5 mt -100.16 100.15 9.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.149 0.499 . . . . 0.23000000000000001 111.294 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 41.3 mt -94.3 99.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.403 -0.591 . . . . 0.16 109.403 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -149.68 124.48 9.87 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.361 -0.836 . . . . 0.5 109.57 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -77.69 -29.18 51.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.231 -0.895 . . . . 1.04 111.949 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 111.63 45.69 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.974 0.416 . . . . 1.29 111.199 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' MET . 24.5 Cg_exo -59.94 -38.42 78.97 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.518 2.812 . . . . 0.58999999999999997 113.158 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.55 -31.82 72.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.70999999999999996 110.745 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 58.3 mt -81.74 -35.09 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.08 -0.509 . . . . 0.46000000000000002 109.817 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.3 m -58.28 -54.32 48.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 1.29 110.644 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 21.7 mmt -64.98 -32.27 73.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 2.3500000000000001 110.555 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -65.87 -47.45 74.85 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.621 -0.718 . . . . 1.3100000000000001 110.136 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 85.8 mt -59.65 -35.94 75.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.295 -0.866 . . . . 0.23999999999999999 111.156 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -57.56 -52.29 66.02 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.055 0.455 . . . . 0.67000000000000004 110.514 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.5 -45.24 91.6 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.69 -0.686 . . . . 0.54000000000000004 110.563 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD23 ' HE ' ' A' ' 250' ' ' ARG . 0.7 OUTLIER -56.96 -49.4 75.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.97 . . . . 1.4199999999999999 111.407 -177.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -74.41 -25.65 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.366 0.603 . . . . 0.28999999999999998 110.707 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -70.18 -36.93 74.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 3.25 110.599 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.8 m -64.94 -19.94 66.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.172 0.51 . . . . 1.1599999999999999 110.867 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.9 mt -85.47 -0.02 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.40000000000000002 111.147 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.05 30.44 42.5 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.009 -0.615 . . . . 0.32000000000000001 112.167 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 90.3 m-70 -110.6 171.27 7.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.812 0.339 . . . . 0.5 110.634 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 142' ' ' SER . 8.7 m-20 -119.56 166.85 12.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.979 -0.555 . . . . 1.1899999999999999 110.877 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.8 mm -103.78 112.31 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.067 0.461 . . . . 0.23000000000000001 110.431 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -80.93 -24.08 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.817 -0.629 . . . . 0.23999999999999999 110.443 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.72 148.48 5.47 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.789 -0.72 . . . . 0.17000000000000001 112.238 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 p -108.91 137.44 46.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.752 0.311 . . . . 0.34999999999999998 110.179 173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -145.17 118.96 9.23 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.474 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -88.03 -2.86 58.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.82 0.343 . . . . 0.28999999999999998 110.945 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 199' ' ' ASP . 43.2 p -136.88 167.39 21.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.32000000000000001 110.769 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.8 ttt180 -69.72 -41.84 74.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.673 0.273 . . . . 0.90000000000000002 110.366 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.5 m -59.9 -43.55 94.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.40000000000000002 111.083 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.1 -37.84 84.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 1.1899999999999999 110.532 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.75 82.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.571 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 97.4 mt-30 -56.05 -44.65 79.04 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.98999999999999999 111.228 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -71.04 -47.31 59.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.056 -0.52 . . . . 2.2400000000000002 111.47 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.53 86.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.40000000000000002 111.026 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.17 -25.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.965 -0.561 . . . . 1.3300000000000001 110.221 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.53 -28.15 67.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.888 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -83.68 -55.68 4.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.427 -0.806 . . . . 2.02 110.699 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -132.07 132.03 42.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.63 110.664 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -86.46 124.71 69.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 1.6200000000000001 110.203 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.477 ' O ' HG21 ' A' ' 216' ' ' VAL . 88.4 Cg_endo -84.65 163.55 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.402 2.735 . . . . 0.26000000000000001 111.732 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.48 -4.01 55.07 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.867 -0.893 . . . . 0.23999999999999999 110.867 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.602 ' HB3' HG22 ' A' ' 145' ' ' VAL . 27.8 tp -154.71 144.91 21.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.533 -0.543 . . . . 0.65000000000000002 109.533 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.4 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.6 t -122.23 141.85 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 0.20000000000000001 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -125.33 134.07 52.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.553 -1.277 . . . . 1.47 107.553 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.452 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -155.51 144.57 20.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.55 0.574 . . . . 0.17999999999999999 112.55 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.628 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -95.36 -178.87 4.58 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.352 -0.981 . . . . 0.38 108.352 169.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.544 HD12 HD11 ' A' ' 204' ' ' ILE . 29.7 mm -87.04 -52.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 O-C-N 121.898 -0.501 . . . . 0.23000000000000001 111.18 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 196' ' ' GLN . 6.2 tp60 -99.07 115.88 30.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.069 0.461 . . . . 2.2799999999999998 110.891 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 59.7 mt -95.76 170.08 9.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.27000000000000002 110.621 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.09 69.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.45000000000000001 112.014 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 175' ' ' THR . 3.7 t70 -63.94 -24.84 67.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.731 -0.668 . . . . 0.94999999999999996 111.555 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.64 1.39 32.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.79 -0.924 . . . . 0.35999999999999999 110.79 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 p -76.87 156.21 32.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.874 -0.417 . . . . 0.33000000000000002 109.874 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 67.1 m -92.35 129.19 38.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.441 0.639 . . . . 1.21 110.737 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.72 -30.47 65.85 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.703 -1.135 . . . . 0.14999999999999999 111.789 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.544 HD11 HD12 ' A' ' 195' ' ' ILE . 66.9 mt -61.7 -43.26 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.28 -0.267 . . . . 0.20999999999999999 110.28 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.449 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -63.4 -40.59 97.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.73 110.724 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.74 95.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.225 0.536 . . . . 0.17000000000000001 110.152 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 218' ' ' VAL . 38.9 t -62.25 -51.66 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.325 -0.852 . . . . 0.20999999999999999 111.133 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.0 mt-10 -58.25 -35.01 71.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.304 -0.407 . . . . 0.57999999999999996 110.966 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.23 -51.72 68.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.678 0.751 . . . . 1.72 109.598 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.16 -42.57 93.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.689 -1.141 . . . . 0.23999999999999999 110.885 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.72 -16.17 64.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 111.88 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.57 -7.68 78.47 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.054 -0.818 . . . . 0.31 111.054 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -108.15 -54.85 2.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.421 0.629 . . . . 0.85999999999999999 109.944 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.6 176.35 7.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.352 -0.84 . . . . 0.39000000000000001 110.396 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.77 70.68 0.91 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.115 -0.948 . . . . 1.98 109.018 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -102.43 148.78 35.95 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.219 -1.355 . . . . 0.25 109.474 -177.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.466 ' O ' HD12 ' A' ' 190' ' ' LEU . 37.9 Cg_endo -64.43 134.45 41.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.28000000000000003 111.773 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.476 HG21 HG13 ' A' ' 207' ' ' VAL . 46.8 t -121.67 130.67 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.284 -0.416 . . . . 0.63 110.719 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -115.2 119.48 61.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 0.19 110.109 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 239' ' ' LEU . 86.4 m-85 -91.9 100.69 13.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.031 -0.531 . . . . 0.34999999999999998 110.45 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.453 HG12 ' HB ' ' A' ' 240' ' ' VAL . 6.4 mt -100.99 108.43 23.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.064 -0.717 . . . . 0.67000000000000004 109.064 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.9 t -153.81 163.94 39.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.947 0.403 . . . . 0.25 110.974 -173.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.96 13.3 27.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.41999999999999998 110.643 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -128.39 68.8 77.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 110.793 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.7 -40.34 74.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.161 . . . . 0.35999999999999999 112.206 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 230' ' ' THR . 11.0 pt-20 -66.42 -19.8 65.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.853 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 195' ' ' ILE . 2.1 tmt_? -61.62 -38.64 88.39 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.352 0.596 . . . . 2.0499999999999998 109.472 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.74 1.28 27.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.52000000000000002 110.825 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 52.9 mt -122.01 20.95 10.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.876 -0.602 . . . . 1.26 110.464 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 226' ' ' GLU . 8.8 t -148.12 -36.98 0.19 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.946 -0.57 . . . . 2.1000000000000001 111.111 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -97.61 2.62 60.67 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.769 -0.933 . . . . 3.4300000000000002 110.769 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.58 91.64 1.99 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.311 -0.996 . . . . 5.2199999999999998 108.311 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 25.6 mmm180 -43.38 -56.67 6.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.928 -1.033 . . . . 7.0999999999999996 111.996 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 72.1 Cg_endo -68.89 146.29 65.09 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.442 2.094 . . . . 2.52 113.069 172.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.48 139.05 28.17 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.021 -0.99 . . . . 1.9299999999999999 111.001 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.81 137.51 32.54 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.865 2.376 . . . . 0.52000000000000002 111.255 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.6 m -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 1.1000000000000001 111.175 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.82 113.6 14.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.073 0.463 . . . . 0.52000000000000002 111.012 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' PHE . 45.7 tp -132.39 123.67 27.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 110.475 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 221' ' ' ILE . 85.5 t -118.84 125.85 74.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.29999999999999999 109.894 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.4 p -88.38 138.79 31.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.855 -0.611 . . . . 0.48999999999999999 111.652 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -93.78 145.43 29.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.78000000000000003 110.903 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 13.7 Cg_exo -68.5 139.04 48.56 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.316 -1.535 . . . . 0.76000000000000001 111.598 -2.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -92.08 159.95 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.077 -0.511 . . . . 0.45000000000000001 111.529 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 249' ' ' VAL . 15.8 mm100 -104.02 126.43 51.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 2.1400000000000001 109.352 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.55 -34.73 62.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 112.283 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 p -69.31 -45.96 68.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 1.3400000000000001 110.49 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -58.58 -40.82 84.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.682 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 245' ' ' GLN . 58.8 t -59.44 -56.27 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.215 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.416 ' HE ' HD23 ' A' ' 161' ' ' LEU . 97.8 mtt180 -52.33 -45.72 65.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.218 0.533 . . . . 2.6899999999999999 110.664 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 57.3 m -54.96 -44.98 74.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.14 -0.937 . . . . 0.27000000000000002 111.439 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.5 m -68.79 -45.2 71.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.672 -0.24 . . . . 0.20000000000000001 111.45 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.441 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -55.09 -46.56 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.059 0.456 . . . . 0.23000000000000001 110.971 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 6.1 p -70.03 -24.52 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 1.1699999999999999 112.147 -174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.7 mm-40 -76.62 -49.06 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.218 0.533 . . . . 2.3399999999999999 109.932 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -52.17 -37.41 54.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.081 -0.963 . . . . 0.35999999999999999 111.321 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.2 0.26 50.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.662 -0.699 . . . . 1.02 111.563 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 254' ' ' SER . 40.9 t80 -85.34 -49.7 7.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.491 0.662 . . . . 1.3799999999999999 109.679 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.29 2.26 41.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.028 -0.987 . . . . 5.3700000000000001 111.189 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -131.62 96.06 3.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.219 0.533 . . . . 5.25 110.728 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.81 -60.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.408 -0.815 . . . . 6.4000000000000004 109.952 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 263' ' ' PRO . 36.3 p -137.93 58.93 17.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 7.9199999999999999 110.57 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 262' ' ' SER . 86.7 Cg_endo -92.65 47.77 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.728 2.286 . . . . 8.9900000000000002 112.39 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.2 m -74.98 102.39 4.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.115 -0.493 . . . . 10.84 109.929 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.87 48.95 10.44 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.085 -0.507 . . . . 11.789999999999999 110.346 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.278 -0.867 . . . . 13.24 111.054 -176.53 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.058 -0.417 . . . . 7.6699999999999999 112.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 64.64 20.49 12.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.137 0.575 . . . . 6.2300000000000004 111.848 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 66.9 mtt -110.43 -14.81 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.004 0.431 . . . . 7.4500000000000002 110.389 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 -154.22 14.21 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.918 -0.658 . . . . 2.8100000000000001 112.569 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 p -80.31 151.11 29.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.447 0.641 . . . . 1.3 111.558 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.436 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 23.5 m -147.46 117.88 7.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.381 -0.97 . . . . 0.51000000000000001 108.381 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 32.4 p-10 -68.68 137.89 54.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.977 0.418 . . . . 0.23000000000000001 110.442 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 162' ' ' VAL . 96.7 t -123.02 136.34 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.317 0.488 . . . . 0.23999999999999999 112.317 -172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.6 tp -98.05 117.31 32.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.708 -0.678 . . . . 0.16 110.178 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.14 110.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.86 0.362 . . . . 0.23000000000000001 111.02 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 38.5 mt -98.45 99.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.567 . . . . 0.16 109.989 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -158.13 127.52 5.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.247 -0.888 . . . . 0.5 108.888 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -74.98 -41.22 59.97 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.626 -0.715 . . . . 1.04 111.165 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 46.3 mt-10 -73.64 113.36 22.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.086 0.47 . . . . 1.29 111.058 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 21.9 Cg_exo -63.21 -38.4 44.92 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.622 2.882 . . . . 0.58999999999999997 113.171 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.05 -40.42 93.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.70999999999999996 110.283 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 242' ' ' LYS . 67.4 mt -75.81 -37.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.46000000000000002 110.246 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 57.6 m -56.43 -52.1 65.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.518 . . . . 1.29 110.917 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.9 mtt -73.53 -25.94 60.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.34 . . . . 2.3500000000000001 111.083 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -62.1 -45.62 92.7 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.217 -0.66 . . . . 1.3100000000000001 109.217 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.57 -41.95 92.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.988 -1.005 . . . . 0.23999999999999999 111.092 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 155' ' ' SER . 49.2 mt-10 -55.07 -58.73 6.47 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.763 0.316 . . . . 0.67000000000000004 110.614 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.33 -42.47 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.779 -0.646 . . . . 0.54000000000000004 111.345 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 249' ' ' VAL . 11.9 tp -61.51 -52.98 62.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.269 -0.878 . . . . 1.4199999999999999 111.35 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 145' ' ' VAL . 6.2 p -74.84 -29.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.982 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 45.4 ttm180 -66.09 -40.5 90.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.446 -0.797 . . . . 3.25 110.209 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.0 t -61.12 -33.37 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.678 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 162' ' ' VAL . 80.8 mt -68.6 -6.35 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 111.416 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.53 36.94 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.884 -0.674 . . . . 0.32000000000000001 112.108 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.9 m-70 -106.1 177.21 4.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.081 -0.34 . . . . 0.5 110.081 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.07 177.54 5.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.365 -0.235 . . . . 1.1899999999999999 110.365 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.1 mm -113.87 119.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.971 0.415 . . . . 0.23000000000000001 109.9 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.63 -34.41 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.918 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 176.17 158.21 19.21 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 111.741 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -117.91 141.18 48.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.803 0.335 . . . . 0.34999999999999998 110.125 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.17 131.95 25.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.179 -0.464 . . . . 0.28999999999999998 110.86 -175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -102.19 -10.21 19.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.831 0.348 . . . . 0.28999999999999998 111.031 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 199' ' ' ASP . 49.3 p -133.13 172.43 12.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.32000000000000001 110.584 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.452 ' HG2' HE21 ' A' ' 180' ' ' GLN . 68.0 ttt180 -70.08 -39.72 75.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 110.115 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -59.89 -47.12 87.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.40000000000000002 110.71 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -60.33 -35.97 76.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 1.1899999999999999 110.562 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.76 82.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 0.25 110.649 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.452 HE21 ' HG2' ' A' ' 176' ' ' ARG . 76.0 mt-30 -61.47 -42.38 98.69 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.901 -0.59 . . . . 0.98999999999999999 110.802 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 22.9 mm-40 -70.3 -46.97 63.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 111.872 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.64 81.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.876 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.3 p -82.64 -24.04 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 110.304 -176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.6 64.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.033 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 56.5 mtpt -79.61 -54.55 5.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.568 -0.742 . . . . 2.02 110.216 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.99 132.2 31.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.745 -0.661 . . . . 0.63 110.516 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -86.11 116.29 65.22 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.608 -0.724 . . . . 1.6200000000000001 110.34 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.3 Cg_endo -77.18 163.08 30.88 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.248 2.632 . . . . 0.26000000000000001 111.927 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -100.93 1.38 55.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.134 -0.786 . . . . 0.23999999999999999 111.134 173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.2 tp -159.99 144.68 14.85 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.817 -0.438 . . . . 0.65000000000000002 109.817 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HB ' HG22 ' A' ' 218' ' ' VAL . 58.0 t -129.5 142.33 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.20000000000000001 111.33 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 219' ' ' ILE . 3.2 mm? -120.56 143.43 48.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.526 -0.916 . . . . 1.47 108.526 173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -157.53 138.3 13.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.406 0.521 . . . . 0.17999999999999999 112.406 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.612 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 17.1 t70 -96.8 169.03 10.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.608 -0.886 . . . . 0.38 108.608 171.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.54 HG12 ' OG1' ' A' ' 222' ' ' THR . 33.8 mm -75.57 -48.13 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.007 0.432 . . . . 0.23000000000000001 110.466 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -92.92 115.88 28.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.67 -0.695 . . . . 2.2799999999999998 110.658 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD11 ' HA2' ' A' ' 203' ' ' GLY . 55.8 mt -101.88 171.32 7.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.875 -0.602 . . . . 0.27000000000000002 110.36 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.19 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.729 0.64 . . . . 0.45000000000000001 112.729 -172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.485 ' H ' HG22 ' A' ' 175' ' ' THR . 29.2 t70 -82.94 -0.92 50.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.207 0.527 . . . . 0.94999999999999996 111.147 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.16 43.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.679 -0.772 . . . . 0.35999999999999999 112.583 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.96 160.72 22.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.33000000000000002 111.295 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.1 t -94.55 128.47 41.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 1.21 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.82 -29.33 72.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.228 -0.896 . . . . 0.14999999999999999 111.829 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 195' ' ' ILE . 63.8 mt -61.78 -43.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.246 0.546 . . . . 0.20999999999999999 110.069 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.82 -46.04 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.296 -0.865 . . . . 1.73 110.175 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.48 -40.9 92.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.464 -0.789 . . . . 0.17000000000000001 110.948 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.2 t -62.04 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.776 . . . . 0.20999999999999999 111.223 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.75 -31.17 71.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.899 -0.591 . . . . 0.57999999999999996 111.682 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 61.3 m-20 -60.41 -50.16 74.7 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.448 0.642 . . . . 1.72 109.524 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.406 HG21 HG21 ' A' ' 191' ' ' VAL . 62.3 mt -57.77 -47.86 84.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 110.662 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.6 mt -71.51 -13.09 61.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.296 -0.865 . . . . 0.71999999999999997 112.216 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.1 -4.48 78.03 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.18 -0.768 . . . . 0.31 111.18 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.7 mt-30 -114.13 -56.77 2.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.375 0.607 . . . . 0.85999999999999999 109.78 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 179.83 4.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 111.127 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -122.32 74.78 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.945 -1.025 . . . . 1.98 109.025 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -112.78 148.73 39.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 114.806 -1.088 . . . . 0.25 109.829 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.486 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 47.0 Cg_endo -68.98 122.71 9.61 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.365 2.043 . . . . 0.28000000000000003 112.018 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.475 HG22 ' HB ' ' A' ' 191' ' ' VAL . 41.8 t -115.52 123.71 71.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.767 -0.651 . . . . 0.63 110.338 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 192' ' ' LEU . 59.7 mt -107.48 117.11 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.828 -0.623 . . . . 0.19 110.25 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.45 ' O ' HD12 ' A' ' 239' ' ' LEU . 82.0 m-85 -83.29 86.63 7.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.34999999999999998 110.545 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.1 mt -89.24 106.74 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.511 -0.922 . . . . 0.67000000000000004 108.511 173.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.569 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 11.9 t -149.32 158.81 44.49 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.053 -0.659 . . . . 0.25 111.567 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.99 13.28 23.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.439 -0.801 . . . . 0.41999999999999998 110.136 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -132.17 65.45 75.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.69999999999999996 110.666 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.5 -39.04 79.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.946 2.431 . . . . 0.35999999999999999 112.431 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.637 ' O ' HG22 ' A' ' 230' ' ' THR . 9.5 pt-20 -60.37 -28.84 68.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.804 -0.635 . . . . 0.93999999999999995 111.533 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.8 tmt_? -62.46 -27.1 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.135 0.493 . . . . 2.0499999999999998 110.128 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.32 -7.84 43.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 111.371 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.44 19.75 14.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.096 0.474 . . . . 1.26 111.24 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 226' ' ' GLU . 13.4 t -163.27 -39.18 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 2.1000000000000001 110.906 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -87.17 6.97 82.38 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.863 -0.684 . . . . 3.4300000000000002 111.87 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -162.26 96.29 0.97 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.866 -1.161 . . . . 5.2199999999999998 107.866 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 34.5 mtp-105 -42.45 -53.4 9.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 113.975 -1.466 . . . . 7.0999999999999996 113.943 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 19.6 Cg_exo -61.99 134.36 49.26 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.649 1.566 . . . . 2.52 111.805 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.65 136.9 30.6 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.494 -0.775 . . . . 1.9299999999999999 110.999 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.93 128.09 17.18 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.98 2.454 . . . . 0.52000000000000002 111.315 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -60.69 -37.6 82.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 1.1000000000000001 110.834 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -130.67 121.55 25.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.899 -0.591 . . . . 0.52000000000000002 109.554 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 220' ' ' PHE . 42.8 tp -136.09 124.88 23.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.239 -0.437 . . . . 0.28000000000000003 110.679 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.451 ' HB ' HG12 ' A' ' 221' ' ' ILE . 97.7 t -126.72 134.21 66.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.882 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 12.0 p -94.9 136.8 34.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 111.526 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 154' ' ' ILE . 41.2 mtpt -94.9 137.62 22.28 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.771 -0.65 . . . . 0.78000000000000003 110.381 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.7 Cg_exo -70.56 144.3 77.93 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.802 -1.333 . . . . 0.76000000000000001 112.417 1.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -104.98 157.67 17.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.154 0.502 . . . . 0.45000000000000001 111.634 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -92.63 124.77 36.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.003 -0.74 . . . . 2.1400000000000001 109.003 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 21.4 mt-10 -54.44 -32.29 57.16 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.59 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.6 t -66.56 -48.57 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.514 -0.312 . . . . 1.3400000000000001 110.213 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.498 ' O ' ' HB ' ' A' ' 251' ' ' THR . 81.8 m -57.23 -44.63 83.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 0.25 110.8 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 161' ' ' LEU . 53.0 t -62.03 -51.65 70.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 0.19 110.732 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 54.3 mtt180 -53.44 -43.33 67.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 2.6899999999999999 110.063 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 248' ' ' THR . 95.8 m -56.1 -44.68 79.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 0.27000000000000002 111.159 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 8.4 m -70.54 -41.21 72.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 111.16 -176.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -57.55 -47.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.661 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.3 t -64.07 -36.91 85.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 1.1699999999999999 111.29 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 3.7 pt20 -75.97 -41.9 50.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.494 0.664 . . . . 2.3399999999999999 110.397 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.78 -35.91 71.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.946 -1.025 . . . . 0.35999999999999999 111.487 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 66.2 mt -82.68 -9.92 59.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.02 111.172 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 263' ' ' PRO . 50.2 t80 -78.87 -42.91 26.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.198 -0.668 . . . . 1.3799999999999999 109.198 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -80.92 60.82 4.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.677 -0.692 . . . . 5.3700000000000001 110.692 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 263' ' ' PRO . 23.8 mm-40 -131.02 178.73 6.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.552 -0.749 . . . . 5.25 110.929 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.89 12.14 9.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.754 -0.657 . . . . 6.4000000000000004 111.043 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 6.6 m -91.26 -49.89 0.33 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.282 -0.417 . . . . 7.9199999999999999 111.34 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.55 ' HG2' ' O ' ' A' ' 258' ' ' PHE . 4.4 Cg_exo -77.66 170.21 19.55 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.224 1.95 . . . . 8.9900000000000002 111.815 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 t -116.28 13.03 15.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 10.84 110.805 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -135.26 69.51 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.015 -0.539 . . . . 11.789999999999999 110.401 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.112 -0.947 . . . . 13.24 111.61 -174.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.798 -0.521 . . . . 7.6699999999999999 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 54.59 43.86 29.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 6.2300000000000004 111.453 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -91.95 74.6 5.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.225 0.536 . . . . 7.4500000000000002 110.439 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.34 -128.88 5.35 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.249 -0.74 . . . . 2.8100000000000001 111.249 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.43 123.31 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 1.3 110.686 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 4.3 m -78.01 110.7 13.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.922 -0.581 . . . . 0.51000000000000001 110.391 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.6 p-10 -71.58 136.53 47.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.328 -0.396 . . . . 0.23000000000000001 110.028 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 190' ' ' LEU . 64.0 t -120.52 137.12 55.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 111.483 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.5 tp -93.45 116.03 28.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.202 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.94 102.52 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 111.227 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 14.1 mt -89.64 99.25 9.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.13 -0.693 . . . . 0.16 109.13 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.06 124.64 7.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.558 -0.747 . . . . 0.5 109.744 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.96 -40.61 62.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.284 -0.871 . . . . 1.04 111.36 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.93 112.14 20.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 121.19 0.519 . . . . 1.29 111.162 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.48 -37.27 72.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.22 2.613 . . . . 0.58999999999999997 112.191 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.25 -37.22 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.278 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 65.1 mt -79.95 -42.05 21.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.46000000000000002 110.327 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 28.9 t -54.71 -55.91 24.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.29 110.942 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.3 mtt -68.57 -27.27 65.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.664 0.268 . . . . 2.3500000000000001 110.891 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -63.33 -48.72 76.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 1.3100000000000001 109.532 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.2 mt -63.82 -39.32 93.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.948 . . . . 0.23999999999999999 110.798 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 53.9 mt-10 -55.43 -57.56 11.35 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 110.384 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.06 -42.35 90.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.54000000000000004 110.837 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 246' ' ' GLU . 2.5 mt -59.3 -54.85 42.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 1.4199999999999999 111.374 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.572 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.1 p -71.31 -27.95 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.335 0.588 . . . . 0.28999999999999998 110.935 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -68.11 -39.38 82.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.332 -0.849 . . . . 3.25 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.2 m -65.48 -22.32 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.1599999999999999 110.802 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.3 mt -80.6 7.59 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.40000000000000002 111.023 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.11 12.48 83.24 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.955 -0.64 . . . . 0.32000000000000001 112.289 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.9 m-70 -98.34 171.89 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.639 -0.504 . . . . 0.5 109.639 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.23 179.6 4.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.721 0.296 . . . . 1.1899999999999999 110.407 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.04 119.99 61.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.109 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.87 -19.49 28.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.065 -0.516 . . . . 0.23999999999999999 110.22 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.12 156.94 8.04 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.687 -0.688 . . . . 0.17000000000000001 111.827 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 p -111.05 144.28 40.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.951 0.405 . . . . 0.34999999999999998 110.027 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 113.67 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.032 -0.531 . . . . 0.28999999999999998 110.781 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.74 43.65 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.864 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.9 p -130.59 167.37 18.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.32000000000000001 110.828 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.83 -37.75 87.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.90000000000000002 110.141 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.4 m -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.042 -0.526 . . . . 0.40000000000000002 110.899 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.98 -33.95 74.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 1.1899999999999999 110.754 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.14 -47.19 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 0.25 110.894 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.94 -37.79 86.95 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.98999999999999999 110.882 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.38 -38.13 77.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.622 . . . . 2.2400000000000002 111.606 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.11 67.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.901 -0.59 . . . . 0.40000000000000002 111.187 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 8.3 m -70.9 -28.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.31 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.4 -28.99 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.514 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -90.51 -52.63 4.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.657 -0.701 . . . . 2.02 111.144 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 27.8 tt0 -141.39 138.19 32.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 0.63 111.483 -177.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -87.27 119.07 70.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.567 -0.742 . . . . 1.6200000000000001 110.104 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.591 ' O ' HG21 ' A' ' 216' ' ' VAL . 73.1 Cg_endo -76.1 151.13 34.39 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.109 2.539 . . . . 0.26000000000000001 111.759 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.01 -14.3 69.78 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.103 -0.799 . . . . 0.23999999999999999 111.103 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 145' ' ' VAL . 28.6 tp -151.04 145.61 25.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.464 -0.569 . . . . 0.65000000000000002 109.464 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 218' ' ' VAL . 76.9 t -118.76 140.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.292 0.568 . . . . 0.20000000000000001 110.796 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -126.79 131.45 51.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.215 -1.402 . . . . 1.47 107.215 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.442 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.6 148.05 27.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.189 -0.604 . . . . 0.17999999999999999 112.561 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.591 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -97.99 178.32 5.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.966 -1.015 . . . . 0.38 108.434 170.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.5 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.3 mm -85.99 -43.84 16.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.045 0.45 . . . . 0.23000000000000001 110.061 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -94.71 116.81 29.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.479 -0.782 . . . . 2.2799999999999998 110.601 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 203' ' ' GLY . 63.1 mt -104.92 167.13 9.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.484 . . . . 0.27000000000000002 110.842 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -51.8 -52.36 49.7 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.866 0.691 . . . . 0.45000000000000001 112.866 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -76.39 -12.6 60.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.219 0.533 . . . . 0.94999999999999996 111.104 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 108.47 4.87 32.38 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.664 -0.779 . . . . 0.35999999999999999 111.939 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.84 166.38 23.72 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.33000000000000002 110.685 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 15.1 m -100.77 125.63 47.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.154 0.502 . . . . 1.21 110.593 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.21 -29.43 71.19 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.14999999999999999 112.886 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.41 ' CD1' ' HD2' ' A' ' 227' ' ' ARG . 62.6 mt -61.53 -45.06 99.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.4 . . . . 0.20999999999999999 110.282 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 10.2 m-20 -61.35 -41.65 97.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.647 -0.706 . . . . 1.73 110.107 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.98 -42.15 93.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.425 0.631 . . . . 0.17000000000000001 110.558 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 218' ' ' VAL . 45.2 t -64.19 -46.81 92.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.327 -0.851 . . . . 0.20999999999999999 111.424 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.93 -30.22 70.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.129 -0.487 . . . . 0.57999999999999996 111.226 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -59.78 -50.97 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.383 0.611 . . . . 1.72 109.727 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 54.9 mt -58.13 -45.59 88.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.064 -0.971 . . . . 0.23999999999999999 110.464 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 70.9 mt -72.87 -6.17 43.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.71999999999999997 112.186 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.2 -2.99 85.25 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.919 -0.872 . . . . 0.31 110.919 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.23 -54.67 1.59 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.356 0.598 . . . . 0.85999999999999999 110.055 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.0 176.47 5.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.266 -0.879 . . . . 0.39000000000000001 111.437 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -125.92 38.55 4.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.194 -0.912 . . . . 1.98 109.487 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -89.71 150.47 44.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.149 -0.932 . . . . 0.25 110.724 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.35 144.74 46.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.84 2.36 . . . . 0.28000000000000003 112.201 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 191' ' ' VAL . 28.5 t -128.28 131.69 68.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.208 -0.451 . . . . 0.63 110.615 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.411 ' HB ' HD22 ' A' ' 192' ' ' LEU . 74.7 mt -114.82 122.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.83 -0.623 . . . . 0.19 109.87 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.425 ' O ' HD12 ' A' ' 239' ' ' LEU . 91.0 m-85 -94.43 95.5 8.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.34999999999999998 110.696 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.1 mt -95.09 107.03 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.719 -0.845 . . . . 0.67000000000000004 108.719 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 12.3 t -152.26 165.54 34.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.217 0.532 . . . . 0.25 111.31 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.05 8.1 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.669 -0.696 . . . . 0.41999999999999998 110.845 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 61.9 m-85 -124.52 70.26 55.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.377 -0.374 . . . . 0.69999999999999996 111.318 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.32 -37.4 50.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.376 2.051 . . . . 0.35999999999999999 111.001 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.31 -28.31 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.073 -0.967 . . . . 0.93999999999999995 111.382 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -71.64 -34.01 69.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 2.0499999999999998 109.531 -176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 15.3 mt -80.02 -8.21 59.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.52000000000000002 111.128 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 64.9 mt -115.17 13.37 16.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 1.26 111.36 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.6 p -124.16 -94.1 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.064 -0.516 . . . . 2.1000000000000001 112.285 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.0 -14.02 67.53 Favored Glycine 0 C--O 1.23 -0.11 0 CA-C-N 116.097 -0.501 . . . . 3.4300000000000002 112.476 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.27 74.79 1.05 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.59 -0.892 . . . . 5.2199999999999998 108.59 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.548 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 32.9 mmt180 -37.31 -54.27 2.05 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.901 -1.499 . . . . 7.0999999999999996 113.75 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 21.3 Cg_exo -59.58 132.36 45.42 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.12 1.213 . . . . 2.52 111.636 176.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.68 135.11 36.26 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.672 -0.695 . . . . 1.9299999999999999 110.59 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.68 126.99 18.6 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.726 2.284 . . . . 0.52000000000000002 111.062 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 12.7 m -62.33 -32.87 73.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.773 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 93.4 m-85 -138.23 116.29 11.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.52000000000000002 109.971 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 220' ' ' PHE . 47.5 tp -125.75 127.38 46.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.28000000000000003 110.735 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 221' ' ' ILE . 96.8 t -122.73 128.74 75.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.626 -0.715 . . . . 0.29999999999999999 109.429 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.9 p -96.14 135.33 38.08 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.894 -0.594 . . . . 0.48999999999999999 111.935 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 90.3 mttt -89.76 144.96 32.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.78000000000000003 111.235 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 15.4 Cg_exo -68.18 134.5 26.54 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.276 -1.552 . . . . 0.76000000000000001 111.838 -2.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.15 161.34 15.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.936 -0.574 . . . . 0.45000000000000001 111.331 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 249' ' ' VAL . 73.9 mm-40 -107.72 128.68 54.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.723 -0.671 . . . . 2.1400000000000001 109.334 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.448 ' HB3' HD21 ' A' ' 161' ' ' LEU . 51.9 mt-10 -55.37 -36.82 66.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.342 -0.844 . . . . 1.6599999999999999 112.445 -173.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.1 m -63.8 -49.85 71.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.345 . . . . 1.3400000000000001 110.07 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.4 m -56.53 -41.03 76.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.896 -0.593 . . . . 0.25 111.161 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 245' ' ' GLN . 50.4 t -59.42 -57.54 11.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.345 -0.388 . . . . 0.19 110.5 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.439 ' HA ' HD11 ' A' ' 165' ' ' LEU . 67.1 mtt180 -52.61 -42.67 64.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.354 0.597 . . . . 2.6899999999999999 110.708 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 52.8 m -59.64 -42.26 92.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.081 -0.963 . . . . 0.27000000000000002 111.595 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.7 m -71.68 -43.29 66.26 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.497 0.184 . . . . 0.20000000000000001 111.497 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.57 -47.43 71.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 111.459 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.6 p -67.37 -24.76 65.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.47 . . . . 1.1699999999999999 111.613 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' THR . 80.4 mm-40 -78.71 -46.58 18.71 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.516 -0.311 . . . . 2.3399999999999999 110.835 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -51.95 -37.58 53.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.217 -0.901 . . . . 0.35999999999999999 111.566 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.96 -24.53 32.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.018 -0.537 . . . . 1.02 111.045 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -78.12 -15.21 59.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.47 0.652 . . . . 1.3799999999999999 109.989 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.9 -11.56 50.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.874 0.845 . . . . 5.3700000000000001 110.016 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -98.4 135.08 40.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.834 -1.076 . . . . 5.25 110.894 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -92.64 43.39 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.284 1.04 . . . . 6.4000000000000004 109.526 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.0 m -90.96 -54.01 0.28 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.742 -1.117 . . . . 7.9199999999999999 111.271 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.51 -42.29 5.34 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.146 1.23 . . . . 8.9900000000000002 112.148 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 4.3 m 49.66 56.67 7.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 10.84 110.624 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -151.86 49.65 0.8 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 11.789999999999999 110.596 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 65.2 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.478 -0.772 . . . . 13.24 110.1 179.61 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.815 -0.514 . . . . 7.6699999999999999 111.815 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.57 84.02 0.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 6.2300000000000004 110.235 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.5 ptp -120.27 127.06 52.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.236 0.541 . . . . 7.4500000000000002 111.408 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.94 64.53 0.57 Allowed Glycine 0 CA--C 1.499 -0.958 0 N-CA-C 109.781 -1.327 . . . . 2.8100000000000001 109.781 173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -53.85 139.58 32.99 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.669 -1.265 . . . . 1.3 112.166 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.44 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 10.5 m -76.54 106.53 8.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.387 -0.824 . . . . 0.51000000000000001 109.916 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.0 p-10 -70.16 138.73 52.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.721 -0.672 . . . . 0.23000000000000001 110.33 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.5 t -121.04 137.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.066 0.46 . . . . 0.23999999999999999 111.385 -175.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.506 -0.77 . . . . 0.16 110.08 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 159' ' ' GLU . 73.7 mt -103.81 108.0 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.225 0.536 . . . . 0.23000000000000001 111.295 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 18.4 mt -97.84 101.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.631 -0.713 . . . . 0.16 109.914 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 127.36 11.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.238 -1.023 . . . . 0.5 108.238 -177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 4.2 p-10 -76.06 -14.47 60.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 1.04 110.665 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.31 109.23 48.94 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 120.941 0.4 . . . . 1.29 110.923 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.38 -35.25 84.59 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.252 2.634 . . . . 0.58999999999999997 112.225 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.68 -51.27 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.749 -0.659 . . . . 0.70999999999999996 110.344 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.1 mt -69.9 -34.72 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.997 -0.547 . . . . 0.46000000000000002 110.358 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 68.5 m -56.31 -56.69 17.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.354 -0.384 . . . . 1.29 111.085 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.427 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 26.6 ptm -68.01 -26.41 65.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 2.3500000000000001 111.071 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 44.5 tp60 -65.27 -48.1 74.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.493 -0.558 . . . . 1.3100000000000001 109.493 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.82 -38.14 87.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.905 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -57.81 -53.32 59.58 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 110.471 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.31 -40.17 95.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.54000000000000004 110.612 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -56.0 -53.39 57.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.993 -1.003 . . . . 1.4199999999999999 110.642 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -75.49 -27.35 19.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.485 0.659 . . . . 0.28999999999999998 110.9 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -64.8 -36.29 83.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.342 -0.845 . . . . 3.25 110.653 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -65.46 -21.52 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.286 0.565 . . . . 1.1599999999999999 110.398 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 162' ' ' VAL . 54.7 mt -84.15 2.51 39.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.40000000000000002 111.238 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.43 20.49 62.09 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.763 -0.732 . . . . 0.32000000000000001 112.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.2 m-70 -102.82 175.07 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.065 -0.346 . . . . 0.5 110.065 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -120.02 174.11 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.341 -0.391 . . . . 1.1899999999999999 110.039 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.8 mm -115.59 115.62 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.002 0.429 . . . . 0.23000000000000001 109.865 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.63 -20.9 32.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.23999999999999999 110.232 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.94 161.08 11.51 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.708 -0.678 . . . . 0.17000000000000001 112.033 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.06 142.46 47.38 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.73 -0.47 . . . . 0.34999999999999998 109.73 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.92 121.76 11.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.575 -0.284 . . . . 0.28999999999999998 111.589 -174.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.63 -5.88 44.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.094 0.473 . . . . 0.28999999999999998 110.525 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 46.9 p -134.95 167.66 20.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.32000000000000001 110.086 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.5 ttt180 -68.63 -35.93 77.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.417 . . . . 0.90000000000000002 109.906 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.4 m -59.94 -45.66 91.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.818 -0.628 . . . . 0.40000000000000002 110.59 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.48 -36.31 77.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.84 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.58 96.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.008 -0.542 . . . . 0.25 110.719 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 91.7 mt-30 -63.46 -41.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.737 -0.665 . . . . 0.98999999999999999 110.627 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 63.9 mt-10 -64.5 -44.26 91.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.01 -0.541 . . . . 2.2400000000000002 110.756 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.79 -54.67 35.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.508 -0.769 . . . . 0.40000000000000002 111.426 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.58 -29.32 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.935 0.398 . . . . 1.3300000000000001 111.224 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.06 -28.98 70.45 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.44 110.308 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 99.1 mttt -85.99 -55.73 3.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 2.02 110.293 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.98 133.74 21.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.554 -0.748 . . . . 0.63 110.825 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -83.11 122.94 77.85 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.474 -0.784 . . . . 1.6200000000000001 110.598 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.19 157.59 23.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.319 2.68 . . . . 0.26000000000000001 112.325 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -10.18 56.7 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.953 -0.859 . . . . 0.23999999999999999 110.953 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.4 tp -150.92 145.34 25.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.247 -0.649 . . . . 0.65000000000000002 109.247 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 218' ' ' VAL . 59.8 t -122.81 143.44 35.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.20000000000000001 110.954 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.3 OUTLIER -126.54 139.5 53.16 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.71 -1.218 . . . . 1.47 107.71 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -154.54 146.67 23.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.695 0.628 . . . . 0.17999999999999999 112.695 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.652 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.1 t70 -103.06 -178.12 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.559 -0.904 . . . . 0.38 108.559 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.403 HG12 ' OG1' ' A' ' 222' ' ' THR . 34.3 mm -87.91 -60.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.018 0.437 . . . . 0.23000000000000001 112.023 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -90.93 87.69 6.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 2.2799999999999998 111.489 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -72.41 159.65 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.065 -0.516 . . . . 0.27000000000000002 110.864 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -68.53 -20.09 64.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.593 -0.73 . . . . 0.45000000000000001 112.254 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 15.4 t70 -76.31 -26.25 55.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.276 0.56 . . . . 0.94999999999999996 110.952 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.82 -5.62 37.1 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.306 -1.117 . . . . 0.35999999999999999 110.306 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.3 p -84.09 157.88 21.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.266 -0.467 . . . . 0.33000000000000002 110.149 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 22.1 m -91.66 134.35 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.074 0.464 . . . . 1.21 110.428 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.31 -26.24 63.72 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.433 -0.803 . . . . 0.14999999999999999 111.701 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.9 mt -61.28 -45.84 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.058 0.456 . . . . 0.20999999999999999 109.861 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.34 -37.46 87.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.73 110.781 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.85 -40.88 98.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.219 0.533 . . . . 0.17000000000000001 110.425 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.459 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.2 t -65.33 -50.64 71.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.44 -0.8 . . . . 0.20999999999999999 111.064 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 57.4 mt-10 -58.79 -34.05 71.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.57999999999999996 110.847 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.2 t70 -57.22 -53.54 56.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 1.72 109.944 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.78 -43.22 96.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.854 -1.066 . . . . 0.23999999999999999 111.332 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.15 -17.84 64.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.292 -0.413 . . . . 0.71999999999999997 111.809 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.17 -3.5 90.54 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.228 -0.749 . . . . 0.31 111.228 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 40.4 mt-30 -113.62 -52.55 2.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.513 0.673 . . . . 0.85999999999999999 109.754 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.24 174.26 6.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.012 -0.995 . . . . 0.39000000000000001 110.794 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -120.95 58.03 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.133 -0.939 . . . . 1.98 108.752 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -100.62 150.77 37.26 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.643 -1.162 . . . . 0.25 110.078 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 190' ' ' LEU . 43.3 Cg_endo -66.06 133.21 32.46 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.672 2.248 . . . . 0.28000000000000003 112.072 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 191' ' ' VAL . 34.6 t -122.7 133.22 69.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.998 0.427 . . . . 0.63 110.598 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.75 120.99 66.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.02 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.472 ' O ' HD12 ' A' ' 239' ' ' LEU . 56.9 m-85 -91.91 103.37 15.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.176 -0.465 . . . . 0.34999999999999998 110.203 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' A' ' 240' ' ' VAL . 8.9 mt -103.14 107.14 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.286 -0.635 . . . . 0.67000000000000004 109.286 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -151.7 164.12 37.65 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.07 0.462 . . . . 0.25 110.475 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 242' ' ' LYS . . . -92.54 5.87 49.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.41999999999999998 110.836 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 227' ' ' ARG . 27.3 m-85 -123.87 74.48 56.27 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.408 . . . . 0.69999999999999996 111.242 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.418 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 42.3 Cg_endo -66.53 -35.69 28.84 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.352 2.035 . . . . 0.35999999999999999 111.803 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 230' ' ' THR . 13.3 pt-20 -61.62 -24.56 66.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.951 -0.568 . . . . 0.93999999999999995 110.808 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -63.56 -44.91 92.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.737 -0.665 . . . . 2.0499999999999998 109.967 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 236' ' ' PRO . 18.2 mt -86.27 -3.93 59.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.366 -0.834 . . . . 0.52000000000000002 111.62 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 85.8 mt -107.05 31.52 5.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.009 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 226' ' ' GLU . 9.3 t -171.37 116.88 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.514 0.673 . . . . 2.1000000000000001 111.413 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.17 -43.84 3.19 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 3.4300000000000002 112.991 175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.08 48.95 1.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.481 . . . . 5.2199999999999998 111.114 -176.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.678 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 5.6 mmp_? 66.97 -175.27 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.91 -1.041 . . . . 7.0999999999999996 110.585 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.678 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 31.7 Cg_exo -63.58 175.03 3.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.99 2.46 . . . . 2.52 112.528 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -51.45 122.41 19.72 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.435 -0.802 . . . . 1.9299999999999999 111.061 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HG3' HD22 ' A' ' 228' ' ' LEU . 52.1 Cg_exo -53.34 142.7 56.59 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.952 2.435 . . . . 0.52000000000000002 112.06 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.5 m -45.1 -49.96 11.39 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.678 0.612 . . . . 1.1000000000000001 111.735 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 99.2 m-85 -133.36 128.37 35.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.52000000000000002 109.892 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 220' ' ' PHE . 55.6 tp -134.06 127.49 32.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.882 0.372 . . . . 0.28000000000000003 110.804 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 221' ' ' ILE . 79.2 t -124.23 131.86 72.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.931 -0.577 . . . . 0.29999999999999999 109.522 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.9 p -97.06 137.46 36.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.084 -0.507 . . . . 0.48999999999999999 112.044 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.43 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 86.7 mttt -86.99 145.5 38.52 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.78000000000000003 110.519 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 6.5 Cg_exo -71.99 143.34 76.7 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.209 -1.58 . . . . 0.76000000000000001 111.522 -1.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.405 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 26.8 p90 -106.54 158.62 16.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.078 0.466 . . . . 0.45000000000000001 111.421 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.558 ' O ' HG23 ' A' ' 249' ' ' VAL . 54.8 mt-30 -100.37 138.51 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.69 -0.686 . . . . 2.1400000000000001 109.342 173.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 38.0 mt-10 -57.25 -37.24 72.01 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.062 0.226 . . . . 1.6599999999999999 111.117 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 26.9 t -60.77 -48.11 83.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.809 0.337 . . . . 1.3400000000000001 110.533 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 62.5 m -59.59 -44.74 93.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.257 -0.429 . . . . 0.25 110.812 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 245' ' ' GLN . 53.5 t -61.21 -54.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.19 110.698 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 61.8 mtt180 -52.57 -45.79 66.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 2.6899999999999999 110.273 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 34.4 m -55.74 -47.31 77.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.904 -1.043 . . . . 0.27000000000000002 111.475 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 25.9 m -67.66 -41.13 84.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.20000000000000001 111.521 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.413 HG13 HD21 ' A' ' 190' ' ' LEU . 1.8 mp -58.43 -48.97 83.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.354 . . . . 0.23000000000000001 110.664 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 27.1 p -67.23 -29.59 69.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.395 -0.366 . . . . 1.1699999999999999 111.921 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.3 pt20 -79.57 -44.05 21.82 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.22 0.533 . . . . 2.3399999999999999 110.267 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -55.28 -39.3 69.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.1 -0.955 . . . . 0.35999999999999999 110.895 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 190' ' ' LEU . 83.2 mt -86.72 -14.85 41.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.9 -0.591 . . . . 1.02 111.06 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.8 -52.38 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.035 0.445 . . . . 1.3799999999999999 109.87 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -78.5 1.26 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.692 . . . . 5.3700000000000001 111.173 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 261' ' ' ASN . 7.7 tt0 -65.64 -53.46 41.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.25 110.55 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 260' ' ' GLN . 17.6 m120 -137.13 171.95 13.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.776 -0.647 . . . . 6.4000000000000004 110.017 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 263' ' ' PRO . 5.7 t -140.73 132.89 14.22 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.599 -0.519 . . . . 7.9199999999999999 109.599 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 262' ' ' SER . 30.6 Cg_exo -62.01 106.58 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.827 2.351 . . . . 8.9900000000000002 112.296 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 49.9 m -78.99 -34.87 43.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.142 -0.481 . . . . 10.84 110.569 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.78 73.61 4.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.873 -0.603 . . . . 11.789999999999999 110.526 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.721 -0.672 . . . . 13.24 111.007 -179.299 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.812 -0.515 . . . . 7.6699999999999999 111.812 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.99 -171.34 0.15 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.884 0.474 . . . . 6.2300000000000004 111.319 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 mmt 59.81 86.46 0.09 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.848 -0.614 . . . . 7.4500000000000002 111.04 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -118.85 0.3 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.495 -0.775 . . . . 2.8100000000000001 112.197 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 4.8 p -81.62 92.07 6.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.543 0.687 . . . . 1.3 110.952 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -79.71 122.89 27.13 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.461 -0.79 . . . . 0.51000000000000001 109.411 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 19.8 p-10 -75.29 133.49 41.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.924 0.393 . . . . 0.23000000000000001 110.387 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.2 t -115.99 135.23 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.104 0.478 . . . . 0.23999999999999999 111.687 -174.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.49 113.29 25.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.54 -0.755 . . . . 0.16 110.229 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.2 mt -101.47 103.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.328 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 40.5 mt -95.79 99.39 9.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.679 -0.691 . . . . 0.16 109.262 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.95 121.72 6.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.516 -0.766 . . . . 0.5 109.283 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -71.23 -29.94 65.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.813 -0.631 . . . . 1.04 111.68 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.91 107.71 12.59 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.084 0.469 . . . . 1.29 111.093 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 17.6 Cg_exo -62.55 -36.7 63.37 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.316 2.677 . . . . 0.58999999999999997 112.816 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.24 -46.51 88.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.70999999999999996 110.257 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 242' ' ' LYS . 50.2 mt -65.4 -37.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.46000000000000002 110.18 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 31.5 m -56.48 -53.99 50.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 1.29 110.603 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.94 -28.68 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 2.3500000000000001 111.113 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -62.1 -48.43 80.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.429 0.633 . . . . 1.3100000000000001 109.56 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.5 mt -62.91 -39.06 93.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.055 -0.975 . . . . 0.23999999999999999 110.883 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -55.38 -56.71 16.97 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.276 0.36 . . . . 0.67000000000000004 110.766 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.25 -42.52 99.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.145 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.91 -52.11 66.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.639 -0.709 . . . . 1.4199999999999999 111.326 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 145' ' ' VAL . 4.3 p -71.87 -30.6 37.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.092 0.472 . . . . 0.28999999999999998 110.828 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 163' ' ' ARG . 44.9 ttm180 -68.89 -35.15 76.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 3.25 110.48 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.4 t -59.6 -34.5 72.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.608 -0.724 . . . . 1.1599999999999999 110.131 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 250' ' ' ARG . 77.9 mt -71.57 -9.93 58.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 0.40000000000000002 111.407 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 94.68 25.88 14.42 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.953 -0.641 . . . . 0.32000000000000001 112.25 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.7 m-70 -109.47 173.06 6.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.63 0.252 . . . . 0.5 110.585 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -119.17 174.77 6.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 1.1899999999999999 110.296 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 159' ' ' GLU . 40.4 mm -110.83 118.54 57.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.23000000000000001 109.865 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.56 ' HA ' ' OE2' ' A' ' 186' ' ' GLU . . . -85.25 -19.59 31.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.895 -0.593 . . . . 0.23999999999999999 110.203 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.14 148.94 5.45 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.722 -0.672 . . . . 0.17000000000000001 112.113 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.63 135.52 50.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.741 -0.466 . . . . 0.34999999999999998 109.741 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.8 123.94 12.89 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.462 -0.336 . . . . 0.28999999999999998 111.237 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -91.9 -5.09 53.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.528 -0.306 . . . . 0.28999999999999998 111.314 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 199' ' ' ASP . 82.1 p -132.8 165.82 23.68 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.102 -0.239 . . . . 0.32000000000000001 111.173 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 74.6 ttt180 -66.67 -44.76 80.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.983 -0.377 . . . . 0.90000000000000002 109.983 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -60.47 -46.17 91.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.24 -0.436 . . . . 0.40000000000000002 111.086 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.33 -35.13 74.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 110.697 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.22 82.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.514 . . . . 0.25 110.527 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 85.1 mt-30 -61.28 -34.94 76.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.98999999999999999 110.823 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.72 -42.26 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.626 . . . . 2.2400000000000002 111.48 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.47 90.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.009 -0.541 . . . . 0.40000000000000002 110.924 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.444 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.5 p -75.59 -23.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.52 0.676 . . . . 1.3300000000000001 110.011 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.98 -26.4 63.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.077 -0.965 . . . . 0.44 110.091 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -83.81 -52.78 6.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.206 -0.906 . . . . 2.02 110.804 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 36.9 tt0 -133.53 137.11 45.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.007 -0.542 . . . . 0.63 110.261 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.425 ' HE3' ' CD1' ' A' ' 214' ' ' PHE . 2.9 ttmp? -91.16 110.83 45.13 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.02 -0.536 . . . . 1.6200000000000001 110.367 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.3 Cg_endo -76.5 154.32 35.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.386 2.724 . . . . 0.26000000000000001 112.409 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -97.71 -9.08 55.24 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.363 -0.695 . . . . 0.23999999999999999 111.363 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 34.8 tp -150.11 144.23 25.59 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.223 -0.658 . . . . 0.65000000000000002 109.223 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 218' ' ' VAL . 70.6 t -121.63 143.47 33.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.995 0.426 . . . . 0.20000000000000001 110.703 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -128.83 133.99 48.18 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.466 -1.309 . . . . 1.47 107.466 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.505 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -151.67 147.94 27.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.643 0.609 . . . . 0.17999999999999999 112.643 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.9 t70 -100.72 -178.63 3.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.39 -0.967 . . . . 0.38 108.39 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.502 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -86.61 -50.43 14.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.004 0.43 . . . . 0.23000000000000001 110.041 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.23 121.19 31.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.476 -0.784 . . . . 2.2799999999999998 110.571 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.7 mt -108.17 171.83 7.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.954 -0.298 . . . . 0.27000000000000002 110.676 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.26 96.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.071 0.462 . . . . 0.45000000000000001 111.627 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -72.51 -12.07 60.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.777 -0.647 . . . . 0.94999999999999996 111.051 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.14 10.44 61.04 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.726 -0.749 . . . . 0.35999999999999999 111.367 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.6 p -85.75 162.11 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.381 -0.409 . . . . 0.33000000000000002 110.099 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 21.9 m -91.77 124.99 36.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.183 0.516 . . . . 1.21 110.504 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.36 -29.05 62.74 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.161 -0.927 . . . . 0.14999999999999999 112.55 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 195' ' ' ILE . 42.2 mt -62.03 -45.96 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.951 0.405 . . . . 0.20999999999999999 110.433 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.32 -39.89 94.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.713 -0.676 . . . . 1.73 110.518 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.79 -41.71 91.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.761 -0.654 . . . . 0.17000000000000001 110.35 177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 218' ' ' VAL . 47.8 t -63.01 -45.93 97.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.326 -0.852 . . . . 0.20999999999999999 110.954 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.01 -32.09 70.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.57999999999999996 111.593 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 75.2 m-20 -59.6 -50.81 72.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.233 0.54 . . . . 1.72 109.698 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.7 -43.45 87.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.23999999999999999 110.743 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.59 -12.87 61.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.517 -0.765 . . . . 0.71999999999999997 111.644 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.2 -8.41 71.77 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.086 -0.806 . . . . 0.31 111.086 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 49.8 mt-30 -106.3 -56.49 2.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.473 0.654 . . . . 0.85999999999999999 109.369 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.444 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -125.77 179.81 5.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.177 -0.919 . . . . 0.39000000000000001 110.491 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.2 59.32 1.09 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.187 0.994 . . . . 1.98 108.853 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -95.35 149.52 36.28 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.351 -1.295 . . . . 0.25 110.012 -176.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.5 ' HG3' HE22 ' A' ' 260' ' ' GLN . 55.8 Cg_endo -66.01 138.26 51.73 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.525 2.15 . . . . 0.28000000000000003 112.037 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG11 HG11 ' A' ' 207' ' ' VAL . 42.0 t -124.69 133.16 70.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.13 -0.486 . . . . 0.63 110.535 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.46 124.75 72.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.072 -0.513 . . . . 0.19 109.854 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.8 111.62 23.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.238 -0.437 . . . . 0.34999999999999998 110.302 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 11.7 mt -111.72 107.67 23.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.726 -0.842 . . . . 0.67000000000000004 108.726 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 241' ' ' THR . 10.2 t -150.9 164.76 35.55 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.7 -0.4 . . . . 0.25 111.084 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.71 5.51 51.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.41999999999999998 110.726 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.13 74.28 49.18 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.69999999999999996 111.359 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.24 -33.75 47.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.622 2.215 . . . . 0.35999999999999999 112.324 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -68.09 -18.15 64.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.022 -0.535 . . . . 0.93999999999999995 111.665 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.1 tmt_? -75.13 -23.73 57.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.581 0.705 . . . . 2.0499999999999998 109.492 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.41 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 34.3 mt -98.28 -42.73 7.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.157 -0.929 . . . . 0.52000000000000002 111.324 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.4 mt -87.45 73.41 9.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.683 -0.69 . . . . 1.26 109.759 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 8.4 p -103.76 -3.68 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.531 -0.758 . . . . 2.1000000000000001 111.857 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 86.45 -68.96 3.21 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.753 -0.737 . . . . 3.4300000000000002 113.225 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.05 -19.5 57.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 5.2199999999999998 111.272 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.686 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 27.9 mmt180 -94.58 179.47 1.2 Allowed Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.552 -0.536 . . . . 7.0999999999999996 109.552 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.686 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.2 Cg_exo -71.4 142.88 41.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.686 2.257 . . . . 2.52 111.386 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.6 140.56 21.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 109.002 -0.74 . . . . 1.9299999999999999 109.002 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 40.5 Cg_endo -67.24 127.34 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.428 2.085 . . . . 0.52000000000000002 111.47 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.6 m -66.83 -31.26 71.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.664 -0.698 . . . . 1.1000000000000001 110.079 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -131.23 111.35 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.52000000000000002 109.977 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 57.3 tp -132.32 121.96 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.252 0.549 . . . . 0.28000000000000003 111.186 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 91.8 t -123.76 137.73 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.13 -0.941 . . . . 0.29999999999999999 108.684 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.8 p -110.53 141.69 43.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.912 0.387 . . . . 0.48999999999999999 112.032 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 154' ' ' ILE . 7.4 mptt -72.63 138.11 80.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.78000000000000003 109.693 173.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.73 135.42 39.83 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.788 -1.338 . . . . 0.76000000000000001 111.394 -2.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -100.12 158.16 16.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.45000000000000001 111.157 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.88 130.52 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.659 . . . . 2.1400000000000001 109.389 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 32.2 mt-10 -56.56 -33.9 66.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.326 -0.852 . . . . 1.6599999999999999 111.936 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 p -63.41 -49.83 72.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.083 0.468 . . . . 1.3400000000000001 110.521 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 59.0 m -58.27 -40.37 81.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.25 111.021 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 63.1 t -59.99 -57.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.588 -0.278 . . . . 0.19 110.377 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 165' ' ' LEU . 21.8 mtm180 -52.74 -43.7 65.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 2.6899999999999999 110.732 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 98.8 m -54.1 -50.61 66.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.25 -0.886 . . . . 0.27000000000000002 110.741 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.3 m -63.0 -42.31 99.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.20000000000000001 111.766 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.94 -45.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.146 0.498 . . . . 0.23000000000000001 110.435 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -27.36 67.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.568 -0.742 . . . . 1.1699999999999999 111.031 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.724 ' HG2' ' O ' ' A' ' 251' ' ' THR . 9.0 mm-40 -76.66 -49.2 16.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.243 0.544 . . . . 2.3399999999999999 110.164 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -59.08 -30.37 68.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.144 -0.934 . . . . 0.35999999999999999 111.636 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.21 3.63 54.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 1.02 111.328 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -79.38 -31.65 42.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.399 0.618 . . . . 1.3799999999999999 109.438 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -111.34 96.8 6.33 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.914 0.864 . . . . 5.3700000000000001 108.977 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.5 HE22 ' HG3' ' A' ' 217' ' ' PRO . 27.8 mm-40 -106.74 92.7 4.21 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.456 -1.247 . . . . 5.25 110.949 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -73.67 -39.46 64.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.938 -0.764 . . . . 6.4000000000000004 108.938 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.6 t -121.11 80.06 34.9 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.174 -0.921 . . . . 7.9199999999999999 109.252 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.25 147.36 65.99 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.642 2.228 . . . . 8.9900000000000002 112.356 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 23.8 p -66.74 128.49 36.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 10.84 110.893 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -66.55 119.46 11.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.791 0.329 . . . . 11.789999999999999 110.479 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.344 -0.836 . . . . 13.24 110.656 -177.457 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.247 -0.341 . . . . 7.6699999999999999 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.25 143.34 35.38 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.926 -0.161 . . . . 6.2300000000000004 110.899 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.3 mtt 57.86 45.76 17.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.164 -0.471 . . . . 7.4500000000000002 110.922 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -130.05 169.41 21.05 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.682 -0.771 . . . . 2.8100000000000001 111.686 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 1.5 m -81.57 143.95 31.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.996 -0.372 . . . . 1.3 109.996 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m -77.82 107.46 10.34 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.826 -0.435 . . . . 0.51000000000000001 109.826 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.1 p-10 -70.68 134.84 47.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.955 0.407 . . . . 0.23000000000000001 110.152 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 162' ' ' VAL . 87.5 t -119.6 136.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.995 0.426 . . . . 0.23999999999999999 111.67 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.82 116.13 28.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.789 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.39 107.51 22.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.011 0.434 . . . . 0.23000000000000001 111.002 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 36.2 mt -95.38 101.99 13.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.793 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -153.95 125.02 7.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.299 -0.864 . . . . 0.5 108.817 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.71 -34.42 64.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.818 -0.628 . . . . 1.04 111.59 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -80.19 108.5 9.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.893 0.378 . . . . 1.29 110.878 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.94 -37.68 75.04 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.455 2.77 . . . . 0.58999999999999997 112.619 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 79.2 mt -57.79 -44.44 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.70999999999999996 110.257 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.59 -31.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.766 -0.652 . . . . 0.46000000000000002 110.451 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 18.9 m -59.85 -56.11 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.508 -0.315 . . . . 1.29 110.247 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.4 mtt -69.38 -27.6 65.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 2.3500000000000001 110.48 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 19.5 tm0? -55.88 -59.69 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.042 -0.725 . . . . 1.3100000000000001 109.042 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.21 -40.15 73.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.344 -1.298 . . . . 0.23999999999999999 111.44 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 155' ' ' SER . 47.3 mt-10 -55.93 -57.58 11.49 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.85 0.357 . . . . 0.67000000000000004 110.603 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.62 -41.85 86.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.54000000000000004 110.754 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -55.04 39.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.4199999999999999 111.331 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.504 HG21 HG21 ' A' ' 145' ' ' VAL . 5.2 p -70.67 -26.73 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.55 0.69 . . . . 0.28999999999999998 110.626 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -66.41 -39.2 88.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.135 -0.939 . . . . 3.25 110.459 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 78.4 p -64.85 -22.48 67.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.244 0.545 . . . . 1.1599999999999999 110.501 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.9 mt -81.51 1.59 32.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.617 -0.719 . . . . 0.40000000000000002 111.438 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.2 17.4 62.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.673 -0.775 . . . . 0.32000000000000001 112.152 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.9 m-70 -102.52 176.54 5.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.219 -0.66 . . . . 0.5 109.219 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 142' ' ' SER . 1.4 t70 -124.86 178.24 5.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.199 -0.297 . . . . 1.1899999999999999 110.199 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mm -114.59 116.84 53.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 109.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -83.56 -27.83 29.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.914 -0.585 . . . . 0.23999999999999999 109.869 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.93 158.27 13.55 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.636 -0.792 . . . . 0.17000000000000001 112.14 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.25 131.39 54.91 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.97 0.414 . . . . 0.34999999999999998 109.982 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -135.92 128.5 30.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.539 . . . . 0.28999999999999998 111.062 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.34 -3.76 39.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.724 0.297 . . . . 0.28999999999999998 111.182 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 199' ' ' ASP . 48.1 p -135.45 165.58 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.616 0.246 . . . . 0.32000000000000001 111.254 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 78.4 ttt180 -65.73 -42.8 90.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.133 0.492 . . . . 0.90000000000000002 109.987 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.8 m -63.3 -39.62 95.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.649 -0.705 . . . . 0.40000000000000002 111.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 181' ' ' GLU . 26.6 mt-30 -62.55 -31.85 72.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.447 -0.342 . . . . 1.1899999999999999 111.261 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.14 81.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 0.25 110.66 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.447 HE21 ' HG2' ' A' ' 176' ' ' ARG . 77.4 mt-30 -59.87 -50.45 73.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.49 -0.777 . . . . 0.98999999999999999 112.214 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 182' ' ' ALA . 6.9 pt-20 -63.72 -43.99 94.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.155 0.503 . . . . 2.2400000000000002 110.927 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 181' ' ' GLU . . . -50.23 -54.76 18.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.823 -1.08 . . . . 0.40000000000000002 111.949 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 12.1 m -69.72 -28.57 37.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.819 0.342 . . . . 1.3300000000000001 111.883 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.61 70.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.047 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -84.47 -54.6 4.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.583 -0.735 . . . . 2.02 110.255 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 31.8 tt0 -141.27 134.62 29.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.844 -0.616 . . . . 0.63 110.639 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.82 122.63 67.78 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.806 -0.634 . . . . 1.6200000000000001 110.736 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' HG21 ' A' ' 216' ' ' VAL . 70.1 Cg_endo -74.37 158.01 44.93 Favored 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 123.168 2.578 . . . . 0.26000000000000001 112.164 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.86 -0.73 61.99 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.22 -0.752 . . . . 0.23999999999999999 111.22 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HB3' HG22 ' A' ' 145' ' ' VAL . 15.0 tp -163.42 144.4 9.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.644 -0.873 . . . . 0.65000000000000002 108.644 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 216' ' ' VAL . 54.0 t -122.99 140.95 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.494 . . . . 0.20000000000000001 111.5 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.481 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.4 mm? -119.37 144.0 47.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.592 -0.892 . . . . 1.47 108.592 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -159.46 147.0 17.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.472 0.545 . . . . 0.17999999999999999 112.472 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 12.4 t70 -101.41 178.77 4.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.211 -1.033 . . . . 0.38 108.211 169.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 202' ' ' SER . 11.8 mm -86.93 -43.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 121.964 -0.46 . . . . 0.23000000000000001 110.014 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -88.41 117.9 27.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 2.2799999999999998 110.726 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.538 HD11 ' HA2' ' A' ' 203' ' ' GLY . 53.8 mt -109.63 164.43 12.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.352 -0.385 . . . . 0.27000000000000002 110.668 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.47 82.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.96 0.409 . . . . 0.45000000000000001 111.931 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 175' ' ' THR . 27.3 t70 -66.17 -24.47 66.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.785 -0.643 . . . . 0.94999999999999996 111.155 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.78 3.29 34.51 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.093 -0.803 . . . . 0.35999999999999999 111.093 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.2 p -84.78 161.48 19.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.745 0.307 . . . . 0.33000000000000002 110.448 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 46.6 t -87.11 129.88 34.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.164 0.507 . . . . 1.21 110.188 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.91 -25.86 64.6 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.258 -0.883 . . . . 0.14999999999999999 111.912 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.543 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 67.1 mt -62.13 -47.45 93.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.014 0.435 . . . . 0.20999999999999999 110.082 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 3.7 m-20 -60.56 -41.39 94.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.59 -0.732 . . . . 1.73 110.725 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.527 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.89 -41.51 91.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.407 0.622 . . . . 0.17000000000000001 110.354 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 218' ' ' VAL . 38.5 t -64.72 -45.81 94.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.169 -0.923 . . . . 0.20999999999999999 110.976 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 52.9 mt-10 -59.03 -34.24 71.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.57999999999999996 111.143 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -58.25 -48.99 78.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.323 0.583 . . . . 1.72 109.837 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.23999999999999999 110.757 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.0 mt -69.23 -12.91 62.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.71999999999999997 112.078 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -82.84 -4.2 90.15 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.166 -0.774 . . . . 0.31 111.166 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -121.1 -52.85 2.06 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.193 0.52 . . . . 0.85999999999999999 110.369 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.3 172.23 7.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.614 -0.721 . . . . 0.39000000000000001 111.354 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -120.83 56.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.162 0.982 . . . . 1.98 108.835 172.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.519 ' CG1' HG23 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -95.65 156.42 37.45 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.726 -1.124 . . . . 0.25 109.609 -177.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' HD2' HG13 ' A' ' 216' ' ' VAL . 45.7 Cg_endo -80.52 137.09 11.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.325 2.016 . . . . 0.28000000000000003 111.491 -173.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 207' ' ' VAL . 35.9 t -122.66 131.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.972 0.415 . . . . 0.63 111.018 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.481 ' HB ' HD13 ' A' ' 192' ' ' LEU . 71.8 mt -115.7 123.61 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.679 -0.692 . . . . 0.19 110.077 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -97.12 108.33 21.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.324 -0.398 . . . . 0.34999999999999998 110.75 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 240' ' ' VAL . 9.6 mt -105.88 108.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.915 -0.772 . . . . 0.67000000000000004 108.915 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 242' ' ' LYS . 9.0 t -154.15 162.75 40.98 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.552 -0.459 . . . . 0.25 111.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.0 6.44 46.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.584 . . . . 0.41999999999999998 110.63 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -122.25 76.71 42.92 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 0.69999999999999996 111.038 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.546 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 33.5 Cg_endo -64.76 -43.36 12.83 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.303 2.002 . . . . 0.35999999999999999 112.176 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.94 -28.54 66.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 0.93999999999999995 111.244 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.447 ' HG2' HG13 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -60.83 -38.39 85.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 2.0499999999999998 110.338 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -87.31 0.24 55.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.82 -0.627 . . . . 0.52000000000000002 111.528 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 37.3 mt -108.47 7.2 26.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.105 -0.498 . . . . 1.26 110.746 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.2 t 179.98 124.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.857 -0.61 . . . . 2.1000000000000001 111.187 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.62 12.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.932 -0.651 . . . . 3.4300000000000002 113.109 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.04 85.7 1.02 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.342 0.591 . . . . 5.2199999999999998 111.718 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.734 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 31.3 mmm180 65.06 -175.6 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.194 -0.912 . . . . 7.0999999999999996 112.039 169.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.734 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 40.7 Cg_exo -61.15 166.75 10.29 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.143 2.562 . . . . 2.52 113.012 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 139.64 97.28 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.323 -0.853 . . . . 1.9299999999999999 110.412 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.66 146.65 43.83 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.934 2.423 . . . . 0.52000000000000002 111.693 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.7 m -75.53 -27.48 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 1.1000000000000001 110.425 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 256' ' ' ALA . 50.1 m-85 -125.88 105.42 8.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.913 -0.585 . . . . 0.52000000000000002 110.521 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.08 115.64 13.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.288 -0.869 . . . . 0.28000000000000003 110.396 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.4 t -113.52 123.14 68.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.679 -0.691 . . . . 0.29999999999999999 109.639 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 222' ' ' THR . 4.3 p -90.21 135.23 33.8 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.697 -0.683 . . . . 0.48999999999999999 111.821 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 61.3 mttt -86.31 142.42 35.56 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.61 -0.723 . . . . 0.78000000000000003 110.584 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 30.0 Cg_endo -65.56 132.35 15.47 Favored 'Cis proline' 0 N--CA 1.463 -0.318 0 C-N-CA 123.607 -1.414 . . . . 0.76000000000000001 112.147 -1.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.405 ' N ' ' HA ' ' A' ' 242' ' ' LYS . 19.9 p90 -91.65 156.2 17.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.157 -0.474 . . . . 0.45000000000000001 111.346 -175.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.6 mt-30 -99.85 126.52 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.98 -0.748 . . . . 2.1400000000000001 108.98 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.02 -37.34 66.51 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.567 0.542 . . . . 1.6599999999999999 111.457 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.1 m -63.09 -49.88 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 1.3400000000000001 110.253 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 95.6 m -56.82 -43.28 80.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.999 -0.546 . . . . 0.25 110.897 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 57.9 t -58.65 -55.49 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.278 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -52.89 -45.96 67.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 2.6899999999999999 110.841 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.7 m -55.48 -38.92 69.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.202 -0.908 . . . . 0.27000000000000002 111.439 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 22.1 m -74.95 -41.11 60.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.333 -0.394 . . . . 0.20000000000000001 111.27 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.46 -48.15 88.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.282 . . . . 0.23000000000000001 110.927 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 p -70.69 -28.2 64.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.463 -0.335 . . . . 1.1699999999999999 111.818 -174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 25.3 pt20 -77.53 -42.07 36.84 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.374 0.607 . . . . 2.3399999999999999 110.29 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . . . -55.55 -39.1 70.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.871 -1.059 . . . . 0.35999999999999999 110.728 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 95.4 mt -95.65 14.87 21.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.422 -0.808 . . . . 1.02 111.344 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -94.89 -70.43 0.71 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.405 -0.361 . . . . 1.3799999999999999 110.297 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -158.47 31.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 5.3700000000000001 110.741 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.488 ' HA ' ' OH ' ' A' ' 238' ' ' TYR . 18.9 mp0 63.53 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.347 0.404 . . . . 5.25 111.64 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -80.83 68.37 7.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.473 0.654 . . . . 6.4000000000000004 110.202 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.505 ' N ' ' HD2' ' A' ' 263' ' ' PRO . 26.7 t -76.15 -48.79 3.34 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.633 -0.712 . . . . 7.9199999999999999 111.231 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 262' ' ' SER . 37.6 Cg_endo -66.18 83.74 0.27 Allowed 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.839 1.692 . . . . 8.9900000000000002 111.697 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.7 m -87.85 -34.14 18.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.684 -0.689 . . . . 10.84 110.28 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -112.75 86.52 2.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.807 -0.633 . . . . 11.789999999999999 109.937 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.7 -0.667 . . . . 13.24 110.349 -179.352 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.86 -0.496 . . . . 7.6699999999999999 111.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.59 66.01 9.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.526 . . . . 6.2300000000000004 110.496 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.9 ttt -70.61 -39.72 73.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 7.4500000000000002 111.112 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.97 -129.31 1.32 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.698 -0.763 . . . . 2.8100000000000001 112.07 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 p -75.45 126.91 31.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.108 0.48 . . . . 1.3 110.561 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -77.11 110.44 11.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.092 -0.504 . . . . 0.51000000000000001 110.178 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.2 p-10 -68.25 135.34 51.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.018 -0.537 . . . . 0.23000000000000001 110.052 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 190' ' ' LEU . 97.8 t -122.43 138.58 52.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.971 0.415 . . . . 0.23999999999999999 111.77 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.1 tp -95.04 121.96 37.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.16 110.162 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.24 101.51 12.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.23000000000000001 111.015 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -91.6 99.58 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.176 -0.675 . . . . 0.16 109.176 174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -155.7 122.44 5.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.659 -0.701 . . . . 0.5 109.757 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 7.8 t70 -78.37 -32.58 49.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.927 -0.579 . . . . 1.04 110.807 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 45.9 mt-10 -69.97 108.77 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.149 0.5 . . . . 1.29 111.149 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 25.9 Cg_exo -60.92 -43.85 28.4 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.708 2.938 . . . . 0.58999999999999997 113.144 -173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.2 mt -65.65 -37.07 85.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.70999999999999996 110.239 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.3 mt -75.65 -42.12 41.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.496 -0.774 . . . . 0.46000000000000002 111.169 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.2 t -55.82 -53.04 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.698 -0.228 . . . . 1.29 110.487 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.441 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 66.1 mtt -66.88 -29.03 68.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 2.3500000000000001 110.975 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -64.21 -48.2 76.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.524 -0.547 . . . . 1.3100000000000001 109.524 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 91.8 mt -62.06 -37.28 84.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.245 -0.889 . . . . 0.23999999999999999 110.985 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.6 mt-10 -58.81 -49.13 78.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.06 0.457 . . . . 0.67000000000000004 110.508 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.07 -40.12 82.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 110.467 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.97 -54.0 47.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.4199999999999999 111.611 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 167' ' ' HIS . 3.6 p -66.22 -28.26 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.966 -0.561 . . . . 0.28999999999999998 110.906 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 163' ' ' ARG . 28.4 ttm180 -66.82 -43.21 84.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.489 -0.778 . . . . 3.25 110.03 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.8 m -65.52 -23.99 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 1.1599999999999999 111.002 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 63.1 mt -79.56 5.1 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.40000000000000002 111.486 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.92 20.06 66.2 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.809 -0.71 . . . . 0.32000000000000001 112.104 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 93.5 m-70 -112.56 177.92 4.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.527 -0.546 . . . . 0.5 109.527 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.99 -175.93 3.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.423 -172.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.34 122.01 66.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.23000000000000001 110.511 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -92.61 -20.64 20.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.312 0.577 . . . . 0.23999999999999999 109.862 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.51 160.07 11.23 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.6 -0.727 . . . . 0.17000000000000001 112.056 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.05 54.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.934 -0.395 . . . . 0.34999999999999998 109.934 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.96 119.33 12.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.091 -0.504 . . . . 0.28999999999999998 111.262 -174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -90.76 -0.17 57.63 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.016 0.436 . . . . 0.28999999999999998 110.566 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 199' ' ' ASP . 40.5 p -136.22 164.96 26.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.012 -0.54 . . . . 0.32000000000000001 110.551 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 74.6 ttt180 -72.49 -37.28 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 110.755 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -65.75 -42.57 90.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.331 -0.395 . . . . 0.40000000000000002 110.74 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -64.35 -31.45 72.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.408 -0.36 . . . . 1.1899999999999999 110.686 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -62.24 -46.51 88.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.013 0.435 . . . . 0.25 110.234 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.2 -38.8 92.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.594 -0.73 . . . . 0.98999999999999999 110.974 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -67.57 -39.31 84.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.044 -0.526 . . . . 2.2400000000000002 111.681 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.61 -52.64 64.8 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.086 -0.506 . . . . 0.40000000000000002 110.938 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 11.1 m -71.36 -29.18 34.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 111.539 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.81 -29.62 69.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.125 0.488 . . . . 0.44 110.436 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.87 -50.51 6.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.728 -0.669 . . . . 2.02 111.178 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.8 tt0 -144.89 138.12 26.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.814 -0.63 . . . . 0.63 111.154 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -86.18 120.72 72.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.752 -0.658 . . . . 1.6200000000000001 110.34 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.606 ' O ' HG21 ' A' ' 216' ' ' VAL . 71.6 Cg_endo -82.09 150.39 15.79 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.155 2.57 . . . . 0.26000000000000001 111.503 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.53 -8.4 80.63 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.501 -0.64 . . . . 0.23999999999999999 111.501 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.649 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -154.36 146.24 23.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.756 -0.461 . . . . 0.65000000000000002 109.756 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 218' ' ' VAL . 64.5 t -126.16 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.976 0.417 . . . . 0.20000000000000001 111.34 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.6 mm? -115.98 145.11 43.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.54 -0.911 . . . . 1.47 108.54 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -156.38 144.92 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.719 0.637 . . . . 0.17999999999999999 112.719 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 26.7 t70 -102.63 176.08 5.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.062 -0.972 . . . . 0.38 108.423 170.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.496 HD12 HD11 ' A' ' 204' ' ' ILE . 29.3 mm -85.44 -51.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 118.498 0.59 . . . . 0.23000000000000001 110.857 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -96.94 100.64 12.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 2.2799999999999998 110.865 -171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.423 HD11 ' HA2' ' A' ' 203' ' ' GLY . 64.4 mt -85.01 171.16 12.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 111.167 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.419 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -60.37 -46.03 91.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 111.686 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 175' ' ' THR . 29.7 t70 -68.48 -14.86 63.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.923 -0.58 . . . . 0.94999999999999996 111.128 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.74 57.86 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.709 -0.758 . . . . 0.35999999999999999 111.298 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 157.73 23.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 110.15 -0.315 . . . . 0.33000000000000002 110.15 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 129.71 34.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.196 0.522 . . . . 1.21 110.313 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.49 -25.94 65.81 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.09 -0.959 . . . . 0.14999999999999999 111.9 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 195' ' ' ILE . 55.8 mt -65.59 -43.37 94.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.868 0.366 . . . . 0.20999999999999999 110.18 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.35 -40.08 96.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.738 -0.665 . . . . 1.73 110.3 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 209' ' ' ASP . . . -61.46 -41.96 98.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.17000000000000001 110.594 177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.414 HG13 HG21 ' A' ' 218' ' ' VAL . 37.2 t -62.33 -47.52 92.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.54 -0.755 . . . . 0.20999999999999999 111.256 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -60.29 -30.68 69.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.97 -0.559 . . . . 0.57999999999999996 111.345 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 89.1 m-20 -58.95 -50.25 74.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.493 0.663 . . . . 1.72 109.836 173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.03 -43.93 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.23999999999999999 110.702 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.37 -18.92 65.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.984 -0.553 . . . . 0.71999999999999997 112.108 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.69 -6.8 89.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.584 -0.817 . . . . 0.31 111.371 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.8 mt-30 -116.28 -50.46 2.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.382 0.61 . . . . 0.85999999999999999 110.305 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.9 179.91 3.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.968 . . . . 0.39000000000000001 110.819 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -125.98 46.5 2.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 1.98 109.389 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.0 OUTLIER -96.72 148.43 34.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.315 -0.857 . . . . 0.25 110.97 -170.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.598 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 30.3 Cg_endo -63.61 137.6 60.13 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.002 2.468 . . . . 0.28000000000000003 112.41 -176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 191' ' ' VAL . 45.2 t -126.3 130.87 71.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.173 -0.467 . . . . 0.63 110.624 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 192' ' ' LEU . 79.6 mt -117.45 125.26 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.682 -0.69 . . . . 0.19 109.734 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.99 121.14 36.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.27 -0.423 . . . . 0.34999999999999998 110.426 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 9.3 mt -117.32 112.32 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.13 -0.692 . . . . 0.67000000000000004 109.13 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.8 t -158.67 162.12 37.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.1 0.476 . . . . 0.25 110.959 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.49 4.9 52.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.593 . . . . 0.41999999999999998 110.37 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -122.9 75.68 48.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.69999999999999996 110.535 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.45 -41.55 19.89 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.499 2.133 . . . . 0.35999999999999999 112.803 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.3 -23.1 63.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.406 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 2.3 tmt_? -64.91 -22.93 67.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 2.0499999999999998 110.001 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 28.0 mt -99.12 -29.24 12.98 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.004 0.742 . . . . 0.52000000000000002 113.004 -176.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.451 ' HG ' ' HG2' ' A' ' 235' ' ' GLU . 10.0 mp -72.33 -3.56 24.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.427 0.529 . . . . 1.26 112.427 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.0 t -164.56 134.55 3.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.673 -0.492 . . . . 2.1000000000000001 109.673 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 161.26 -30.84 0.33 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.717 -0.754 . . . . 3.4300000000000002 112.704 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -162.24 -73.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.315 0.579 . . . . 5.2199999999999998 111.297 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HB2' ' CD ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -110.73 -177.43 0.46 Allowed Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.284 -0.871 . . . . 7.0999999999999996 109.958 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.628 ' CD ' ' HB2' ' A' ' 233' ' ' ARG . 52.2 Cg_exo -59.02 175.19 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.462 2.108 . . . . 2.52 113.768 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HG2' ' HG ' ' A' ' 229' ' ' LEU . 38.5 mt-10 -53.34 149.78 13.27 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.991 -1.004 . . . . 1.9299999999999999 111.851 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 60.1 Cg_endo -71.07 154.45 62.46 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.776 2.317 . . . . 0.52000000000000002 111.509 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.2 m -66.01 -37.77 86.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.594 -0.73 . . . . 1.1000000000000001 111.516 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.82 129.04 33.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.409 -0.359 . . . . 0.52000000000000002 110.328 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 tp -142.6 123.58 14.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.217 0.532 . . . . 0.28000000000000003 111.147 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.17 119.21 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.29999999999999999 109.75 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 222' ' ' THR . 12.0 p -86.19 138.65 31.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.977 -0.556 . . . . 0.48999999999999999 112.108 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.451 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 82.4 mttt -90.99 143.21 28.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.78000000000000003 110.971 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 42.6 Cg_endo -70.26 145.09 79.62 Favored 'Cis proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.204 -1.582 . . . . 0.76000000000000001 111.646 -1.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.428 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 29.9 p90 -107.91 160.17 15.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.149 0.5 . . . . 0.45000000000000001 111.443 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 249' ' ' VAL . 49.0 mt-30 -101.0 135.79 41.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.514 -0.767 . . . . 2.1400000000000001 109.694 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -56.13 -37.16 69.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 1.6599999999999999 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.9 p -61.46 -51.74 67.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 1.3400000000000001 110.623 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 93.8 m -55.57 -43.66 76.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.25 111.079 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 245' ' ' GLN . 59.3 t -59.65 -57.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.19 110.679 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 22.2 mtm180 -54.19 -39.72 66.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.302 0.572 . . . . 2.6899999999999999 110.666 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.634 ' O ' ' HG3' ' A' ' 255' ' ' GLN . 70.8 m -62.4 -33.36 74.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.116 -0.947 . . . . 0.27000000000000002 111.588 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.8 m -82.05 -41.0 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.349 -0.219 . . . . 0.20000000000000001 111.236 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.59 -45.59 47.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.901 0.381 . . . . 0.23000000000000001 110.916 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 13.7 p -67.72 -22.85 65.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.102 -0.499 . . . . 1.1699999999999999 111.789 -176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 251' ' ' THR . 61.0 mt-30 -74.59 -54.04 8.24 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.822 0.82 . . . . 2.3399999999999999 109.682 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -60.18 -30.35 69.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.021 -1.445 . . . . 0.35999999999999999 111.817 -176.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 190' ' ' LEU . 86.4 mt -97.88 -0.71 44.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.106 -0.497 . . . . 1.02 111.235 -177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 254' ' ' SER . 10.7 t80 -86.28 -43.27 13.06 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.292 -1.003 . . . . 1.3799999999999999 108.292 173.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.71 80.84 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 5.3700000000000001 110.518 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -79.79 -51.65 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.15 -0.685 . . . . 5.25 109.15 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -164.8 69.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.146 -0.933 . . . . 6.4000000000000004 108.934 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.3 p -106.71 126.43 30.32 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 7.9199999999999999 111.125 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.97 -1.22 11.42 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.872 2.381 . . . . 8.9900000000000002 112.283 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.4 t -174.06 164.96 4.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 10.84 109.724 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.04 82.01 1.86 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.785 -0.189 . . . . 11.789999999999999 110.511 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.179 -0.915 . . . . 13.24 110.758 -179.608 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.008 -0.437 . . . . 7.6699999999999999 112.008 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.96 -59.84 4.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.95 0.405 . . . . 6.2300000000000004 111.08 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.35 88.15 2.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.716 -0.846 . . . . 7.4500000000000002 108.716 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.11 -116.52 4.46 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.429 -0.891 . . . . 2.8100000000000001 111.261 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 159.11 21.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.037 0.446 . . . . 1.3 110.156 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.466 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 4.2 m -77.98 97.61 5.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.51000000000000001 109.705 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 13.4 p-10 -77.13 137.84 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.826 -1.079 . . . . 0.23000000000000001 109.833 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 162' ' ' VAL . 94.5 t -116.69 132.31 66.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.106 0.479 . . . . 0.23999999999999999 112.01 -173.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.57 118.6 31.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.58 -0.736 . . . . 0.16 109.774 174.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.6 mt -110.05 107.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.979 0.419 . . . . 0.23000000000000001 111.205 -177.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 13.9 mt -95.47 99.5 9.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.16 109.732 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.65 125.94 6.1 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.611 -0.722 . . . . 0.5 109.165 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -37.04 69.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.315 -0.857 . . . . 1.04 111.739 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 28.4 mt-10 -77.54 110.02 11.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 1.29 110.955 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.722 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 14.2 Cg_exo -66.1 -34.4 37.46 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.111 2.541 . . . . 0.58999999999999997 113.112 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.49 -25.89 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.184 0.516 . . . . 0.70999999999999996 110.07 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.425 HG21 ' HE3' ' A' ' 242' ' ' LYS . 71.7 mt -89.72 -39.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.544 -0.753 . . . . 0.46000000000000002 110.796 177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.722 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 65.3 p -59.87 -49.7 76.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.61 -0.268 . . . . 1.29 110.449 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 23.4 ptp -66.81 -28.1 68.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 2.3500000000000001 110.798 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 42.2 tp60 -65.45 -48.65 71.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 175.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.01 -36.3 81.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.405 -0.816 . . . . 0.23999999999999999 110.611 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' SER . 46.5 mt-10 -56.35 -59.58 4.76 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 110.528 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.8 -38.44 91.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 110.827 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -55.76 -55.63 30.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.539 -0.755 . . . . 1.4199999999999999 111.01 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 145' ' ' VAL . 6.0 p -76.12 -28.23 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 111.098 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 53.9 ttp180 -67.89 -31.06 70.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.595 -0.729 . . . . 3.25 110.175 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 t -66.47 -25.0 66.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 1.1599999999999999 110.016 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 162' ' ' VAL . 58.2 mt -79.26 2.22 22.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.812 -0.631 . . . . 0.40000000000000002 111.086 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.37 11.21 69.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.32000000000000001 112.166 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.466 ' ND1' ' HB ' ' A' ' 143' ' ' THR . 93.2 m-70 -98.69 175.73 5.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.059 -0.349 . . . . 0.5 110.059 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -119.68 179.3 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.465 -0.334 . . . . 1.1899999999999999 110.298 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.08 121.92 68.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.57 -0.53 . . . . 0.23000000000000001 109.57 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -87.29 -24.94 24.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.036 -0.529 . . . . 0.23999999999999999 110.148 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.25 158.21 9.67 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.873 -0.679 . . . . 0.17000000000000001 112.017 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 ' HB ' ' A' ' 147' ' ' ILE . 2.2 p -117.06 140.89 48.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.91 -0.404 . . . . 0.34999999999999998 109.91 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.9 123.87 16.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.314 -0.403 . . . . 0.28999999999999998 110.928 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.04 -10.5 41.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.814 0.34 . . . . 0.28999999999999998 110.897 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.9 p -132.96 164.9 25.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.32000000000000001 110.767 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 65.1 ttt180 -67.72 -36.59 80.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.09 0.471 . . . . 0.90000000000000002 110.103 178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.9 m -62.14 -46.81 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.866 -0.606 . . . . 0.40000000000000002 110.52 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.24 -34.94 75.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 1.1899999999999999 110.656 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.52 83.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.25 110.718 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -63.29 -36.63 84.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.048 -0.524 . . . . 0.98999999999999999 111.231 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 14.2 mm-40 -76.68 -42.75 40.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 111.621 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -58.93 -42.71 90.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.40000000000000002 110.937 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.412 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 2.6 p -79.77 -22.83 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.555 0.693 . . . . 1.3300000000000001 110.139 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.44 -29.47 69.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.072 -0.967 . . . . 0.44 110.03 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 89.3 mttt -79.08 -58.32 3.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.577 -0.738 . . . . 2.02 110.266 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.12 137.18 42.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.576 -0.738 . . . . 0.63 111.309 -173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -85.77 120.72 73.04 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.644 -0.707 . . . . 1.6200000000000001 110.298 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.603 ' O ' HG21 ' A' ' 216' ' ' VAL . 75.0 Cg_endo -82.58 157.21 16.41 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.294 2.663 . . . . 0.26000000000000001 112.13 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.47 -3.29 63.04 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.336 -0.706 . . . . 0.23999999999999999 111.336 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 145' ' ' VAL . 22.6 tp -161.83 145.33 12.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.561 -0.533 . . . . 0.65000000000000002 109.561 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.83 137.25 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.344 0.592 . . . . 0.20000000000000001 111.664 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 219' ' ' ILE . 4.5 mm? -117.78 144.0 45.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.415 -0.957 . . . . 1.47 108.415 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -162.05 147.71 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.351 0.501 . . . . 0.17999999999999999 112.351 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 6.7 t70 -101.43 -179.54 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.843 -1.169 . . . . 0.38 107.843 170.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.589 HG12 ' OG1' ' A' ' 222' ' ' THR . 36.1 mm -86.5 -57.8 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 118.177 0.444 . . . . 0.23000000000000001 110.332 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -84.21 115.2 22.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.707 -0.679 . . . . 2.2799999999999998 110.79 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.4 HD11 ' HA2' ' A' ' 203' ' ' GLY . 70.5 mt -98.23 170.28 8.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.171 -0.468 . . . . 0.27000000000000002 110.59 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.35 91.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.305 0.574 . . . . 0.45000000000000001 110.844 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 175' ' ' THR . 26.9 t70 -70.28 -11.14 60.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.274 -0.875 . . . . 0.94999999999999996 111.563 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.67 -1.48 71.85 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.775 -0.726 . . . . 0.35999999999999999 111.349 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 164.29 26.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.381 -0.41 . . . . 0.33000000000000002 110.219 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 123.95 39.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 1.21 110.691 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -30.45 64.97 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.053 -0.976 . . . . 0.14999999999999999 112.356 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 195' ' ' ILE . 61.8 mt -59.4 -46.97 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 0.20999999999999999 110.447 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.33 -38.27 87.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.72 . . . . 1.73 110.525 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -59.69 -40.25 87.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.499 0.666 . . . . 0.17000000000000001 110.343 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 211' ' ' LEU . 36.0 t -63.48 -50.89 76.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 111.089 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -61.98 -28.21 69.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.57999999999999996 111.991 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 20.1 m-20 -58.33 -43.37 88.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.212 0.53 . . . . 1.72 110.263 172.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 55.6 mt -66.02 -49.42 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.31 -0.859 . . . . 0.23999999999999999 110.516 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.3 OUTLIER -59.42 -29.06 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.71999999999999997 111.678 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.98 -6.57 68.25 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.31 111.616 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 32.8 mt-30 -112.62 -48.52 3.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.294 0.569 . . . . 0.85999999999999999 110.251 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -132.98 175.36 9.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.472 -0.785 . . . . 0.39000000000000001 110.747 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -115.68 82.21 1.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.848 0.832 . . . . 1.98 109.964 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 188' ' ' PRO . 0.5 OUTLIER -119.27 157.79 50.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.791 -1.095 . . . . 0.25 109.584 -175.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.504 ' HD2' HG13 ' A' ' 216' ' ' VAL . 72.0 Cg_endo -84.54 143.0 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.339 2.026 . . . . 0.28000000000000003 111.614 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG21 HG13 ' A' ' 207' ' ' VAL . 22.4 t -126.07 131.18 71.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.63 110.971 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.512 ' HB ' HD13 ' A' ' 192' ' ' LEU . 63.4 mt -114.29 112.08 38.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.633 -0.712 . . . . 0.19 109.599 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.517 ' O ' HD12 ' A' ' 239' ' ' LEU . 74.2 m-85 -84.61 97.51 9.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.889 -0.596 . . . . 0.34999999999999998 110.392 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 9.2 mt -96.73 106.24 18.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.771 -0.826 . . . . 0.67000000000000004 108.771 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.618 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 8.1 t -148.56 162.24 40.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 0.25 111.912 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.9 5.23 50.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.408 -0.814 . . . . 0.41999999999999998 110.515 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -125.42 71.73 65.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.253 -0.43 . . . . 0.69999999999999996 110.993 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.571 2.181 . . . . 0.35999999999999999 112.594 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.43 -22.55 65.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.93999999999999995 111.577 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 1.5 tmt_? -63.38 -29.91 71.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 2.0499999999999998 110.349 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -88.93 -13.46 38.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.682 -0.69 . . . . 0.52000000000000002 111.743 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.49 36.91 3.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.207 -0.451 . . . . 1.26 110.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.4 t -140.58 24.49 2.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.623 0.725 . . . . 2.1000000000000001 110.423 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -98.49 -6.3 56.54 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.8 -0.92 . . . . 3.4300000000000002 110.8 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.0 t70 73.0 -9.88 1.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.644 0.777 . . . . 5.2199999999999998 111.324 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 26.4 mmt180 -141.59 -60.84 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 112.775 0.658 . . . . 7.0999999999999996 112.775 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 8.1 Cg_exo -67.16 136.92 42.29 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.404 1.403 . . . . 2.52 112.397 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 129.85 21.54 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.387 -0.824 . . . . 1.9299999999999999 110.045 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.68 128.2 14.87 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.679 2.253 . . . . 0.52000000000000002 111.142 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.4 m -63.48 -38.63 91.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 1.1000000000000001 110.387 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 219' ' ' ILE . 86.6 m-85 -135.76 130.03 33.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.52000000000000002 109.828 178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 220' ' ' PHE . 48.1 tp -138.33 123.79 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.991 0.424 . . . . 0.28000000000000003 111.01 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 89.1 t -126.65 129.74 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.719 -0.673 . . . . 0.29999999999999999 109.489 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 11.9 p -87.32 151.04 23.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.916 0.389 . . . . 0.48999999999999999 111.965 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 221' ' ' ILE . 24.9 mmtm -86.98 133.68 38.64 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.672 -0.695 . . . . 0.78000000000000003 109.557 173.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.51 157.42 93.12 Favored 'Cis proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.861 -1.308 . . . . 0.76000000000000001 112.103 -2.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -108.01 153.04 23.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.426 0.632 . . . . 0.45000000000000001 111.651 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.52 ' O ' HG23 ' A' ' 249' ' ' VAL . 80.6 mm-40 -96.62 127.18 42.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 2.1400000000000001 108.883 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 24.4 mt-10 -57.65 -32.49 67.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 111.793 -175.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.21 -45.69 83.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 1.3400000000000001 109.952 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.4 m -60.36 -42.9 96.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.561 . . . . 0.25 110.366 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 245' ' ' GLN . 46.6 t -61.53 -53.58 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.063 -0.517 . . . . 0.19 110.466 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 67.1 mtt180 -52.7 -45.74 67.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.223 0.535 . . . . 2.6899999999999999 110.333 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.0 m -54.55 -43.79 72.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.972 -1.013 . . . . 0.27000000000000002 111.181 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 18.9 m -73.53 -42.29 61.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.174 -0.466 . . . . 0.20000000000000001 111.354 -175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.463 HG13 HD21 ' A' ' 190' ' ' LEU . 1.6 mp -55.88 -48.24 78.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.643 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.6 t -63.76 -36.34 83.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.855 -0.612 . . . . 1.1699999999999999 111.236 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 26.6 pt20 -77.84 -43.89 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 2.3399999999999999 110.697 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.5 67.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.348 -0.842 . . . . 0.35999999999999999 111.328 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 85.8 mt -84.11 -26.59 28.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.091 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -70.32 -22.9 62.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.397 0.618 . . . . 1.3799999999999999 109.66 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -80.6 -3.41 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.13 -0.941 . . . . 5.3700000000000001 110.221 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.423 ' OE1' ' HD3' ' A' ' 217' ' ' PRO . 69.8 mt-30 -130.05 -166.31 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.915 . . . . 5.25 109.633 177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 59.2 46.63 12.71 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.324 -0.621 . . . . 6.4000000000000004 109.324 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.4 m 68.34 76.32 0.26 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.362 -1.29 . . . . 7.9199999999999999 109.851 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 103.3 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.707 2.271 . . . . 8.9900000000000002 112.626 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.8 m -73.67 -42.3 61.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.842 -0.617 . . . . 10.84 109.706 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 48.24 65.74 1.24 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.453 -0.794 . . . . 11.789999999999999 112.05 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.998 -1.001 . . . . 13.24 110.712 179.228 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.939 -0.465 . . . . 7.6699999999999999 111.939 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.88 -66.9 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.13 0.491 . . . . 6.2300000000000004 110.261 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -130.53 40.52 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.491 0.662 . . . . 7.4500000000000002 110.01 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.67 -19.27 13.79 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 115.29 -0.868 . . . . 2.8100000000000001 111.402 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.6 p -72.37 141.49 48.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.292 -0.954 . . . . 1.3 110.413 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -147.43 124.39 11.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.706 -0.679 . . . . 0.51000000000000001 109.75 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.8 p-10 -73.15 125.64 28.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.529 0.68 . . . . 0.23000000000000001 109.873 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 162' ' ' VAL . 91.5 t -110.88 134.72 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.636 -0.711 . . . . 0.23999999999999999 112.242 -171.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.506 ' O ' HD22 ' A' ' 192' ' ' LEU . 33.7 tp -96.92 116.21 28.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.367 -0.833 . . . . 0.16 110.616 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.438 ' HA ' HD23 ' A' ' 192' ' ' LEU . 23.2 mt -103.58 102.8 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.467 -0.333 . . . . 0.23000000000000001 111.015 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 mt -88.37 99.44 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.16 109.291 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -156.8 129.56 7.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.5 109.451 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.23 -37.26 53.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.201 -0.909 . . . . 1.04 111.71 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 25.3 mt-10 -78.19 115.01 47.42 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.1 0.476 . . . . 1.29 111.366 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.3 Cg_exo -62.49 -36.34 66.13 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.127 2.551 . . . . 0.58999999999999997 111.96 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.27 -48.51 81.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.852 -0.613 . . . . 0.70999999999999996 110.613 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.9 mt -70.48 -38.49 73.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.46000000000000002 110.506 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 43.0 t -58.21 -54.47 46.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.48 -0.327 . . . . 1.29 110.981 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -67.54 -26.01 66.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.828 0.347 . . . . 2.3500000000000001 110.586 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 49.2 tp60 -65.39 -49.1 70.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.481 -0.562 . . . . 1.3100000000000001 109.481 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.89 -36.07 82.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.23999999999999999 110.827 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -56.9 -57.0 14.4 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 123.175 0.297 . . . . 0.67000000000000004 110.49 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.91 -39.97 94.34 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.163 0.506 . . . . 0.54000000000000004 110.85 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -54.87 -54.37 43.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.159 -0.928 . . . . 1.4199999999999999 111.248 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 165' ' ' LEU . 5.1 p -75.98 -28.0 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 0.28999999999999998 110.939 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -65.99 -37.31 85.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 3.25 110.322 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.3 t -62.0 -28.23 69.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 1.1599999999999999 110.077 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 162' ' ' VAL . 71.2 mt -77.86 1.52 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.40000000000000002 111.323 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 25.13 46.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.879 -0.677 . . . . 0.32000000000000001 112.213 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.462 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.9 m-70 -107.29 176.63 5.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 0.5 110.031 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -120.62 173.73 7.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.573 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.6 mm -114.17 113.62 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.511 -0.313 . . . . 0.23000000000000001 110.384 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.58 -23.49 29.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 111.018 -177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.33 161.03 13.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.317 -0.944 . . . . 0.17000000000000001 112.472 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.1 p -115.59 141.37 48.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.05 -0.352 . . . . 0.34999999999999998 110.05 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -141.1 112.66 7.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.285 -0.416 . . . . 0.28999999999999998 111.285 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -89.06 -8.43 53.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.86 0.362 . . . . 0.28999999999999998 110.729 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 199' ' ' ASP . 46.7 p -136.26 168.91 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.32000000000000001 110.13 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 205' ' ' ASP . 79.4 ttt180 -65.94 -40.18 91.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.677 -0.49 . . . . 0.90000000000000002 109.677 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.5 m -59.69 -46.84 87.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.49 -0.777 . . . . 0.40000000000000002 111.004 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.36 -35.25 73.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 1.1899999999999999 110.706 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.35 84.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.084 -0.507 . . . . 0.25 110.819 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 84.0 mt-30 -62.67 -38.19 89.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.807 -0.633 . . . . 0.98999999999999999 110.136 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -69.39 -43.53 73.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.057 -0.974 . . . . 2.2400000000000002 111.426 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -53.76 -52.82 58.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 111.3 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 15.3 m -71.58 -28.63 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.185 -0.462 . . . . 1.3300000000000001 111.418 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -28.9 69.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.302 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -89.35 -56.84 3.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.772 -0.649 . . . . 2.02 110.567 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 30.7 tt0 -136.91 133.68 35.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.63 110.502 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -83.52 117.59 69.07 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.665 -0.698 . . . . 1.6200000000000001 110.165 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.4 Cg_endo -76.58 154.23 35.03 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.709 2.273 . . . . 0.26000000000000001 111.413 174.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 217' ' ' PRO . . . -95.95 -10.44 56.31 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.717 -0.953 . . . . 0.23999999999999999 110.717 173.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 217' ' ' PRO . 0.4 OUTLIER -142.09 148.19 37.98 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.249 -0.649 . . . . 0.65000000000000002 109.249 176.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 218' ' ' VAL . 51.5 t -137.89 137.79 44.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.189 -0.3 . . . . 0.20000000000000001 110.189 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.607 ' H ' HD22 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -130.53 165.62 22.31 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.595 -0.891 . . . . 1.47 108.595 169.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -170.16 147.09 3.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.854 -0.612 . . . . 0.17999999999999999 111.814 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.554 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.4 t0 -94.81 -179.75 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.829 -1.174 . . . . 0.38 107.829 169.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.554 HG12 ' OG1' ' A' ' 222' ' ' THR . 44.2 mm -86.22 -61.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.171 0.51 . . . . 0.23000000000000001 110.524 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -87.2 104.45 16.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.568 -0.742 . . . . 2.2799999999999998 110.453 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 61.7 mt -86.92 174.35 8.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.27000000000000002 111.043 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.67 96.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.45000000000000001 111.221 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 175' ' ' THR . 27.7 t70 -70.18 -15.63 62.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.338 -0.846 . . . . 0.94999999999999996 111.002 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.37 -8.93 64.73 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.246 -0.742 . . . . 0.35999999999999999 111.246 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -73.22 162.38 29.46 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.536 -0.332 . . . . 0.33000000000000002 110.135 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 t -90.59 130.74 36.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.263 0.554 . . . . 1.21 110.737 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.27 -25.64 65.0 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.984 -1.007 . . . . 0.14999999999999999 111.642 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 195' ' ' ILE . 59.1 mt -63.76 -50.05 79.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.051 0.453 . . . . 0.20999999999999999 109.978 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 1.1 m-20 -60.04 -41.46 92.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 1.73 110.547 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -60.52 -43.11 97.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.224 0.535 . . . . 0.17000000000000001 110.592 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 218' ' ' VAL . 25.3 t -65.33 -47.64 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.499 -0.773 . . . . 0.20999999999999999 111.272 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.75 -30.55 68.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.293 -0.412 . . . . 0.57999999999999996 111.304 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 87.1 m-20 -60.19 -45.82 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.415 0.626 . . . . 1.72 110.054 173.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.07 -43.09 85.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.206 -0.906 . . . . 0.23999999999999999 110.695 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.1 mt -67.9 -14.72 63.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.71999999999999997 111.599 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.91 -5.3 89.88 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.145 -0.782 . . . . 0.31 111.145 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -116.88 -54.32 2.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.495 0.664 . . . . 0.85999999999999999 109.949 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.54 167.29 10.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.39000000000000001 111.201 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -113.66 75.79 0.94 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.14 -1.059 . . . . 1.98 108.14 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 148.11 40.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 114.647 -1.161 . . . . 0.25 110.035 -173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.57 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 36.6 Cg_endo -65.85 133.93 35.61 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.561 2.174 . . . . 0.28000000000000003 111.568 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 191' ' ' VAL . 33.2 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.967 0.413 . . . . 0.63 110.47 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.36 122.24 66.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.888 -0.597 . . . . 0.19 110.041 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.95 95.21 8.91 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.572 -0.285 . . . . 0.34999999999999998 111.223 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 240' ' ' VAL . 3.2 mp -90.89 107.11 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.992 -1.114 . . . . 0.67000000000000004 107.992 172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.554 ' OG1' HG12 ' A' ' 195' ' ' ILE . 10.0 t -146.75 164.1 33.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.256 0.55 . . . . 0.25 111.114 -175.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.33 4.66 50.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.514 -0.766 . . . . 0.41999999999999998 110.235 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -124.58 72.92 60.94 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.397 -0.365 . . . . 0.69999999999999996 111.201 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.37 -36.27 67.93 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.693 2.262 . . . . 0.35999999999999999 112.719 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.67 -16.81 64.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.93999999999999995 111.51 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 195' ' ' ILE . 3.4 tmt_? -75.29 -22.83 57.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 2.0499999999999998 109.55 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 44.5 mt -99.34 -25.86 14.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.094 -0.957 . . . . 0.52000000000000002 111.225 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.2 mt -104.2 57.27 0.72 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 1.26 109.914 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 p -87.41 -27.37 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.56 -0.745 . . . . 2.1000000000000001 110.917 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 88.17 -28.91 5.84 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.673 -0.694 . . . . 3.4300000000000002 111.946 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.34 -31.22 19.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.01 0.433 . . . . 5.2199999999999998 110.632 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.674 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 33.6 mmt180 -100.39 -179.61 0.85 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.807 -0.633 . . . . 7.0999999999999996 109.571 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.674 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 14.0 Cg_exo -70.51 142.96 45.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.461 2.108 . . . . 2.52 111.727 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.58 136.6 25.05 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.01 -0.541 . . . . 1.9299999999999999 109.778 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 228' ' ' LEU . 46.0 Cg_endo -68.6 134.72 31.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.843 2.362 . . . . 0.52000000000000002 112.083 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -70.91 -32.06 68.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 1.1000000000000001 109.867 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 98.5 m-85 -134.26 118.04 17.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.8 . . . . 0.52000000000000002 109.933 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 29.0 tp -127.41 129.4 47.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.28000000000000003 110.887 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 221' ' ' ILE . 90.5 t -126.76 126.21 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.489 -0.778 . . . . 0.29999999999999999 109.617 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 4.8 p -96.78 141.27 30.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.112 -0.494 . . . . 0.48999999999999999 111.724 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.532 ' HE3' HG22 ' A' ' 221' ' ' ILE . 93.1 mttt -90.46 146.26 34.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.752 -0.658 . . . . 0.78000000000000003 111.002 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.6 Cg_exo -72.27 131.77 23.29 Favored 'Cis proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.392 -1.503 . . . . 0.76000000000000001 112.034 -0.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -87.84 157.03 19.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.046 -0.525 . . . . 0.45000000000000001 111.585 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 mt-30 -102.39 133.27 47.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.043 -0.725 . . . . 2.1400000000000001 109.043 174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 1.8 mp0 -57.38 -35.44 70.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.055 -0.521 . . . . 1.6599999999999999 111.472 -178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 36.1 m -63.53 -47.77 80.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 1.3400000000000001 110.407 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 251' ' ' THR . 85.2 m -57.71 -41.28 81.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.147 -0.479 . . . . 0.25 110.936 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 245' ' ' GLN . 52.9 t -61.34 -54.3 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.19 110.349 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 40.3 mtm180 -54.18 -40.86 67.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.987 0.423 . . . . 2.6899999999999999 110.744 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.685 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 35.2 m -56.26 -53.39 57.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.27000000000000002 110.867 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.5 m -62.34 -44.62 96.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.506 . . . . 0.20000000000000001 111.592 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.41 -50.39 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.708 0.29 . . . . 0.23000000000000001 111.046 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 43.5 t -58.63 -33.69 70.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.246 -0.434 . . . . 1.1699999999999999 111.116 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.4 mm-40 -76.14 -43.76 41.45 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.216 0.531 . . . . 2.3399999999999999 110.279 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -56.42 -35.33 67.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.758 -1.11 . . . . 0.35999999999999999 110.91 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.85 -29.9 26.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.779 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -67.25 -13.18 61.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.183 -0.462 . . . . 1.3799999999999999 110.273 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -73.69 -3.12 26.3 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.731 0.777 . . . . 5.3700000000000001 111.143 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.76 53.87 9.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.282 -1.326 . . . . 5.25 112.514 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.82 126.28 28.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 6.4000000000000004 110.253 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.9 t -71.3 123.86 90.04 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.096 -0.502 . . . . 7.9199999999999999 110.602 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.38 121.65 9.93 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.352 2.035 . . . . 8.9900000000000002 110.466 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.8 m 63.54 78.64 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.93 -0.767 . . . . 10.84 108.93 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -53.76 137.18 38.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 11.789999999999999 112.548 -171.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.245 0.819 0 CA-C-N 115.257 -0.883 . . . . 13.24 110.008 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 143' ' ' THR . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.985 -0.446 . . . . 7.6699999999999999 111.985 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.84 169.09 9.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.554 -0.165 . . . . 6.2300000000000004 110.554 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 60.4 mtm 57.61 78.87 0.22 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.607 0.567 . . . . 7.4500000000000002 111.286 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.28 -118.37 4.1 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.458 -0.877 . . . . 2.8100000000000001 111.877 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 p -69.59 95.83 0.88 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.122 0.486 . . . . 1.3 110.855 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 1.4 m -78.4 116.48 18.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.923 -0.58 . . . . 0.51000000000000001 109.872 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.8 p-10 -68.52 138.88 55.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.934 -0.395 . . . . 0.23000000000000001 109.934 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.0 t -122.75 141.37 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.065 0.459 . . . . 0.23999999999999999 111.831 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -97.42 122.07 40.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.257 -0.883 . . . . 0.16 109.64 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.93 109.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.939 0.399 . . . . 0.23000000000000001 111.393 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 34.6 mt -101.74 100.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.932 -0.576 . . . . 0.16 109.924 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.32 122.44 6.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.877 -0.601 . . . . 0.5 109.657 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.535 ' OD1' ' HB2' ' A' ' 198' ' ' ALA . 3.3 t70 -74.75 -38.54 62.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.445 -0.798 . . . . 1.04 111.891 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 38.0 mt-10 -76.03 110.82 12.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.29 110.801 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.725 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 15.9 Cg_exo -64.11 -34.2 58.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.042 2.495 . . . . 0.58999999999999997 112.744 -172.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.82 -28.21 69.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.70999999999999996 110.695 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.2 mt -93.46 -37.91 9.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.46000000000000002 110.44 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.725 ' OG ' ' HA ' ' A' ' 152' ' ' PRO . 79.1 p -61.31 -51.22 69.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.548 -0.296 . . . . 1.29 111.138 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptt? -69.25 -26.52 64.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 110.386 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -66.29 -46.3 77.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.663 -0.699 . . . . 1.3100000000000001 109.362 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.3 mt -61.14 -37.8 84.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.194 -0.912 . . . . 0.23999999999999999 110.903 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 155' ' ' SER . 40.8 mt-10 -57.41 -52.86 63.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.88 0.371 . . . . 0.67000000000000004 110.289 176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.53 -44.53 93.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 111.032 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.04 -53.41 57.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.028 -0.987 . . . . 1.4199999999999999 111.154 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 165' ' ' LEU . 2.8 p -72.75 -28.22 26.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.049 0.452 . . . . 0.28999999999999998 110.777 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -64.28 -46.8 82.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.661 -0.7 . . . . 3.25 110.547 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.6 t -58.67 -29.95 66.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.851 -0.613 . . . . 1.1599999999999999 111.01 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 162' ' ' VAL . 89.6 mt -70.22 -17.47 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.40000000000000002 112.016 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.64 20.2 13.77 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.576 -0.821 . . . . 0.32000000000000001 111.948 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.477 ' HD1' ' HB ' ' A' ' 143' ' ' THR . 69.4 m-70 -97.3 -176.04 3.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.096 -0.335 . . . . 0.5 110.096 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -132.98 172.55 12.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.207 -0.451 . . . . 1.1899999999999999 109.832 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.13 111.07 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.023 0.44 . . . . 0.23000000000000001 110.205 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -81.43 -27.15 34.83 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.635 -0.712 . . . . 0.23999999999999999 110.193 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.22 161.87 24.26 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.576 -0.738 . . . . 0.17000000000000001 111.621 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.91 142.4 50.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.932 0.396 . . . . 0.34999999999999998 110.417 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -144.88 140.13 28.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.034 -0.53 . . . . 0.28999999999999998 111.058 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -114.17 -2.38 13.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.28999999999999998 110.022 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 60.0 p -137.17 169.87 17.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 0.32000000000000001 110.006 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' HE21 ' A' ' 180' ' ' GLN . 73.0 ttt180 -70.92 -38.34 72.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.027 176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 m -61.91 -42.95 99.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.40000000000000002 110.649 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.46 -35.35 77.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.237 -0.438 . . . . 1.1899999999999999 110.949 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -63.66 -43.84 95.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.25 110.563 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.515 HE21 ' HG2' ' A' ' 176' ' ' ARG . 73.4 mt-30 -60.78 -44.09 97.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 0.98999999999999999 110.296 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 56.9 mt-10 -65.28 -42.3 93.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 2.2400000000000002 111.419 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.92 -54.48 42.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.679 -0.691 . . . . 0.40000000000000002 111.21 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 179' ' ' ALA . 11.5 m -71.89 -24.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.313 -0.403 . . . . 1.3300000000000001 111.357 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.11 69.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.26 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 27.9 mtpp -86.78 -55.8 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 2.02 110.86 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 25.9 tt0 -144.89 141.21 28.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.938 -0.574 . . . . 0.63 111.077 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.39 117.8 69.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.642 -0.708 . . . . 1.6200000000000001 110.475 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.6 Cg_endo -76.84 145.18 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.905 2.403 . . . . 0.26000000000000001 111.345 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.46 -8.91 82.57 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.591 -0.814 . . . . 0.23999999999999999 111.386 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.582 ' HB3' HG22 ' A' ' 145' ' ' VAL . 25.3 tp -150.04 142.49 24.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.204 -0.665 . . . . 0.65000000000000002 109.204 175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.403 ' HB ' HG22 ' A' ' 218' ' ' VAL . 84.9 t -119.78 127.94 75.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.20000000000000001 111.144 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 221' ' ' ILE . 13.1 tp -112.71 138.91 48.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.162 -0.926 . . . . 1.47 109.357 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -158.5 148.1 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.867 0.691 . . . . 0.17999999999999999 112.867 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.601 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 14.6 t70 -99.7 179.96 4.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.067 -0.97 . . . . 0.38 108.612 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.561 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.5 mm -85.98 -44.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.089 0.471 . . . . 0.23000000000000001 110.114 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.32 114.62 27.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.669 -0.696 . . . . 2.2799999999999998 111.134 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 40.9 mt -107.35 162.18 14.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 110.662 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB2' ' OD1' ' A' ' 150' ' ' ASP . . . -69.14 -19.15 64.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.516 -0.766 . . . . 0.45000000000000001 112.401 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.455 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 25.0 t70 -81.84 -24.24 35.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.148 0.499 . . . . 0.94999999999999996 110.877 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 107.33 -2.7 34.84 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.879 -0.889 . . . . 0.35999999999999999 110.879 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.2 p -89.12 164.69 14.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.864 0.364 . . . . 0.33000000000000002 110.797 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 49.3 m -92.68 132.48 36.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 1.21 110.75 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.85 -27.0 67.79 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.397 -0.82 . . . . 0.14999999999999999 112.2 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 68.6 mt -59.37 -52.24 63.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.04 0.447 . . . . 0.20999999999999999 110.233 175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.451 ' HB3' ' NH1' ' A' ' 176' ' ' ARG . 2.1 m-20 -62.65 -31.98 72.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.491 -0.777 . . . . 1.73 110.711 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -64.42 -46.24 84.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.981 0.42 . . . . 0.17000000000000001 110.129 175.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 218' ' ' VAL . 43.7 t -59.41 -48.39 87.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.20999999999999999 110.783 176.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 44.6 mt-10 -59.71 -34.02 72.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.96 -0.564 . . . . 0.57999999999999996 111.567 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.67 -46.88 88.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.458 0.647 . . . . 1.72 109.548 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.97 -40.72 90.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.75 -1.113 . . . . 0.23999999999999999 110.811 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.68 -15.47 62.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.71999999999999997 111.329 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.07 -4.18 90.01 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.978 -0.849 . . . . 0.31 110.978 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -113.49 -57.05 2.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.604 0.716 . . . . 0.85999999999999999 109.526 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -116.49 167.75 10.78 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.944 -1.026 . . . . 0.39000000000000001 110.732 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -117.74 71.46 0.82 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.97 -1.014 . . . . 1.98 108.497 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -109.52 152.67 42.89 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.471 -1.24 . . . . 0.25 109.465 -175.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.517 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 55.7 Cg_endo -66.86 143.14 65.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.39 2.06 . . . . 0.28000000000000003 111.974 -176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.568 HG11 HG11 ' A' ' 207' ' ' VAL . 44.0 t -131.64 138.01 53.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.003 -0.544 . . . . 0.63 110.644 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 192' ' ' LEU . 72.2 mt -122.81 123.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.928 -0.578 . . . . 0.19 110.07 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.53 95.3 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.029 -0.532 . . . . 0.34999999999999998 110.289 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 192' ' ' LEU . 7.2 mt -99.03 107.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.738 -0.838 . . . . 0.67000000000000004 108.738 174.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 241' ' ' THR . 9.3 t -153.89 168.02 27.76 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.966 0.412 . . . . 0.25 111.195 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.43 40.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.513 . . . . 0.41999999999999998 110.734 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' A' ' 227' ' ' ARG . 98.3 m-85 -125.9 74.04 70.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.69999999999999996 111.45 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 -41.06 11.09 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.443 2.095 . . . . 0.35999999999999999 110.952 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.1 -33.37 70.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.771 -1.104 . . . . 0.93999999999999995 111.658 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 224' ' ' TYR . 0.0 OUTLIER -73.5 -25.13 60.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 2.0499999999999998 110.185 -173.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.48 -15.45 56.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 0.52000000000000002 111.048 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.4 mt -103.15 34.26 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.706 -0.679 . . . . 1.26 110.167 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -170.19 151.92 4.04 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.34 -0.615 . . . . 2.1000000000000001 109.34 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 119.51 11.44 7.27 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.686 -0.688 . . . . 3.4300000000000002 112.249 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.1 t70 65.1 27.18 12.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.763 0.792 . . . . 5.2199999999999998 109.724 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.424 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 87.4 mtt180 -115.1 171.06 4.81 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.447 -0.797 . . . . 7.0999999999999996 110.413 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 38.1 Cg_exo -67.76 160.1 49.79 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.533 2.822 . . . . 2.52 111.894 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.46 141.26 22.97 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.425 -0.583 . . . . 1.9299999999999999 109.425 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.02 127.18 14.03 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.716 2.277 . . . . 0.52000000000000002 112.553 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 58.5 m -72.27 -28.34 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.776 -0.647 . . . . 1.1000000000000001 110.393 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -126.45 103.85 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.52000000000000002 109.911 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.9 124.18 36.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.537 -0.756 . . . . 0.28000000000000003 110.523 -176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.419 ' HB ' HG12 ' A' ' 221' ' ' ILE . 58.3 t -123.92 141.01 45.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.128 -0.693 . . . . 0.29999999999999999 109.128 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.1 p -107.76 141.75 38.83 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.336 0.495 . . . . 0.48999999999999999 112.336 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.489 ' HE3' HG22 ' A' ' 221' ' ' ILE . 2.3 mptm? -83.94 135.2 42.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.923 -0.58 . . . . 0.78000000000000003 109.673 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -76.14 139.31 59.75 Favored 'Cis proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.492 -1.462 . . . . 0.76000000000000001 111.59 -1.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -98.97 159.47 14.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 111.27 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 249' ' ' VAL . 47.0 mt-30 -96.92 125.55 41.44 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.288 -1.004 . . . . 2.1400000000000001 108.288 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 2.3 mp0 -55.51 -33.52 63.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 1.6599999999999999 111.456 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.7 t -68.46 -42.57 78.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.999 -0.371 . . . . 1.3400000000000001 109.999 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 91.3 m -59.47 -41.03 88.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.981 0.419 . . . . 0.25 110.131 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 245' ' ' GLN . 49.1 t -62.31 -53.97 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 0.19 110.153 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 57.5 mtt180 -51.8 -42.28 62.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.335 0.588 . . . . 2.6899999999999999 110.716 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 55.0 m -59.03 -52.81 64.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.27000000000000002 111.345 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.4 m -62.21 -44.17 97.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.20000000000000001 111.906 -174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.79 -49.44 58.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 120.872 0.367 . . . . 0.23000000000000001 110.725 175.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 258' ' ' PHE . 20.3 t -62.73 -24.28 67.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.958 -0.565 . . . . 1.1699999999999999 111.01 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 251' ' ' THR . 24.2 mm-40 -77.76 -47.06 19.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.257 0.551 . . . . 2.3399999999999999 110.168 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -58.73 -33.97 70.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.157 -0.929 . . . . 0.35999999999999999 110.953 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -92.36 -8.99 43.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.767 -0.651 . . . . 1.02 110.902 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 254' ' ' SER . 70.8 t80 -78.05 -52.41 8.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.372 0.606 . . . . 1.3799999999999999 109.725 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -85.6 -11.85 52.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.474 -0.784 . . . . 5.3700000000000001 110.888 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 53.37 31.65 12.35 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.624 -1.171 . . . . 5.25 112.137 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -156.42 158.16 36.83 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.812 -0.44 . . . . 6.4000000000000004 109.812 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 263' ' ' PRO . 34.3 m -147.94 -48.22 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.271 -0.422 . . . . 7.9199999999999999 111.375 177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.518 ' CD ' ' H ' ' A' ' 262' ' ' SER . 3.5 Cg_exo -76.38 162.59 33.41 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.872 1.715 . . . . 8.9900000000000002 111.673 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 82.5 p 50.41 34.26 8.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.355 0.662 . . . . 10.84 111.968 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -102.17 127.18 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.16 -0.473 . . . . 11.789999999999999 111.051 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.679 -0.677 . . . . 13.24 109.848 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.965 -0.454 . . . . 7.6699999999999999 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.53 -28.6 13.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 6.2300000000000004 110.845 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -78.69 121.04 24.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.104 -0.498 . . . . 7.4500000000000002 110.697 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -165.6 -138.24 2.38 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.717 -0.674 . . . . 2.8100000000000001 111.495 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 0.6 OUTLIER -81.26 94.52 6.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 1.3 110.315 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -77.19 132.15 38.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.381 -0.827 . . . . 0.51000000000000001 111.069 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.9 p-10 -77.58 139.65 39.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.031 -0.531 . . . . 0.23000000000000001 110.415 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.4 t -121.68 137.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.152 0.501 . . . . 0.23999999999999999 111.634 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.4 tp -94.82 115.53 27.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.467 -0.788 . . . . 0.16 110.057 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.99 101.98 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.222 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 46.1 mt -95.76 100.84 11.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.16 109.567 175.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.51 124.23 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.339 -0.846 . . . . 0.5 108.746 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.36 -25.81 46.47 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.212 -0.449 . . . . 1.04 111.655 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 22.8 tt0 -96.24 111.14 55.61 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-O 120.861 0.362 . . . . 1.29 110.598 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 17.0 Cg_exo -63.58 -30.17 70.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.061 2.507 . . . . 0.58999999999999997 112.349 -173.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 74.9 mt -55.81 -42.03 75.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.597 -0.729 . . . . 0.70999999999999996 110.573 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.96 -36.51 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.016 -0.538 . . . . 0.46000000000000002 110.637 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 13.7 m -54.32 -49.99 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.239 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.456 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 22.6 ptp -67.04 -27.93 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 2.3500000000000001 111.681 -175.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.466 HE21 ' HB3' ' A' ' 157' ' ' GLN . 10.5 mt-30 -63.42 -52.79 60.05 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.001 -0.74 . . . . 1.3100000000000001 109.001 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.55 -38.93 75.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.151 -1.386 . . . . 0.23999999999999999 111.242 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 155' ' ' SER . 42.8 mt-10 -57.15 -53.02 62.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.062 0.458 . . . . 0.67000000000000004 110.685 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.72 -43.09 73.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 111.098 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.61 -48.14 81.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.904 . . . . 1.4199999999999999 110.965 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 3.0 p -71.5 -28.21 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.157 0.503 . . . . 0.28999999999999998 110.719 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -67.85 -36.52 80.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 3.25 110.166 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.9 m -66.2 -22.67 66.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 1.1599999999999999 110.718 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 162' ' ' VAL . 64.1 mt -83.63 5.45 24.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.40000000000000002 111.143 175.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.8 32.88 39.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.985 -0.626 . . . . 0.32000000000000001 112.185 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.548 ' HB2' HG22 ' A' ' 162' ' ' VAL . 96.6 m-70 -118.71 173.19 7.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.546 -0.385 . . . . 0.5 110.943 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -124.49 172.72 8.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 1.1899999999999999 110.423 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 159' ' ' GLU . 46.5 mm -105.92 121.15 57.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.378 -0.374 . . . . 0.23000000000000001 110.364 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -88.47 -24.31 23.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.015 -0.539 . . . . 0.23999999999999999 110.385 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.26 159.53 11.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.791 -0.719 . . . . 0.17000000000000001 112.27 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 p -121.49 131.74 54.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.199 -0.297 . . . . 0.34999999999999998 110.199 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -139.51 123.02 17.28 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.364 -0.38 . . . . 0.28999999999999998 111.389 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 150' ' ' ASP . . . -94.79 -0.64 54.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.28999999999999998 111.093 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 199' ' ' ASP . 69.5 p -141.34 163.37 33.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.881 -0.415 . . . . 0.32000000000000001 109.881 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 27.9 ttt180 -68.48 -34.97 76.86 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 120.033 -0.667 . . . . 0.90000000000000002 109.881 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 87.2 m -57.66 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.40000000000000002 111.083 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -63.49 -31.53 72.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.362 -0.381 . . . . 1.1899999999999999 110.798 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.15 -44.84 94.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.25 110.594 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.7 mt-30 -58.89 -47.76 83.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.98999999999999999 110.65 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 40.5 mt-10 -63.83 -51.96 62.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2400000000000002 111.139 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.26 -45.32 76.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.49 -0.777 . . . . 0.40000000000000002 111.551 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.71 -24.52 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.214 0.53 . . . . 1.3300000000000001 110.252 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.85 -26.61 64.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.893 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 60.7 mtpt -83.95 -55.67 4.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.371 -0.831 . . . . 2.02 110.58 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.52 133.63 38.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.089 -0.505 . . . . 0.63 110.755 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -86.15 117.63 69.03 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.643 -0.708 . . . . 1.6200000000000001 110.151 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.438 ' O ' HG21 ' A' ' 216' ' ' VAL . 80.8 Cg_endo -76.01 151.1 34.73 Favored 'Trans proline' 0 C--N 1.33 -0.409 0 C-N-CA 123.279 2.653 . . . . 0.26000000000000001 111.834 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.82 -9.53 64.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.183 -0.767 . . . . 0.23999999999999999 111.183 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB3' HG22 ' A' ' 145' ' ' VAL . 29.5 tp -150.17 144.1 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.019 -0.734 . . . . 0.65000000000000002 109.019 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 218' ' ' VAL . 62.8 t -121.75 140.69 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.156 0.503 . . . . 0.20000000000000001 111.118 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.6 OUTLIER -121.72 135.76 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.914 -1.143 . . . . 1.47 107.914 177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -152.23 144.41 23.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.609 0.596 . . . . 0.17999999999999999 112.609 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.647 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 15.0 t70 -98.86 178.44 4.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.206 -1.035 . . . . 0.38 108.206 170.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 202' ' ' SER . 30.9 mm -85.87 -50.75 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 O-C-N 121.905 -0.497 . . . . 0.23000000000000001 110.45 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -89.3 103.58 16.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 2.2799999999999998 110.923 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.487 HD11 ' HA2' ' A' ' 203' ' ' GLY . 58.0 mt -92.37 160.46 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.27000000000000002 109.971 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.78 -11.34 60.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.45000000000000001 111.986 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.567 ' HB2' ' CG2' ' A' ' 175' ' ' THR . 32.7 t70 -89.28 -10.73 45.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.534 0.683 . . . . 0.94999999999999996 110.031 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.65 -4.56 66.39 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.093 -0.803 . . . . 0.35999999999999999 111.093 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.4 p -84.17 158.05 21.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.733 0.301 . . . . 0.33000000000000002 110.602 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 68.5 m -88.07 134.91 33.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.242 0.544 . . . . 1.21 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.44 -26.88 60.07 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.14999999999999999 112.216 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 54.6 mt -59.45 -42.94 89.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.135 0.493 . . . . 0.20999999999999999 110.258 175.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -63.73 -39.89 95.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 1.73 109.725 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.85 96.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.448 -0.797 . . . . 0.17000000000000001 110.609 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 203' ' ' GLY . 42.7 t -62.44 -47.15 94.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.112 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 41.7 mt-10 -57.63 -36.19 71.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.123 -0.489 . . . . 0.57999999999999996 111.24 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 6.6 t70 -57.35 -50.97 71.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.696 0.76 . . . . 1.72 109.25 177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 57.9 mt -60.35 -46.48 94.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.593 -1.185 . . . . 0.23999999999999999 111.206 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.89 -20.21 66.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.821 -0.627 . . . . 0.71999999999999997 112.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.99 -8.69 86.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.633 -0.794 . . . . 0.31 111.264 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 36.1 mt-30 -109.55 -51.04 2.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.33 0.586 . . . . 0.85999999999999999 110.307 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 179.49 5.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.492 -0.777 . . . . 0.39000000000000001 110.878 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -125.74 71.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.079 0.942 . . . . 1.98 109.362 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -108.61 151.25 41.57 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.423 -1.262 . . . . 0.25 109.325 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.1 139.32 50.37 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.225 1.95 . . . . 0.28000000000000003 112.241 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 191' ' ' VAL . 47.9 t -126.09 134.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.069 -0.514 . . . . 0.63 110.725 -176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.408 ' HB ' HD22 ' A' ' 192' ' ' LEU . 75.9 mt -118.26 128.75 75.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.909 -0.587 . . . . 0.19 110.087 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -100.91 100.72 11.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 0.34999999999999998 110.334 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 242' ' ' LYS . 8.5 mt -101.21 107.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.614 -0.884 . . . . 0.67000000000000004 108.614 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.512 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 11.8 t -154.39 165.16 37.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.535 -0.466 . . . . 0.25 111.111 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.18 12.83 33.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.522 . . . . 0.41999999999999998 110.661 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.18 70.33 78.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.495 -0.321 . . . . 0.69999999999999996 111.193 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.12 -32.25 74.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.612 2.208 . . . . 0.35999999999999999 111.851 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 226' ' ' GLU . 8.7 pt-20 -72.27 -12.75 61.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.466 -0.788 . . . . 0.93999999999999995 111.771 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -79.89 -22.96 42.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.587 0.708 . . . . 2.0499999999999998 109.325 175.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 26.6 mt -97.02 -29.24 13.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.268 -0.878 . . . . 0.52000000000000002 112.155 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.57 53.24 2.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 1.26 110.609 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.3 t 174.94 158.86 0.18 Allowed 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.911 -0.774 . . . . 2.1000000000000001 108.911 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 233' ' ' ARG . . . 110.0 21.0 7.26 Favored Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.846 -0.616 . . . . 3.4300000000000002 112.662 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.6 t70 73.61 -28.31 0.19 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.438 0.695 . . . . 5.2199999999999998 111.804 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 231' ' ' GLY . 18.1 ptt180 -65.72 167.27 11.66 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.547 -0.751 . . . . 7.0999999999999996 111.542 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -72.21 153.62 56.71 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.185 2.59 . . . . 2.52 111.635 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -63.28 139.73 97.6 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 109.018 -0.734 . . . . 1.9299999999999999 109.018 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 16.8 Cg_endo -58.67 127.0 22.92 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.499 2.133 . . . . 0.52000000000000002 111.562 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.9 m -58.08 -34.31 70.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.904 -1.044 . . . . 1.1000000000000001 111.284 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.641 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 87.7 m-85 -141.37 112.85 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.617 -0.512 . . . . 0.52000000000000002 109.617 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.62 125.3 43.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.144 0.497 . . . . 0.28000000000000003 110.977 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.63 114.9 44.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.582 -0.735 . . . . 0.29999999999999999 109.314 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 222' ' ' THR . 11.7 p -84.95 139.74 31.6 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.854 -0.612 . . . . 0.48999999999999999 111.788 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 88.0 mttt -92.53 145.56 30.72 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.78000000000000003 111.359 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 14.6 Cg_exo -68.1 138.84 46.29 Favored 'Cis proline' 0 C--N 1.345 0.377 0 C-N-CA 123.4 -1.5 . . . . 0.76000000000000001 111.843 -1.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 28.8 p90 -99.0 175.03 6.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.558 . . . . 0.45000000000000001 111.302 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -117.04 123.75 47.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.316 -0.856 . . . . 2.1400000000000001 109.28 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -54.47 -32.29 57.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.094 -0.957 . . . . 1.6599999999999999 111.86 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.6 p -62.98 -51.47 66.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 110.331 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 87.2 m -55.91 -40.21 72.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.844 -0.616 . . . . 0.25 110.838 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.8 -56.34 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.309 -0.405 . . . . 0.19 110.282 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' A' ' 165' ' ' LEU . 61.7 mtt180 -48.17 -49.44 32.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.331 0.586 . . . . 2.6899999999999999 110.424 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 87.2 m -53.82 -48.4 69.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.648 -1.16 . . . . 0.27000000000000002 111.297 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.1 m -64.67 -41.77 95.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.191 -0.459 . . . . 0.20000000000000001 111.537 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.84 -49.69 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.451 0.167 . . . . 0.23000000000000001 111.305 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 p -65.39 -26.93 68.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 1.1699999999999999 111.626 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 251' ' ' THR . 12.0 mm-40 -80.09 -47.09 15.36 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.467 0.651 . . . . 2.3399999999999999 110.196 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -60.2 -36.61 78.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.239 -0.891 . . . . 0.35999999999999999 110.667 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.06 -28.25 60.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.063 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.61 -24.36 67.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.868 -0.79 . . . . 1.3799999999999999 108.868 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 22.9 t80 55.92 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.428 -1.26 . . . . 5.3700000000000001 111.978 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.03 108.26 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.301 -1.318 . . . . 5.25 110.105 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 261' ' ' ASN . 0.9 OUTLIER -64.43 145.1 56.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 6.4000000000000004 110.74 -176.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.526 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 33.3 m -52.63 -51.89 69.2 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.531 0.567 . . . . 7.9199999999999999 112.531 -176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 51.8 Cg_exo -53.72 -62.95 0.26 Allowed 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 121.972 1.781 . . . . 8.9900000000000002 112.564 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.1 t -156.04 147.91 23.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.634 -0.712 . . . . 10.84 110.695 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -157.75 36.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.341 0.591 . . . . 11.789999999999999 109.842 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.211 -0.9 . . . . 13.24 110.942 -176.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.533 ' N ' ' HG ' ' A' ' 254' ' ' SER . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.015 -0.434 . . . . 7.6699999999999999 112.015 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.41 107.71 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.995 0.426 . . . . 6.2300000000000004 110.976 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.9 ptm -137.46 21.74 2.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.267 0.556 . . . . 7.4500000000000002 110.094 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.25 171.76 32.34 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.997 -0.841 . . . . 2.8100000000000001 110.997 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 2.5 p -80.06 94.14 5.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 1.3 111.056 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 167' ' ' HIS . 1.3 m -78.31 118.8 20.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.502 -0.772 . . . . 0.51000000000000001 109.584 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.6 p-10 -71.88 134.16 45.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.948 0.404 . . . . 0.23000000000000001 110.171 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 190' ' ' LEU . 60.1 t -118.3 137.96 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.994 0.426 . . . . 0.23999999999999999 111.403 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -94.53 114.33 26.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.207 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 172' ' ' THR . 69.3 mt -102.76 102.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.242 0.544 . . . . 0.23000000000000001 111.185 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 44.1 mt -92.13 99.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.584 -0.735 . . . . 0.16 109.221 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -152.76 122.36 6.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.362 -0.836 . . . . 0.5 109.859 -172.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.27 -37.33 71.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.423 -0.808 . . . . 1.04 111.636 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.59 111.32 20.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.103 0.478 . . . . 1.29 111.248 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.54 -34.61 74.7 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.194 2.596 . . . . 0.58999999999999997 111.895 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.0 mt -59.76 -51.95 67.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.798 -0.637 . . . . 0.70999999999999996 110.374 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 63.0 mt -68.23 -36.96 77.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.837 -0.619 . . . . 0.46000000000000002 110.473 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 37.3 t -56.25 -55.25 35.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.29 110.846 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.56 -33.29 75.27 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.958 0.408 . . . . 2.3500000000000001 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 154' ' ' ILE . 6.3 tp60 -59.59 -47.22 86.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 109.784 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.02 -37.3 83.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 111.2 177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.3 mt-10 -58.34 -53.09 62.24 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.67000000000000004 110.402 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.28 -41.98 96.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.807 -0.633 . . . . 0.54000000000000004 110.973 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 246' ' ' GLU . 1.1 mt -55.81 -56.66 17.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.211 -0.904 . . . . 1.4199999999999999 111.385 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 145' ' ' VAL . 3.4 p -70.86 -27.21 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.525 . . . . 0.28999999999999998 110.781 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.73 -40.76 92.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 3.25 110.396 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 45.5 m -63.15 -24.47 67.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 1.1599999999999999 110.886 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 162' ' ' VAL . 69.7 mt -82.59 4.92 22.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.40000000000000002 111.596 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 142' ' ' SER . . . 78.55 28.21 55.69 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.575 -0.821 . . . . 0.32000000000000001 112.247 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.558 ' HB2' HG22 ' A' ' 162' ' ' VAL . 97.4 m-70 -114.33 174.07 6.14 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.636 -0.505 . . . . 0.5 109.636 176.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.65 175.71 6.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 110.632 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.98 118.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.997 -0.547 . . . . 0.23000000000000001 109.694 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.75 -25.65 28.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.23999999999999999 110.114 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.55 160.1 11.28 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.67 -0.695 . . . . 0.17000000000000001 111.946 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 147' ' ' ILE . 1.2 p -118.13 138.6 52.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.34999999999999998 110.114 175.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -140.32 118.3 11.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.204 -0.453 . . . . 0.28999999999999998 110.97 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.94 -9.66 57.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.491 -0.322 . . . . 0.28999999999999998 111.202 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 199' ' ' ASP . 58.2 p -133.3 167.86 19.63 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.197 -0.201 . . . . 0.32000000000000001 111.213 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.493 ' HG3' ' HA ' ' A' ' 206' ' ' ALA . 78.3 ttt180 -69.24 -42.39 75.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.053 0.454 . . . . 0.90000000000000002 110.336 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.4 m -63.56 -47.21 82.5 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.40000000000000002 110.73 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.1 -28.08 69.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.087 -0.506 . . . . 1.1899999999999999 110.914 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.67 84.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.265 -0.425 . . . . 0.25 110.14 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.31 -38.14 82.74 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.723 -0.671 . . . . 0.98999999999999999 110.519 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.07 -47.44 68.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.87 -0.605 . . . . 2.2400000000000002 111.366 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.83 92.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.588 -0.733 . . . . 0.40000000000000002 110.988 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 214' ' ' PHE . 1.6 p -77.96 -24.46 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 121.552 0.692 . . . . 1.3300000000000001 110.009 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.88 -27.68 63.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.133 -0.94 . . . . 0.44 109.844 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -76.81 -51.71 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.613 -0.721 . . . . 2.02 111.156 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -142.21 137.4 30.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.666 -0.697 . . . . 0.63 110.632 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -88.09 114.06 57.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.255 0.55 . . . . 1.6200000000000001 110.6 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 216' ' ' VAL . 72.7 Cg_endo -74.86 158.46 42.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.247 2.631 . . . . 0.26000000000000001 112.003 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.82 -8.42 58.16 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.874 -0.89 . . . . 0.23999999999999999 110.874 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.581 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.0 tp -151.58 144.89 24.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.326 -0.62 . . . . 0.65000000000000002 109.326 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -120.48 142.51 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.20000000000000001 110.848 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 193' ' ' ALA . 0.7 OUTLIER -127.73 130.93 49.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.497 -1.297 . . . . 1.47 107.497 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -150.96 145.84 25.85 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.188 -0.605 . . . . 0.17999999999999999 112.571 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.656 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.9 t70 -99.8 177.9 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.265 -1.013 . . . . 0.38 108.265 170.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.551 HG12 ' OG1' ' A' ' 222' ' ' THR . 19.5 mm -85.53 -39.37 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.014 -0.736 . . . . 0.23000000000000001 109.014 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.61 105.69 12.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.988 -1.006 . . . . 2.2799999999999998 110.288 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 203' ' ' GLY . 37.4 mt -108.5 152.01 25.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.365 -0.38 . . . . 0.27000000000000002 110.257 174.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -50.37 -47.18 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.8 . . . . 0.45000000000000001 113.161 -171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 175' ' ' THR . 28.2 t70 -76.95 -6.09 51.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.04 0.448 . . . . 0.94999999999999996 111.406 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.98 13.47 39.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.803 -0.713 . . . . 0.35999999999999999 111.698 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.19 160.06 15.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.848 0.356 . . . . 0.33000000000000002 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.501 ' HB3' ' OD1' ' A' ' 205' ' ' ASP . 32.6 t -91.57 132.22 36.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.901 -0.591 . . . . 1.21 110.052 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -61.05 -27.07 66.61 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.305 -0.861 . . . . 0.14999999999999999 111.871 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.86 -46.97 95.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.038 -0.356 . . . . 0.20999999999999999 110.038 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 202' ' ' SER . 3.2 m-20 -57.2 -43.99 83.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.579 -0.737 . . . . 1.73 110.43 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.53 -40.99 98.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.17000000000000001 110.727 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLY . 44.0 t -64.04 -44.88 97.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.569 -0.741 . . . . 0.20999999999999999 110.893 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.38 -32.76 68.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.213 -0.449 . . . . 0.57999999999999996 111.221 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 76.2 m-20 -61.49 -50.73 71.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.253 0.549 . . . . 1.72 110.037 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.61 -43.02 90.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.205 -0.907 . . . . 0.23999999999999999 110.622 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.38 -17.63 64.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.71999999999999997 111.284 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -86.45 -6.04 81.37 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.277 -0.729 . . . . 0.31 111.277 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 53.7 mt-30 -107.18 -53.0 2.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.335 0.588 . . . . 0.85999999999999999 109.597 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' HE2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -130.68 179.61 5.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.173 -0.921 . . . . 0.39000000000000001 110.57 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -122.18 69.88 0.96 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.288 -0.869 . . . . 1.98 109.12 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -105.56 149.91 38.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.818 -1.083 . . . . 0.25 109.673 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 190' ' ' LEU . 58.7 Cg_endo -67.86 140.41 50.59 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.533 2.155 . . . . 0.28000000000000003 111.783 -176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 207' ' ' VAL . 38.6 t -125.69 130.19 72.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.255 -0.43 . . . . 0.63 110.869 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -112.09 126.09 69.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.873 -0.603 . . . . 0.19 109.769 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.37 100.96 12.09 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.177 -0.465 . . . . 0.34999999999999998 110.65 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 7.9 mt -101.62 107.61 21.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.707 -0.849 . . . . 0.67000000000000004 108.707 173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.629 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 9.7 t -152.1 162.0 41.78 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.509 . . . . 0.25 111.28 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.47 15.35 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.41999999999999998 110.531 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -134.16 71.38 72.96 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 111.732 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.452 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 28.7 Cg_endo -62.08 -30.95 83.35 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.581 2.188 . . . . 0.35999999999999999 111.543 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -53.91 -36.7 63.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.409 -0.814 . . . . 0.93999999999999995 111.705 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -39.91 82.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.257 0.551 . . . . 2.0499999999999998 109.853 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 39.3 mt -77.25 -27.65 53.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.132 -0.485 . . . . 0.52000000000000002 111.676 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 52.6 mt -77.91 -13.15 59.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 1.26 109.972 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 61.7 p -112.59 14.46 20.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.035 -0.984 . . . . 2.1000000000000001 110.538 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -41.22 97.88 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.189 -0.764 . . . . 3.4300000000000002 111.189 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -162.7 -76.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.106 -0.702 . . . . 5.2199999999999998 109.106 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.663 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 95.2 mtt180 -154.06 -54.62 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.74 -1.118 . . . . 7.0999999999999996 109.989 177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 27.7 Cg_exo -63.09 160.85 32.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.142 1.895 . . . . 2.52 111.93 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.14 154.4 37.66 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.686 -0.688 . . . . 1.9299999999999999 110.449 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 31.8 Cg_endo -62.84 141.28 84.1 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.78 2.32 . . . . 0.52000000000000002 110.994 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 14.3 m -64.73 -32.78 74.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.492 -0.776 . . . . 1.1000000000000001 111.493 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 256' ' ' ALA . 80.2 m-85 -138.4 106.77 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.226 -0.443 . . . . 0.52000000000000002 110.621 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 34.2 tp -124.3 120.92 33.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.844 -0.616 . . . . 0.28000000000000003 110.672 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 43.9 t -118.35 114.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.29999999999999999 109.243 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 13.6 p -83.98 140.12 32.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.932 -0.576 . . . . 0.48999999999999999 111.587 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 243' ' ' PRO . 85.9 mttt -87.04 142.5 33.92 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 110.583 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 7.9 Cg_exo -71.26 140.82 67.02 Favored 'Cis proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.575 -1.427 . . . . 0.76000000000000001 111.873 0.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.407 ' HD2' ' HG2' ' A' ' 242' ' ' LYS . 39.1 p90 -101.58 156.55 17.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.018 0.437 . . . . 0.45000000000000001 111.586 -173.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.566 ' O ' HG23 ' A' ' 249' ' ' VAL . 79.1 mt-30 -98.68 129.13 45.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 2.1400000000000001 109.744 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.507 ' HG2' HD11 ' A' ' 161' ' ' LEU . 41.5 mt-10 -57.26 -35.09 69.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.285 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -50.37 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 1.3400000000000001 110.403 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.5 m -55.42 -44.03 75.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.654 . . . . 0.25 110.713 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 245' ' ' GLN . 60.3 t -58.71 -57.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.541 -0.3 . . . . 0.19 110.891 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.502 ' HB3' HD21 ' A' ' 165' ' ' LEU . 38.9 mtm-85 -51.27 -43.41 61.56 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.36 0.6 . . . . 2.6899999999999999 110.707 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.65 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 93.8 m -57.67 -45.7 85.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 110.997 176.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.5 m -65.31 -45.37 84.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.20000000000000001 111.727 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.09 -47.42 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.687 0.279 . . . . 0.23000000000000001 111.117 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 138' ' ' GLY . 28.7 t -67.64 -25.27 65.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.313 -0.403 . . . . 1.1699999999999999 111.29 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 251' ' ' THR . 75.5 mm-40 -79.81 -46.25 17.27 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.444 0.64 . . . . 2.3399999999999999 110.436 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 238' ' ' TYR . . . -57.47 -32.16 66.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.299 -0.864 . . . . 0.35999999999999999 111.803 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 81.7 mt -93.62 -2.13 54.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.283 0.563 . . . . 1.02 111.078 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -86.76 -24.74 24.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.524 -0.762 . . . . 1.3799999999999999 109.801 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 33.6 t80 65.81 118.13 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 5.3700000000000001 111.283 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.66 69.51 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.479 -0.782 . . . . 5.25 111.246 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.01 -63.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.468 -0.567 . . . . 6.4000000000000004 109.468 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 46.1 m -154.21 65.09 4.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.12 -0.491 . . . . 7.9199999999999999 110.036 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.94 -58.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.828 2.352 . . . . 8.9900000000000002 112.295 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.4 m 63.28 63.23 0.92 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.293 -0.867 . . . . 10.84 109.993 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -121.65 156.96 31.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.563 -0.744 . . . . 11.789999999999999 110.638 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.163 -0.922 . . . . 13.24 111.37 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.859 -0.497 . . . . 7.6699999999999999 111.859 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.45 45.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.866 -0.42 . . . . 6.2300000000000004 109.866 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 88.4 mtp 62.87 24.64 14.66 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 123.461 0.476 . . . . 7.4500000000000002 109.899 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.23 -134.15 36.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.552 -0.749 . . . . 2.8100000000000001 111.795 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 p -129.23 142.03 50.97 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.981 0.42 . . . . 1.3 110.808 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' ND1' ' A' ' 167' ' ' HIS . 16.2 m -77.35 116.48 17.98 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.51000000000000001 110.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 24.1 p-10 -82.01 140.68 33.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.916 -0.402 . . . . 0.23000000000000001 109.916 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.8 t -119.66 133.89 64.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.335 0.588 . . . . 0.23999999999999999 112.034 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.0 tp -95.06 111.41 23.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.779 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' LEU . 52.6 mt -100.23 104.7 16.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.081 0.467 . . . . 0.23000000000000001 111.349 -176.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 193' ' ' ALA . 52.0 mt -91.66 100.53 11.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.867 -0.606 . . . . 0.16 109.692 176.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -152.38 129.91 11.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.5 109.367 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.96 -33.62 33.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.247 -0.888 . . . . 1.04 111.674 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.5 111.91 32.51 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.992 0.425 . . . . 1.29 110.828 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.8 -39.01 55.56 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.222 2.614 . . . . 0.58999999999999997 112.086 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.24 -42.59 98.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.70999999999999996 110.733 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 59.0 mt -74.04 -37.97 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.178 -0.465 . . . . 0.46000000000000002 110.394 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 40.9 t -59.92 -51.17 70.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.102 -0.499 . . . . 1.29 110.739 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.529 ' HA ' ' OE2' ' A' ' 159' ' ' GLU . 24.9 ptm -67.14 -28.6 68.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 2.3500000000000001 110.747 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -64.0 -48.53 76.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.039 -0.528 . . . . 1.3100000000000001 109.717 173.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 96.5 mt -62.82 -36.86 84.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.674 -0.693 . . . . 0.23999999999999999 110.79 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 155' ' ' SER . 44.9 mt-10 -57.86 -54.02 51.64 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 120.857 0.36 . . . . 0.67000000000000004 110.105 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.53 -42.95 99.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.54000000000000004 110.675 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 246' ' ' GLU . 0.6 OUTLIER -57.17 -55.62 32.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.839 -1.073 . . . . 1.4199999999999999 111.37 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 145' ' ' VAL . 4.1 p -70.14 -26.82 30.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.442 0.639 . . . . 0.28999999999999998 110.75 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -66.07 -40.0 90.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.205 -0.907 . . . . 3.25 110.696 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.8 t -63.73 -28.38 69.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.009 0.433 . . . . 1.1599999999999999 110.671 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 162' ' ' VAL . 68.9 mt -70.35 -13.95 62.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.40000000000000002 111.069 176.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.57 27.04 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.051 -0.595 . . . . 0.32000000000000001 112.255 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 162' ' ' VAL . 94.5 m-70 -99.81 172.84 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.015 0.436 . . . . 0.5 110.848 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.87 165.66 13.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.794 -0.639 . . . . 1.1899999999999999 110.506 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.31 116.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.022 0.439 . . . . 0.23000000000000001 110.411 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.97 -24.54 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.23999999999999999 110.504 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.07 159.21 11.11 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.837 -0.697 . . . . 0.17000000000000001 112.231 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.84 131.93 53.97 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.939 -0.393 . . . . 0.34999999999999998 109.939 175.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -138.97 124.77 19.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.445 -0.343 . . . . 0.28999999999999998 111.312 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -94.82 2.66 55.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.527 -0.306 . . . . 0.28999999999999998 111.531 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 199' ' ' ASP . 67.4 p -140.06 167.57 21.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.04 -0.356 . . . . 0.32000000000000001 110.04 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 22.6 ttt180 -72.57 -39.96 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.444 -0.502 . . . . 0.90000000000000002 110.441 177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 m -63.55 -42.1 98.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.869 0.366 . . . . 0.40000000000000002 110.617 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.23 -33.09 74.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 1.1899999999999999 110.563 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.28 91.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.25 110.247 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 96.4 mt-30 -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.596 -0.729 . . . . 0.98999999999999999 110.631 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 185' ' ' LYS . 23.9 mm-40 -66.82 -45.24 78.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.641 . . . . 2.2400000000000002 111.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.12 97.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 110.817 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.8 p -76.48 -22.26 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.457 0.646 . . . . 1.3300000000000001 110.072 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.82 -28.54 64.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.25 -0.886 . . . . 0.44 109.909 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 181' ' ' GLU . 68.5 mttm -79.87 -52.42 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.811 . . . . 2.02 110.637 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.38 136.06 31.04 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.863 -0.608 . . . . 0.63 110.571 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -85.89 118.98 71.51 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.887 -0.597 . . . . 1.6200000000000001 110.296 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 216' ' ' VAL . 92.2 Cg_endo -84.13 144.52 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.381 2.72 . . . . 0.26000000000000001 112.113 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.8 -17.02 66.55 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.383 -0.687 . . . . 0.23999999999999999 111.383 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.627 ' HB3' HG22 ' A' ' 145' ' ' VAL . 24.7 tp -143.52 145.3 32.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.346 -0.613 . . . . 0.65000000000000002 109.346 175.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.481 ' HB ' HG22 ' A' ' 218' ' ' VAL . 67.1 t -123.86 138.2 54.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.178 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 147' ' ' ILE . 3.6 mt -115.91 154.77 29.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.069 -0.715 . . . . 1.47 109.069 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 148' ' ' ILE . . . -168.6 147.11 4.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.552 0.575 . . . . 0.17999999999999999 112.552 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.629 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.5 t70 -105.63 -178.5 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 169.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.572 HG12 ' OG1' ' A' ' 222' ' ' THR . 26.0 mm -86.9 -52.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 110.186 177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -89.11 102.05 14.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.468 -0.787 . . . . 2.2799999999999998 110.951 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 62.5 mt -89.54 166.79 13.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.251 -0.432 . . . . 0.27000000000000002 110.599 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.48 94.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.194 0.521 . . . . 0.45000000000000001 111.511 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.489 ' H ' HG22 ' A' ' 175' ' ' THR . 8.6 t70 -62.69 -22.64 66.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.459 -0.792 . . . . 0.94999999999999996 111.48 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 106.02 -10.98 44.62 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.799 -0.92 . . . . 0.35999999999999999 110.799 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 154.63 41.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.926 0.393 . . . . 0.33000000000000002 110.361 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 19.3 m -86.17 128.87 34.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.122 -0.49 . . . . 1.21 110.185 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -58.88 -26.66 60.9 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.46 -0.791 . . . . 0.14999999999999999 112.33 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.429 ' O ' ' HG3' ' A' ' 208' ' ' GLU . 63.4 mt -60.13 -42.95 91.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.786 0.326 . . . . 0.20999999999999999 110.303 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -64.78 -39.12 93.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.59 . . . . 1.73 109.79 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.08 99.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.17000000000000001 110.408 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.452 ' CG1' HG11 ' A' ' 218' ' ' VAL . 37.3 t -63.72 -49.92 80.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.395 -0.82 . . . . 0.20999999999999999 111.234 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 47.6 mt-10 -58.61 -32.1 68.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.57999999999999996 111.115 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 7.3 t70 -60.49 -53.72 54.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.507 0.67 . . . . 1.72 109.698 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 53.5 mt -60.56 -42.66 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.039 . . . . 0.23999999999999999 110.808 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.3 mt -66.85 -16.05 64.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.71999999999999997 111.617 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -88.14 -10.11 69.31 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.321 -0.712 . . . . 0.31 111.321 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 37.7 mt-30 -104.04 -52.5 2.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.225 0.536 . . . . 0.85999999999999999 109.704 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 178.41 6.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.295 -0.866 . . . . 0.39000000000000001 109.752 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -121.82 63.54 0.92 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.963 0.887 . . . . 1.98 109.423 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -99.78 151.29 37.42 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.502 -1.226 . . . . 0.25 109.75 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.494 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 54.7 Cg_endo -66.97 134.59 34.89 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.491 2.127 . . . . 0.28000000000000003 112.14 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.481 HG22 ' HB ' ' A' ' 191' ' ' VAL . 38.9 t -123.44 136.65 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.117 -0.492 . . . . 0.63 110.284 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.44 ' HB ' HD22 ' A' ' 192' ' ' LEU . 67.8 mt -120.27 127.11 75.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.894 -0.594 . . . . 0.19 109.797 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -95.97 102.4 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.257 -0.429 . . . . 0.34999999999999998 110.852 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 221' ' ' ILE . 2.8 mp -96.99 107.29 19.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.938 -1.134 . . . . 0.67000000000000004 107.938 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 195' ' ' ILE . 8.8 t -153.74 167.3 30.07 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.41 -0.516 . . . . 0.25 111.129 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -97.24 9.16 42.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.904 -0.589 . . . . 0.41999999999999998 110.983 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -127.38 76.25 76.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.869 0.366 . . . . 0.69999999999999996 111.634 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.603 ' O ' ' HG ' ' A' ' 229' ' ' LEU . 37.7 Cg_endo -66.56 -40.14 14.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.627 2.218 . . . . 0.35999999999999999 111.806 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.6 -18.89 63.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.93999999999999995 111.041 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -73.87 -43.96 56.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.291 0.567 . . . . 2.0499999999999998 109.599 176.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.511 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 18.8 mt -83.13 -22.03 33.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.63 -0.714 . . . . 0.52000000000000002 112.362 -172.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 225' ' ' PRO . 58.8 mt -80.48 12.11 3.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.083 0.468 . . . . 1.26 110.774 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.1 t -151.25 44.52 0.8 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.583 0.706 . . . . 2.1000000000000001 110.295 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.4 -73.77 0.44 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.914 -0.66 . . . . 3.4300000000000002 111.503 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -130.35 -45.49 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.903 -0.777 . . . . 5.2199999999999998 108.903 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.649 ' HB2' ' HD3' ' A' ' 234' ' ' PRO . 57.2 mtp180 -148.9 -59.52 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.368 -0.833 . . . . 7.0999999999999996 111.636 173.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 233' ' ' ARG . 4.0 Cg_exo -76.68 153.58 34.09 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.236 1.957 . . . . 2.52 112.625 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 236' ' ' PRO . 7.7 pt-20 -95.71 160.29 30.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.649 -0.871 . . . . 1.9299999999999999 108.649 173.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.511 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 49.8 Cg_endo -67.4 133.61 30.8 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.515 2.143 . . . . 0.52000000000000002 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.449 HG21 HE22 ' A' ' 260' ' ' GLN . 6.5 m -61.98 -30.45 70.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.844 -0.616 . . . . 1.1000000000000001 111.607 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 75.3 m-85 -126.46 111.89 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 0.52000000000000002 110.276 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 30.1 tp -135.29 124.72 24.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 110.72 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 221' ' ' ILE . 84.8 t -122.08 124.92 72.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.29999999999999999 109.522 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 222' ' ' THR . 9.8 p -98.92 139.56 34.39 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.452 0.538 . . . . 0.48999999999999999 112.452 -173.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.404 ' HE2' HD13 ' A' ' 154' ' ' ILE . 5.8 mptt -81.1 138.86 49.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.547 . . . . 0.78000000000000003 110.129 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.39 141.46 71.83 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.615 -1.411 . . . . 0.76000000000000001 111.371 -4.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -101.17 155.83 17.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.439 0.637 . . . . 0.45000000000000001 112.115 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 249' ' ' VAL . 50.8 mt-30 -98.23 130.4 44.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.087 -0.96 . . . . 2.1400000000000001 108.928 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.416 ' HB3' HD21 ' A' ' 161' ' ' LEU . 42.7 mt-10 -57.94 -33.95 69.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 1.6599999999999999 111.032 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 66.4 m -64.6 -49.0 72.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 1.3400000000000001 110.68 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 97.9 m -57.03 -41.65 78.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.25 110.834 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 t -60.67 -58.06 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.19 110.479 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -52.72 -39.46 62.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.162 0.506 . . . . 2.6899999999999999 110.983 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.68 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 78.2 m -59.5 -44.53 93.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.326 -0.852 . . . . 0.27000000000000002 111.051 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 25.6 m -69.92 -43.78 71.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.494 -0.321 . . . . 0.20000000000000001 111.483 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 190' ' ' LEU . 1.7 mp -54.03 -46.92 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.653 0.263 . . . . 0.23000000000000001 111.508 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.1 p -69.27 -25.06 64.07 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.972 -0.291 . . . . 1.1699999999999999 111.731 -174.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 251' ' ' THR . 70.1 mm-40 -78.08 -46.69 20.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.286 0.565 . . . . 2.3399999999999999 109.926 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -57.18 -36.53 70.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.092 -0.958 . . . . 0.35999999999999999 111.149 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 190' ' ' LEU . 64.4 mt -89.27 6.62 39.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.98 -0.555 . . . . 1.02 111.52 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -84.3 -4.43 58.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.411 -0.959 . . . . 1.3799999999999999 108.411 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 10.4 t80 69.45 51.24 0.49 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.71 -1.586 . . . . 5.3700000000000001 111.591 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.449 HE22 HG21 ' A' ' 237' ' ' THR . 20.5 mm-40 66.79 102.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.829 -1.078 . . . . 5.25 112.278 172.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.79 -27.27 15.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 6.4000000000000004 110.739 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 263' ' ' PRO . 15.4 m -60.88 -46.05 96.79 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.188 -0.46 . . . . 7.9199999999999999 111.804 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 262' ' ' SER . 10.7 Cg_exo -74.34 62.69 5.29 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.041 1.827 . . . . 8.9900000000000002 110.884 171.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.6 m -58.63 129.97 44.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.416 -0.811 . . . . 10.84 111.055 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -78.46 78.91 4.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.992 -0.549 . . . . 11.789999999999999 110.927 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.978 -0.556 . . . . 13.24 111.013 179.667 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.659 ' N ' ' HG ' ' A' ' 262' ' ' SER . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.133 -0.387 . . . . 7.6699999999999999 112.133 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.23 171.03 8.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.634 0.254 . . . . 6.2300000000000004 110.679 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 67.2 mtt -139.51 85.35 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.842 0.353 . . . . 7.4500000000000002 110.845 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.16 -153.8 24.79 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.687 -0.768 . . . . 2.8100000000000001 112.181 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.2 p -69.04 96.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.186 0.517 . . . . 1.3 110.988 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -76.65 118.6 19.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.568 -0.742 . . . . 0.51000000000000001 110.082 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 23.9 p-10 -71.88 129.17 37.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.23000000000000001 110.551 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 190' ' ' LEU . 61.1 t -113.78 134.85 55.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.739 -0.664 . . . . 0.23999999999999999 111.911 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -93.08 113.81 26.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.412 -0.813 . . . . 0.16 110.134 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.29 105.15 17.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.099 0.476 . . . . 0.23000000000000001 111.286 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 45.2 mt -98.24 99.44 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.16 109.643 175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -152.35 126.1 8.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.284 -0.871 . . . . 0.5 108.884 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -35.73 66.86 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.45 -0.796 . . . . 1.04 111.412 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 11.9 tp10 -76.91 114.47 39.65 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-O 120.834 0.349 . . . . 1.29 110.744 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 6.8 Cg_exo -70.82 -32.28 14.41 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.989 2.46 . . . . 0.58999999999999997 112.414 -172.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.29 -34.94 79.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.088 0.471 . . . . 0.70999999999999996 110.538 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.19 -34.91 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.92 -0.582 . . . . 0.46000000000000002 109.837 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 49.0 m -56.09 -58.2 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.632 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 152' ' ' PRO . 27.1 ptm -63.48 -29.49 70.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.488 -0.324 . . . . 2.3500000000000001 111.059 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -60.48 3.73 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.874 0.845 . . . . 1.3100000000000001 109.182 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.9 mt -50.82 -41.97 57.94 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.66 -1.609 . . . . 0.23999999999999999 111.725 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.7 mt-10 -54.78 -53.34 56.37 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.012 0.434 . . . . 0.67000000000000004 110.556 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.63 -43.77 83.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.759 -0.655 . . . . 0.54000000000000004 110.956 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 tp -57.42 -52.24 66.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.505 -0.77 . . . . 1.4199999999999999 111.268 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 165' ' ' LEU . 3.3 p -71.01 -28.96 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.154 -0.476 . . . . 0.28999999999999998 110.905 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 167' ' ' HIS . 45.2 ttm180 -71.03 -33.5 70.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 3.25 110.269 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.6 m -66.67 -24.06 66.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 110.548 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 162' ' ' VAL . 75.9 mt -76.65 -11.62 59.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.992 -0.549 . . . . 0.40000000000000002 111.006 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.94 49.47 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.713 -0.756 . . . . 0.32000000000000001 111.962 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 162' ' ' VAL . 98.7 m-70 -98.91 179.39 4.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.21 179.01 5.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 111.741 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 159' ' ' GLU . 41.0 mm -114.6 116.09 51.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 0.23000000000000001 109.713 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -84.29 -20.02 32.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 110.089 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.72 155.69 7.9 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.431 -0.804 . . . . 0.17000000000000001 111.86 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.7 p -113.42 139.37 48.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.982 -0.377 . . . . 0.34999999999999998 109.982 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.84 131.96 21.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.228 -0.442 . . . . 0.28999999999999998 111.075 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -102.86 -3.95 25.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.628 0.251 . . . . 0.28999999999999998 111.011 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.3 p -137.19 168.24 20.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.015 -0.365 . . . . 0.32000000000000001 110.015 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 32.2 ttt-85 -70.6 -35.08 72.8 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -58.47 -46.29 86.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.40000000000000002 110.712 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -62.35 -38.63 90.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.1899999999999999 110.597 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.525 ' O ' HG22 ' A' ' 183' ' ' VAL . . . -61.48 -43.21 99.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.25 110.7 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.6 mt-30 -65.5 -29.8 70.48 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.962 -0.563 . . . . 0.98999999999999999 110.895 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -81.45 -36.92 28.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 111.416 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.1 38.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.603 . . . . 0.40000000000000002 111.039 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 179' ' ' ALA . 6.8 m -68.88 -27.6 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.178 -0.464 . . . . 1.3300000000000001 111.514 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.96 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.145 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -86.62 -60.97 1.84 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.593 -0.73 . . . . 2.02 110.59 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 28.1 tt0 -134.2 137.26 44.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.602 -0.727 . . . . 0.63 111.214 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -86.43 113.81 54.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.49 -0.777 . . . . 1.6200000000000001 109.784 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 216' ' ' VAL . 63.0 Cg_endo -73.04 154.2 52.53 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.161 2.574 . . . . 0.26000000000000001 112.14 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -94.36 -10.51 58.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.119 -0.792 . . . . 0.23999999999999999 111.119 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.549 ' HB3' HG22 ' A' ' 145' ' ' VAL . 30.8 tp -152.75 144.48 23.55 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.21 -0.663 . . . . 0.65000000000000002 109.21 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.6 t -121.52 139.99 46.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.347 0.594 . . . . 0.20000000000000001 111.068 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.3 135.0 54.01 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.655 -1.239 . . . . 1.47 107.655 178.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.58 143.37 20.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.86 0.689 . . . . 0.17999999999999999 112.86 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.606 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 21.9 t70 -98.76 165.31 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.38 108.839 171.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.534 HG12 ' OG1' ' A' ' 222' ' ' THR . 28.2 mm -74.47 -47.63 38.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 118.096 0.407 . . . . 0.23000000000000001 110.943 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -95.16 104.07 15.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.082 0.468 . . . . 2.2799999999999998 110.802 -171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 203' ' ' GLY . 56.4 mt -92.23 166.77 12.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.004 -0.544 . . . . 0.27000000000000002 110.679 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.51 -37.24 85.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.19 0.519 . . . . 0.45000000000000001 111.659 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 175' ' ' THR . 19.4 t70 -69.55 -17.14 63.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.733 -0.667 . . . . 0.94999999999999996 110.973 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.79 -12.83 62.63 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.684 -0.967 . . . . 0.35999999999999999 110.684 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 17.6 p -67.48 147.01 53.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.253 -0.474 . . . . 0.33000000000000002 110.142 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ILE . 37.5 m -77.99 129.67 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.026 0.441 . . . . 1.21 110.2 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -59.77 -24.34 59.94 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.548 -0.751 . . . . 0.14999999999999999 112.324 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 195' ' ' ILE . 56.2 mt -63.23 -42.37 96.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.904 0.383 . . . . 0.20999999999999999 110.166 175.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.48 -39.6 94.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.834 -0.621 . . . . 1.73 109.749 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 210' ' ' ILE . . . -61.22 -45.27 95.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.63 -0.714 . . . . 0.17000000000000001 110.282 176.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 211' ' ' LEU . 41.3 t -61.2 -56.63 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.53 -0.759 . . . . 0.20999999999999999 111.259 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -55.18 -33.94 63.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.57999999999999996 111.308 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 213' ' ' GLN . 8.1 t70 -60.34 -50.17 74.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.424 0.631 . . . . 1.72 109.723 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 206' ' ' ALA . 60.9 mt -56.66 -47.95 81.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.825 -1.079 . . . . 0.23999999999999999 110.894 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 207' ' ' VAL . 0.5 OUTLIER -59.91 -28.5 67.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.638 0.732 . . . . 0.71999999999999997 112.079 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.49 -8.05 59.02 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.174 -0.921 . . . . 0.31 111.639 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 209' ' ' ASP . 35.2 mt-30 -117.52 -46.73 2.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.316 0.579 . . . . 0.85999999999999999 110.505 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -118.42 -179.0 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.39000000000000001 111.42 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -128.02 76.25 1.67 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.066 -0.97 . . . . 1.98 108.859 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.1 t -124.1 149.25 59.85 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.469 -0.787 . . . . 0.25 110.474 -170.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 190' ' ' LEU . 56.5 Cg_endo -69.43 140.55 44.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.888 2.392 . . . . 0.28000000000000003 111.951 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG21 HG13 ' A' ' 207' ' ' VAL . 23.1 t -126.81 133.05 69.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.63 110.738 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 69.3 mt -115.65 123.23 70.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.746 -0.661 . . . . 0.19 109.715 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 239' ' ' LEU . 92.0 m-85 -95.8 91.42 6.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.148 -0.478 . . . . 0.34999999999999998 110.914 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.461 HG12 ' HB ' ' A' ' 240' ' ' VAL . 12.7 mt -89.83 107.55 18.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.478 -0.934 . . . . 0.67000000000000004 108.478 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.554 ' HA ' ' OD1' ' A' ' 194' ' ' ASP . 15.2 t -153.35 163.73 39.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.311 -0.556 . . . . 0.25 111.097 -173.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.48 12.05 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.139 -0.482 . . . . 0.41999999999999998 110.527 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' A' ' 195' ' ' ILE . 53.7 m-85 -128.06 75.16 78.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.69999999999999996 110.527 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.89 -46.72 8.02 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.009 2.472 . . . . 0.35999999999999999 113.2 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -65.99 -21.46 66.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.546 -0.297 . . . . 0.93999999999999995 111.417 -175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 0.3 OUTLIER -62.89 -26.88 69.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.366 0.603 . . . . 2.0499999999999998 109.73 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 236' ' ' PRO . 20.6 mt -98.22 -12.7 21.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.41 -0.814 . . . . 0.52000000000000002 112.4 -177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.93 0.94 54.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.483 0.658 . . . . 1.26 110.395 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 6.6 t -167.16 48.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.938 -1.028 . . . . 2.1000000000000001 110.046 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -83.16 -63.1 1.75 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.685 -0.769 . . . . 3.4300000000000002 111.749 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -172.08 -32.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.532 0.682 . . . . 5.2199999999999998 109.705 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.649 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 38.3 mtt180 -104.82 -170.65 0.21 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.126 -0.943 . . . . 7.0999999999999996 108.765 177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.649 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 12.4 Cg_exo -70.0 175.3 8.48 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.943 1.762 . . . . 2.52 111.756 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.93 138.02 97.11 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.38 -0.827 . . . . 1.9299999999999999 109.955 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 228' ' ' LEU . 42.2 Cg_endo -66.36 127.92 18.33 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.946 2.431 . . . . 0.52000000000000002 111.845 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -65.43 -28.49 69.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 110.899 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 55.8 m-85 -127.16 103.06 7.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.878 -0.601 . . . . 0.52000000000000002 110.307 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 220' ' ' PHE . 32.7 tp -133.32 123.95 26.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.344 -0.844 . . . . 0.28000000000000003 110.291 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' A' ' 221' ' ' ILE . 46.3 t -125.6 125.07 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.097 -0.501 . . . . 0.29999999999999999 109.771 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 222' ' ' THR . 10.0 p -89.49 135.11 33.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.101 -0.5 . . . . 0.48999999999999999 111.637 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 222' ' ' THR . 39.4 mtpt -90.68 140.07 26.45 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.78000000000000003 110.644 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 242' ' ' LYS . 11.8 Cg_exo -70.34 148.05 87.19 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.798 -1.334 . . . . 0.76000000000000001 111.924 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -111.07 173.66 6.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.57 . . . . 0.45000000000000001 112.066 -170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 249' ' ' VAL . 65.3 mt-30 -107.75 125.97 52.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.277 -0.874 . . . . 2.1400000000000001 109.089 175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 43.3 mt-10 -60.41 -33.4 72.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.6599999999999999 111.171 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.0 m -64.65 -46.19 83.55 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.897 0.379 . . . . 1.3400000000000001 110.445 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 98.2 m -58.94 -44.25 91.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.952 -0.567 . . . . 0.25 110.486 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 245' ' ' GLN . 66.5 t -58.68 -55.26 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.383 . . . . 0.19 110.98 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 50.9 mtt180 -51.32 -48.21 62.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.45 0.643 . . . . 2.6899999999999999 110.277 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.3 m -54.72 -44.17 73.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.616 -1.175 . . . . 0.27000000000000002 111.496 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.52 ' HA ' ' HG2' ' A' ' 255' ' ' GLN . 25.1 m -70.77 -43.9 67.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.464 -0.335 . . . . 0.20000000000000001 111.393 -175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.4 -48.46 68.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.969 0.414 . . . . 0.23000000000000001 110.556 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 15.5 t -63.93 -41.93 97.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.86 -0.609 . . . . 1.1699999999999999 111.085 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 252' ' ' THR . 27.0 pt20 -74.1 -41.29 61.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 2.3399999999999999 110.781 -175.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -53.82 -39.93 65.95 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.824 -1.08 . . . . 0.35999999999999999 111.501 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 190' ' ' LEU . 82.1 mt -78.52 -24.52 45.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.17 -0.468 . . . . 1.02 111.553 -177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -73.71 -12.84 60.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 1.3799999999999999 109.867 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 256' ' ' ALA . 58.3 t80 -81.66 -2.87 51.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.766 0.793 . . . . 5.3700000000000001 110.341 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.31 122.71 29.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.381 -0.827 . . . . 5.25 110.647 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.98 123.51 22.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.165 -0.47 . . . . 6.4000000000000004 109.893 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.659 ' HG ' ' N ' ' A' ' 138' ' ' GLY . 23.5 m -119.58 85.48 32.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.968 0.413 . . . . 7.9199999999999999 110.974 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.23 -8.72 21.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.077 2.518 . . . . 8.9900000000000002 111.923 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.9 p -81.89 -21.33 37.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.485 -0.78 . . . . 10.84 110.901 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.97 81.76 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.529 . . . . 11.789999999999999 110.637 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.53 -0.747 . . . . 13.24 109.987 -179.419 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.939 -0.464 . . . . 7.6699999999999999 111.939 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.5 -27.75 6.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.764 0.316 . . . . 6.2300000000000004 111.483 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.83 29.53 7.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.334 0.588 . . . . 7.4500000000000002 110.666 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.04 123.65 1.37 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.172 -0.771 . . . . 2.8100000000000001 111.172 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 p -92.46 118.12 30.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.039 0.447 . . . . 1.3 111.505 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.4 m -78.54 125.3 29.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.98 -0.555 . . . . 0.51000000000000001 109.776 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 27.8 p-10 -73.88 140.87 45.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.844 -0.616 . . . . 0.23000000000000001 111.094 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' 190' ' ' LEU . 57.5 t -123.3 140.53 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.053 -0.522 . . . . 0.23999999999999999 111.177 -176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.08 121.02 36.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.512 -0.767 . . . . 0.16 110.257 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.41 107.04 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.994 0.426 . . . . 0.23000000000000001 111.203 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 24.9 mt -101.07 99.68 8.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.697 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.33 124.07 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.626 -0.715 . . . . 0.5 109.211 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -75.7 -31.42 59.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 1.04 111.63 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 41.9 mt-10 -82.63 111.58 30.23 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 1.29 111.1 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 23.4 Cg_exo -61.03 -37.9 72.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.604 2.87 . . . . 0.58999999999999997 113.071 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.67 -46.66 83.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.141 0.496 . . . . 0.70999999999999996 110.241 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.28 -34.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.469 -0.787 . . . . 0.46000000000000002 110.422 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.561 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 20.0 m -57.51 -57.34 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.29 110.714 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 84.4 mmm -61.32 -35.39 77.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 2.3500000000000001 110.93 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 47.4 tp60 -60.78 -48.55 81.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 109.808 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.3 -37.38 83.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.502 -0.772 . . . . 0.23999999999999999 111.03 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 155' ' ' SER . 36.6 mt-10 -59.41 -50.38 74.16 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.67000000000000004 110.808 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.02 -42.12 73.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.838 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -53.88 -50.52 66.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.41 -0.814 . . . . 1.4199999999999999 110.642 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 167' ' ' HIS . 2.9 p -72.67 -27.34 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.976 -0.557 . . . . 0.28999999999999998 110.871 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 163' ' ' ARG . 15.2 ttp180 -67.08 -39.71 86.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.715 -0.675 . . . . 3.25 110.586 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.4 t -58.39 -28.85 65.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.318 0.58 . . . . 1.1599999999999999 110.31 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 250' ' ' ARG . 54.6 mt -83.5 5.41 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.539 -0.755 . . . . 0.40000000000000002 111.743 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 138' ' ' GLY . . . 73.35 36.99 54.66 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.893 -0.67 . . . . 0.32000000000000001 112.019 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.6 ' HB2' HG22 ' A' ' 162' ' ' VAL . 95.1 m-70 -116.24 171.84 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.112 -0.329 . . . . 0.5 110.112 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 169.22 12.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.057 -0.52 . . . . 1.1899999999999999 110.077 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 40.7 mm -100.0 117.94 45.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.964 0.411 . . . . 0.23000000000000001 110.383 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -82.04 -20.8 37.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.775 -0.648 . . . . 0.23999999999999999 109.907 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.77 153.36 7.16 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.346 -0.843 . . . . 0.17000000000000001 111.529 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -112.99 139.78 48.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.967 0.413 . . . . 0.34999999999999998 109.97 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -143.22 134.32 25.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.28999999999999998 110.951 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -104.65 -5.28 21.54 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.28999999999999998 110.438 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 199' ' ' ASP . 72.4 p -134.88 169.34 17.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.593 -0.276 . . . . 0.32000000000000001 110.584 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.8 ttt180 -65.42 -42.21 92.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.027 -0.36 . . . . 0.90000000000000002 110.027 176.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.8 m -58.45 -45.04 89.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.764 -0.653 . . . . 0.40000000000000002 110.829 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -61.9 -37.47 84.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.1899999999999999 110.897 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.36 -41.16 96.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.055 -0.52 . . . . 0.25 110.824 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 46.3 mt-30 -68.01 -33.89 75.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.847 -0.615 . . . . 0.98999999999999999 110.574 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.109 -0.496 . . . . 2.2400000000000002 111.013 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.17 -54.02 50.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.819 -0.628 . . . . 0.40000000000000002 111.073 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 186' ' ' GLU . 16.0 m -70.04 -29.12 38.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 1.3300000000000001 111.499 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.31 -29.54 69.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.49 175.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -89.13 -52.4 5.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.89 -0.595 . . . . 2.02 110.645 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 183' ' ' VAL . 29.4 tt0 -143.21 135.05 26.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.57 -0.741 . . . . 0.63 110.698 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -86.57 119.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.867 -0.606 . . . . 1.6200000000000001 110.645 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.427 ' CD ' HG12 ' A' ' 183' ' ' VAL . 74.8 Cg_endo -78.02 144.75 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.124 2.55 . . . . 0.26000000000000001 111.885 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.28 -8.76 77.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.727 -0.749 . . . . 0.23999999999999999 111.231 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.603 ' HB3' HG22 ' A' ' 145' ' ' VAL . 31.2 tp -150.71 144.16 24.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.062 -0.718 . . . . 0.65000000000000002 109.062 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 218' ' ' VAL . 57.3 t -122.11 139.66 48.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 0.20000000000000001 110.981 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 130.4 52.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 1.47 108.141 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.23 145.91 27.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.477 0.547 . . . . 0.17999999999999999 112.477 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 222' ' ' THR . 7.9 t70 -100.62 179.74 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 170.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 ' OG1' ' A' ' 222' ' ' THR . 31.7 mm -86.68 -54.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.07 0.462 . . . . 0.23000000000000001 110.388 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.17 110.76 19.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 110.729 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 57.9 mt -96.24 -179.32 4.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 110.169 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.54 -52.83 19.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.355 0.502 . . . . 0.45000000000000001 112.355 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 175' ' ' THR . 12.4 t70 -87.04 30.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 111.079 -172.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.05 -3.81 56.32 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.925 -0.655 . . . . 0.35999999999999999 113.157 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 1.3 p -74.27 154.55 38.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.914 0.357 . . . . 0.33000000000000002 110.617 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.515 ' HB2' ' OD1' ' A' ' 205' ' ' ASP . 27.6 m -96.73 132.18 42.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.152 0.501 . . . . 1.21 110.325 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.16 -30.3 70.32 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.234 -0.893 . . . . 0.14999999999999999 112.501 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.501 HD11 HD12 ' A' ' 195' ' ' ILE . 56.5 mt -62.71 -42.88 97.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.227 -0.286 . . . . 0.20999999999999999 110.227 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 202' ' ' SER . 1.8 m-20 -61.96 -39.04 90.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.73 110.342 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.72 99.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.79 -0.641 . . . . 0.17000000000000001 110.087 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 218' ' ' VAL . 40.8 t -63.66 -49.72 81.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.20999999999999999 111.265 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 204' ' ' ILE . 48.8 mt-10 -57.79 -35.55 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.57999999999999996 110.881 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.65 -50.6 72.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.391 0.615 . . . . 1.72 109.819 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.514 ' HA ' HE21 ' A' ' 213' ' ' GLN . 54.9 mt -58.47 -44.65 89.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.966 -1.016 . . . . 0.23999999999999999 110.862 174.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.32 -14.99 63.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.862 -0.608 . . . . 0.71999999999999997 112.429 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -81.51 -9.83 85.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.456 -0.878 . . . . 0.31 110.977 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 210' ' ' ILE . 34.0 mt-30 -112.11 -54.18 2.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.589 0.709 . . . . 0.85999999999999999 109.728 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -109.56 176.32 5.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.942 -1.026 . . . . 0.39000000000000001 110.239 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.54 56.14 1.66 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.315 -0.994 . . . . 1.98 108.315 172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.66 152.27 39.03 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 114.479 -1.237 . . . . 0.25 109.878 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 190' ' ' LEU . 49.0 Cg_endo -66.6 132.02 27.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.545 2.163 . . . . 0.28000000000000003 111.838 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 207' ' ' VAL . 43.5 t -122.62 128.97 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.121 0.486 . . . . 0.63 110.568 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.0 mt -111.98 122.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.19 110.108 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 239' ' ' LEU . 87.5 m-85 -93.63 108.02 19.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.977 -0.556 . . . . 0.34999999999999998 110.2 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.5 mt -113.22 107.48 23.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.881 -0.785 . . . . 0.67000000000000004 108.881 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.669 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.7 t -149.31 162.75 39.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.283 0.563 . . . . 0.25 111.811 -171.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 242' ' ' LYS . . . -89.0 3.22 52.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.41999999999999998 110.403 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -124.93 68.92 56.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.69999999999999996 110.936 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.89 -33.9 83.11 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.666 2.244 . . . . 0.35999999999999999 112.001 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 230' ' ' THR . 10.6 pt-20 -68.3 -18.3 64.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.93999999999999995 111.712 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' A' ' 227' ' ' ARG . 3.9 tmt_? -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.322 0.582 . . . . 2.0499999999999998 109.845 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 21.8 mt -97.87 1.23 47.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 111.067 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 37.7 mt -120.69 -133.17 0.3 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.719 -0.673 . . . . 1.26 110.225 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 226' ' ' GLU . 14.8 p 58.61 4.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.017 1.327 . . . . 2.1000000000000001 112.461 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.47 67.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.203 -0.523 . . . . 3.4300000000000002 112.553 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 -37.46 10.07 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 5.2199999999999998 111.21 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.588 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 26.1 mmt180 -113.84 -178.29 0.51 Allowed Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.585 -0.734 . . . . 7.0999999999999996 110.217 -174.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 10.4 Cg_exo -72.83 137.29 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.632 2.222 . . . . 2.52 111.347 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.45 119.61 75.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.602 -0.726 . . . . 1.9299999999999999 110.207 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.06 139.94 19.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.14 2.56 . . . . 0.52000000000000002 112.358 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.3 m -80.45 -30.13 37.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 1.1000000000000001 110.245 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 256' ' ' ALA . 64.4 m-85 -126.37 107.12 10.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.936 -0.575 . . . . 0.52000000000000002 110.043 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 220' ' ' PHE . 46.1 tp -132.14 124.48 29.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 0.28000000000000003 111.008 -175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 99.4 t -125.43 142.31 42.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.563 -0.744 . . . . 0.29999999999999999 109.141 176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 222' ' ' THR . 16.7 p -101.57 146.25 27.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.057 0.455 . . . . 0.48999999999999999 111.879 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -93.14 134.45 27.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.78000000000000003 109.56 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.56 144.23 78.43 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.905 -1.29 . . . . 0.76000000000000001 111.915 -1.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -95.06 170.52 9.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.5 0.667 . . . . 0.45000000000000001 111.967 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 249' ' ' VAL . 16.2 mm100 -109.92 123.87 50.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.885 -1.052 . . . . 2.1400000000000001 108.652 172.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 25.9 mt-10 -56.62 -33.04 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.546 -0.752 . . . . 1.6599999999999999 112.53 -172.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.605 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 5.9 t -67.27 -43.09 82.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.951 -0.388 . . . . 1.3400000000000001 109.951 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' A' ' 251' ' ' THR . 96.7 m -61.89 -42.26 98.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.25 110.429 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 245' ' ' GLN . 42.5 t -61.49 -53.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.19 110.744 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 247' ' ' SER . 62.3 mtm180 -51.03 -43.85 60.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.282 0.563 . . . . 2.6899999999999999 110.629 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 248' ' ' THR . 53.7 m -57.33 -44.14 83.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.948 -1.024 . . . . 0.27000000000000002 111.422 176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 8.1 m -70.25 -44.94 67.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.208 -0.451 . . . . 0.20000000000000001 111.388 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.69 -47.02 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 111.02 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -34.96 72.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 1.1699999999999999 111.169 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 252' ' ' THR . 3.6 pt20 -75.18 -42.33 56.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.213 0.53 . . . . 2.3399999999999999 110.509 -177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 238' ' ' TYR . . . -59.39 -34.63 72.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.043 -0.981 . . . . 0.35999999999999999 111.679 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 190' ' ' LEU . 37.2 mt -80.3 -12.01 59.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.296 0.569 . . . . 1.02 111.205 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -86.59 -45.49 11.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.523 -0.917 . . . . 1.3799999999999999 108.523 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HD2' ' ND2' ' A' ' 261' ' ' ASN . 1.4 t80 60.26 88.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.519 -1.219 . . . . 5.3700000000000001 110.933 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -79.39 104.6 10.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.23 -1.35 . . . . 5.25 110.234 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 259' ' ' PHE . 7.5 p30 -159.16 -44.84 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.768 -0.196 . . . . 6.4000000000000004 110.902 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.5 p 176.49 146.63 0.27 Allowed Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 122.939 0.496 . . . . 7.9199999999999999 109.669 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.96 53.29 4.11 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.682 2.255 . . . . 8.9900000000000002 111.697 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.7 m -148.69 123.22 9.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.752 -0.658 . . . . 10.84 110.134 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . 58.73 44.94 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.214 0.531 . . . . 11.789999999999999 111.083 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.248 1.005 0 CA-C-N 116.102 -0.499 . . . . 13.24 110.522 179.112 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.939 -0.464 . . . . 7.6699999999999999 111.939 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.56 77.87 9.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.853 0.359 . . . . 6.2300000000000004 110.156 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.1 mmt 63.64 44.95 4.85 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.509 -0.769 . . . . 7.4500000000000002 110.552 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.51 -129.09 30.69 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.128 -0.789 . . . . 2.8100000000000001 111.128 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -82.55 118.68 23.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.799 -0.815 . . . . 1.3 108.799 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -76.23 122.45 24.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.016 0.436 . . . . 0.51000000000000001 110.757 -173.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 25.2 p-10 -77.39 143.06 38.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 110.425 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 190' ' ' LEU . 59.0 t -122.77 139.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.075 0.464 . . . . 0.23999999999999999 111.757 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.1 tp -97.0 119.3 35.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.16 110.236 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.72 108.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 111.268 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 173' ' ' ALA . 50.5 mt -101.03 99.69 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.16 109.885 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -158.06 126.2 5.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.325 -0.852 . . . . 0.5 109.088 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -73.53 -37.93 65.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.485 -0.78 . . . . 1.04 111.972 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.421 ' OE2' HG13 ' A' ' 154' ' ' ILE . 40.2 tt0 -76.97 110.59 12.42 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 110.051 -0.351 . . . . 1.29 110.051 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' GLU . 18.3 Cg_exo -63.63 -28.77 69.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.866 2.377 . . . . 0.58999999999999997 111.494 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.35 -45.97 87.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.106 -0.952 . . . . 0.70999999999999996 110.454 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' OE2' ' A' ' 151' ' ' GLU . 93.3 mt -72.0 -36.95 59.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.46000000000000002 110.16 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 15.0 m -55.44 -56.18 23.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.29 110.777 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.2 ptp -67.01 -30.04 70.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 2.3500000000000001 111.17 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -61.64 -46.3 90.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.337 0.589 . . . . 1.3100000000000001 109.467 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.5 -42.16 92.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.009 -0.996 . . . . 0.23999999999999999 111.057 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 155' ' ' SER . 43.0 mt-10 -55.48 -52.48 63.49 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.852 0.358 . . . . 0.67000000000000004 110.367 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.69 -44.54 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.54000000000000004 111.276 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 161' ' ' LEU . 13.8 tp -63.86 -51.25 65.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.429 -0.805 . . . . 1.4199999999999999 111.018 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 145' ' ' VAL . 4.0 p -68.99 -29.05 41.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.644 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.35 -41.46 89.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.514 -0.767 . . . . 3.25 110.429 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 44.1 m -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.832 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 250' ' ' ARG . 82.5 mt -72.7 -12.59 61.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.40000000000000002 111.346 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.22 36.81 5.83 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.151 -0.547 . . . . 0.32000000000000001 112.347 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.549 ' HB2' HG22 ' A' ' 162' ' ' VAL . 86.8 m-70 -117.98 170.87 8.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.216 0.532 . . . . 0.5 111.207 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -115.51 163.35 15.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 110.582 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 39.1 mm -99.34 119.46 47.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 109.922 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 144' ' ' ASN . . . -86.44 -21.59 26.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 0.23999999999999999 110.314 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.14 157.33 9.67 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.747 -0.739 . . . . 0.17000000000000001 112.161 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.1 p -122.36 130.92 53.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.904 0.383 . . . . 0.34999999999999998 110.158 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' ILE . . . -137.41 135.88 37.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.015 -0.539 . . . . 0.28999999999999998 111.089 -174.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -103.77 -12.01 17.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.396 -0.365 . . . . 0.28999999999999998 111.2 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 199' ' ' ASP . 69.7 p -131.72 170.9 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.272 -0.27 . . . . 0.32000000000000001 110.272 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.572 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 78.7 ttt180 -68.06 -40.24 82.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.976 -0.379 . . . . 0.90000000000000002 109.976 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.558 ' O ' ' HG3' ' A' ' 181' ' ' GLU . 21.7 m -61.16 -45.13 95.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.40000000000000002 110.708 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.5 -37.69 81.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.416 . . . . 1.1899999999999999 110.37 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.84 99.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.25 110.837 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 176' ' ' ARG . 73.2 mt-30 -59.31 -46.47 88.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.832 -0.622 . . . . 0.98999999999999999 110.186 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 177' ' ' THR . 31.9 mt-10 -61.66 -52.9 62.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.699 -0.682 . . . . 2.2400000000000002 111.131 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.61 74.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.919 -1.037 . . . . 0.40000000000000002 111.287 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 214' ' ' PHE . 0.7 OUTLIER -82.34 -22.8 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.232 0.539 . . . . 1.3300000000000001 110.403 -175.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.32 -26.74 62.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.599 -0.728 . . . . 0.44 110.018 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -80.15 -55.28 5.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.535 -0.757 . . . . 2.02 110.192 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 170' ' ' ALA . 31.9 tt0 -134.52 136.67 43.26 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.539 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -89.88 113.33 56.59 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.701 -0.681 . . . . 1.6200000000000001 110.275 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.472 ' O ' HG21 ' A' ' 216' ' ' VAL . 84.7 Cg_endo -76.67 150.62 31.38 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.196 2.598 . . . . 0.26000000000000001 111.725 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -89.22 -7.13 70.33 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.016 -0.833 . . . . 0.23999999999999999 111.016 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 145' ' ' VAL . 39.1 tp -150.9 144.29 24.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 218' ' ' VAL . 73.9 t -123.0 139.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.20000000000000001 110.961 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 192' ' ' LEU . 0.4 OUTLIER -123.17 133.95 54.21 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.206 -1.035 . . . . 1.47 108.206 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 192' ' ' LEU . . . -153.03 146.99 25.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.388 0.514 . . . . 0.17999999999999999 112.388 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.634 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 9.2 t70 -98.86 -177.16 3.56 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.632 -0.877 . . . . 0.38 108.632 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.577 HG21 ' HG3' ' A' ' 227' ' ' ARG . 34.1 mm -86.86 -48.06 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 121.943 -0.473 . . . . 0.23000000000000001 110.73 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.0 127.31 42.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 2.2799999999999998 110.578 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' ALA . 51.8 mt -109.97 175.99 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.684 -0.689 . . . . 0.27000000000000002 110.348 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.92 91.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.073 0.464 . . . . 0.45000000000000001 112.026 -175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 175' ' ' THR . 16.9 t70 -80.26 -6.68 58.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.285 0.564 . . . . 0.94999999999999996 111.053 -175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.88 3.73 63.86 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.54 -0.838 . . . . 0.35999999999999999 111.541 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.01 155.91 38.08 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 110.125 -0.324 . . . . 0.33000000000000002 110.125 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 20.5 m -90.41 125.91 35.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.21 110.63 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 194' ' ' ASP . . . -60.58 -28.94 68.52 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.091 -0.959 . . . . 0.14999999999999999 112.091 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.467 HD11 HD12 ' A' ' 195' ' ' ILE . 63.7 mt -59.5 -47.45 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.20999999999999999 109.926 175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -37.48 87.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.7 . . . . 1.73 110.703 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 176' ' ' ARG . . . -62.81 -43.1 99.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.17000000000000001 110.132 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 218' ' ' VAL . 25.0 t -60.45 -51.85 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.373 -0.83 . . . . 0.20999999999999999 111.029 176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.78 -32.61 71.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.895 -0.593 . . . . 0.57999999999999996 111.292 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.54 -52.78 63.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.532 0.682 . . . . 1.72 109.631 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 61.1 mt -59.31 -44.24 91.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.979 . . . . 0.23999999999999999 110.944 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.2 mt -69.23 -13.06 62.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.71999999999999997 111.693 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -80.92 -7.67 88.32 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.615 -0.994 . . . . 0.31 110.615 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.35 -53.54 2.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.092 -0.554 . . . . 0.85999999999999999 109.936 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.583 ' HE2' HG22 ' A' ' 183' ' ' VAL . 3.1 m-85 -116.83 172.43 7.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.3 -0.863 . . . . 0.39000000000000001 111.369 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -116.84 57.34 0.78 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.18 0.991 . . . . 1.98 108.605 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 188' ' ' PRO . 1.2 t -104.91 147.56 34.67 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.581 -1.19 . . . . 0.25 109.816 -175.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.474 ' HG3' ' NE2' ' A' ' 260' ' ' GLN . 71.6 Cg_endo -71.47 140.23 36.08 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.359 2.039 . . . . 0.28000000000000003 112.265 -173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.511 HG21 HG13 ' A' ' 207' ' ' VAL . 31.3 t -125.22 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.152 -0.476 . . . . 0.63 110.852 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.66 120.21 62.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.19 110.032 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 239' ' ' LEU . 79.4 m-85 -88.99 108.39 19.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.147 -0.479 . . . . 0.34999999999999998 110.144 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' VAL . 6.9 mt -114.39 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.158 -0.682 . . . . 0.67000000000000004 109.158 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.594 ' HA ' ' OD2' ' A' ' 194' ' ' ASP . 7.8 t -151.22 164.41 36.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.985 0.422 . . . . 0.25 111.205 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.35 2.01 53.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 0.41999999999999998 110.707 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -124.14 77.57 59.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.226 -0.443 . . . . 0.69999999999999996 110.986 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.32 -34.72 34.31 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.557 2.171 . . . . 0.35999999999999999 111.623 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.98 -18.51 65.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.331 -0.849 . . . . 0.93999999999999995 111.34 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -69.03 -30.65 69.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 2.0499999999999998 109.381 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 236' ' ' PRO . 20.8 mt -92.48 -46.66 7.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.136 -0.938 . . . . 0.52000000000000002 110.613 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.92 69.84 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.772 -0.649 . . . . 1.26 110.791 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 233' ' ' ARG . 2.2 p -81.44 51.92 1.75 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.851 -0.613 . . . . 2.1000000000000001 111.782 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.67 -110.86 3.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.632 . . . . 3.4300000000000002 112.959 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.52 4.78 53.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.827 0.346 . . . . 5.2199999999999998 111.414 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.596 ' HB3' ' CD ' ' A' ' 234' ' ' PRO . 76.3 mtt180 -85.16 -178.85 1.26 Allowed Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.398 -0.594 . . . . 7.0999999999999996 109.398 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.596 ' CD ' ' HB3' ' A' ' 233' ' ' ARG . 2.8 Cg_exo -70.86 141.6 41.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.412 2.075 . . . . 2.52 112.814 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.99 142.21 24.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 115.375 -0.829 . . . . 1.9299999999999999 109.893 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 228' ' ' LEU . 37.2 Cg_endo -66.55 130.9 24.7 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.994 2.463 . . . . 0.52000000000000002 111.533 177.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 17.1 m -64.12 -33.36 75.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 1.1000000000000001 111.418 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -126.74 113.92 17.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.155 -0.475 . . . . 0.52000000000000002 109.8 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 220' ' ' PHE . 56.7 tp -139.74 125.84 19.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.176 0.512 . . . . 0.28000000000000003 111.051 -176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 92.4 t -127.56 137.19 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.816 . . . . 0.29999999999999999 109.292 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 222' ' ' THR . 24.3 p -94.37 141.36 28.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.071 0.462 . . . . 0.48999999999999999 111.701 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -85.17 135.22 39.52 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.395 -0.82 . . . . 0.78000000000000003 109.345 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.75 141.29 69.23 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 C-N-CA 124.288 -1.13 . . . . 0.76000000000000001 111.87 -2.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -88.56 156.19 19.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.935 -0.575 . . . . 0.45000000000000001 112.116 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 249' ' ' VAL . 85.2 mt-30 -91.0 124.53 35.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.1400000000000001 108.686 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 250' ' ' ARG . 51.0 mt-10 -56.15 -36.32 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.578 -0.737 . . . . 1.6599999999999999 111.682 -174.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 67.9 m -65.9 -47.59 74.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.667 -0.242 . . . . 1.3400000000000001 110.8 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 251' ' ' THR . 99.7 m -57.71 -42.29 83.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.987 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 245' ' ' GLN . 77.3 t -59.95 -56.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.19 110.722 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 246' ' ' GLU . 25.6 mtm180 -53.81 -40.95 66.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.212 0.53 . . . . 2.6899999999999999 110.648 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 255' ' ' GLN . 90.2 m -56.41 -47.1 79.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.134 -0.939 . . . . 0.27000000000000002 110.894 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 18.5 m -68.17 -42.58 79.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.139 -0.482 . . . . 0.20000000000000001 111.515 -175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.9 -46.62 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.875 0.369 . . . . 0.23000000000000001 110.882 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 47.8 t -66.36 -26.79 67.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 1.1699999999999999 111.472 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 251' ' ' THR . 14.7 mm-40 -78.63 -46.98 17.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.329 0.585 . . . . 2.3399999999999999 110.215 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 217' ' ' PRO . . . -55.94 -32.61 63.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.158 -0.928 . . . . 0.35999999999999999 111.683 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.575 ' HA ' ' NE2' ' A' ' 260' ' ' GLN . 82.8 mt -93.68 5.25 52.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.171 0.51 . . . . 1.02 111.559 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -104.64 -52.68 2.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.868 -0.605 . . . . 1.3799999999999999 110.138 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -79.42 72.46 6.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.473 -0.785 . . . . 5.3700000000000001 111.077 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 257' ' ' LEU . 80.3 mt-30 -134.05 156.73 47.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.55 -0.75 . . . . 5.25 110.325 176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.75 -62.84 1.52 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.549 -0.537 . . . . 6.4000000000000004 109.549 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.0 p -142.89 105.55 5.29 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.798 -0.637 . . . . 7.9199999999999999 110.402 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.39 -2.29 11.9 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.34 2.027 . . . . 8.9900000000000002 112.356 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 40.5 p -113.32 3.53 15.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.911 -0.586 . . . . 10.84 111.025 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -148.21 169.74 19.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 11.789999999999999 111.234 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.246 -0.883 . . . . 13.24 110.213 178.197 . . . . . . . . 0 0 . 1 stop_ save_